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Thesis Summary 
Globally, fertility problems have severe negative consequences. In Low and Middle 
Income Countries (LMIC) like Sudan women especially bear the burden of the inability to 
achieve pregnancy and childlessness. The severity of these consequences coupled with the 
lack of fertility knowledge motivated the need to enhance fertility awareness in LMIC. 
Recently several fertility awareness tools have been developed. One such tool is the Fertility 
Status Awareness Tool (FertiSTAT), a short, one page self-administered tool that provides 
information about the signs, symptoms and preventable causes of fertility problems. This tool 
provides personalized risk knowledge that allows women to make informed decisions about 
their fertility. The FertiSTAT was developed and validated in the UK but it has utility as a 
cost-effective tool to enhance fertility awareness in LMIC where this simple tool could be 
embedded in existing (but resource limited) reproductive health services. The aim of the 
studies presented in this thesis was to culturally adapt the FertiSTAT to ensure that it was 
comprehensive in its coverage of risks and it is acceptable and feasible for use in Sudan.   
The potential new risk factors for inclusion in FertiSTAT were identified through 
literature search, expert consultations and survey. The risk factors were subjected to 
systematic review and meta-analysis. 
Results of the studies indicated that cultural adaptation would require cultural 
targeting to be inclusive of new risk factors relevant to Sudan and other LMIC and be 
linguistically and graphically culturally appropriate. The risk factors found to be associated
with fertility problems were genital tuberculosis, HIV, bacterial vaginosis, female genital 
mutilation and consanguinity. Results of stakeholder meetings and patient interviews lead to 
recommendations about changes to language and presentation of materials to enhance 
acceptability and feasibility of FertiSTAT. These recommendations included the need for 
adding provider-administered versions of the FertiSTAT to enable cultural tailoring of
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 information to each user’s level of literacy and cultural attributes.  
An integration of all knowledge acquired from these studies lead to two adapted 
versions of the FertiSTAT, a flipchart and a checklist. It is anticipated that these tools can be 
used to enhance fertility awareness in Sudan. The studies can also be used as an adaptation 
protocol such that the procedural knowledge gained from adaptation in Sudan can be 
transferred to other LMIC. Such undertakings can potentially help improve individual and, 
in time, societal awareness of fertility problems with the eventual aim to prevent fertility 
problems, alleviate individual suffering for the most vulnerable and aid in the global efforts 
to promote sexual and reproductive health equity where it is most needed.  
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General Introduction and Thesis Overview 
Infertility is a health concern that affects individuals and communities globally. The 
importance of allocating resources to the research and treatment of infertility to ensure 
adequate knowledge, equity, and accessibility has been indicated and reinforced by the global 
community in such arenas as the International Conference on Population and Development 
(ICPD), United Nations (UN) general assembly and the World Health Organization (WHO), 
to name a few. “Improved reproductive health and reproductive rights via universal access to 
sexual and reproductive health care services…” was initially established as a Millennium 
Developmental Goal in 2007, and continues as a target (3.7) within the Sustainable 
Development Goals (UN, 2015). The World Disability Survey identified infertility as an 
impairment of function, and it was ranked fifth on the list of moderate-to-severe disabilities 
(World Bank and World Health Organization, 2011). At the 1994 International Conference 
on population and Development it was stated that reproductive health should include the 
capacity and choice to reproduce, and that it is every couple’s right to decide the number of 
children they wish to have. Additionally, it was mentioned that infertility prevention and 
treatment should be included in future action (United Nations Population Fund, 2004). The 
inclusion of infertility care as part of family planning services was one of the five priority 
aspects of reproductive health emphasised in the WHO strategy on reproductive health at the 
World Health Assembly in 2004 and the World Summit in 2005 (United Nations, 2004, 
2005). 
Research in the 70s and 80s sponsored by the WHO Human Reproduction Programme 
(HRP) led to an understanding of the burden of disease and the global patterns of causation of 
infertility (van der Poel, 2012). In the 90s WHO guidelines for the management of infertile 
individuals were developed, and in the decade that followed, recommendations for 
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stakeholders were made and focus shifted to the identification of inequity and barriers to 
access to care (van der Poel, 2012). The shift to focus on prevention was based on the idea 
that preventing Sexually Transmitted Infections (STIs), Reproductive Tract Infections (RTIs), 
complications from childbirth and unsafe practices would yield greater benefit especially in 
Low and Middle Income Countries (LMIC), than treatment (van der Poel, 2012).  Despite 
gains in other areas of reproductive, maternal and new-born health since the millennium 
development goals (MDG, 1995), the WHO has found that the prevalence of infertility, and 
thus access to care, has changed very little over the last 20 years (Mascarenhas, Flaxman, 
Boerma, van der Poel & Stevens, 2012), highlighting the need to develop or update cost-
effective and innovative modalities of prevention not only of infertility but of fertility 
problems in general. Fertility problems is a more general term that encompasses infertility 
defined as the inability to achieve pregnancy after 12 months of regular unprotected sexual 
intercourse (Zegers-Hochschild et al., 2017). The prevention of fertility problems requires 
efforts to enhance symptom awareness and appropriate provider screening at all levels of 
health care.  
Global Health and Risk Factors 
An understanding of global health, risk factors and fertility knowledge is necessary to 
understand the purpose of the current project and the activities carried out. The term global 
health has been defined as “an area for study, research, and practice that places a priority on 
improving health and achieving health equity for all people worldwide” (Koplan et al., 2009). 
Beaglehole and Bonita (2010) defined global health as “collaborative trans-national research 
and action for promoting health for all”. In the current project a combination of both 
definitions was used to signify that the purpose of the work was to advance health promotion 
efforts that aim to enhance health equity through collaborative trans-national research.  
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The WHO defines risk as “a probability of an adverse outcome, or a factor that raises 
this probability” (Defining and assessing risks to health, WHO, 2002). The WHO emphasises 
that the key to the prevention of disease and injury is the focus on risk to health. They also 
indicate that an individual’s perception of risk is based on values formed from the processing 
of information ascertained from various sources. Information is attained from the media, 
family, familiar and peer groups, as well as messages from scientific sources, and other past 
experiences (Defining and assessing risks to health, WHO, 2002). Having an understanding 
of reproductive issues such as the fertile period and of risk factors (RFs) impacting on 
fertility such as age, STIs and lifestyle factors is important in the prevention of fertility 
problems.  
Risk factors such as STIs might have the same biological impact on the reproductive 
tracts of people the world over, however the prevalence and predictive factors that affect 
whether or not a person will contract and STI and whether they will seek treatment for it 
might differ globally.  
A global perspective on health implies integrating education and prevention programs 
health risks arising in different nations due to variation in socio-cultural, environmental, 
institutional and economic determinants of health (Huynen, Martens & Hilderink, 2005). 
Evidence from narrative reviews of risk profiles from the sub-Sahara, the Indian subcontinent 
and the Middle East suggest that socio-economic and cultural factors in these populations 
affect the risk profile for female fertility problems (Leke, Oduma, Bassol-Mayagoitia, Bacha, 
and Grigor, 1993; Bosdou, Kolibianakis, Tarlatzis and Fatemi, 2016). Reproductive health 
experts concur and suggest that, owing to geographic variation in prevalence and limited 
quality reproductive health services, women in LMIC or in certain socioeconomic or cultural 
settings could be at greater risk from different factors.  This complex risk profile for fertility 
problems in LMIC, in addition to global risks (e.g., smoking, obesity, alcohol) includes 
exposure to communicable disorders (e.g., HIV), poorly managed 
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infections owing to constrained healthcare systems (e.g., bacterial vaginosis) or reproductive 
events (e.g., birth), consequences of cultural practices (e.g., consanguineous marriages) or 
dubious use of procedures (e.g., dilatation and curettage).  
The importance of preventative care in fertility health 
Benefits of preventative fertility heath include: educating people about true risks and 
dispelling myths, more cost-effective than treatment, benefit a greater number of people, 
more effective at eliminating the social consequences of fertility problems, could improve 
health status of women in other ways, and could help motivate people to use other prevention 
services (e.g., family planning). 
Primary prevention focused on the reduction of RFs for fertility problems such as 
STIs, pelvic inflammatory disease (PID) and lifestyle changes, could potentially reduce the 
prevalence of fertility problems, improve quality of life and reduce costs to healthcare 
systems and individuals (Macaluso et al., 2010). Secondary prevention focused on early 
diagnosis and management is an effective mechanism to restore fertility (Macaluso et al., 
2010). Therefore, prevention efforts should target the general population as well as health 
care providers at all levels of the healthcare system. The disseminating of information 
through awareness campaigns (e.g. provider flipcharts) about fertility health, especially the 
preventable causes and the use of standardized diagnosis (e.g. checklist at primary level) can 
potentially enhance prevention efforts for fertility problems. 
Fertility Knowledge. 
The lack of knowledge about the signs, symptoms and preventable causes of fertility 
problems could be contributing to prevalence of infertility because people do not know 
whether or when to seek help. It is well documented that fertility knowledge is poor in High 
Income Countries (HIC) (Bunting & Boivin, 2008, Bunting et al. 2013) and LMIC (Ali et al., 
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2011; Bunting & Boivin 2012; Dyer, 2008). Fertility knowledge and help seeking are similar 
in both HIC and LMIC (Bunting & Boivin 2012; Dyer, 2008), however, the harsher 
consequences of childlessness in LMIC make women especially more desperate to seek help, 
yet this is not reflected in the numbers because of the availability and affordability of 
treatment options. The most commonly found consequences in LMIC include but are not 
limited to stigma, isolation, marital instability, violence and divorce and women usually bear 
the brunt (van Balen & Bos, 2010; Rouchou, 2013). Thus, a cost-effective tool that could 
potentially help increase awareness of factors impacting on fertility could be used to help 
women in LMIC. 
Pennings and colleagues (ESHRE Task Force on Ethics and Law, 2009) suggested 
that from a rights based approach, reproductive autonomy, which is defined as the right to 
decide when, how many and with whom to have children, should be protected. They stated 
that the burden of overpopulation should not be borne by the infertile, that contraception and 
family planning provide a means for controlling population growth without violating 
anyone’s rights (ESHRE Task Force on Ethics and Law, 2009). The authors also noted that 
limited access to and prohibitive cost of infertility treatment in resource poor nations is less 
likely to result in population growth. They propose that prevention in the case of fertility 
problems is much more cost effective and long lasting and reduces the possibility of harm 
even if treatment is available (ESHRE Task Force on Ethics and Law, 2009). Prevention 
measures include the reduction of STIs through the use of condoms and reduced high risk 
sexual behaviours, improving postnatal and abortion practices as well as informing the public 
about the impact of lifestyle choices such as smoking and obesity on fertility (ESHRE Task 
Force on Ethics and Law, 2009). The use of a cheap, effective tool to enhance awareness of 
fertility problems in a low resource country like Sudan is not only ethically justifiable but it is 
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also practical. One such tool is the fertility status awareness tool (FertiSTAT) (Bunting & 
Boivin, 2010; Bunting, Tsibulsky & Boivin, 2012).  
Health Promotion 
Health promotion is defined as health education combined with economic, 
organizational and environmental support that targets individual/group/community behaviour 
that is conducive to health (Green & Kreuter, 1991). The attention to the global burden of 
diseases and health inequalities has been augmented by the National Health Promotion and 
Disease Prevention Objectives and Healthy People 2010 (U.S. Department of Health and 
Human Services, 1991, 2000), and the WHO (WHO, 2007). The effectiveness of health 
education and promotion has been demonstrated in various meta-analyses and review articles. 
For example Aarvaa, Haesb, and Visser (1997), reviewed the literature and in their meta-
analysis reported mean effect sizes for primary prevention (0.46) and secondary prevention 
(0.49). The authors also emphasized that a strong determinant of the effectiveness of health 
promotion and educational tools depended on the use of theory in the development of such 
tools. 
In a review of the literature over the past 10 years, Noar (2006) reported on the 
effectiveness of health mass media campaigns.  The author examined the use of design 
principles and theory in the development and implementation of campaigns in the reviewed 
studies. In addition the author also reported on how such campaigns are evaluated and what 
effect that has on their effectiveness. The author concluded that there is growing evidence 
that change in behaviours as well as health knowledge, beliefs, and attitudes can be achieved 
through health mass media campaigns (with small-to-moderate effect size) that are accurately 
targeted and well-executed (Noar, 2006).  The author did not report on his search strategy but 
stated that although the review is not meant to be exhaustive it is representative of the 
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literature since the articles reviewed were obtained from a variety of international journals in 
different disciplines. The range and breadth of articles used in this review enhance the 
applicability and generalizability of the results.     
The proposed mechanism of change of most educational campaigns is to change 
individual awareness, opinions, attitudes and behaviours. The increased level of knowledge is 
expected to change the individual’s attitude which in turn is supposed to change their 
behaviour. However, the move from attitude shift to behavioural change is not always easily 
achieved. 
Numerous systematic reviews have shown that interventions with a theoretical 
framework have more powerful effects than those without theoretical bases (for example, see 
Ammerman et al., 2002; and Legler et al., 2002). The theoretical framework on which the 
FertiSTAT was developed is the Health Belief Model (HBM). The HBM is a conceptual 
framework developed to explain and predict behaviours related to health (Rosenstock 1988, 
1990).  Rosenstock (1988) notes, “that the energy/motivation to change behaviour is provided 
by the combination of perceived susceptibility and severity, and that the preferred path to 
action is provided by the perception of benefits less barriers”. The “cue to action” is then seen 
as the stimulus for action that might be internal (e.g. symptoms), or external (e.g. mass media 
communications, interpersonal interactions, or reminder postcards from health care 
providers). In order to change behaviour to reduce risk for a certain disease, cognitive 
appraisal is required, where people must first perceive a personal risk or susceptibility to the 
disease and they must perceive the disease as a serious threat (Rosenstock, 1990). According 
to the HBM for behaviour to change one must not only perceive personal risk but the benefits 
must outweigh the barriers. Personalised interventions that target the determinants associated 
with a particular health problem have demonstrated effectiveness in moderating harmful 
health effects (Champion et al., 2003). Champion et al. (2003) conducted a randomized 
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prospective study using a personalized intervention to study the effect of five such 
interventions on mammography screening adherence. The variables included in the five 
tailored interventions were based on the HBM, including perceived susceptibility, perceived 
benefits and perceived barriers. Although the sample size was large (n=773) the response rate 
was low (between 44-26%). The authors reported that the rate of adherence to mammogram 
screening was significantly greater in the intervention groups than the control group 
(Champion et al., 2003). The most significant change was observed in the group that was 
initially not thinking of getting a mammogram (from 13 to 30%). The results of this study 
demonstrate that tailored interventions that are theoretically designed can help increase health 
promoting behaviours such as cancer screening. 
 Fulford, Bunting, Tsibulsky & Boivin 2013 demonstrated the use of the HBM 
construct of perceived susceptibility in women’s intentions to optimize their future fertility. 
The authors postulated that it is not just the lack of knowledge about causes of infertility that 
affects women’s behaviours, but that there is also the added effect of perceived susceptibility. 
The authors explained that a woman is unlikely to behave in ways that protect her fertility if 
she does not feel susceptible to fertility problems (Fulford et.al, 2013). The authors collected 
data from an international online study, to demonstrate the effect of knowledge and perceived 
susceptibility on behaviours that can enhance the chance of becoming pregnant (i.e. help 
seeking and making lifestyle changes).  The number of participants was 10045, they were 
men and women from 79 countries, trying to conceive for at least 6 months and the majority 
of participants were between the age of 18 and 29 (Fulford et.al, 2013). Results of statistical 
analysis indicated that knowledge and perceived susceptibility significantly predicted 
medical help seeking, and that the intention to seek help was greater when there was a 
suspected fertility problem. Greater knowledge also affected intentions to change lifestyle. 
Results also showed that the relationship between perceived susceptibility and intention to 
seek medical care was stronger in women who had been trying 
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to conceive for more than 12 months. The results of this study demonstrated that women’s 
intention to change their behaviour to enhance the chance of pregnancy (help seeking or 
lifestyle change) are affected by knowledge of and feeling susceptible to infertility (Fulford 
et.al, 2013). The large sample size, the use of an international sample and the overall 
robustness of the study increases generalizability of the results.  
Beyond feeling susceptible to disease and targeting information to the needs of a 
specific group, the personalization of health messaging to the individual’s risk profile can 
enhance behaviour change. As demonstrated in Kok, van den Borne and Mullen (1997), the 
effectiveness of health educational tools was largely due to perceived quality. The quality 
was in turn impacted by the personalization of health messaging. Edwards et al. (2012) 
conducted a Cochrane review that included 41 studies that looked at whether receiving 
personalized risk information would alter the individual’s likelihood of undergoing screening 
for disease. Results of the review indicated that informed decision making about taking 
screening tests as well as knowledge and risk perception were enhanced with personalised 
risk communication (Edwards et al., 2012). In addition to personalized risk culturally 
adapting the materials to meet the needs of the target group has been found to be efficacious 
(Healey et al., 2017). Finally culturally tailoring the materials to the needs of each individual 
is also necessary and beneficial (Kreuter & Skinner, 2000). Given that personalized, 
culturally targeted and tailored messaging enhances perceived quality of health promotion, an 
effective health education tool, should have a theoretical framework, be targeted to the 
population of interest, elicit a sense of susceptibility and provide personalized and tailored 
information. The following section describes one such tool. 
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The FertiSTAT 
The FertiSTAT is a self-administered tool developed to increase personal awareness 
of RFs for fertility problems (Bunting & Boivin, 2010, see Appendix A). The tool takes 
women through 22 lifestyle and reproductive questions (i.e., risk indicators) to generate a risk 
profile and, from it, personalised (colour coded) fertility guidance. Women using the 
FertiSTAT tick all the RFs that apply to them.  These responses generate the personalised 
guidance that informs them of the factors affecting their fertility and actions they could take 
to optimize fertility health. The function of the FertiSTAT is to assist women make informed 
decisions about their current lifestyle and reproductive behaviour, to take action to safeguard 
their future fertility and, if need be, seek timely medical advice when clear symptoms of 
disease are present (Bunting & Boivin, 2010).  
The development of the FertiSTAT was based on an assessment of the RFs for 
fertility problems ascertained from a literature review, a Delphi round with fertility experts 
and a cross sectional validation study with fertile and infertile women (Bunting & Boivin, 
2010, Bunting, 2008). PubMed was used to search for information for the literature review, 
in addition guidelines from National Institute for Clinical Excellence (NICE) and WHO and 
other specific reproductive health references where used. The literature review resulted in 31 
RFs being identified and grouped into three categories: demographic (e.g. age), reproductive 
(e.g. menstrual cycle) and lifestyle (e.g. smoking).  The precise level of exposure required to 
have a significant effect on female fertility potential, known as the critical threshold (e.g. 
number of cigarettes per day or units of alcohol per week) was obtained from the original 
research. These RFs and associated critical thresholds where then discussed by an expert 
panel. This panel comprised experts in reproductive health including medical doctors, 
psychologist, social worker and patient advocates. From this pool of RFs, nine were excluded 
for the following reasons: (a) the factor was not independent from other RFs, (b) evidence of  
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the effect of the factor on infertility was weak or inconsistent, (c) the factor impacted on 
ability to carry a pregnancy to term and not just ability to become pregnant e.g. increased risk 
of miscarriage, ectopic pregnancy, genetic abnormalities and/or perinatal risks and (d) non-
reproductive diseases (e.g., cancer, coeliac disease) were excluded because of very low 
incidence or likelihood that individuals with such diseases would be informed of the effect of 
the disease on their fertility by the treating physician (Bunting & Boivin, 2010, Bunting, 
2008).   
Development of the FertiSTAT included the generation of guidance that would make 
the tool personally relevant. The wording and layout of the guidance section of the 
FertiSTAT was discussed by the expert panel and potential formats were explored. The final 
format was then pilot tested on 15 women in different phases of their reproductive life cycle. 
This version of the guidance consisted of four colour coded categories: (a) blue: trying to 
conceive for less than 12 months (or 6 if over 34 years) and no RFs, continue to monitor 
situation because fertility declines with age, (b) yellow: negative lifestyle factor, modify 
health habits, (c) orange: reproductive factor, discuss with doctor, (d) red: serious risks e.g. 
absence of periods and class A drug use, must discuss with doctor if trying to conceive.  
The FertiSTAT was developed and validated in the UK and Europe, and the 
personalized risk profile guidance was developed according to UK reproductive health 
guidelines and clinical recommendations of experts from Europe, Canada and Australia 
(Bunting & Boivin, 2010).  Using a multifactorial weighted model the FertiSTAT was shown 
to discriminate between medically confirmed infertile and fertile women to a high degree 
(i.e., 85.8%, Bunting & Boivin, 2010).  The FertiSTAT was designed to also assist in public 
health campaigns about fertility, and has been used to that effect in Europe (e.g., Belgium 
“test your fertility”, de Cock, 2011).  
According to the authors, the FertiSTAT is the most comprehensive fertility 
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awareness tool in its coverage of RFs as well as inclusion of specific critical thresholds e.g. 
units of alcohol and number of cigarettes (Bunting & Boivin, 2010).  The FertiSTAT also 
accounts for the variable importance of RFs in predicting fertility (e.g. smoking vs. 
amenorrhea) through its colour-coded scheme (e.g., risks requiring immediate action versus 
risks that could be monitored until pregnancy attempted). Furthermore, the FertiSTAT takes 
into consideration the multiplicative relationship between RFs (e.g. age and years infertile). 
All these considerations lead to a more comprehensive overall guidance than other online 
fertility awareness tools that were available at that time. Although, the FertiSTAT was 
developed in 2010, as seen in Appendix B, systematic review evidence indicates that original 
RFs included are still valid. To date the FertiSTAT has not been evaluated or used in other 
settings. 
Significance of Fertility Health for LMIC such as Sudan 
An integral aspect of the adaptation process of the FertiSTAT was the consideration 
of the specific cultural differences in reproductive health. One of the main issues that needed 
to be addressed was that in Africa, social, behavioural and cultural factors are key 
contributors to infertility (Ericksen & Brunette 1996). Historically, infection was described 
as the leading cause of infertility in Africa; 85% (Cates et al. 1985), and 64 % (WHO, 
Infections, pregnancies, and infertility, 1987) of African women had infertility attributable to 
infection. Regional studies on infection as a cause of infertility are lacking in the literature, 
however, studies from different countries on specific types of infection are abound. There are 
various types of infection contributing to infertility, the most commonly reported in LMIC 
being pelvic infection due to chlamydia, gonorrhoea, bacterial vaginosis and other 
microorganisms (WHO 1995, Malik et.al 2006, Wessels et al. 1991, Mehanna, et al.  1995, 
Swasdio et.al 1996, Siemer et al. 2008, Shahzad 2012, Salah et.al 2013). Other sources of 
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infection include unsanitary postnatal and abortion practices and cultural practices like 
female genital mutilation/cutting (FGM/C) (Almoroth et.al 2005, Umeora et.al 2007, Larsen
2002). Other issues that need to be addressed include the influence and effect of religion and 
religious practices on fertility problems. There are a number of groups who have been 
working in the area of infertility within a few Arabian and Islamic nations, for example, 
Serour from Egypt noted that religions continue to influence behaviour, attitudes and policy-
making in the Middle East (Serour, 2000, 2002). He noted that in places with poor access to 
health care, common preventable causes of infertility include post-partum and post-abortion 
infections, tuberculosis and untreated sexually transmitted infections (Serour, 2008). Other 
researchers like Inhorn have conducted research in the region namely Egypt, Lebanon and 
Iran on attitudes and acceptance of treatments that are viewed by Muslim clerics as opposing 
to Islamic law such as adoption and gamete donation (Inhorn 2004, Inhorn 2006). An 
important step in the adaptation process is the understanding of the specific cultural and 
reproductive features of the region generally and Sudan specifically that might be impacting 
on fertility.  
Sudan is an LMIC with varying estimates of infertility, as low as 3% from 
demographic data (Larsen, 2000) and as high as 80% in clinic based studies of infertile 
patients (Osman, 2010; Osman 2011; Abdalla, 2011). An understanding of the patterns of 
infertility in Sudan is complicated by the fact that published studies used samples from 
infertility treatment centres. Additionally, it is difficult to draw conclusions about national 
prevalence rates due to the small sample sizes, lack of controls and randomization in the 
selection of participants in these studies.  Five studies conducted in Sudan reporting on 
prevalence of infertility, were summarized in Table 1.1. Overall the results of these studies 
indicated a higher percentage of primary (range 80 to 62.4%) than secondary (37.6 to 20%) 
infertility.  However, the methodological biases in these studies as well as the lack of large 
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scale epidemiological studies make it difficult to establish a true infertility prevalence in 
Sudan.  
Table 1.1. 
Published Studies Reporting on Infertility in Sudan 
Study Design Location and 
Sample size 
Results Possible bias 
Elussein et al, 2008 Cohort/cross-sectional (all 
patients seen for 
infertility) 
Khartoum Fertility 
Centre, medical 
records 
n=710  
62.4% primary 
infertility  
37.6% secondary 
infertility  
No control group 
Osman, 2011 Cohort  
(random selection form all 
patients attending four 
primary health care 
centres) 2007-2009 
Wad Medani City, 
Gezira State  
n=200 couples  
80% primary 
infertility  
20% secondary 
infertility 
No control group 
Did not report 
what the patients 
were seeking 
treatment for 
(infertility or 
other)  
Osman, 2010 Cohort  
(random selection form all 
patients attending four 
primary health care 
centres) 2001-2002 
Wad Medani City, 
Gezira State 
79.5% primary 
infertility  
20.5% secondary 
infertility 
No control group 
Did not report 
what the patients 
were seeking 
treatment for 
(infertility or 
other) 
Abdalla, 2011 Cohort  
(random selection form 
patients attending primary 
health care centres for 
infertility)  
Wad Medani City, 
Gezira State 
n=200 
79.5% primary 
infertility  
20.5% secondary 
infertility 
No control group 
Ahmed et al, 2009 Cohort  
(form patients attending 
hospital for renal disease 
and surgery) 
Gezira Hospital 
n=194 males 
55.2% primary 
infertility  
13.9% secondary 
infertility 
No control group 
No indication of 
how patents 
were selected, no 
control group  
Khalifa and Ahmed (2012) reported on infertility in Sudan in a compendium of work 
with the WHO addressing barriers, access and ethical issues affecting biomedical care 
(Khalifa & Ahmed 2012).  According to the authors, infertility now is more of a concern in 
Sudanese society as reflected by the growing number of private treatment clinics. They 
reported that there are shortcomings in the type and quality of public sector services 
available; where there is minimal specialized training, limited privacy, no counselling and 
women usually presenting alone (Khalifa & Ahmed 2012).  
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Reproductive health policy in Sudan. 
At the being of this project in 2014, in the Sudanese national reproductive health (RF) 
policy infertility care was included under the banner of family planning services, as one 
component among many others. The policy stipulated that infertility care should be offered in 
the public health sector through primary health care facilities (Sudan national RH policy, 
2010).  
Pathways for the investigation of the infertile couple like those provided by the WHO 
manual for the investigation of the infertile couple (Rowe, 1993) or the NICE guidelines are 
not clearly specified in the policy or the strategy. The current Sudanese RH policy does not 
place infertility care as a priority nor is it one of its indicators, and provision of infertility care 
is not addressed in the previous RH policy. However, the MoH is updating the RH policy and 
infertility is to be included as one of the products in the new “10 in 5” strategy (Maternal and 
Child Health Unity [MCH] of the Sudan FMoH, 2017). Activities in the new strategy include: 
(a) desk review on RFs and management of infertility, (b) study to detect baseline burden of 
infertility (prevalence and availability of services), (c) develop national guidelines for 
detection, referral and management of infertility, (d) assess available infertility services as 
compared to international standards, and (e) update reproductive health services to provide 
infertility care independent of family planning services (MCH of the Sudan FMoH, 2017).  
The Aim and Objectives of this Project 
The aim of this project was the adaptation of the FertiSTAT to an LMIC such as 
Sudan, via assessing the suitability and comprehensiveness of 22 FertiSTAT risk indicators to 
the Sudanese population. The desired outcome of the project was a prototype of the adapted 
FertiSTAT and a protocol for the adaptation process that could be used in other LMIC. 
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Intermediate outcomes would be attainment of feasibility and acceptability data for the use of 
FertiSTAT in Sudan and the region.  
Objectives 
Adaptation of FertiSTAT for use in culturally and linguistically different settings 
required an understanding of the differences in reproductive and cultural aspects of the 
intended adaptation population. This adaptation process comprised addressing the 
comprehensiveness of the RFs and addressing the cross-cultural acceptability and feasibility 
of the tool. The first objective was to evaluate whether the RFs in the FertiSTAT were 
comprehensive enough to suit the new context. Therefore, RFs more pertinent to LMIC 
including cultural practices (e.g. consanguineous marriages) and reproductive health (e.g. 
genital tuberculosis) were uncovered and empirically validated. The second objective was to 
determine the cultural acceptability and feasibility of the adapted FertiSTAT from several 
perspectives. Therefore, once these new RFs were included in the adapted FertiSTAT, 
translation and pilot testing of the adapted FertiSTAT to ensure cultural acceptability and 
feasibility was conducted.  
Strategies to Achieve Objectives 
Achieving objectives consisted of five stages, see Figure 1.1: (1) identification of RFs 
to be reviewed and considered for inclusion in the adapted FertiSTAT, (2) a systematic 
review of the literature for each newly identified RF, (3) stakeholder meetings to consider 
newly identified RFs and assess acceptability and feasibility, (4) pilot testing the acceptability 
and feasibility of the adapted FertiSTAT from the users perspective, and (5) integrating the 
components of all previous activities to generate the adapted FertiSTAT.  
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second to determine the magnitude and nature of said association and finally, to integrate 
both new and old evidence to suggest potential causal pathway models depicting how the RF 
affects fertility.  
Third, stakeholder meetings were conducted regionally in the Middle East and locally 
in Sudan. The objective of these meetings was to ascertain perceptions of including the 
‘newly’ identified RFs in the adapted FertiSTAT and to assess the acceptability and 
feasibility of using this adapted version in the region and in Sudan from multiple perspectives 
mainly fertility experts. This required networking with possible stakeholders, preparing 
materials, holding the meetings, analysing and reporting results of the meetings. Design of 
FertiSTAT would then be based on incorporating results of the stakeholder meetings and the 
systematic review. This phase would include decisions on format (e.g., flip chart, or provider 
tool for Community health workers), 
Fourth, acceptability and feasibility of the adapted FertiSTAT tools were assessed 
from the users perspective. This required pilot testing the adapted tool with potential users in 
Sudan, to ascertain acceptability of content and feasibility of implementing the tool in Sudan.  
The final products of this project would be the adapted FertiSTAT as well as the protocol for 
the adaptation of the FertiSTAT to other LMIC.  
Finally, all the information gathered through the previous stages will be integrated to 
propose and design the adapted version of the FertiSTAT, to be tested on a larger scale in the 
Sudan in future research. 
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Chapter 2 
Evaluation of Perceived Comprehensiveness, Feasibility and Acceptability of 
the FertiSTAT  
General Introduction 
The importance of sociocultural, geographic and economic influences on fertility and 
infertility has been explored in narrative reviews (e.g.: Bosdou, Kolibianakis, Tarlatzis & Fatemi, 
2016; Ericksen & Brunette 1996; Leke, Oduma, Bassol-Mayagoitia, Bacha, & Grigor, 1993; 
Sharma, Mittal & Aggarwal, 2009).  These reviews define how geography and sociocultural 
environments can influence the nature of RFs for fertility problems to which people are likely to 
be exposed. Educational efforts to improve knowledge of such risk factors should take into 
account the various influence on the risks presented within their tools. The aim of the present 
studies was to examine how such influences could be integrated into ensuring acceptability and 
feasibility of existing fertility awareness tools. 
Recently there has been an emergence of educational tools aiming to increase public and 
self-awareness about fertility health.  These tools seek to improve fertility awareness via 
websites dedicated to fertility that tailor the information visitors receive based on the risks they 
endorse on the site (e.g., ‘yourfertility’ website, Hammarberg, et al., 2013), public health 
initiatives that use self-assessment tools as a hook to attract people to sites that provide relevant 
fertility education (“test your fertility”, de Cock, 2011) or, more recently, fertility assessment 
clinics where people can have their fertility evaluated through history taking and biomedical tests 
(Hvidman et al., 2015; Petersen, et al., 2015). To maximize the impact of such tools globally it 
would be imperative to ensure that such tools are comprehensive in their coverage of RFs 
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and acceptable for implementation in diverse geographic and sociocultural contexts. In the 
present chapter, we demonstrate the process of assessing comprehensiveness, acceptability and 
feasibility of education materials, using the fertility status awareness tool (FertiSTAT) to be 
utilized within a Middle Eastern context. 
The overall aims of the present studies were to determine the perceived 
comprehensiveness, feasibility and acceptability of the FertiSTAT among multiple stakeholders 
(providers and users) in settings other than the FertiSTAT development context, namely the 
Middle East.  A mixed method approach was undertaken. The input of experts from diverse 
geographic locations was sought to ensure the original and adapted components were sensitive to 
regional and local needs (e.g., cultural acceptability, illiteracy, and wording).  
Study 2.1: International survey of fertility doctors to assess the comprehensiveness of the 
FertiSTAT risk factors and to identify additional risk factors  
Introduction 
It is well known that the global distribution of disease and the corresponding patterns of 
health risk vary by geographic and demographic characteristics (WHO, 2009, Chapter 2).   
These patterns could be relevant to fertility health. Bosdou et al. (2013) examined sociocultural 
factors affecting female fertility in the Middle East. The results of the review showed that 
consanguinity, obesity, and vitamin D deficiency were risk factors prevalent in the region that 
could negatively impact women’s fertility. The authors concluded that public health campaigns 
need to educate women about these potential risk factors to fertility.  In an earlier review Leke et 
al. (1993) had also reported that there were risk factors that could be specific to a region or 
settings e.g. “female circumcision is an old and unhealthy practice in Africa” 
(Leke, et al., 1993), or malnutrition and environmental toxins in studies from Africa and parts of 
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South America. These narrative reviews suggested that women could be exposed to risks 
arising from geographic and sociocultural variations in the prevalence of medical procedures 
(e.g., dilatation and curettage (D&C)), cultural practices (e.g., consanguinity (CSG), female 
genital mutilation/cutting (FGM/C)) or communicable disease (e.g., HIV, genital tuberculosis 
(GTB)) that were risks not represented in the original FertiSTAT tool. The specific aim of 
Study 2.1 was to ascertain the comprehensiveness of the risk factors of the original 
FertiSTAT and to identify additional RFs to be considered during an adaptation of the 
FertiSTAT tool for global utility.  
Materials and Methods 
Participants and recruitment. 
In order to build a list of global experts predominantly from outside of the UK and 
Europe, we obtained a list of experts active in education and training in low and middle-income 
countries from past Director of Medical Education, the International Federation for Fertility 
Societies. Additionally, information was obtained from fertility clinic websites in Africa and the 
Middle East in order to generate a list of 150 fertility doctors to invite to participate in the 
survey.  Eligibility included being a fertility doctor who is currently diagnosing and treating 
individuals with fertility problems (e.g., obstetricians and gynecologists, OBGYN) with or 
without additional specialist training e.g. Reproductive Medicine (RM), Reproductive 
Endocrinology and Infertility (REI).  Fertility doctors were invited to the survey via email and 
were not provided financial incentives for participation. The School of Psychology (Cardiff 
University) Ethics Committee provided review and approval for the project, see Appendix C. 
Materials. 
Study questions were embedded in an online study generated with Qualtrics (Qualtrics, 
Provo, UT). The questionnaire was developed specifically for the study to ascertain the 
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comprehensiveness of risk factors in the FertiSTAT, see Appendix D. It comprised three 
sections: (1) the 22 lifestyle and reproductive risk factors in the original FertiSTAT; (2) a 
‘structured list’ that contained (a) medical conditions considered in the development of the 
FertiSTAT, and (b) proposed additional risk factors identified from literature reviews of risk 
factors in diverse regions; (3) open text box for participants to generate any other risk factors 
they felt were relevant (‘participant generated list’).  Participants could indicate, for each item on 
the ‘structured list’, whether they felt that the item was a risk factor for impaired female fertility 
(yes/no). In an open text box participants were asked to provide reason(s) or justification(s) for 
why they would suggest inclusion of that particular risk factor in an adapted version of 
FertiSTAT (hereafter ‘adapted FertiSTAT’). The percentage of patients generating each risk was 
reported and reasons for inclusion of the risk (structured and participant generated) were 
categorized according to type, and their frequency reported.  
Background questions were asked about country of practice, type of specialization 
(OBGYN, RM, REI, specific training in infertility, other specialist certification in or related to 
reproductive endocrinology and infertility, and/or other specialist medical training), number of 
years practicing as a medical doctor, as a fertility doctor, site(s) of practice (public sector, private 
sector, other), number of fertility patients seen per week, percentage of practice spent with 
fertility patients. All survey questions were marked optional. 
Procedure. 
Eligible participants were invited to the study via email.  Those wishing to participate 
were instructed to click on a study hyperlink that lead them to information about the study, the 
consent form, and the questionnaire. At the end of the survey was a ‘submit’ button that 
participants clicked to submit their data.   
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Results 
In total, 41 of 150 (27.3%) invited fertility doctors participated in the survey. The 
participants were predominantly from South Africa (n=10, 24%) and Sudan (n=6, 14.6%). The 
remaining sample included two (4.9%) participants each from Kenya, Nigeria, Uganda, Nepal, 
Russia, Spain, and one (2.4%) participant from each of Egypt, Libya, Tunisia, Khasikistan, 
Turkey, Taiwan, Paraguay, Uruguay, Panama, Belguim, UK and USA. Almost all the 
participants (97.4%, n=32 of 33 who responded to this question) had specialist training in 
addition to OBGYN training (e.g. RM or REI). Participants had, on average, 28.7 (SD= 9.4) 
years of practice and 19.3 (SD= 10.75) years experience as a fertility doctor. Of the 34 fertility 
doctors providing professional information, 50% (n=17) practiced in the private sector only, 15% 
(n=5) in the public sector only, and 26% (n=9) in both. A further 8.8% (n=3) practiced in other 
settings (e.g. academic institutions). The average number of fertility patients (or couples) 
managed per week was 31.58 (SD= 18.4, median= 30).   
Table 2.1.1 shows percent agreement that RFs and medical conditions on the 
‘structured list’ could be risks for fertility problems in women to be assessed for inclusion into an 
‘adapted FertiSTAT’.  The percent agreement varied between 38 and 97%, with medical and 
reproductive conditions (e.g., cancer, HIV) generating higher endorsement as risks than 
‘practices’ (e.g., consangunity, FGM/C).  In the open text free comment section (‘participant 
generated list’), 25 participants suggested other medical risk factors (e.g. medications, thyroid 
disease), reproductive risk factors (e.g. adhesions/fibroids) or lifestyle risk factors (e.g. vitamin 
D deficiency, occupation/exposure). The most commonly suggested factors were related to 
medication or medical/reproductive conditions.  
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Table 2.1.1 also includes justifications for the inclusion of RFs in the ‘structured’ and 
‘participant generated’ lists.  In general, few participants provided a specific reason for 
perceiving a risk factor as a risk factor with most participants providing no justification, but this 
depended on the type of risk.  Specifically, between 7.7% (1 of 13) and 15.4% (2 of 13) of those 
endorsing one of the ‘practices’ as a risk provided a justification (i.e., reduces ovarian reserve, 
causes recurrent miscarriage) whereas between 5.9% (2 of 34) and 34.6% (9 of 26) of those 
endorsing a reproductive condition reported a justification (e.g., Asherman’s syndrome, tubal 
damage).  Uncertainty also differed between types of risk with 18.8% of people endorsing a 
‘practice’ stated being unsure versus 5.9% for reproductive or medical conditions. A reason was 
reported for about half of the participant generated RFs, mainly for the proposed lifestyle risks. 
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Table 2.1.1 
Percentage of participants who endorsed risk factors in structured list (1), the risk factors generated by participants (2) and principle 
reasons given to justify risk  
Risk factors Endorsed 
n/N (%) 
Principal reasons given to justify endorsement (n/N of 
responses) 
1. Structured
list
Unsure 
n/N (%) 
Specific reason 
n/N, (%) 
No reason 
given 
n/N (%) 
Practices FGM/C 13/24 (54.2) 2/13 (15.4) Reduces ovarian reserve (1/13, 7.7) 10/13 (76.9) 
Consanguinity 13/26 (50.0) 1/13 (7.7) Recurrent miscarriage (2/13, 15.4) 10/13 (76.9) 
Water Pipe smoking 9/24 (37.5) 3/9 (33.3) Reduces ovarian reserve (1/9, 11.1) 5/9 (55.6) 
Reproductive 
factors 
Bacterial vaginosis 12/27 (44.4) 0/12 (0) Recurrent miscarriage (1/12, 8.3); Tubal damage (1/12, 8.3) 10/12 (83.3) 
HIV 22/29 (75.9) 4/22 (18.2) Reduces ovarian reserve (3/22, 13.6); Endometrial damage (6/22, 
27.3) 
9/22 (40.9) 
GTB 32/33 (97.0) 2/32 (6.3) Reduces ovarian reserve (1/32, 3.1); Asherman’s (adhesions) 
(5/32, 15.6); Tubal damage (7/32, 21.9); Endometrial damage 
(3/32, 9.4) 
14/32 (43.8) 
Post-abortion infection 34/36 (94.4) 2/34 (5.9) Asherman’s (adhesions) (7/34, 20.6); Tubal damage (10/34, 
29.4); Endometrial damage (2/34, 5.9) 
13/34 (38.2) 
Post-partum infection 28/30 (93.3) 2/28 (7.1) Asherman’s (adhesions) (7/28, 25); Tubal damage (7/28, 25); 
Endometrial damage (2/28, 7.1) 
10/28 (35.7) 
Repeated D&C 26/30 (86.7) 1/26 (3.8) Asherman’s (adhesions) (9/26, 34.6); Cervical damage (1/26, 3.8) 15/26 (57.7) 
Cervical electrocautery 14/25 (56.0) 0/14 (0) Endometrial damage (1/14, 7.1); Cervical damage (2/14, 14.3) 11/14 (78.6) 
Medical 
Conditions* Diabetes 26/35 (74.3) 
Kidney disease 22/32 (68.8) 
SLE (lupus) 25/34 (73.5) 
Sickle cell anaemia 16/32 (50.0) 
Cancer 32/37 (86.5) 
2. Participant
generated list
Unsure 
n/N (%) 
Specific reason 
(n/N, %) 
No reason 
given 
n/N (%) 
Medical Medications (pharmaceutical, 
psychotropic or traditional) 
3/25 (12.0) 0/3 (0) Toxins (3/3, 100) 0/3 (0) 
Male factor (e.g. cancer 
treatment) 
6/25 (24.0) 0/6 (0) Reduced male fertility (6/6, 100) 0/6 (0) 
Thyroid disease/treatment 7/25 (28.0) 0/7 (0) (0/7, 0) 7/7 (100) 
Anaemia 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
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Risk factors Endorsed 
n/N (%) 
Principal reasons given to justify endorsement 
(n/N of responses) 
Unsure 
n/N (%) 
Specific reason n/N, (%) No reason 
given 
n/N (%) 
Autoimmune diseases 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Cushing’s syndrome 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Chronic liver disease 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Inflammatory Bowel Disease 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Reproductive Adhesions/fibroids 2/25 (8.0) 0/2 (0) Tubal damage (2/2, 100) 0/2 (0) 
Vaginitis 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Dyspareunia 1/25 (4.0) 0/1 (0) Reduced coitus (1/1, 100) 0/1(0) 
Pelvic tuberculosis  1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Pregnancy-related infection 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Hyperprolactinemia 1/25 (4.0) 0/1 (0) (0/1, 0) 1/1 (100) 
Lifestyle Low vitamin D 1/25 (4.0) 0/1 (0) Poor oocyte quality (1/1, 100) 0/1 (0) 
Occupation/exposure 3/25 (12.0) 0/3 (0) Male factor (3/3, 100) 0/3 (0) 
IUD 2/25 (4.0) 0/2 (0) Risk of PID (1/2, 50) 1/2 (50) 
Extreme exercise 1/25 (4.0) 0/1 (0) Reduction in pulatile GnRH release (1/1, 100) 0/1 (0) 
Undernutrition/anorexia 1/25 (4.0) 0/1 (0) (0/1, 0) 0/1 (0) 
Vaginal lubricants 1/25 (4.0) 0/1 (0) May be spermicidal (1/1, 100) 0/1 (0) 
Anal sex 1/25 (4.0) 0/1 (0) Increases risk of Prostatitis (1/1, 100) 0/1 (0) 
Note. *Participants were not asked to provide reasons for these medical conditions.  Sample size varies by question, n = number responding affirmative; N = 
number responding to question; NR = not reported; Unsure = participant indicated not knowing how risk factor affects fertility; FGM/C = female genital 
mutilation/cutting; GTB = genital tuberculosis; D&C = dilatation and curettage for any reason; SLE = Systemic lupus erythematosus; IUD = intra uterine 
device; PID = pelvic inflammatory disease.  
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Discussion 
The main findings were that the RFs included in the original FertiSTAT were not 
perceived to comprise a fully comprehensive list of RFs applicable to several participant’s 
country of practice. Specifically, 44% to 97% of an international sample of fertility doctors 
primarily from Africa and the Middle East endorsed the inclusion in an ‘adapted FertiSTAT’ of 
additional RFs arising from infection or communicable (e.g., HIV, GTB, postpartum infection) 
and non-communicable (e.g., diabetes, lupus) diseases.  A smaller percentage, 38% to 54%, 
endorsed risks arising from cultural practices (e.g., FGM/C, water pipe smoking).  It is not clear 
from the present study whether the inclusion of the risks would be justified. It is also not clear 
whether the difference observed between willingness to endorse cultural versus medical or 
reproductive types of risk is justified. Nevertheless, it can be inferred from our survey that there 
could be RFs not currently included in the original FertiSTAT that would need to be examined to 
achieve a more global understanding of RFs for fertility problems to which women could be 
exposed in the Middle East.   
The variation in endorsement across types of risks (medical, cultural) could reflect the 
reality that less endorsed risks (i.e., associated with cultural practices) are actually less risky for 
fertility than the communicable or non-communicable risks endorsed. Alternatively, it could be 
that evidence about these cultural practices and their impact on fertility is either not robust, or 
that the evidence has not yet been adequately communicated to or accepted by fertility doctors.  
Additionally, the fact that more participants reported a reason/justification for the ‘reproductive’ 
RFs than for the cultural ‘practice’ risk factors, and that justifications were in line with those 
provided in existing literature on causal mechanisms suggests better knowledge of the 
mechanisms of action of ‘reproductive’ risk factors most likely due to medical training and 
Chapter 2  Evaluation of FertiSTAT 
28 
clinical expertise. However, we could not fully evaluate knowledge levels for mechanisms of 
action because the majority of participants did not provide a justification for endorsing a risk. 
 In the original FertiSTAT medical conditions were excluded on the grounds that within 
the UK and Europe, it was expected that the general practitioner or disease specialist would have 
informed patients affected by these diseases or disorders of the associated potential risk to 
fertility (Bunting & Boivin, 2010).  However, results of Study 2.1 suggested that not all 
participating fertility doctors knew about the fertility effects of medical conditions examined, for 
example, 14% did not agree that cancer could be a risk for fertility problems.  This suggests that 
at least some doctors might not inform patients of the effects of cancer on fertility.  A systematic 
review that postdates the original FertiSTAT showed that approximately a third of cancer 
survivors surveyed, did not recall being told about the effects of cancer or its treatment on their 
fertility or reproductive potential (Tschudin et al. 2010). Together these findings would suggest 
that certain medical conditions should be integrated in the ‘adapted FertiSTAT’, possibly more 
so within settings where there is limited access to universal health care, or where there is 
inadequate adherence to, or lack of best practice guidelines in reproductive care. 
The main limitation of the study was the low survey response rate, however it is known 
that when surveys are received without prior notice as was the case in our study, the response 
rate is approximately 20% (Kelly, Clark, Brown & Sitzia, 2003). Another limitation was that the 
majority of participants are highly experienced fertility doctors working within the private sector. 
However, the development of fertility health services is mainly based within the private sector in 
the countries surveyed (IFFS Surveillance, 2016; Sullivan, et al., 2013). Therefore, patients 
whom these fertility doctors treat could be representative of the typical patient seen in general 
practice, but it is possible that patients accessing private practice could differ in risk exposure, 
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access to overall quality health care, and type of fertility risk exposure than that observed in 
patients who must rely only on the public health care sector.  
Future research should aim to review and synthesise available data on these additional 
RFs not previously included in the original FertiSTAT, and, in due course, to generate 
prospective data on effects of identified risks such that evidence-based information can be used 
to inform existing and future fertility awareness tools. Even with evidence based and RFs 
integrated, the international effectiveness of awareness tools might nevertheless be compromised 
if it is not feasible to integrate them because the tools or the topics themselves are not perceived 
to be acceptable to new audiences. 
Study 2.2: Assessing the feasibility and acceptability of implementing an adapted 
FertiSTAT in the Middle East among multiple stakeholders  
Introduction 
Public health efforts assess the prevention of disease through addressing distal (e.g., 
unprotected intercourse with multiple partners) and proximal (e.g., pelvic inflammatory disease) 
RFs in targeted interventions such as education and awareness activities (Ezzati, et al, 2006, 
Chapter 4). The effectiveness of addressing risk factors through health campaigns and 
educational tools has been demonstrated (Noar, 2006). The implementation of evidence-based 
educational tools about RFs developed in one country into another country raises several issues. 
First, practicality (i.e. how can the materials best be disseminated e.g. setting and target 
audience) and acceptability (i.e. are the topics covered culturally appropriate) of the educational 
tool need to be determined. Second, public health campaigns designed to educate people about 
risk factors need to use a language of communication (wording) that is not only effective but that 
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is culturally appropriate. Given these issues, it is therefore imperative that feasibility and 
acceptability of using educational tools such as the FertiSTAT, outside the context of 
development, need to be examined prior to direct dissemination and implementation.  
The aim of Study 2.2 was to consult with multiple stakeholders in the Middle East (as a 
potential target population) to evaluate perceptions of including additional risk factors identified 
in Study 2.1 in the ‘adapted FertiSTAT’ and to examine the feasibility and acceptability of using 
this adapted version in the region. A stakeholder is an individual or group with an interest in or 
affected by an organization or process (Partridge, Jackson, Wheeler & Zohar, 2005). A 
stakeholder meeting brings together the relevant stakeholders in a structured interactive process 
to generate collective understanding, joint decision making and courses of action (PMNCH & 
WHO, 2014). They are used in various fields from corporate to healthcare, and are usually 
conducted to involve stakeholders in the development or implementation of a program. The 
involvement of stakeholders enhances adherence to recommendations, increases the credibility 
of findings, reduces distrust, increases awareness and leads to support and advocacy for the 
program (Salabarría-Peña, Apt, & Walsh, 2007). In healthcare the relevant stakeholders include: 
policy makers, healthcare professionals, institutions, non-governmental organizations (NGOs), 
national and international societies, researchers, academics, technical experts, donors and users 
(PMNCH & WHO, 2014). Steps involved in conducting a stakeholder meeting include: (1) 
identifying the relevant stakeholders, (2) choosing a facilitator(s), (3) designing the dialogue 
process, (3) preparing the logistics and (4) holding the meeting (PMNCH & WHO, 2014). The 
data generated are then subjected to qualitative data analysis and it is anticipated that the process 
will facilitate implementation efforts.  
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Materials and Methods 
Participants and recruitment. 
Two separate meetings were held in the Middle East. The first was held in Egypt at the 
Middle East Fertility Society (MEFS) annual conference on 04/11/2016. The MEFS 
administration identified, and then emailed 30 fertility doctors, practicing in the Middle East and 
planning to attend the MEFS conference in order to invite them to the study. Of the 30 invited, 
28 (93.3%) agreed to participate and 21 (75%) were able to attend the group meeting facilitated 
by RB and SvdP, while 7 (25%) participated in individual meetings with the facilitators, at a 
later time on the same day of the group session. The second meeting was held in Sudan under 
the guidance and leadership of the National Reproductive Health Program (NRHP) of the 
Sudanese Federal Ministry of Health (FMoH) on 03/12/2016.  The NRHP sent invitations to 
representatives from policy-makers, women’s and youth groups, service providers, UN, users 
(patients), local experts in qualitative research methodologies and group collaboration in Sudan. 
Of the 15 invited, 11 (73%) were able to attend the meeting facilitated by RB and JB. The 
invitations for both sets of meetings stated that the meeting agenda would be regarding the 
comprehensiveness of the ‘adapted FertiSTAT’ and the feasibility and acceptability of its use it 
in the Middle East. 
Materials and procedure. 
  Prior to the meetings, the facilitators were advised by international experts that the use 
ofa self-administered tool in the Middle East might not be feasible given educational levels. 
Therefore, the authors developed two versions of the tool. A flipchart version appropriate for use 
with patients of lower literacy and a checklist version appropriate for fertility doctors to 
administer with their patients who could not complete the FertiSTAT on their own.  The flipchart 
is one of the methods the World Health Organization (WHO) and other NGOs such as the 
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Population Council would use at the level of primary care in regions of lower literacy when 
communicating reproductive health issues between health care providers and their clients (e.g., 
to provide education on contraception, WHO, 2005, Department of Reproductive Health and 
Research). The flipchart version of the FertiSTAT was based on the WHO family planning 
flipchart (WHO, Department of Reproductive Health and Research, Decision-making tool for 
family planning, 2005).  It has a two-sided page format, with one page facing the client and the 
other facing the provider. The page facing the client depicts information about risk using pictures 
and simple graphics; the flip page faces the service provider and displays corresponding key 
questions, detailed information and discussion points for the provider to educate the client 
enabling informed choice and understanding of the reproductive issue of interest.  The checklist 
version of the FertiSTAT is a two-part tool, with a list of signs, symptoms and risk factors for 
men and women that could be beneficial for settings where circumstances may not permit use of 
a flipchart. Checklists are increasingly used to efficiently condense a large quantity of 
information, describe essential evidence-based criteria, and enhance the objectivity and 
reproducibility of communications between practitioners and patients, including settings where 
there is low literacy (Hales, Terblanche, Fowler & Sibbald, 2008). Checklists can also stimulate 
reliable information-gathering and provision (Hales, et al., 2008).  Both versions (flip chart, 
checklist) included the 22 original FertiSTAT items, as well as the additional risk factors 
identified in Study 2.1. The section for men was based on the factors included in the original 
FertiSTAT, however an update of risk factors impacting on male fertility was beyond the scope 
of the current thesis, nevertheless this area should not be neglected in future research.  
During all meetings, information regarding FertiSTAT development, validation and 
applicability in the UK and Europe, as well as information about the additional risk factors 
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identified in Study 2.1 and the two versions of the tool were presented to the participants. The 
presentation was followed by discussion of the comprehensiveness, applicability, feasibility and 
cultural/regional acceptability of the original FertiSTAT items and the additional risk factors. 
Discussion also included specifics of implementation e.g. target audience, setting, practicality of 
use such as format most suitable given level of education and wording appropriate to the cultural 
and religious confines of the region.  Due to the sensitivity of the topics discussed, recording 
devices were not utilized, however detailed notes for the first set of meetings were taken by SvdP 
and RB, and by a Sudanese research assistant for the meeting in the Sudan. 
Data analysis. 
RB and SvdP conducted thematic analysis (as coders) (Braun & Clarke, 2006).  The 
thematic analysis steps followed were: (1) familiarisation with the data, (2) generating initial 
codes, (3) searching for themes, (4) reviewing themes, (5) defining and naming themes and (6) 
producing the report (Braun & Clarke, 2006).  Coders derived codes from the meeting notes 
through inductive coding. Codes with the same meaning (e.g., “population of interest” and 
“target population”) were combined together. Coders discussed and reached agreement on 
whether each code communicated a unique meaning or fit with other existing codes.  Each coder 
organized codes into main themes independently and these were discussed between coders to 
deepen the analytic process, enhance trustworthiness of the findings and to ensure the 
cohesiveness of each theme and consistency with the overall meanings in the dataset. Sub-
themes within the main themes were also identified to facilitate understanding and presentation 
of the results. Participant quotes were used to illustrate meanings. The use of parentheses within 
quotations indicates text added for clarity, while omitted text is represented using the following: 
(…).  Illustrative quotations are from fertility doctors, unless otherwise specified. 
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Results 
The attendees of the first meetings at the MEFS conference were fertility doctors 
practicing in ten countries in the Middle East (Algeria, Egypt, Iraq, Jordan, Lebanon, Libya, 
Saudi Arabia, Sudan, Syria and Turkey). The attendees of the second meeting were stakeholders 
from Sudan including representatives from: the Ministry of Health, medical societies (Sudanese 
Society of OBGYN and Sudanese Reproductive Health and Embryology Society), reproductive 
health experts from UN agencies, national NGOs, previous patients, epidemiologists, medical 
doctors from local universities (University of Khartoum, Ahfad University, National Ribat 
University) and fertility doctors practicing in both the public and private sectors. As shown in 
Table 2.2.1 thematic analysis resulted in five main themes, which are described in detail in the 
next section.  
Table 2.2.1 
Themes that emerged from thematic analysis of data gathered from both meetings 
Theme Summary of theme 
Need for fertility awareness 
in the Middle East 
Fertility awareness was endorsed based on societal emphasis on childbearing and 
widespread fertility misconception of  information  
Content acceptability and 
specific tool changes 
The content of the FertiSTAT found to be acceptable.  
The wording of certain items was found to be unacceptable or acceptable if modified 
to be more culturally sensitive.  
Target audience Suggestions for the appropriate age and marital status of the target audience 
included: couples preparing for marriage, newly-married couples and young 
unmarried individuals.  
Suggestions about subcultures e.g. refugees as separate target audience were made. 
Setting for implementation Macro level settings: disagreement about the possibility of a regional tool  
Micro level settings: urban and rural settings may have different needs.  
Possible settings for implementation include: schools, primary healthcare facilities, 
infertility clinics (tertiary level), community and media.  
Need for further research 
(setting specific) and a 
working group 
Next steps require setting up a working group to finalize the content of the material 
and oversee necessary regional research  
Areas for future research: identify settings and target populations, identify which 
format would be suitable for which setting, field-testing the wording used to 
communicate sensitive and stigmatized topics to determine acceptability and 
alternatives, evaluate research to ensure highest possible quality of research 
(empirically sound), ethical problems e.g. screening will lead to huge demand and 
services need to be available 
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1. Need for fertility awareness in the Middle East.
It was stated that fertility awareness was necessary and timely, “there is a niche for such 
tools especially because our societies are geared towards childbearing”. There is a lack of 
knowledge about when to seek medical advice, reflected in patients seeking treatment “too early 
or too late”, indicating a lack of awareness. It was also noted that there is a lack of “information 
about risk factors” or “misconception about what is a risk.” It was indicated that knowledge 
about when to seek advice, risk factors and the signs and symptoms of fertility problems would 
help “reduce the burden” on healthcare systems and individuals, as well as to potentially reduce 
the prevalence of known preventable causes of infertility e.g. time to treatment and age: “if they 
know when to get help” and “they don’t know what age (decline in fertility starts)”. The social 
stigma of infertility was highlighted especially for men (…) “they (men) deny having the 
problem because it is shameful, makes him less of a man” and a previous patient agreed: “male 
infertility is a stigma”. Another issue highlighting the need for fertility awareness was the 
misconception of information accessed by patients from the internet: “the main problem is the 
internet, where individuals look up on say polycystic ovary syndrome (PCOS) and immediately 
find infertility as the end”.  It is known that 80% of PCOS patients have either infertility or an 
extended time to pregnancy, however managed PCOS decreases this risk (Balen et al, 2016).  
2. Content acceptability and specific tool changes.
There were two acceptability sub-themes that emerged (a) acceptability of the content, 
and (b) acceptability of the wording. There was consensus that the original content, the medical 
conditions and the additional risk factors e.g. FGM/C were necessary for a Middle East version 
of the FertiSTAT: “yes it’s (original FertiSTAT) good but you need these (medical conditions, 
and additional risk factors) others”, and that “with some adjustment to the language” the 
Chapter 2  Evaluation of FertiSTAT 
36 
‘adapted FertiSTAT’ could potentially be culturally acceptable and used in the Middle East. 
Several participants also noted the absence of PCOS from the ‘adapted FertiSTAT’, stating that 
it was common in their practices: “30% of my patients have PCOS”.  
There were conflicting opinions regarding wording. Some suggested that it was necessary 
to make specific changes to the wording of some items in the ‘adapted FertiSTAT’ due to 
sensitivity of specific topics, most notably, use of illegal drugs and unprotected sex with multiple 
partners. Some suggested certain risk factors should be removed, altered or only communicated 
to specific audiences (e.g. married couples only):  
“Some items (drugs and sex) are not acceptable and we cannot ask questions so openly like 
this.”  
“Sex with multiple partners is unacceptable in a community of husbands and wives (…) the 
word ‘partner’ particularly should not be used.”  
“Items regarding things like multiple partners need to be delivered in a sensitive manner (…) 
use ‘extramarital affairs’ or ‘previous relationships’ (…) but you have to ask.” 
A reproductive health expert from a Sudanese NGO added the importance of the 
behaviour of the provider who would be asking about these risk factors: “you have to be careful 
when asking these women (…) your body language, choice of words”.  
However, others felt that the ‘adapted FertiSTAT’ tools could be used as is in their 
countries or clinic settings.  Most of the terminology was “comprehensible” but “medical 
terminology like endometriosis and PID (pelvic inflammatory disease) should be replaced with 
more understandable terminology, which would require deliberation at length and with several 
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experts”. Some also felt that wording/phrasing might need to be “country specific (…) or 
specific to subcultures (within countries)”. 
3. Target audience.
Three target audiences were specifically suggested for the ‘adapted FertiSTAT’ tools, 
namely young unmarried individuals, couples preparing for marriage and newly-married couples. 
A difference in opinion about possible target audiences was observed.  For example, a 
reproductive health expert from a Sudanese NGO suggested that the materials should “target 
couples who are about to get married”, a representative from a UN agency in Sudan noted that 
“school children (and) university students are the main targets” and fertility doctors noted the 
following: 
“Young adults preparing for marriage (…) thinking about having children are most 
primed to receive (educational) information about their current and future fertility”.  
“You can’t talk about these things (sex) with people who are not married yet (…) that’s 
not acceptable (…) it is only acceptable for all formats (of the ‘adapted FertiSTAT’) to be 
delivered to married couples.” 
 “Times are changing and in some places it is now more acceptable to do (educational 
materials) with younger unmarried people. Younger generations are more accepting of 
such things (sex and drugs).” 
“Yes, yes adolescents and unmarried young adults (since) there is a shift in attitudes 
towards sensitive topics.” 
It was suggested that “the tool (‘adapted FertiSTAT’) can be integrated” into existing 
programs that target young adults like the “premarital counseling for young adults (…) young 
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couples’ premarital counseling package”. For example, one fertility doctor stated that premarital 
counseling is “mandatory about certain medical disorders such as HIV and hepatitis B and C to 
receive a marriage certificate in Egypt”. In Sudan, it was suggested by a representative from a 
local university that the ‘adapted FertiSTAT’ could be integrated into the “free youth workshops 
held by the Ministry of Youth, targeting couples who are about to get married and educating 
them about things like family planning, HIV testing”.  
Within this main theme there was also the possibility of targeting subcultures, which 
referred to “unique subcultures within each country that may have different needs and level of 
understanding (…) acceptability” that need to be explored. For example: refugees “who despite 
their circumstances are very keen on having children and the need for fertility awareness is 
acute” in this group. A suggestion was made about a potential target audience for testing of the 
tools: “these tools should be tested at community level targeting the general population, for 
example via media campaigns.” 
4. Setting for implementation.
The fourth main theme concerned the setting for implementation of fertility awareness 
tools with sub-themes: macro and micro level settings. There was overall agreement that “it 
(‘adapted FertiSTAT’) can be implemented without great difficulty in specific setting(s)”. At the 
macro level there were suggestions that there should be a regional level tool, “a Middle East 
version” that was tailored to the needs of that specific region.  However, others disagreed: there 
“cannot be a regional tool” and we “cannot (even) have a country tool” and “a regional tool may 
not be possible but a national tool would be beneficial”.  The main reason given for why a macro 
level tool would be difficult to implement was diversity of people within the region or a country 
and the exposure to different risks e.g. FGM/C highly prevalent in Sudan and Egypt but almost 
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non-existent in Lebanon and Oman.  The fertility doctors made the observation that even within 
each country, different settings could have different needs, for example there may be a “need to 
develop a rural and an urban version for each country”, a reproductive health expert from a 
Sudanese NGO made a similar suggestion, emphasizing the difference in literacy levels across 
the country that may affect understanding of the questions and the application of the tool to guide 
behaviours.  
At the micro level, discussions lead to the suggestion of several settings for use and 
dissemination including schools, primary health care facilities, infertility clinics (tertiary level), 
media and community. There was agreement that the primary care level setting would help reach 
the widest audience, but diverse opinions were expressed about fertility awareness education in 
schools. Several fertility doctors expressed an opinion that the school setting (regardless of age 
of pupils) would not be appropriate due to the sensitive issues raised (e.g., sexual activity and 
illegal drug use) although not all fertility doctors agreed, as some felt that adolescents were 
already exposed to these issues. Others, including an epidemiologist and representatives from 
Sudanese NGOs, expressed the view that “integrating the material in the curriculum of schools 
and universities would be best”. This was further reinforced by ongoing activities for example 
that in Sudan the “Ministry of Health and Ministry of Education with the support of UNICEF are 
in the process of rolling out (in schools) an adolescent health module on fertility, targeting ages 
10-19 years”. It was stated that “interventions have to start early (…) first place should be at the
school, train the teachers, give the information to the educators”.  There was consensus that 
further research was necessary to ascertain acceptability and utility in schools, and if and how to 
target different adolescent and young adult age groups.  
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Opposing views were expressed regarding the utility of using the tools with patients 
attending infertility clinics.  Participants expressed the view that “all my clients are infertile and 
this (‘adapted FertiSTAT’) would be useless (at this stage)”, while others stated that “we get 
many (patients) who are NOT infertile, but they think they are, so it (‘adapted FertiSTAT’) 
would be very helpful” in identifying those who indeed required medical attention. The use of 
media such as TV, radio, internet and social media (e.g. Facebook, WhatsAPP) was discussed as 
potential viable dissemination platforms in both meetings. It was suggested that in Sudan the 
material could be disseminated in group format rather than one-on-one, for example “village 
meetings, community gatherings, rather than individuals” or via print media “in clinics, 
outpatient departments, magazines”. A representative from a local university suggested taking 
advantage of existing health promotion programs like the “rural extension program at Ahfad 
University”, which sends students to the villages to deliver health education messages within 
these rural communities. Midwives and health visitors were also suggested as potential providers 
who could be trained to disseminate this information, since they are the “main care providers in 
rural areas where 80% of deliveries are at home”. The demographic characteristics of 
participants (e.g., education, socioeconomic status) were perceived to possibly necessitate the 
use of “different tools/formats for different settings”. For example, the provider flipchart would 
be useful for settings where individuals have lower education, the checklist would be helpful 
within a fertility care clinic or centre, while a self-administered questionnaire would be suitable 
only for settings were potential users are “well educated”.  
5. Need for further research (setting specific) and a working group.
More research was thought to be necessary for updating the FertiSTAT prior to 
implementation within the Middle East. The MEFS experts thought that the creation of a 
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working group that could “finalize the content of the material” and oversee necessary regional 
research was the logical next step for implementation of the ‘adapted FertiSTAT’.  In addition, 
research was needed to ensure the assignment of blue, yellow, orange or red flags for new risk 
factors, and further prospective testing in multifactorial models to detect how these factors would 
alter prediction compared to the original FertiSTAT factors was perceived to be essential to 
ensure appropriate guidance or referral. It was noted that the “integration of fertility awareness 
tools and research regarding testing different formats” would require the involvement of 
“professional societies” and “public health experts who would be more able to advise on where 
within existing healthcare services the tools can be integrated and what level of content 
(difficulty)”. Five main areas that were perceived to require further research prior to 
implementation were acknowledged. First, identify settings and target populations that would be 
most receptive and for whom the tool would have the most impact. Second, identify which 
format would be suitable for which setting, a “flipchart should be tested at primary care level” 
and a “screening tool (checklist) can be tested at secondary (general OBGYN) or tertiary level 
(specialist infertility clinic)”.  Third, field-testing the wording used to communicate sensitive and 
taboo topics, to determine if acceptable and if not, what the more acceptable alternatives are.  
Fourth, identify mechanisms to ensure or evaluate reports to generate the highest possible quality 
of research conducted using the FertiSTAT. One participant stated that ‘the research needs to be 
well-coordinated and implemented (…) one bad application or extreme negative outcome could 
potentially destroy the whole project for example one person saying it’s inappropriate for the 
region or our people”. There was agreement that the research also needs to be empirically sound, 
requiring “systematic reviews and proof of principle for a model for adaptation” including 
research design for pilot testing of tools (e.g., population of interest, sampling), and a detailed 
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methodology to support research protocols used for any adaptation process. Finally, there was 
concern that “this project can be very complex, the aim of the educational program is prevention 
through screening programs however when that (the screening) starts (and may identify risks to 
or fertility problems), there will be a huge demand that may cause an ethical problem, you have 
to provide services or a referral pathway to cope with the demand generated by the screening”. 
Discussion 
Fertility doctors from various countries within the Middle East supported the use of an 
‘adapted FertiSTAT’ that included the additional risk factors, in their practices and communities. 
There was an overall positive attitude regarding feasibility and acceptability of implementing the 
‘adapted FertiSTAT’ in the Middle East. Hoverer, some concerns were expressed about wording, 
how the provider would approach questions and certain risks, appropriate target audiences and 
implementation settings that would need to be resolved through implementation research.   The 
consensus about the need for educational campaigns to help increase awareness about fertility 
based on region specific research echoed recent recommendations that educational tools should 
include all additional risk factors (Bosdou, et al., 2016).  Perceptions of participants were in line 
with published accounts of prevention and treatment of infertility and importance of 
investigating region-specific risk factors in the Middle East (Serour, 2002; Bosdou, et al., 2016) 
and other regions (see Leke, et al., 1993). 
Although there was an overall acceptance of the original FertiSTAT items, the original 
FertiSTAT was not perceived to be comprehensive due to the omission of risk factors relevant to 
the Middle East (e.g., FGM/C, CSG) and its exclusion of medical conditions (e.g., diabetes, 
cancer, PCOS) as was found in Study 2.1. Additionally, there was concern about appropriateness 
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of wording and taboo topics (e.g., drugs, unprotected intercourse with multiple partners) for 
some Middle-Eastern countries, and appropriate target subpopulations within countries e.g. 
adolescents, unmarried individuals, requiring further exploration. The discussion made clear that 
what was “appropriate” was reference to social conventions about the discussion of taboo topics 
with different members of a community. Social norms are a powerful driver of medical health 
care seeking especially in low and middle-income countries (Finlayson & Downe, 2013; 
Thaddeus & Maine, 1994).  However, hesitation could also be due to the significant penalties or 
shame of engaging in illegal activities e.g., alcohol use (Islam and Alcohol, 2012) in Muslim 
countries.  Together violation of social or legal norms would indicate that divulging exposure to 
some risks could be very problematic for individuals, but also could place medical doctors in a 
compromised legal position by learning about them.  Implementation research including 
qualitative studies could help identify how best to integrate fertility awareness tools in specific 
communities taking into consideration the diversity of views on wording, target audiences and 
setting.  
Although there was agreement that the additional risk factors are necessary for a 
regionally (macro level) adapted tool, it was noted that further research was essential to 
accumulate empirical evidence on the risk factors and their impact on fertility, and to test the 
regional applicability of a version of the adapted tool at national or sub-national level, all of 
which would require a ‘working group’ to ensure all aspects are adequately researched before 
implementation. The generalizability of data gathered in primary research about a specific risk 
factor, for example, may not extend beyond the context in which it was conducted (Ezzati, et al., 
2006, Chapter 4).  Therefore, risk profiles need to be examined in light of context differences 
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between countries, or a meta-analysis across countries could be considered as necessary next 
steps. 
Generally, the strength of involving multiple stakeholders is that they can provide unique 
insights, assist with implementation and ultimately lead to increased consensus for the program.  
Specifically, the meetings were well attended with a diverse group of participants from the 
Middle East. However, the main limitation is that the results may be region specific and would 
require testing in other regions and countries to ascertain global applicability and 
comprehensiveness. Another limitation is that if the stakeholders’ recommendations are not 
heeded this can lead to unmet expectations, distrust and ultimately hamper implementation 
efforts. Therefore, follow through on recommendations is imperative.  
General conclusion 
Findings from Study 2.1 and 2.2 indicated that the process of adapting the FertiSTAT
could be improved through the inclusion of medical conditions (e.g. diabetes) and risk factors 
arising from culturally influenced practices (e.g. FGM/C, consanguineous marriages), 
preventable infectious disease (e.g. HIV and GTB) and medical procedures (e.g. D&C). Before 
the adaptation process can be fully implemented, existing research should be evaluated to 
determine to what extent the proposed additional risk factors have been associated with fertility 
problems. Additionally, appropriate wording, target audience and settings for implementation 
need to be investigated.  Such evaluations should provide foundational knowledge to guide the 
type of research needed to improve gaps in knowledge (e.g. risk imposed by endocrine disrupting 
chemicals) and enhance comprehensiveness and utility of the FertiSTAT.  
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The process of globalizing the FertiSTAT and similar tools requires more implementation 
research validating their predictive value across countries and demonstrating their use in such 
settings. However, the processes used in the present studies concur with cross-cultural adaptation 
guidelines that recommend consultations with health experts from the target population before 
implementation (Guillemin, Bombardier & Beaton, 1993; Beaton, Bombardier, Guillemin, & 
Ferraz, 2000).  Globalizing health awareness through the adaptation of fertility awareness tools 
(including FertiSTAT) should aim to ensure recognition of diversity in opinion of experts and 
advisors with the aim to accommodate the needs of the end-user. 
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Chapter 3 
Systematic review and meta-analyses of new risk factors for fertility problems in women 
General Introduction 
The WHO has made a compelling case for the importance of understanding and 
addressing exposure to risk as a public health initiative (World health report 2002).   The 
impact of reducing burden of disease by targeting distal and proximal risk factors through 
tailored prevention programs applied to communicable and non-communicable disease could 
potentially be applied to fertility problems. Macaluso and colleagues (2010) suggested that 
the burden of infertility could be reduced by applying a public health approach that is focused 
on primary prevention of modifiable risks such as STIs (Macaluso et al., 2010). 
Research thus far suggests that women in low resource countries may be facing 
unique threats to their fertility. These risks should be taken into account in the adaptation of 
fertility education and awareness materials. Since the FertiSTAT was developed and tested 
only in the UK, there may be risk factors (RFs) that are population specific that are not 
included in this tool.  To facilitate the use of FertiSTAT (and similar tools) in LMIC, the 
comprehensiveness of RFs in the tool must be determined to ensure it covers likely risks in 
LMIC. Possible risks could be selected through a systematic examination of the literature for 
specific RFs relevant to the intended LMIC population, country or region and then 
determination of pooled estimates (i.e., meta-analysis) where possible. However, not all risks 
identified in this way warrant deeper evaluation and meta-analysis. Frameworks to 
understand the global burden of disease have criteria that can be used for the selection of risk 
factors (Ezzati et al., 2002).  To the authors knowledge, there are no standardized criteria 
used to select risk factors for disease. However, similar considerations to identify global risks 
for disease have been used by the WHO (World Health Report, WHO, Chapter 2, 2002) and 
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Ezzati et al. (2002).  The first consideration is to determine if the RF is potentially among the 
primary causes of disease, globally and regionally. If this is unlikely then consider whether 
the risk can be prevalent and hazardous, or highly concentrated amongst a specific sector e.g. 
Female Genital Mutilation/Cutting (FGM/C) can be as high as 98% of women in countries 
like Somalia (UNFPA-UNICEF, 2014).   The second consideration would be to assess 
whether there is a probability of causality based on aggregate of interdisciplinary scientific 
information. The third consideration would be to determine if data on risk levels and 
exposure is available or easily extrapolated. The final consideration is to determine if the risk 
is potentially modifiable. Such considerations help ensure that risks submitted for deeper 
study and analysis are likely to be relevant for the disease of interest. 
 In the present thesis, RFs that might be unique to fertility problems in low resource 
settings were ascertained from available research, a survey of fertility doctors and discussions 
with experts in the field of infertility working in low resource countries (see Chapter 2). The 
RFs identified and endorsed were: consanguinity (CSG), FGM/C, genital tuberculosis 
(GTB), HIV, dilatation and curettage (D&C), cervical electrocautery (CE), vitamin D 
deficiency and water-pipe smoking. The considerations used by the WHO (World Health 
Report, WHO, Chapter 2, 2002) and Ezzati et al. (2002) for the selection of RFs were applied 
to the identified RFs and summarized in Table 3.1.  
Table 3.1. 
Application of Considerations for the Selection of Risk Factors, as well as Identification and 
Endorsement Attained in Previous study in this Project (Chapter 2) 
Risk 
Factor 
Primary 
causes of 
disease 
Prevalent 
or 
hazardous 
a
Potential 
causality 
Data on 
exposure 
available 
Potentially 
modifiable 
Found in 
search in 
LMIC b 
Endorsed by 
experts in 
survey c 
CSG No Yes Yes Yes Yes Yes Yes 
FGM/
C 
No Yes Yes Yes Yes Yes Yes 
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Risk 
Factor 
Primary 
causes of 
disease 
Prevalent 
or 
hazardous 
a
Potential 
causality 
Data on 
exposure 
available 
Potentially 
modifiable 
Found in 
search in 
LMIC b 
Endorsed by 
experts in 
survey c 
HIV Yes Yes Yes Yes Yes Yes Yes 
GTB Yes Yes Yes Yes Yes Yes Yes 
BV No Yes Yes Yes Yes Yes Yes 
D&C No Unknown Yes No Yes Yes Yes 
CE No Unknown Unknown/
anecdotal 
No Yes Yes Yes 
Vit D 
def 
Yes 
(musculoske
letal) 
Yes Yes Yes Yes Yes Yes 
Water
pipe 
smokin
g 
Yes 
(smoking in 
general) 
Yes Yes Yes 
(smoking 
and 
equivalence 
to smoking) 
Yes No Yes 
Note. Considerations from: Chapter 2, World Health Report, WHO, 2002; Ezzati et al., (2002). aEzzati et al., 
(2002) suggest that when the risk is not a primary cause of disease, consider the prevalence and or hazardous 
nature of the RF. b Was the RF found in the preliminary search of the literature reported in Chapter 2. c Was the 
RF endorsed by fertility experts in the survey reported in Chapter 2.  CSG = consanguinity; FGM/C = female 
genital mutilation/cutting; GTB = genital tuberculosis; BV = bacterial vaginosis; D&C = dilatation and 
curettage; CE = cervical electrocautery, Vit D def = vitamin D deficiency.   
In the present chapter, the validity of these RFs as predictors of fertility problems was 
submitted to deeper analysis examined in a series of systematic reviews (and where possible 
meta-analyses) using the operational definitions of fertility problems and RF applied in the 
original development of FertiSTAT (Bunting & Boivin, 2010). The overall aim of the 
reviews conducted in this Chapter was to determine if the newly identified RFs (Table 3.1) 
were associated with fertility problems (ability to become pregnant, to have a live birth or the 
time taken to achieve either) as this would determine whether or not the new risk indicator 
should be integrated into the adapted FertiSTAT. The present chapter describes the 
conceptual and methodological issues related to this aim, and how these differ from the 
approach taken in the development of the original FertiSTAT. 
Chapter 3 Systematic Reviews 
49 
I. Operational Definitions for Fertility Problems
The FertiSTAT is used to determine the risk for fertility problems.  Fertility problems 
could be considered from several perspectives. There are three dimensions that characterise 
definitions of fertility problems in the literature. The first is based on the fertility outcome, 
which is either an inability to become pregnant or an inability to produce a live birth. The 
International Committee for Monitoring Assisted Reproductive Technology (ICMART) and 
the WHO updated the 2009 glossary of 87 terms relevant to medically assisted reproduction 
(Zegers-Hochschild et al., 2009) and now includes 283 terms (Zegers-Hochschild et al., 
2017). In the updated glossary, the clinical definition of infertility is: “a disease characterized 
by the failure to establish a clinical pregnancy after 12 months of regular, unprotected sexual 
intercourse or due to an impairment of a person’s capacity to reproduce either as an 
individual or with his/her partner” (Zegers-Hochschild et al., 2017). Live birth is defined 
separately as “the complete expulsion or extraction from a woman of a product of 
fertilization, after 22 completed weeks of gestational age; which, after such separation, 
breathes or shows any other evidence of life, such as heart beat”. However, live birth is not 
used in the definition of infertility, implying that an inability to achieve pregnancy rather than 
to produce a live birth is the defining feature of infertility.  In a recent systematic review on 
the definition of infertility, it was reported that definitions are discipline based; 
epidemiologist and clinicians use a definition based on ability to achieve pregnancy, while 
demographers tend to define infertility as ability to produce a live birth (childlessness or 
absence of children) (Gurunath, Pandian, Anderson & Bhattacharya, 2011).  
The second dimension that characterises the definition of fertility problems is the 
duration of exposure to unprotected intercourse required before infertility is declared. 
Depending on the preferred outcome (pregnancy, birth, childlessness) duration of exposure is 
operationalized as ‘time to pregnancy/birth’ or ‘time trying to achieve pregnancy/birth’ or 
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‘duration of childlessness’. The latter incorporates duration of lack of pregnancy, lack of live 
birth and duration of being without a (another) child.  The duration of exposure is the interval 
of time during which the couple are assumed to be having unprotected sexual intercourse 
before pregnancy or birth occurs, respectively. As noted, the ICMAART and WHO glossary 
uses a period of 12 months, but a duration of 12 or 24 months has been used by clinicians to 
express time to pregnancy, while five or seven years of childlessness has been used by 
demographers (Gurunath, et al., 2011). These time frames of 12, 24 months or five years are 
not arbitrary but originate from the likelihood to become pregnant over time. Evers (2002) 
used a mathematical model to model the exposure period required for pregnancy among the 
most fertile to the least fertile couples (developed by te Velde, Evers & te Velde, 2001). 
According to the model 100% of couples referred to as “superfertile” would have become 
pregnant by 6 months, 93% of “normal fertile” couples would have become pregnant by 12 
months (100% by 24 months). By five years 95% of the “moderately subfertile” and 45% of 
the “severely subfertile” would also have become pregnant. This model thus provides an 
expected time band for pregnancy for the range of fertility from the superfertile to severely 
infertile. According to the model, 12 months gives couples with normal to high fertility a 
reasonable chance to become pregnant while five years gives all who can reasonably be 
expected to be fertile this opportunity. Clinicians want to intervene as soon as subfertility can 
be detected therefore define infertility in relation to the point at which most couples would 
have become pregnant (i.e., 12 months’ duration of trying to become pregnant). 
Demographers want to detect fertility problems after the longest period of exposure expected 
to detect the capacity to reproduce and therefore tend to use the five-year period of exposure 
(Gurunath, et al, 2011).  
The third, and final dimension to consider in defining fertility problems is the time 
span that encompasses the period of infertility.  Current prevalence refers to the individual 
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presently experiencing the infertility (however defined) whereas lifetime prevalence refers to 
probability that an individual will have had the disease at some point in their life up to their 
present age (Rothman, 2012). Lifetime prevalence depends on present age and should not be 
confused with end of reproductive life prevalence. End of reproductive life for women is the 
end of the fertile phase where she is no longer able to produce biological offspring and is 
marked by menopause (Eunice Kennedy Shriver National Institute of Child Health and 
Human Development, 2013).  
In the original literature search used for the development of the FertiSTAT, the search 
terms used were fertility and infertility (Bunting & Boivin, 2010). The same terms were used 
in this review as well. These search terms yielded the following outcomes: ‘risk of infertility’ 
defined as lack of conception after 12 months and/or a medical diagnosis of infertility (e.g., 
tubal factor infertility); ‘time to pregnancy’ defined as the number of months needed to 
achieve pregnancy; reduced ‘conception rate’ defined as a reduced chance of clinical 
pregnancy; ‘menstrual irregularities’ defined as short (<21 days) or long (>35 days) 
menstrual cycles and/or sporadic or unpredictable periods; and ‘specific diagnosis’ which 
were defined as a medical diagnosis of a reproductive disorder (e.g., pelvic inflammatory 
disease, endometriosis).  
Outcomes yielded from the search that were related to reduced post-implantation 
ability for a live birth (e.g., gestation and delivery difficulties) were not included in the 
original FertiSTAT due to the number of these factors, existing awareness tools for such 
problems e.g., the ‘Antenatal assessment tool’ (NICE, National Collaborating Centre for 
Women’s and Children’s Health, 2008) and the Pregnancy and health profile: A screening 
and risk assessment tool (March of Dimes, 2016) and the fact that these risk indicators are 
routinely addressed during prenatal care (Bunting & Boivin, 2010).  
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 Outcomes yielded from the search that were relating to live birth or childlessness 
were included in the current study because studies from low resource settings tend to use 
demographic definitions of fertility and related outcomes (e.g., childless, live birth) rather 
than clinical outcomes (e.g., pregnancy). Including only pregnancy outcomes might therefore 
have missed important risk indicators hidden within the broader fertility outcomes present in 
demography. Moreover, measuring the effect on pregnancy and live birth can enable 
specification of where in the reproductive process the RF exerts its impact. This is especially 
relevant for less established RFs where it is unclear how the RF affects fertility (e.g., CSG, 
FGM/C). Therefore for this chapter and the adaptation of the FertiSTAT, the broader term 
‘fertility problems’ was used and was operationally defined as inability to achieve and sustain 
pregnancy and achieve desired family size.  
   
II. Use of systematic review methodology 
In the development of the FertiSTAT a narrative literature review was used to identify 
RFs (Bunting & Boivin 2010).  An RF was considered a potential risk if at least one study 
reported an association between the RF and fertility problems. In the present study a 
systematic review methodology was applied and, where possible, meta-analyses were 
conducted.  
The reason to adopt systematic review methodology lies in the fact that decision 
making in all aspects of health care needs to be informed by the best research evidence 
available (CRD; Centre for review and Dissemination, 2008). However, the available 
evidence can be weak or conflicting owing to primary research that is biased, flawed, context 
specific or suffers from other methodical inconsistencies (CRD, 2008). Therefore, it becomes 
difficult to know which evidence is most reliable or applicable to a specific situation. 
Systematic review offer a solution to these shortcomings in primary research, because they 
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evaluate and summarise all the available evidence (CRD, 2008). Additionally, combined 
effects estimates can be pooled to provide more precise and reliable approximations of the 
effect of an intervention or exposure. In this way, a thorough and transparent systematic 
review allows for defensible conclusions to be made, and can help identify gaps in 
knowledge and research that can then be addressed more consistently and rigorously in future 
research (CRD, 2008). 
To ensure robustness of systematic review methodology and resultant findings, the 
data collection, analysis and presentation of findings of the reviews conducted in the present 
Chapter were conducted as per best practice guidelines presented in the Centre of Review and 
Dissemination’s guidance for undertaking reviews in health care (2009) and the Critical 
Appraisal Skills Program (CASP; Critical Appraisal Skills Program, 2017).  Notable aspects 
of best practice are now discussed as relates to the reviews in the present Chapter. 
According to best practice for meta-analysis, the search should be focused solely on 
one of the outcomes as the primary outcome (e.g., inability to conceive or childless for more 
than 5 years).  However, the research base on current RFs is not voluminous and there is 
significant diversity in the outcomes of primary studies reporting on fertility problems (e.g., 
time to pregnancy, childlessness). Therefore, such a strategy would risk ending up with 
insufficient studies.  Accordingly to adapt the FertiSTAT the search strategy involved 
searching broadly for studies that included the RF and the words fertility and infertility. 
Inclusion and exclusion criteria were then applied to ensure the studies would provide 
relevant data on the relation between the specific RF and fertility problems. Each search 
included all possible outcomes but not all searches yielded data on all outcomes. As a result 
each review examined all the outcomes tested in the primary studies for that risk but these did 
not necessarily comprise all outcomes that defined fertility problems across the set of 
reviews. Therefore, pooled estimates were calculated separately for different outcomes 
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because combining outcomes (e.g., inability to become pregnant with inability to have live 
birth or with likelihood of having amenorrhea) would not be informative. Indeed, different 
outcomes could reflect problems in different parts of the reproductive system (e.g., damage to 
ovaries or uterus) or different points in the reproductive process (e.g., pre-pregnancy, 
gestation).  
III. Use of Bradford Hill criteria to evaluate causality between RFs and fertility
problems and inform final selection of risk factors 
In the original FertiSTAT development study the risk factors identified in the 
literature were presented to and discussed with 25 fertility and reproductive health experts to 
determine which risk factor should be included in FertiSTAT. Included factors were those 
that experts considered had reliable evidence and were independent of each other.  In present 
adaptation of FertiSTAT the Bradford Hill criteria were used to evaluate the causal nature of 
the relationship between new RFs and ‘fertility problems’. The Bradford Hill criteria are an 
example of guidelines used to aid in making causal inferences from epidemiological research 
by exploring the strength and consistency of available evidence (Fedak, Bernal, Capshaw & 
Gross, 2015), through the use of the nine criteria shown in Table 3.2. In a recent evaluation of 
the application of the Bradford Hill criteria to current epidemiology, Fedak and colleagues 
(2015) defined the criteria to be valid and useful when establishing causation. The updated 
evaluation of the criteria (Fedak et al., 2015) determined that these criteria were still 
applicable with added integration of data from molecular level research to determine 
causation.  
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Table 3.2. 
Bradford Hill Criteria and Definitions 
Criteria Definition 
1. Strength A larger associations indicates that causality is more likely, but a small association 
doesn’t mean there is no casual effect 
2. Consistency The consistency of findings across different studies in different populations and 
settings, but also molecular level studies bolster the epidemiological evidence from 
observational studies, decreasing the need for repetitions of observational studies 
3. Specificity A causal relationship is more likely if the association between a factor and the effect 
is more specific 
4. Temporality The cause has to occur before the effect 
5. Biological
gradient
The presence of a dose-response (more exposure-more effect) relationship increases 
the likelihood of a causal relationship 
6. Plausibility The biological evidence provides a model that helps explain the association of 
interest 
7. Coherence Consistency between laboratory and epidemiological findings increases likelihood of 
a causal relationship, similar to ‘consistency’ 
8. Experiment Evidence from experimental manipulation such that cessation of exposure leads to 
decrease in disease lends strong support to causal relationship 
9. Analogy Considering the effect of similar factors 
Note. Definitions derived from Hill, 1965; Fedak et al., 2015 
Randomized controlled trials (RCTs) are the gold standard and often believed to be 
the most effective and robust research design because they attempt to reduce all biases that 
can invalidate results and can therefore be used to make inferences about causality (Barlow, 
2003). However, they are not always practical or ethical especially with risk research (Mann, 
2003) such as the current research. Therefore, in the current Chapter the effect of the RFs on 
fertility was ascertained from pooled estimates of observational studies. The inclusion of 
observational studies only limited the determination of an exact causal relationship. 
Therefore, in the absence of RCTs, the evaluation of the causal nature of a relationship can 
be enhanced by applying the Bradford Hill criteria to the evidence. For example, an 
integration of the results of the meta-analyses conducted in the present Chapter with existing 
epidemiologic and molecular level evidence, can also be used to further determine causality 
as per criteria 6, 7 and 8 (Table 3.2).   
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IV. Visual representation of proposed pathways
The consideration of causality implied in the Ezzati selection criteria and the 
Bradford Hill criteria presented a need to clearly propose how RFs were considered to link to 
fertility problems. Diagrams depicting proposed pathways describing potential impact of RF 
on fertility were developed to depict these associations, to help identify gaps in the literature 
and to guide recommendations for future research. The diagrams were derived from the body 
of past research and the results of narrative and meta-analyses conducted in the present 
Chapter. 
 Figure 3.1 shows the general form of these diagrams. These diagrams illustrate the  
proposed pathway between exposure and fertility health, namely exposure to the RF, the potential 
mechanisms involved in its effect and the fertility outcomes associated with exposure to the 
RF in the available literature. This is the generic template that was modified for each risk 
factor. Exposure is defined as per Porta (2014, p. 104): “the variable whose causal effect is to 
be estimated”. Mechanisms are the potential pathways via which exposure leads to the 
outcomes (e.g. exposure to sexually transmitted infections [STIs] can lead to the inability to 
achieve pregnancy via tubal damage). More distal risk factors, such as education or socio-
economic status are not shown on the figure, as the overarching aim of this thesis was to 
understand the effects of the novel risk factors identified for examination in this study. The 
potential mechanisms shown in the diagrams are informed by an aggregation of the 
information available in the best quality reviews in the literature.  Biological 
mechanisms refer to changes or effects to physiology or anatomy (e.g. contracting an 
infection or the formation of scar tissue).  Behavioural mechanisms refer to an effect on the 
actions people take as a result of the exposure (e.g. abstaining from sex after exposure to 
HIV). Clinical care mechanisms refer to the clinical care required due to the exposure (e.g. 
obstetric care will change for a woman with Female Genital Mutilation/Cutting [FGM/C]). 
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Outcome is the consequence of the exposure, defined as “all the possible results that may 
stem from exposure to a causal factor” (Porta, 2014, pp 206). In this study, outcomes are 
markers of fertility problems as present in available studies and can include an inability to 
achieve pregnancy, gestational or delivery problems, an inability to achieve live birth or 
neonatal death. 
Figure 3.1. Proposed pathways describing potential impact of RF on fertility. Figure shows 
the exposure, the potential mechanisms and the potential outcomes affected.  
V. Overall Aim of all Systematic Reviews
The main aim of the present reviews was to determine whether the investigated factor 
should be included as a new RF in the adapted FertiSTAT for use in LMICs. For the intent
of this review the influence of a RF on any dimension of fertility that leads to reduced 
pregnancy or reduced live births was included under the umbrella term ‘fertility problems’, 
and outcomes indicative of ‘fertility problems’ (e.g., being childless, episode of infertility) 
obtained from primary studies were noted. Therefore, RFs shown to be associated with 
poorer fertility on any of these outcomes (e.g., lower likelihood of pregnancy, longer 
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time to live birth, diagnosis of tubal factor infertility) were considered for inclusion in the 
FertiSTAT. Therefore, an RF found to impair ability to become pregnant would be included 
in the adapted FertiSTAT, whereas if the effect were limited to impaired ability to have a live 
birth it would not be included in the adapted self-administered FertiSTAT but will be used to 
inform comprehensive educational awareness programs such as a flipchart based on 
FertiSTAT.  
VI. General Method for all Systematic Reviews and Meta-analyses
Guidelines such as the Centre for Reviews and Dissemination (CDR, 2008) were used 
to develop methodology for the current systematic reviews. The CDR recommends checking 
for an existing review addressing the research question before undertaking the current review. 
If such a review is found then its quality should be evaluated systematically using established 
checklists or criteria (CRD, 2008). The Guidelines recommend that evaluation should include 
determining whether a well-defined research question guided the review, the methodology 
used was comprehensive, rigorous and well reported, there was no bias in the assessment of 
primary studies, data extraction and synthesis, and the review process was transparent and 
reproducible.   
Using these guidelines the following strategy was adopted for all RF reviews in the 
present chapter.  Figure 3.2 illustrates the strategy.  A systematic search was conducted using 
the relevant terms.  If the search identified reviews published less than five years previously 
then these were evaluated using the “Critical Appraisal of Systematic Reviews” (WHO, 
Abalos, Carroli, Mackey & Bergel, 2001). If the review met quality criteria then it was 
summarized in the current review and upheld as the most valid evidence for that risk factor. If 
a review was not identified or an existing review was of poor quality or published more than 
5 years previously then standard systematic review methodology was followed. Specifically,  
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the primary studies identified in the search were subjected to screening, assessing 
eligibility using inclusion and exclusion criteria, quality evaluation, meta-analysis (where 
relevant) and reporting. If the eligible primary studies contained relevant data a meta-analysis 
was conducted otherwise the results were summarised narratively. For all RFs, results of the 
systematic review were aggregated with extant literature to develop pathway diagrams that 
could aid in the decision about inclusion in FertiSTAT and gaps in knowledge that need to be 
addressed in future research. The specific steps in the review procedure are shown below. 
Search Strategy 
Ovid Medline was searched from 1946 to April 2015.  Fertility problems were 
searched and combined with ‘OR’ using the following MeSH terms: ‘female fertility’, 
‘female infertility’, ‘fertility’ and ‘infertility’. All terms related to the potential RF (e.g. 
consanguinity) were searched and combined with ‘OR’. Search terms for the RF were 
combined with search terms for fertility problems using ‘AND’ (see Appendix E for the order 
of steps and MeSH terms used). No limits on language or date were used in the search. The 
same search strategy was used to search Embase 1947 to July 2015, the Cochrane library and 
other databases that might be relevant to low resource settings including LILACS, INDMED, 
Africana Periodical Literature and African Index Medicus. Key organisational websites were 
searched using the same search terms, including the WHO, United Nations Population Fund 
(UNFPA), as well as regional sites of these organizations such as the Eastern Mediterranean 
Regional Office (EMRO) and African Regional Office (AFRO) of the WHO.  
For all reviews the primary outcome used was ‘fertility problems’. The same search 
terms (fertility and infertility) as those used in the development of the FertiSTAT (Bunting & 
Boivin, 2010) were used in the current review.  All outcomes yielded from these search terms 
(e.g. time to pregnancy, medical diagnosis of infertility) including outcomes of gestational 
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problems and childlessness, were included. The gestational problems and childlessness 
outcomes were used to enable an examination of the impact of the RF on ability to become 
pregnant separately from the ability to have a live birth. 
The exclusion criteria were: (1) use of non-human animal data only, (2) use of male 
data only, (3) fertility related outcome not reported, (4) association between the RF and 
fertility outcome not reported, (5) the RF reported not of interest, (6) time to birth/duration of 
childlessness was (on average) less than 21 months because that would imply that pregnancy 
had occurred within the presumed fertile period of 12 months (i.e., 12 months trying plus 9 
months gestation) and (7) study used secondary or qualitative data or was a publication or 
duplicate record of an included study (see Appendix F for full list of exclusion criteria). 
A search of the reference lists of the included articles was conducted to identify new 
studies and authors were contacted for missing information. All searches were updated in 
December 2016 to ensure newer studies were included. To ensure the comprehensiveness of 
the original search terms we had to determine if we had missed relevant studies that measured 
the RF and specific fertility problems without mentioning the word fertility and infertility. 
Therefore, we tested the robustness of our decision by replicating the searches combined with 
MeSH terms for specific fertility problems (e.g., tubal occlusion, amenorrhea, time to first 
birth) that did not include the words fertility and infertility, see Appendix G for list of 
updated MeSH terms.  Results reported in each review pertain to original and updated 
searches (number reported separately in review flow charts). 
Assessment of Bias 
The term bias is defined as divergence of results or inferences from the truth, or any 
process leading to such a change (Grimes & Schulz, 2002). There are various types of bias 
that can affect the internal validity of meta-analyses: selection bias, information bias, recall 
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bias, and bias due to confounder. In the present study the different types of bias were assessed 
using the modified version of the Newcastle-Ottawa Scale [NOS] (Wells, et al., 2010).  
Selection bias occurs when the exposed and non-exposed group differ on important 
aspects other than the exposure, which can cause misleading results (Grimes & Schulz, 
2002). Information bias occurs when data is collected in a different manner from the exposed 
and non-exposed groups (Grimes & Schulz, 2002). Recall bias arises when there is 
differential reporting of information (intentional or unintentional) about the exposure or 
outcome by subjects in one group compared to the other group (Sackett, 1979). This can lead 
to misclassification of the subjects according to the exposure or outcome (Grimes & Schulz, 
2002) and can be a risk to the internal validity of the study (Hassan, 2005). Recall bias is 
greater in situations where the disease or event being studied is critical or significant e.g. 
cancer, congenital malformations; if a specific exposure is perceived as a RF for the disease 
or if a scientifically ill-established association has been publicised by the media (Margetts, 
Vorster & Venter, 2003; Wynder, 1994; Raloff, 1998).  Bias due to confounder occurs when 
confounders are not taken into account either through study design or in the statistical 
analysis. A confounder is a variable that is associated with the exposure and has an impact on 
the outcome, but is not an intermediate link between the two (Grimes & Schulz, 2002). 
Researchers should identify all possible variables that can indirectly affect the association 
under study, and develop a suitable design that can incorporate the effect of these variables. 
This can be done through matching of exposed and non-exposed group subjects, by including 
these confounders in a multivariate analysis of the data or by stratification, i.e. the grouping 
of results by levels of the confounder (Grimes & Schulz, 2002).   
Data Extraction and Quality Assessment 
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A standard form was developed and used for extraction of data from included studies. 
The author and her supervisor pilot tested several iterations of the standard form, see 
Appendix H.  The author and research assistant (Kawther Mohamed, KM) extracted the 
information.  Information was extracted on study design (case-controlled, cross-sectional), 
sample (location, size), definition of RF (type of relative, coefficient of inbreeding), the 
primary outcome fertility problems (as indicated by different outcomes available for each 
RF), confounders and data relevant to effect size calculation. Quality assessment of the 
included studies was based on an adapted version of the NOS and included six criteria. First, 
RF was adequately assessed when there was independent validation (e.g. more than one 
person/record/time/process, or reference to primary record source such as medical/hospital 
records) (1 point) and if the RF was representative of the cohort i.e. drawn from the same 
population (1 point). Second, controls (non-exposed) were considered to be adequately 
assessed when selection was comparable to cases, and RF was excluded properly in the 
control population (up to 2 points). Third, comparability of controls was achieved if 
exposed/non-exposed were matched or adjustment for confounds made during analysis. One 
point was awarded for control of (the most relevant confounder for that RF) or for any other 
confounder (e.g. education) for a maximum of 2 points. Fourth, confounders were considered 
adequately assessed if data were obtained from records or a blind interview (1 point), and 
when the same method was used for both case and control groups (1 point) (maximum 2 
points). Fifth, fertility problems outcome was adequately assessed if independent or blind 
assessment was stated in the study, or confirmation of the outcome by reference to secure 
records (e.g. medical records) (up to 1 point). Sixth, one point was given if attrition was less 
than 20% for both groups (this is only applicable to longitudinal studies). The overall quality 
rating was low (0 to 3 points), average (4 to 6 points), or high (7 to 10 points). 
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Publication Bias 
Bias that can affect the generalizability of the results of the review such as publication 
bias, was also examined. Publication bias refers to the situation where research findings are 
published or not-published, contingent on the nature and direction of the results (Higgins & 
Green, 2011, Chapter 10). Although the selective recommendation by peer reviewers has 
been suggested as a source of publication bias, it appears that the selective submission of 
papers by authors may be the prevailing contributor. One method suggested to avoid this 
bias is the inclusion of grey literature (Higgins & Green, 2011, Chapter 10). Publication bias 
can be investigated using various techniques including funnel plots. It has been suggested in 
the literature that 10 or more studies are required to enable visual assessment of the funnel 
plot (Mavridis & Salanti, 2014).  With fewer studies the test would have very little power to 
distinguish real funnel plot asymmetry from chance (Higgins & Green, 2011, Chapter 10).  
Funnel plots can be supplemented with other tests of publication bias such as Eggers test and 
trim and fill procedures. Egger’s test is used to identify if there is evidence of any bias, 
whereas trim and fill is used to assess the impact of the bias (Borenstein, Hedges, Higgins & 
Rothstein, 2009, Chapter 30). Egger’s test calculates the slope of the regression (bias 
coefficient) which is used to specify the degree of bias. Trim and fill method is an iterative 
non-parametric procedure used to impute the number of “missing” studies in the meta-
analysis, and to calculate the adjusted pooled effect estimate with the “missing” studies. 
However, the trim and fill procedure assumes that publication bias is the only source of 
funnel plot asymmetry, which is an unrealistic assumption (Mavridis & Salanti, 2014). These 
methods do not guarantee the validity of the results of the meta-analysis (Sutton, Song, 
Gilbody & Abrams, 2000; Kicinski, 2014), but they allow an identification of a potential 
shortcoming of the review. All these methods were used in the present study to ascertain the 
presence and impact of publication bias on the results of the current meta-analyses.  
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Data Synthesis and Analysis 
Review Manager (RevMan) [Computer program]. Version 5.3. (Copenhagen: The 
Nordic Cochrane Centre, The Cochrane Collaboration, 2014), was used to calculate effect 
sizes and meta-analysis and to generate forest plots.  The primary outcome measure of 
association between an exposure and an outcome used was the odds ratio (OR). ORs were 
calculated from raw data presented in the primary studies as number of events and totals 
(Kirkwood & Sterne, 2003, Chapter 16, pp159-160, see Appendix I for calculations).  
In all included analyses an OR of one implied no difference between the exposed (RF) 
and non-exposed (no-RF) groups, an OR greater than one indicated that the exposed group 
were more likely to have fertility problems (as indicated by the outcomes available in each 
search) than the non-exposed group, and an OR less than one indicated that the exposed 
group were less likely to have fertility problems than the non-exposed group.   
When means and standard deviations were presented in the primary studies, the 
primary outcome measure was the mean difference (MD) between exposed and non-exposed 
groups and original units of measurement were used. Meta-analyses were computed 
separately for the different outcomes of fertility problems that were reported in the primary 
studies in each review.  
Given that multiple mechanisms may influence how the RFs affect fertility there may 
not be one true effect size, therefore a random effects model was deemed appropriate for the 
data analysis. Heterogeneity was tested using the Q statistic and I² index, which specifies the 
proportion of variance in the effect size not due to chance. Where heterogeneity was 
statistically significant, subgroup/sensitivity analysis were conducted. The subgroup analyses 
were based on differences in methodological characteristics of the study e.g. type of control 
group, subcategories of infertility (tubal factor vs ovulatory). Funnel plots, Egger’s test and 
trim and fill procedures were used to evaluate publication bias using Comprehensive Meta-
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Analysis software (Comprehensive Meta-Analysis (Version 2) [Computer software]. (2014). 
A probability level of P<0.05 was used to determine the significance of change in the pooled 
effect size. Where there were only two studies in an analysis publication bias could not be 
assessed using funnel plots or trim and fill. Any alterations to this general method were 
reported in the individual reviews’ method section.   
When data in primary studies were not sufficient to calculate pooled estimates in 
meta-analyses a narrative review of the systematic evidence was conducted. In such cases the 
available evidence from the search and from known sources was summarized and conclusions 
on the potential impact of the RF on fertility were reported.  
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Study 3.1: Systematic Review and Meta-analysis of observational studies examining the 
association of consanguinity and fertility problems 
Introduction 
Consanguinity was one of the risk factors identified through the process of adapting 
the FertiSTAT and was endorsed by the experts in Study 2.1 (Chapter 2, pp. 25). The validity 
of this risk factor as a predictor of fertility problems was examined in the current systematic 
review using the operational definitions of fertility problems and risk factor applied in the 
original development of FertiSTAT (Bunting & Boivin, 2010). 
 
Description of consanguinity 
A consanguineous (CSG) marriage is one that is contracted between close biological 
relatives (Bittles, 2001). Consanguinity (CSG) can be measured using a coefficient of 
inbreeding, which expresses the degree of relatedness of the couple as a percentage of shared 
genetic makeup between the two individuals. Figure 3.1.1 is an illustration of degree of 
relatedness among different family members. As shown in Figure 3.1.1 a person married to 
their first cousin would have 12.5% shared genetic material.  Marriages further than second 
cousins (i.e., coefficient of inbreeding equal to or less than 0.0156) are not considered CSG 
as the shared genetic material in these marriages is similar to that in the general population. 
The worldwide prevalence of CSG marriages is divided into areas of low (less than 1%), 
medium (1-10%) and high (20-50%) percentage of marriages (Bittles, 2001; Bittles, 2014).  
Figure 3.1.2 shows that America, Europe and Australasia are in the low group, Japan and 
South America in the medium group and North Africa, West, Central and South Asia in the 
high group. Sudan has one of the highest prevalence of CSG in the world, with more than 
50% of marriages being CSG, second only to Pakistan (Bittles, 2014). Some religions like 
Judaism, Buddhism and Islam allow CSG marriages whereas other religions such as 
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Christianity and Hinduism prohibit first-degree cousin marriage (Bittles, 2001). In many 
countries including China and some American states, there are civil laws prohibiting CSG 
marriages. First-degree cousin marriage is not prohibited in the Quran, and is considered as 
Sunna meaning that it is ‘favoured’ (Bittles, 2001). These religious and legal differences 
between countries can help explain international differences in rate of CSG shown in Figure 
3.1.2. There is a distinction between CSG and endogamy. The former is marriage between 
biological relatives whereas the latter is marriage between members of a, tribe, ethnic group 
or clan  
Figure 3.1.1. Degree of relatedness in CSG relative to the self. Numbers in the red box 
represent the degree of relatedness as a percentage of shared genetic makeup to self. Blue 
shading is uncle/aunt, Green shading is cousin. Yellow shading is parents, siblings, 
grandparents, grandchildren, nieces and nephews. Figure from 
http://greatoaksgrow.blogspot.com/ Copyright by Judi Heit. Reprinted with permission 
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Figure 3.1.2. Prevalence of consanguinity. Figure from Bittles A.H. and Black M.L. (2015) 
Global Patterns & Tables of Consanguinity. http://consang.net Copyright by A. H. Bittles 
[2009]. Reprinted with permission 
(Bittles & Black, 2010). In endogamy the genes from a common ancestor will pool more 
gradually than in a CSG marriage, thus the effect of the shared genes will take longer to 
become manifest. Additionally, a study of endogamous groups would theoretically show the 
impact of inbreeding due to the couple only as well as due to the several in bred generations 
i.e. effect of inbred parents on their reproductive abilities and progeny. Thus, a study
examining the effect of CSG on individual infertility should be limited to the effects of 
marriages between relatives rather than focusing on populations with high rates of endogamy, 
to enable inferences on the direct impact of couple genetic similarity on individual fertility.  
Plausible Mechanisms to Explain why CSG Could be Associated with Fertility Problems 
Numerous causal mechanisms linking CSG and fertility have been proposed to 
explain the heterogeneity in study results, see Figure 3.1.3. The arguments proposing that 
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CSG could indirectly have a positive effect on fertility, have suggested the following 
mechanism as an explanation; younger age at marriage, longer reproductive span, 
reproductive compensation and gamete compatibility. Cultures that encourage CSG 
marriages also encourage a younger age at marriage, and thus younger age could be a 
moderator of the effect of CSG on fertility. In cultures where CGS marriages are most 
common, the average age of marriage for women tends to be much younger (e.g. 17.8 in 
India, for 2006) than where CSG is relatively rare, for example in western countries [e.g. 29.9 
in the UK for 2009] (UN, Department of Economic and Social Affairs, Population Division, 
2013). Age and age at marriage can impact on other risk factors that could then potentially 
have a cumulative effect, as in the case of the multiplicative relationship between age and 
time trying (Bunting & Boivin, 2010). Younger age may lead to higher pregnancy rate 
because of age per se, or because the longer reproductive span would allow reproductive 
compensation over time. Reproductive span refers to the period during which the individual 
is biologically fertile and thus able to reproduce (International Institute for population 
Sciences, 2000).  Reproductive compensation refers to the eventual replacement of lost 
infants or foetuses with surviving infants through subsequent reproductive effort (Reed, 
1971).  Age, a longer reproductive span and reproductive compensation have been examined 
in studies assessing the impact of CSG on pregnancy, abortion, stillbirth and live birth rate.  
It has also been proposed that CSG has a negative impact on fertility. One argument is 
that the concentration of recessive genes leads to increased morbidity and mortality in the 
offspring of CSG couples due to increased homozygosity and the genetic abnormalities it 
produces (Bittles & Black, 2010). Recessive genes are those that are only expressed in the 
offspring if inherited from both parents, and increased homozygosity refers to offspring that 
have inherited the same gene from both parents regardless of whether the gene is recessive or 
not (Hamamy, 2012). 
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Figure 3.1.3. Proposed pathways for the impact of Consanguinity (CSG) on fertility. Solid 
line = Recent evidence (primary studies); Double solid line = meta-analytic evidence; 
Dashed line =Proposed pathway/historic evidence; Dashed-Dotted line = Well established  
Reproductive Health Consequences of CSG 
Extant research is mixed about whether CSG is a risk factor for fertility problems, 
with some studies reporting a negative impact, while others report a positive impact. Table 
3.1.1 condenses results of five reviews summarized below. The reviews summarized were 
subjected to quality evaluation using the “Critical Appraisal of Systematic Reviews” 
published by the WHO (Abalos, Carroli, Mackey & Bergel, 2001). 
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Table 3.1.1. 
Summary of reproductive health consequences of CSG reported in the literature 
Reproductive 
outcome  
Effect of CSG Statistics reported 
(where available) 
Review  
 Positive effect    
Live birth rate Statistically significant in 
the first cousin only but not 
in other categories of CSG 
 
First cousins had 0.26 
more children  
Bittles et al., 
2002 
 
 Higher live birth rate in first 
cousin marriages compared 
to non-CSG marriages 
Mean live births range in 
first cousins (2.26-7.48) 
in non-CSG (2.14-5.83) 
Hussain and 
Bittles, 2004 
 Negative effect    
Mortality of 
offspring   
More mortality in progeny 
of first cousins compared to 
non-CSG progeny 
Meta-analysis showed 
significant mean excess 
mortality of 3.5% in the 
CSG progeny (r2 = 0.70; 
P < 0.00001) 
 
Bittles & Black, 
2010 
Mortality and 
morbidity of 
offspring   
Higher rates of infant 
morbidity and mortality in 
offspring of CSG couples 
than non-CSG couples 
where reported 
Range of infant 
morbidity 1.34-42% in 
CSG and 0.81-25% in 
non-CSG, mortality 0.95-
8.6% in the CSG and 
0.63-5.3% in non-CSG  
 
Bhasin & 
Shampa, 2012 
Recessive 
genes in 
offspring  
Probability of inheriting 
recessive gene increases 
with the increase in the 
proximity of the relationship 
between parents 
NR Hamamy, 2012 
Note. NR = not reported; CSG = consanguinity/consanguineous  
 
In a systematic review of the CSG literature, Bittles, Grant, Sullivan, and Hussain 
(2002) included data from 30 populations in six countries, and investigated the number of 
live births in four CSG categories (second cousin, uncle-niece, first cousin and double first 
cousin) versus non-CSG groups. A positive association between CSG and live births at all 
levels of CSG was reported, reaching statistical significance at first cousin level, indicating 
that first cousins had on average 0.26 more live births than non-CSG couples. In addition to 
the systematic review, multivariate analysis was also computed on data from the National 
Family and Health Survey conducted in India (1992-1993) to examine the effect of 
socioeconomic variables. The results of the multivariate analysis revealed no significant 
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association between CSG and live births when variables predictive of high fertility (i.e., 
duration of marriage, reproductive compensation, illiteracy, earlier age at marriage and lower 
contraceptive uptake) were included in the analysis. From these data, Bittles et al. (2002) 
concluded that the two most important variables to explain higher live births in 
consanguineous marriages were a longer reproductive span and reproductive compensation. 
Other proposals have been made for a beneficial effect of CSG on live births.  For example, 
that the similarity and presumed compatibility of the uniting gametes (maternal and paternal) 
due to shared genes is beneficial (Shami, Schmitt, & Bittles, 1990; Hann, 1984; Bittles, 
Mason, Grenne & Rao, 1991) but no evidence has been given to support this hypothesis. 
In a narrative review Hussain and Bittles (2004) reported results of the effects of CSG 
on live birth rate, from a literature review of CSG studies and Demographic and Health 
Survey (DHS) data from Pakistan and India. The authors used the comprehensive database on 
consanguineous marriage which was developed by Bittles and is reported to be the most 
comprehensive database of all published and unpublished studies on CSG. Additionally, data 
from the DHS were used to estimate live birth rate in CSG and non-CSG marriages. Although 
the methodology of the review was adequate pooled estimates were not reported. Results 
from the literature review showed a higher live birth rate in first cousin marriages compared 
to non-CSG marriages, however, this finding was not supported using DHS data. 
Specifically, data from Pakistan showed lower live birth in CSG versus non-CSG marriages, 
and data from India showed similar rates between CSG and non-CSG groups. Paradoxically, 
the multivariate analysis in India and Pakistan showed that CSG was associated with lower 
maternal education, younger maternal age at marriage, less contraceptive use, and rural 
residence; all factors associated with higher live birth.  The proposed explanation for this 
paradoxical result was that there could be misclassification of degree of CSG in the Pakistani 
DHS data.  The participants may have misclassified themselves as closer relatives (first 
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cousins) when the relationship was in fact further apart, which is likely because of the highly 
endogamous nature of the Pakistani society (Hussain & Bittles, 2004). This misclassification 
would then inflate the degree of non-genuine consanguinity, which in turn would dilute the 
effect of CSG marriages, hence underestimating the effect.   
In a review on the impact of CSG on fertility, Bittles and Black (2010) conducted a 
meta-analysis examining case-controlled studies comparing progeny of first cousins with 
non-CSG progeny in 69 populations (15 countries) with a total sample size of 2.14 million. 
Although the review was very comprehensive and meta-analysis was conducted search 
methodology was not reported and could thus not be gauged or replicated. The results 
revealed a significant mean excess mortality of 3.5% in the CSG progeny versus non-CSG 
group.  The difference was attributed to biological factors (i.e. homozygosity of recessive 
genes) as well as contextual factors, such as marital violence and family income.   
In a recent review of studies in India examining the relationship between CSG and 
fertility, 78 studies from India were examined with regards to increased morbidity and 
mortality in the offspring of CSG versus non-CSG couples (Bhasin and Shampa, 2012). The 
authors present data mainly on India and a brief summary of studies published elsewhere, 
however, search methodology was not presented, limiting an evaluation of the quality of 
methods. Higher rates of infant morbidity and mortality in offspring of CSG couples than 
non-CSG couples where reported, but a meta-analysis was not conducted, therefore no 
overall pooled effect size were available. The range of infant morbidity reported was 1.34-
42% in the CSG and 0.81-25% in the non-CSG groups, while mortality was 0.95-8.6% in the 
CSG and 0.63-5.3% in the non-CSG groups, results varied by disease and region included in 
the reviewed studies. According to Hamamy (2012) a possible explanation of this higher rate 
is that the common genetic material increases the likelihood of recessive genes being pooled 
i.e. increased homozygosity for harmful genetic conditions.  
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In a narrative review of the literature on social and biological aspects of 
consanguinity, Hamamy (2012), reported on studies that indicate an increased expression of 
autosomal recessive disorders due to mutations inherited from a common ancestor. Although 
this review was comprehensive in its coverage of topics and number of studies cited, search 
methodology was not reported, limiting evaluation of the review and replicability. The results 
showed that the probability of inheriting identical copies of the recessive gene increases with 
the increase in the proximity of the relationship between the parents. However, specific rates 
or overall effects were not reported because this was a narrative review. Thus offspring of 
CSG couples are more likely to have expression of harmful autosomal recessive disorders. 
Although these disorders can result in increased loss of foetuses and infant mortality they 
would not impact the ability to achieve pregnancy. As such they might need to be included in 
the FertiSTAT 
In addition to the reviews discussed thus far, another argument supporting the 
negative impact of CSG comes from studies of the Hutterites, a group of 30,000 people that 
descended from 100 ancestors, with a very high rate of inbreeding (Martin, 1979). The 
suggested mechanism is that couples’ that share human leukocyte antigens (HLAs) will take 
longer to become pregnant (Ober, Elias, Kostyu & Hauck, 1992; Ober, Hyslop, & Hauck, 
1999). HLAs (also known as major histocompatibility complex [MHC]) are a group of genes 
that are part of the immune system (Janeway, Travers, Walport & Shlomchik, 2001). The 
HLAs help the immune system to differentiate self-cells from non-self-cells (foreign cell). A 
cell that has the person’s HLA will be recognised as a self-cell, whereas a cell not displaying 
the persons’ HLA will be identified as foreign and the immune system will respond 
accordingly. Some HLAs are involved with foreign proteins inside the cell (HLA-A, B and 
C) and others are involved with foreign proteins outside the cell (HLA-DP, DM, DOA, DOB, 
DQ, and DR). HLA compatibility refers to similarity of antigens, for example between donor 
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and recipient in a transplant or between the foetus and mother in pregnancy (Bolis, Soro, 
Martinetti Bianchi, & Blevedere, 1985). A CSG couple share more HLAs than a non-CSG 
couple and the closer the level of CSG the more HLAs will be common. Consequently, HLA 
compatibility between foetus and mother will increase with level of CSG because the HLAs 
inherited from the father will be similar to those of the mother. Ober et al. (1992) studied the 
effect of HLA on pregnancy in 104 couples among the Hutterites of the United States. The 
average degree of relatedness in the sample was slightly greater than that of first cousins once 
removed (coefficient of inbreeding F=0.0368). HLAs were determined by genetic testing of 
blood samples from all participants in the study. A significantly longer time to clinical 
pregnancy was observed in the Hutterite group that had shared antigens at a specific type of 
locus (HLA-DR) than in the group that did not have shared antigens at that locus. 
Specifically, the group with shared HLA-DR took 5.1 months to become pregnant whereas 
the group with no shared HLA-DR took 2 months.   
The effect of inbreeding on time to pregnancy was re-examined in the Hutterites in a 
later study (Ober et al., 1999). In this study a sample of 132 women was sampled from a 
subgroup of the Hutterites known as the S-leut (average coefficient of inbreeding F=0.032). 
Results indicated that the time to pregnancy was significantly longer in women with F greater 
than 0.04 (6 months), compared with women with F less than 0.04 (less than 5 months). As 
the difference in foetal loss was not significant, it suggested that the longer time to pregnancy 
was likely due to delay in conceiving rather than delay due to repeated miscarriage. It is 
important to note that in both Ober et al. (1992) and Ober et al. (1999), inbreeding was 
studied at a population level, which means that inferences may not be applicable at the 
individual couple level. Since couples in endogamous populations are themselves descended 
from parents and grandparents that are genetically similar it is difficult to determine if the 
effect on fertility is that of the parent being a progeny of relatives or the effect of the couple 
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being related. The findings on time to pregnancy in the Hutterites will therefore not be used 
to support the current review, rather they are provided to elucidate potential mechanism of 
action that could provide a plausible explanation for the impact of shared genes on fertility 
problems. 
The mixed results in extant literature may be due to methodological difference in: 
outcomes (pregnancy, live birth); exposure duration and time frames (12, 24 months, 5 years, 
current, life time), and;  sample (population or individual). Heterogeneity in design makes it 
difficult to ascertain whether CSG impacts on ability to get pregnant, to maintain a 
pregnancy, or morbidity and mortality of the offspring. Hypotheses about which aspects of 
the reproductive process are affected have been proposed, however, a lack of rigour and 
consistency in reporting on search methodology in the available reviews limits their utility 
and necessitates a systematic review with rigorous methodology and transparency.   
 
Rational, Aim and Objectives  
The results of the studies reviewed thus far indicated that CSG (shared genetic 
material) may compromise fertility at multiple points in the reproductive process, including a 
longer time to pregnancy (conception), a lower or higher number of live births (gestation), 
and higher infant mortality and morbidity (postnatal). The biological plausibility of CSG 
effects on the reproductive process coupled with the high prevalence of CSG in some 
developing countries and the results of the survey of physicians [CSG endorsed as a potential 
risk factor by 50% of responders] (Chapter 2, pp. 25), highlights the need to investigate 
whether CSG should be included as a risk factor in the adapted FertiSTAT. The present study 
reports on results of a systematic review and meta-analyses of studies on consanguinity. The 
objective of the review was to examine whether CSG was associated with fertility problems 
in women, and at what point in the reproductive process CSG might exert its effects.  The 
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population of interest for the reviews was women, the exposure was CSG at the individual 
level and the outcome of interest was fertility problems. In the current study analyses were 
separated by outcome (pregnancy and childlessness) as well as duration (time to first birth, 
10/20 or more years of marriage and lifetime) to identify whether the effect of CSG was on 
ability to become pregnant or post-implantation (gestation, perinatal) and how long CSG 
exerts its effect. The overall aim of this review was to determine whether CSG should be 
included as a risk factor in the adapted FertiSTAT. 
Materials and Methods 
Search Strategy 
The search terms included words related to consanguinity, for a complete list of 
MeSH terms see Appendix J. Studies were excluded if level of CSG was at group level (i.e. 
kinship and endogamy), because only the effects of CSG on the individual was of interest, 
therefore endogamy or kinship was not included.   
Data Extraction and Quality Assessment 
The data extraction form (Appendix H) was adapted to include information relevant to 
CSG. The NOS form was adapted to reflect quality criteria for the assessment of CSG and 
additional confounders. GTB was adequately assessed if independent validation of the degree 
of relatedness was assessed (e.g. more than one person/record/time/process, or reference to 
primary record source such as medical/hospital records) or coefficient of CSG was 
calculated. The most relevant confounder was ‘age at marriage’. 
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Data synthesis and analysis
Meta-analyses were computed for the outcomes reported in the studies and subgroup/
sensitivity analyses were planned according to methodological characteristics of the study, 
including duration of outcome measure.  One study reported on several groups with varying 
durations of marriage (Rao, 1979).  The results from the different subgroups within this study 
were treated as different studies in the analyses, because the groups were independent. 
          Results 
Study selection 
Figure 3.1.4 shows the flowchart for number, reason and stage of exclusion of 
articles. A total of 451 records were identified (after duplicates removed) and most studies 
(274 of 451, 60.8%) were excluded because they included male data only, did not include the 
outcome of interest, reported no association between fertility problems and CSG or reported 
CSG at group level only. For three of nine non-English studies (two in Japanese and one in 
Russian) translations were not available at the time of analysis, and these studies could not be 
included. Six studies used the terms ‘infertility’ or ‘sterility’, without an operational 
definition. The authors were contacted to provide the definition of ‘infertility’ and duration of 
infertility to inform decision about inclusion. Three authors replied and the studies (Guz, 
1989; Zlotogora, 1997; Fuster, 2003) were excluded because they did not meet inclusion 
criteria. One author did not reply and the study was excluded (Freire-Maia, 1975). Search of 
the reference lists of the included studies and contact with authors resulted in no additional 
studies. One study (Haq, 2008) reported on women diagnosed with PCOS and infertility in 
CGS versus non-CSG marriages, however, no other study reported similar outcome to 
compare it with. Of the 48 full text articles assessed for inclusion, 24 met inclusion criteria 
and were included in meta-analyses.  
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Figure 3.1.4. PRISMA Flow Diagram for consanguinity. Figure shows the exclusion of 
articles at the different stages and the reasons for exclusion. Records identified through 
datbase searching of Medline and Embase includes original search, an update from the time 
of original search and a search using new MeSH terms. 
The searches using the updated MeSH terms (see Chapter 3 General Methods, pp 60) 
indicated that all relevant studies had been captured using the words fertility and infertility, 
and the additional studies captured were not relevant according to our inclusion/exclusion 
criteria (e.g., on fertility in non-human animals). This was the case for all RFs reviewed.  
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Characteristics and Design of Included Studies 
Table 3.1.2 shows selected sample characteristics of the included studies. The 
majority (20 of 24, 83.3%) of studies were carried out in Asia and the Middle East and four 
(16.7%) were conducted in Europe. Only six of the 24 (25%) studies included information 
related to participant age at marriage. The average age (years) at marriage in CSG women 
was 23.1 (6 studies), in non-CSG women was 23.6 (5 studies), in CSG men was 26.3 (4 
studies) and in non-CSG men was 27.9. Table 3.1.3 shows methodological characteristics of 
included studies. The design of 20 studies was cross-sectional and four studies were cohort 
(three retrospective and one prospective). The majority obtained data through household 
interview.  CSG was reported as type of relationship between spouses (e.g., cousin, uncle) in 
all studies. The following outcomes were reported in the included studies: (1) three reported 
‘never-pregnant’, (2) five reported ‘childless’, (3) seven reported ‘miscarriages’, (4) seven 
reported ‘stillbirths’, (5) seven reported ‘neonatal death’, (6) two reported mean ‘time to 
pregnancy’ in years, (7) five reported mean number of ‘pregnancies’, and (8) seven reported 
mean number of ‘live births’. 
 
Study Quality, Fertility Problems Outcome Measure and Bias 
Table 3.1.4 shows the results of quality assessment (see table footnote for criteria).  
CSG was adequately assessed and representative of the population in 13 of the 24 studies 
(54.2%).  The non-CSG group were selected from the same populations and exclusions were 
adequately reported in 21 of 24 studies (87.5%). Comparability of at least one confounder 
was reported in 17 of 24 studies (70.8%). Half the studies used only self-report to assess  
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Table 3.1.2.  
Sample characteristics of the 24 included Studies 
Study Location  Sample (n) 
 
CSG (n) Non- CSG 
(n) 
Mean age at marriage 
Women Men 
CSG Non-CSG CSG Non-CSG 
Edo, 1985 
 
Spain 965 couples 272 693 25.74 26.02 28.9 29.2 
Hann, 1984 
 
Karnataka State in 
South India 
1885 women 722 1163 NR    
Tanaka, 
1977 
 
Fukuoka, Japan 1450 couples 
 
346 1104 NR    
Yamaguchi, 
1975 
Fukuoka, Japan 4026 couples 
 
2173 1853 NR    
Bittles, 
1993 
 
Punjabi Provence 
of Pakistan 
9520 women 4784 4736 18.97 19.74 23.81 25.97 
Rao, 1979 
 
Southern India 
District of Tamil 
Nadu 
15, 926 women 6379 9547 NR    
Shami, 
1990 
Punjabi Provence 
of Pakistan 
3329 women 2227 1102 18.95 19.93 23.7 26 
Al-Kandari 
2007 
Kuwait 7315 women 4009 3306 NR    
Bener 2006 Qatar  1515 women 818 687 NR    
         
Blanco 
2006 
Leon, Spain 2670 women 474 2196 25.63 26.70 28.81 30.39 
         
Ciceklioglu 
2013 
Bayrakli, suburb of 
Izmir, Turkey 
170 women 85 85 NR    
         
Devi 1981 Karnataka, South 
India 
3254 women            920 2301 NR    
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Study Location Sample (n) CSG (n) Non- CSG 
(n) 
Mean age at marriage 
Women Men 
CSG Non-CSG CSG Non-CSG 
Fuster 2003 Los Nogales, 
Galicia, Spain 
1581 132 1449 24.58 
Khlat 1988 Beirut, Lebanon 2801    705 2096 NR 
Khoury 
2000 
Jordan  1867    947 920 24.6 25.8 
Luna 1990 La Alpujarra, 
Andalusia, Spain 
647    75 572         NR 
Abdulrazza
q 1997 
Alain & Dubai, 
UAE 
2033 1026 100        NR 
Al Husain 
1996 
Riyadh, KSA 2001 couples 1022 979       NR 
Asha 1981 South India 377 women 156 211       NR 
Gharyeb 
2014 
Yatta, Palestine 500 women 305 195       NR 
Islam 2013 Oman  2037 women 1052 985       NR 
Saha 1990 Khartoum, Sudan 926 women 586 340       NR 
Verma 
1992 
Pondicherry, India 1000 women 308 692       NR 
Yuksel 
2009 
Malatya, Turkey 409 women 116 293       NR 
Note: CSG = consanguineous/consanguinity; a Mean age for women at the beginning of the study; NR= data not reported 
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Table 3.1.3.  
Characteristics of the design of the 24 included studies 
Study Study design Data collection Study 
period 
CSG measure Fertility Problems outcome measure 
(duration) 
Edo, 1985 Retrospective 
cohort 
Extracted from parish records and 
civil registries 
1900-
1974 
1st and 2nd degree cousins Childless marriages at the end of reproductive 
life (age 45) 
Hann, 1984 Cross-sectional Household interviews Not 
reported 
1st degree cousin and Uncle-
niece 
Primary sterility defined as never having 
conceived in (1) women who have completed 
reproduction (over 40, menopausal or widowed) 
or (2) after 10 years without contraception in 
women of reproductive age 
Tanaka, 1977 Retrospective 
cohort 
Household interviews in 2 rural 
villages and cross-checked with 
records 
Not 
reported 
CSG between spouse, 
between husband’s parents 
and between wife’s parents 
Infertility defined as never been pregnant after 
living with husband for more than 5 years 
Yamaguchi, 
1975 
Retrospective 
cohort 
Household interviews in rural 
villages and cross-checked with 
records 
Not 
reported 
CSG between spouse, 
between husband’s parents 
and between wife’s parents 
Sterility defined as no pregnancy after more than 
5 years of marriage 
Bittles, 1993 
(not in 71) 
Cross-sectional Household & hospital interviews 
in 11 cities 
1979-
1985 
Mixed, double 1st cousin, 1st 
cousin, double second cousin, 
second cousin, 
Time to first delivery from start of marriage in 
years  
Rao, 1979 Cross-sectional Household interviews in In 14 
rural and urban districts 
1969-
1975 
Mixed, uncle-niece, first 
cousin, beyond first cousin  
Primary sterility defined as a married woman 
who has not had a live-born baby after 
consummation of marriage and 
unprotected sexual activity (duration in 5 
year intervals)  
Shami, 1990 Cross-sectional from general hospital and labour 
wards, as well as door-to-door 
interviews 
1980-
1983 
Mixed, double first cousin, 
first cousin, first cousin once 
removed, second 
Cousin.  
Time to first birth from start of marriage in years 
Al-Kandari 
2007 
Cross-sectional Questionnaires filled by women 
attending 10 different PHC  
2002 Double cousin, first cousin, 
second cousin, third cousin 
Number of births per women 
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Study Study design  Data collection Study 
period  
CSG measure Fertility Problems outcome measure 
(duration) 
 
Bener 2006 Cross-sectional Questionnaires filled by face-to-
face interviews from 10 health 
centres mostly visited and 
women’s hospital 
2004 Double cousin, first cousin, 
first cousin once removed, 
second cousin, less than 
second cousin  
Number of pregnancies and live births 
      
Blanco 2006 Cross-sectional La Cabrera parish registers 1880-
1959 
Up to third degree Live births 
      
Ciceklioglu 
2013 
Cross-sectional Community based in-person 
interviews from 3 neighbourhoods 
in Bayraklu  
2009 First and second degree 
cousins 
Number of pregnancies and deliveries 
      
Devi 1981 Cross-sectional 17 hospitals, maternity homes and 
health centres from records or 
interviews by staff 
1971 Beyond second cousin, 
second cousin, first cousin, 
uncle-niece 
Mean number of live born  
      
Fuster 2003 Cross-sectional Biodemographic data from parish 
and Lugo bisphoric records 
1871-
1977 
Uncle-niece, first cousin, first 
cousin once removed, second 
cousin, second cousin once 
removed, third cousin 
Mean birth 
      
Khlat 1988 Cross-sectional 2752 household were interviewed 1983-
1984 
First cousin and more distant 
than first cousin 
Mean number of pregnancies, live births  
      
Khoury 2000 Cross-sectional  Community based, 7200 
households 
1980 Double first cousins, first 
cousin 1,2.3 and 4, first 
cousins once removed, from 
the family 
Number of pregnancies 
      
Luna 1990 Cross-sectional  Community based. 8 villages in an 
isolated mountain population 
NR Level of CSG NR Average number of pregnancies, live births 
      
Abdulrazzaq 
1997 
Cross-sectional Antenatal, postnatal and 
immunization centres based 
interviews and questionnaires 
1994-
1995 
Double first degree, first 
cousin, first cousin once 
Number of abortions and still births 
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Study Study design  Data collection Study 
period  
CSG measure Fertility Problems outcome measure 
(duration) 
removed, second cousin, less 
than second cousin 
      
Al Husain 
1996 
Cross-sectional PHC and antenatal care clinic 
interviews 
1993 Double first cousin, first 
cousin, second cousin, more 
distant relative 
Abortion, still birth and neonatal death 
      
Asha 1981 Prospective 
cohort study 
NR NR Uncle-niece, first cousin, first 
cousin once removed, second 
cousin, second cousin once 
removed, third cousin 
Abortion (termination =<28 weeks), still birth 
(born with no heart beat), neonatal death (within 
first 28 days of life) 
      
Gharyeb 
2014 
Cross-sectional Community based, personally 
interviewed by structured 
questionnaires 
NR First degree, second degree, 
third degree 
Abortion (at or before 28 weeks), still births 
      
Islam 2013 Cross-sectional ONHS data, 2013 household were 
interviewed 
2000 First cousin; father’s side, 
first cousin; mother’s side, 
other; second cousin and 
beyond 
Mean number of pregnancies, live births, number 
of miscarriage, number of still birth 
      
Saha 1990 Cross-sectional  ANC clinic in the OBGYN 
department, faculty of Medicine, U 
of K 
NR First cousins; mother’s 
brother & sister, father’s 
brother & sister, Other type of 
CSG marriages 
Abortion, Still birth, neonatal deaths 
      
Verma 1992 Cross-sectional Interview  in maternity ward in 
JIPMER hospital 
1978 First cousin; MBD or FSD, 
uncle-niece, other; beyond 
first cousin 
Neonatal death 
      
Yuksel 2009 Cross-sectional  Household interviews, face to face 
questionnaires 
NR First cousin, others; half first 
cousin and second degree 
cousin, distant CSG marriages 
Spontaneous abortions, still births 
Note. CSG = consanguineous/consanguinity; NR = not reported; PHC = primary health care 
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Table 3.1.4.  
Quality ratings for the 24 included studies on the basis of an adapted Newcastle-Ottawa quality assessment scale 
 
 
 
Study  
 
Quality Criterion  
 
Overall 
rating g 
Adequacy of 
CSG(exposed) 
measurea 
Max 2 points  
Adequacy of 
control (non-
exposed), 
definition and 
selection b 
Max 2 points  
Comparability 
of control c 
Max 2 points 
Confounders 
adequately 
assessed  
Max 2 points d 
Adequacy of 
outcome Fertility 
Problems measure e 
Max 1 point 
None response 
rate or loss to 
follow-up f 
Max 1 point 
Edo, 1985 1 2 1 1 1 NR Average 
Hann, 1984 2 2 0 0 0 NA Average 
Tanaka, 1977 2 2 1 0 1 NR Average 
Yamaguchi, 1975 2 2 1 0 1 NR Average 
Bittles, 1993 2 2 1 1 0 NA Average 
Rao, 1979 2 2 1 1 0 NA Average 
Shami, 1990 2 2 0 1 0 NA Average 
Al-Kandari 2007 1 2 1 1 0 NA Average 
Bener 2006 1 2 0 1 0 NA Low  
 
Blanco 2006 1 2 1 2 1 NA High 
Ciceklioglu 2013 2 2 1 2 1 NA High 
Devi 1981 2 2 0 2 1 NA High  
Fuster 2003 1 2 0 2 1 NA Average  
Khlat 1988 1 2 1 2 0 NA Average  
Chapter 3          Systematic Reviews 
88 
 
 
 
 
Study  
 
Quality Criterion  
 
Overall 
rating g 
Adequacy of 
CSG(exposed) 
measurea 
Max 2 points  
Adequacy of 
control (non-
exposed), 
definition and 
selection b 
Max 2 points  
Comparability 
of control c 
Max 2 points 
Confounders 
adequately 
assessed  
Max 2 points d 
Adequacy of 
outcome Fertility 
Problems measure e 
Max 1 point 
None response 
rate or loss to 
follow-up f 
Max 1 point 
Khoury 2000 2 1 1 2 0 NA Average  
Luna 1990  1 1 2 0 0 NA Low  
Abdulrazzaq 1997 1 2 1 2 0 NA Average  
Al Husain 1996 2 2 1 1 0 NA Average 
Asha 1981 2 1 1 2 0 NR Average  
Gharyeb 2014 1 2 1 1 0 NA Average 
Islam 2013 1 2 0 2 0 NA Average  
Saha 1990 1 2 1 2 0 NA Average  
Verma 1992 2 2 1 2 0 NA High 
Yuksel 2009 2 2 1 2 0 NA High  
Note. CSG = consanguineous/consanguinity; NR = not reported; NA = not applicable  
a CSG was adequately assessed when independent validation of the degree of relatedness was assessed or coefficient of CSG(F) calculated, (e.g. >1 
person/record/time/process to extract information, or reference to primary record source such as medical/hospital records) and it was representative of the cohort i.e. drawn 
from the same population (up to 2 points); b Controls were adequately assessed when selection was comparable to cases, and CSG was excluded properly in the 
control population (up to 2 points); c Comparability of controls was achieved if exposed/non-exposed were matched or adjustment during analysis conducted. 
One point for age at marriage and one point for any other confounder (e.g. education) (up to 2 points); d Confounders were adequately assessed if they were 
obtained from records or a blind interview, and one point was given if the same method was used for both groups (up to 2 points); e Fertility problems 
outcome was adequately assessed if independent or blind assessment was stated in the paper, or confirmation of the outcome by reference to secure records 
(medical records, etc.) (up to 1 point); f Point given if same rate for both groups and <20% loss to follow up reported; g The overall quality rating was low (0 
to 3 points), average (4 to 6 points), or high (7 to 10 points).
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confounders but only one of controlled for confounders. Fertility problems outcome was 
adequately measured in seven of the included studies, as indicated by blind or independent 
assessment. Overall the majority (22 of 24, 91.7%) of studies were of high or average quality 
as per quality assessment in the adapted NOS.   
Results reported in Table 3.1.5 indicated that fewer couples in the CSG group had 
never been pregnant or were childless than in the non-CSG group and the mean number of 
pregnancies and live births were higher in CSG couples than non-CSG couple. However, 
CSG couples were more likely to experience miscarriage, stillbirths and neonatal death than 
the non-CSG couples. Additionally, CSG couples experienced longer time to first birth.  
 
Table 3.1.5. 
Proportion of specific outcome in CSG and non-CSG couples in the included studies, (k=24) 
Outcome CSG  Non-CSG  
Outcome (number of studies) Number (%) Number (%) 
Never pregnant (k=3) 92 of 3241 (2.8) 186 of 4120 (4.5) 
Childless (K=5) 380 of 6651 (5.7) 717 of 10,240  (7.0) 
Miscarriages (k=7) 1069 of 3372 (31.7) 1030 of 3485 (29.6) 
Stillbirths (k=7) 243 of 3372 (7.2) 211 of 3485 (6.1) 
Neonatal death (k=7) 151 of 2072 (7.3) 144 of 2232 (6.5) 
Outcome (number of studies) Mean (SD), total  Mean (SD), total 
Mean time to first birth in years  (k=2) 1.8 (24.8), 7011 1.6 (9.4), 2608 
Mean number of pregnancies (k=5) 5.0 (3.0), 2735 4.6 (2.9), 4435 
Mean number of live births (k=7) 3.9 (2.5), 7433 3.7 (2.3), 10142 
Note. CSG = Consanguineous; Non-CSG = none consanguineous 
 
Results of Meta-analyses 
Eight meta-analyses were performed and subgroup/sensitivity analysis were 
conducted where data permitted.  Figure 3.1.5 shows the forest plot and meta-analysis result 
for the two studies investigating mean ‘time-to-first-birth’ (years). The meta-analysis showed 
a non-significant overall effect (MD 0.24, 95% CI -0.39 to 0.87) and non-significant 
heterogeneity (I² = 0%. P = 0.96). Results indicated that CSG and non-CSG groups were no 
different in time to first birth (comparable fertility problems). 
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Figure 3.1.5. Odds ratio for ‘time-to-first-birth’ (in years) in the CSG and non-CSG groups  
 
 
Figure 3.1.6 shows the forest plot and meta-analysis result for the three studies 
investigating the proportion of couples who were ‘never-pregnant’.  The meta-analysis 
showed a significant overall effect (OR 0.66, 95% CI 0.45 to 0.98), and non-significant 
heterogeneity (I² = 49%. P = 0.14). Results indicated that the CSG group were less likely to 
experience never being pregnant than the non-CSG group (less likely to have fertility 
problems). One study used a duration of 10 years of marriage or lifetime, while the other two 
used a duration of five years after marriage. A sensitivity analysis excluding the study with 
longer duration was performed, see Figure 3.1.7. When this study was removed heterogeneity 
was not significant (I²=0%, P=0.32). However, the overall effect remained significant. 
 
 
 
 
Figure 3.1.6. Odds ratio for proportion of couples who were ‘never-pregnant’ in the CSG 
and non-CSG groups  
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Figure 3.1.7. Sensitivity analysis by duration for the comparison odds ratio for proportion 
of couples who were ‘never-pregnant’ in the CSG and non-CSG groups  
Figure 3.1.8 shows the forest plot and meta-analysis result for the five studies that 
investigated the proportion of ‘childless’ couples.  The meta-analysis showed a non-
significant overall effect size (OR 0.83, 95% CI 0.74 to 0.95), and significant heterogeneity 
(I² = 60%, P = 0.04).  Results indicated that the CSG group were equally likely to be 
‘childless’ as the non-CSG group (comparable fertility problems).  One study measured 
childlessness at the end of reproductive life, while the others used five-year durations after 
marriage (5-9, 10-14, 15-19 and >20). A subgroup analysis separated studies were couples 
were childless for less than 20 years, from those that were childless for more than 20 years, 
see Figure 3.1.9.  
Figure 3.1.8. Odds ratio for proportion of ‘childless’ couples in the CSG and non-CSG 
groups 
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In the subgroup analysis of longer duration (>20 years) heterogeneity was not 
significant (I²=0%, P=0.32), and the overall effect was not significant (OR 0.88, 95% CI 0.63 
to 1.24). The same was true in the subgroup analysis of shorter duration (<20 years), where 
only the studies with less than 20 years were included (5-9, 10-14 and 15-19 years), 
heterogeneity remained significant (I² = 76%, P = 0.02), and the overall effect was not 
significant (OR 0.86, 95% CI 0.17 to 0.97).  
Figure 3.1.10 shows the forest plot and meta-analysis result for the five studies that 
investigated the mean ‘number of pregnancies’ in the CSG and non-CSG couples.  The meta-
analysis showed a significant overall effect size (MD 0.40, 95% CI 0.10 to 0.71), and 
significant heterogeneity (I² = 66%. P = 0.02).  Results indicated that the CSG group were 
more likely to have pregnancies than the non-CSG group (less likely to have fertility 
problems).   
Figure 3.1.9. Subgroup analysis by duration (>20 years vs <20 years) for the comparison 
odds ratio for the proportion of ‘childless’ couples in the CSG and non-CSG groups  
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Figure 3.1.10. Mean difference for ‘Number of pregnancies’ in the CSG and non-CSG 
groups  
Figure 3.1.11 shows forest plot and meta-analysis result for the seven studies that 
investigated the mean ‘number of live births’ in the CSG and non-CSG groups. The meta-
analysis showed a significant overall effect size (MD 0.24, 95% CI 0.05 to 0.43), and 
significant heterogeneity (I²=79%. P < 0.0001).  Results indicated that the CSG group were 
more likely to have live births than the non-CSG group (less likely to have fertility 
problems).  Figure 3.1.12 shows the sensitivity analysis for the mean difference for the 
‘number of Live births’ in the CSG and non-CSG groups. The overall effect size remained 
significant (MD 0.32, 95% CI 0.21 to 0.44) but heterogeneity was no longer significant (I² = 
19%. P = 0.29).   
Figure 3.1.11. Mean Difference for ‘Number of live births” in the CSG and non-CSG 
groups 
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Figure 3.1.12. Sensitivity analysis for the Mean Difference for ‘Number of live births” in 
the CSG and non-CSG groups (without DEVI, 1981) 
 
 
 
  
Figure 3.1.13 shows the forest plot and meta-analysis result for the five studies that 
investigated the proportion of ‘miscarriages’ in CSG and non-CSG groups.  The meta-
analysis showed a non-significant overall effect size (OR 1.10, 95% CI 0.93 to 1.30), and 
non-significant heterogeneity (I² = 50%, P = 0.09).  Results indicated that the CSG group 
were equally likely to have ‘miscarriages’ as the non-CSG group (comparable fertility 
problems).  Figure 3.1.14 shows the forest plot and meta-analysis result for the five studies 
that investigated the proportion of ‘stillbirths’ in CSG and non-CSG groups.  The meta-
analysis showed a significant overall effect size (OR 1.28, 95% CI 1.04 to 1.57), and non-
significant heterogeneity (I² = 7%, P = 0.36).  Results indicated that the CSG group were 
more likely to have ‘stillbirths’ than the non-CSG group (more likely to have fertility 
problems).   
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Figure 3.1.13. Odds ratio for proportion of ‘miscarriages’ in the CSG and non-CSG groups 
 
 
 
 
Figure 3.1.14. Odds ratio for proportion of ‘stillbirths’ in the CSG and non-CSG groups  
 
 
Figure 3.1.15 shows the forest plot and meta-analysis result for the four studies that 
investigated the proportion of ‘neonatal death’ in CSG and non-CSG groups.  The meta-
analysis showed a significant overall effect size (OR 1.57, 95% CI 1.22 to 2.02), and non-
significant heterogeneity (I² = 0%, P = 0.46).  Results indicated that the CSG group were 
more likely to have ‘neonatal deaths’ than the non-CSG group (more likely to have fertility 
problems). 
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Figure 3.1.15. Odds ratio for proportion of ‘neonatal deaths’ in the CSG and non-CSG 
groups  
Publication bias assessment. 
Publication bias was assessed using funnel plots, Eggers test and trim and fill 
procedures for seven of the eight analyses, but this was not possible for the ‘time-to-first-
birth’ analysis because it comprised only two studies and the software was unable to compute 
any publication bias analysis. Publication bias was not assessed by visual assessment of 
funnel plot asymmetry exclusively because there were less than 10 studies (Higgins & Green, 
2011, Chapter 10).  Egger’s tests performed for the seven meta-analyses were all not 
significant at P<0.05, indicating the lack of publication bias. Trim and fill was used to 
estimate the number of ‘missing’ studies and if there were any changes to the magnitude of 
the pooled effect size if ‘missing’ studies were included. The procedure revealed two missing 
studies in the analysis ‘never-pregnant’ (Figure 3.1.16) and addition of the ‘missing’ studies 
reduced the pooled effect size from (0.62 95% CI 0.48 to 0.80) to (0.50 95% CI 0.41 to 0.63), 
indicating that had the ‘missing’ studies been included the direction of the effect would not 
change i.e. CSG are less likely to be infertile than the non-CSG group, see Figure 3.1.16. The 
procedure revealed no ‘missing’ studies in the ‘childless’ analysis (Figure 3.1.17), ‘number of 
pregnancies’ analysis (Figure 3.1.18) and ‘number of live births’ analysis (Figure 3.1.19). 
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Figure 3.1.16. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the percentage ‘never-pregnant’ analysis  
Figure 3.1.17. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the percentage ‘childless’ analysis  
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Figure 3.1.18. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the Mean Difference for ‘Number of Pregnancies’ analysis  
Figure 3.1.19. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the Mean Difference for ‘Number of live births’ analysis  
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The procedure revealed two ‘missing’ studies in the ‘miscarriage’ analysis (Figure 3.1.20), 
and addition of the ‘missing’ studies reduced the pooled effect size from (01.10 95% CI 0.93 
to 1.30) to (0.99 95% CI 0.83 to 1.19), indicating that had the ‘missing’ studies been included 
the direction of the effect would not change i.e. CSG are less likely to be infertile than the 
non-CSG group. The procedure revealed no ‘missing’ studies in the ‘stillbirth’ analysis 
(Figure 3.1.21) and ‘neonatal’ analysis (Figure 3.1.22).  
Figure 3.1.20. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the percentage ‘Miscarriage’ analysis  
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Figure 3.1.21. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the percentage ‘Stillbirth’ analysis 
Figure 3.1.22. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the percentage ‘Neonatal Death’ analysis 
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Discussion 
Principal Findings 
The result of the present study suggest that while CSG couples were more likely to 
achieve pregnancy and live birth, they were equally as likely to be childless and to have 
miscarriages. On the other hand, they were more likely to have adverse effects such as 
stillbirths and neonatal deaths. Additionally, the CSG group did not take longer to have live 
birth than the non-CSG group, indicating that in the short-term CSG did not exert an impact 
on ability to have a live birth. It can be inferred from these results aggregated together that 
CSG may facilitate pregnancy but hinder fertility through perinatal losses. The results of the 
review are important because they imply that women in CSG partnerships will not experience 
problems achieving pregnancy but ultimately have similar numbers of children due to more 
distressing reproductive events like stillbirths and neonatal deaths than women in non-CSG 
partnerships. Future research should include longitudinal cohort studies that follow CSG 
couples over time to fully capture the effects of consanguinity. 
A possible explanation for the increased ability to become pregnant and have a live 
birth in the CSG group is through the increased compatibility of gametes produced by CSG 
as proposed in the literature (Shami et al., 1990; Hann, 1984; Bittles, 1991), pathway 1, 
Figure 3.1.3. A second explanation for the enhanced ability to get pregnant could be due to 
the mechanism of factors like age and age at marriage, since CSG couples tend to be younger 
and married at a younger age in the samples as shown in the characteristics of the primary 
studies reviewed (where available), pathway 2, Figure 3.1.3. The younger age at marriage 
could be relevant for two reasons: (a) fertility is higher at younger ages, and peaks in the 
early 20s [19-26 years] (Dunson, Colombo & Baird, 2001), (b) younger age leads to a longer 
reproductive span during which the couple can eventually achieve pregnancy. A third 
explanation for the greater number of pregnancies could be due to reproductive compensation 
during which CSG couples compensate for post-natal death caused by CSG (Bittles et al., 
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2002), pathway 3, Figure 3.1.3. Current meta-analytic results showing more pregnancies and 
live births in CSG couples indicated that one or many of these pathways are in effect, which 
pathway, however could not be determined due to lack of primary studies.  Current meta-
analytic evidence also supports reports of post-natal outcomes like stillbirths and neonatal 
deaths, pathways 4, b and c, Figure 3.1.3. However, current meta-analysis differed from 
literature (Shami, Schmitt, & Bittles, 1990; Hann, 1984; Bittles, Mason, Grenne & Rao, 
1991) indicating more negative gestational outcomes like miscarriage, pathway 4 a, Figure 
3.1.3. Pathway 4 d (death of offspring) was not assessed due to lack of such studies in the 
current search. Therefore, the current results support enhanced ability to achieve pregnancy 
through pathways 1, 2 and/or 3, confirm pathways 4 b (stillbirths) and c (neonatal deaths) as 
pathways that lead to more fertility problems. The results indicating similar number of 
miscarriages but increased likelihood of stillbirths and neonatal deaths indicates that the 
congenital effects exert more impact after gestation. However, this should be interpreted with 
caution because very early miscarriages may be more difficult to determine than stillbirths 
and neonatal deaths.  The results aggregated together suggested that what advantage CSG 
offers of younger age at marriage, reproductive compensation and gamete compatibility must 
level off as indicated by the comparable childlessness as suggested in the literature (Shami, 
Schmitt, & Bittles, 1990; Hann, 1984; Bittles, Mason, Grenne & Rao, 1991). This levelling 
off is likely because of counter effects of the increased risk of stillbirth and neonatal deaths 
due to congenital abnormalities that occur more in CSG couples as a results of the cumulative 
effect of recessive genes pooling over time (Bittles & Black, 2010; Bhasin & Shampa, 2012; 
Hamamy, 2012).  
In the present study the effect of CSG on fertility was examined in a set of meta-
analyses of observational studies. This systematic approach demonstrated that CSG was 
associated with increased likelihood of stillbirth and neonatal deaths but less likelihood of 
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never achieving pregnancy. However, a causal relationship could not be confirmed, nor could 
a specific mechanism of action be specified.  Therefore, if we apply the ‘Bradford Hill 
criteria’ noted in the General Methods (pp. 55), we can see that three of the nine apply to the 
current review and enhance confidence in the causal relationship between CSG and fertility 
problems.  The criterion of ‘Biological gradient’ was met because reports in the literature 
show that the closer the relationship (especially first degree cousins) the more likely the 
impact on fertility (Bittles et al., 2002; Bittles & Black, 2010; Hussain & Bittles, 2004), 
however it was not possible to support this in the current meta-analyses due to lack of data. 
The criterion of ‘temporality’ was met since CSG occurs before sexual activity in the 
societies where it is practiced and consequently all reproductive output is considered after 
marriage. Finally, the criterion of ‘plausibility’ was met because the model set forth in the 
literature regarding pooling of recessive genes leads to increase likelihood of morbidity and 
mortality in offspring (Bittles & Black, 2010; Hamamy, 2012) as well as the gamete 
compatibility leading to increased likelihood of pregnancy (Hussain & Bittles, 2004; Bittles 
et al., 2002) are biologically sound and supported by the current meta-analyses.    
Justification for not including CSG in the original FertiSTAT. 
Results demonstrated that CSG provided an advantage at the time of pregnancy, as 
suggested in the literature (Hussain, 2004; Bittles, 2002). Since FertiSTAT is used to inform 
women about risk factors associated with a reduced ability to become pregnant, the results of 
the current meta-analyses indicated that inclusion of CSG in FertiSTAT as a new risk factor 
would not increase predictive ability of the tool in developing countries.  
Implications of Findings 
Although results indicated that CSG would not improve prediction of impaired 
ability to achieve pregnancy, awareness of the risks associated with it should nevertheless be  
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communicated to couples due to the corroboration of the reported increased likelihood of 
postnatal mortality (stillbirths and neonatal deaths) among women in CSG partnerships. 
Therefore, if the adapted FertiSTAT is to be used to inform women of factors that could 
potentially hinder their ability to have a live birth, then CSG should be included in the 
adapted version because it was found to be associated with increased likelihood of stillbirth 
and neonatal deaths. 
The implication of the present review is that couples should be counselled before 
marriage and/or becoming pregnant about the potential effects of CSG on the likelihood of 
pregnancy and postnatal outcomes. Couples should be informed that although CSG may be 
associated with an enhanced ability to achieve pregnancy, it will not ultimately increase the 
number of children they will have (Hussain & Bittles, 2004 and Bittles et al., 2002), and that 
they are more likely to experience adverse outcomes such as stillbirth and neonatal death due 
to genetic abnormalities in the offspring (Bittles & Black, 2010; Bhasin & Shampa, 2012; 
Hamamy, 2012). Couples need to be informed that the closer the biological relationship 
between father and mother the more likely their progeny will inherit recessive genes that may 
be harmful (Bittles et al. 1991; Bittles & Black 2010; Hamamy et al. 2011; Hamamy, 2012). 
These issues are best communicated via a comprehensive pre-pregnancy care package. Pre-
pregnancy care covers the delivery of medical, behavioural and social interventions to 
women and couples prior to pregnancy, with the aim of improving health and reducing risk 
factors (behavioural and environmental) that impact on maternal and child health 
(Preconception care: maximizing the gains for maternal and child health, WHO, 2013).   
Strength and Limitations in Included Studies 
The heterogeneity in study methodology, outcome measures and sample size in 
included studies could affect the comparability of these studies and the generalizability of the 
results of this review. 
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Heterogeneity in CSG measure (e.g. varying degrees of relatedness), fertility problems 
outcome (e.g. different duration of childlessness, time to first birth, inability to become 
pregnant), study design (e.g. cohort and cross-sectional) and data collection methods (e.g. 
records and interviews) can affect the practical applicability of the results.  However, issues 
of heterogeneity were dealt with both in comparing different outcomes separately and 
through subgroup analysis. The quality of each study independently did not appear to affect 
the overall results of the review since the majority of studies were of sound quality.  
Bias relating to the primary studies included selection bias, information bias and 
recall bias. It can be assumed that since the selection of participants was from the same 
sample and information was gathered using the same method for both the exposed and non-
exposed groups in all the studies, that selection and information bias may not affect results 
significantly. Recall bias can affect the internal validity of results where data was collected in 
interviews that require recall of old events, but this is more substantial for recall of details 
(Hassan, 2005). Thus, recall bias might not have been considerable because the interviews 
did not required recall of details e.g. period of childlessness or degree of relatedness with 
spouse. Bias due to confounder is a major limitation of the studies included, because 
matching the groups for confounders or including confounders in the analysis was not 
reported in any of the included studies. The most important confounder ‘age at marriage’ 
which increases the reproductive span was only recorded in three studies. There could have 
been an unequal distribution of other confounders in the exposed and non-exposed groups but 
this was not reported in the studies. The effect of confounders like age, age at marriage, and 
duration of marriage might have influenced the relationship between CSG and fertility 
problems reported in these studies.  
Another limitation relating to the primary studies was the use of observational studies. 
In the case of CSG, randomization would not have been possible or ethical, therefore the 
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most rigorous design would be cohort studies, followed by case-control and cross-sectional 
(Mann, 2003). Cohort studies are thought to be superior to cross-sectional designs in 
establishing cause and effect relationships because they measure events in chronological 
order (Mann, 2003). Cross-sectional studies can be a good starting point to identify 
associations that can then be followed by more rigorous studies (Mann, 2003). Four of the 
seven studies were cohort studies and the other 20 were cross-sectional, therefore, the results 
of meta-analysis can only be used to infer association. However, due to the adequate quality, 
the large sample sizes and the diverse samples of the studies included at least the nature and 
direction of the effect of CSG on fertility problems can be accepted. Additionally, the low 
cost of cross-sectional studies might make them the most feasible choice in resource 
constrained settings, thus research from developing countries may be confined to this design. 
Ideally the research that could help shed light on the nature of the impact of CSG on different 
aspects of the reproductive process is a longitudinal cohort study that follows couples in CGS 
and non-CGS (of varying degree of consanguinity) partnerships over time to determine the 
number of pregnancies, pregnancy losses, stillbirths and health outcomes for the progeny of 
these unions. Such a study should incorporate genetic testing for the couple as well as all 
offspring. Additionally, it should include controls that are matched for confounders such as 
age, age at marriage, education, socioeconomic status and other factors that may moderate or 
mediate the effect of CSG on reproduction.  If matching is not possible these confounders 
should be included in multivariate analysis.   
Future Research 
 To fully capture the effects of CSG future research needs to consider its effect on 
ability to become pregnant separately from ability to carry to term and deliver a live baby. 
Studies that use live birth as the outcome do not permit inferences to be made as to whether 
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the effect is on ability to become pregnant, carry to term or delivery.
Future research to unravel the effect of CSG on fertility problems requires 
longitudinal cohort studies to examine the CSG couple’s reproductive process to examine 
outcomes like duration to first pregnancy, early miscarriage, gestational problems and birth 
outcomes as well as genetic problems in offspring. Future research that includes genetic 
testing of parents and offspring should consider at a molecular level an understanding of the 
reasons for the higher pregnancy rate. Such research can investigate the hypothesis of 
compatible uniting gametes, as well as factors affecting overall fertility such as pooling of 
recessive genes, reproductive span and reproductive compensation. Studies could match 
groups for or include in analysis confounders like age at marriage to investigate reproductive 
span and compensation.   
Conclusion 
There have been many theories to explain the paradox between the higher rate of 
morbidity and mortality in the offspring of CSG couples and the overall equivalent if not 
higher rates of fertility (number of live births). Our results helped shed light on this issue by 
separating the ability to become pregnant from being childless and by examining postnatal 
outcomes. It can be concluded from the results that factors such as gamete compatibility 
combined with longer reproductive span and reproductive compensation can increase the 
likelihood of pregnancy but the pooling of recessive genes balances out this advantage 
through increased stillbirths and neonatal deaths, so that the risk of childlessness is similar in 
both CSG and non-CSG couples. In light of the results, inclusion of CSG as a new risk 
factor for fertility problems in the adapted FertiSTAT cannot be justified since it is not 
associated with reduced ability to achieve pregnancy.  
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Study 3.2: Systematic Review and Meta-analysis of Observational Studies Examining 
the Association of FGM/C and Fertility Problems 
 
Introduction 
Female genital mutilation/cutting (FGM/C) was one of the risk factors identified 
through the process of adapting the FertiSTAT and was endorsed by the experts in Study 2.1 
(Chapter 2, pp. 25). The validity of this risk factor as a predictor of fertility problems was 
examined in the current systematic review using the operational definitions of fertility 
problems and risk factor applied in the original development of FertiSTAT (Bunting & 
Boivin, 2010). 
 
Description of FGM/C 
FGM/C also known as female circumcision or cutting is a cultural practice in over 25 
African countries and some Asian regions (Toubia & Sharief 2003). The World Health 
Organization (WHO) defines FGM/C as “all procedures that involve partial or total removal 
of the external female genitalia or other injury to the female genital organs for non-medical 
reasons” (WHO, 2014, FGM/C Fact sheet No241). Table 3.2.1 and Figure 3.2.1 show the 
WHO classification of the FGM/C procedure into four categories. Type I and II are milder 
forms of the practice, while Type III, also known as infibulation is more severe, involves 
suturing and is mostly practised in north-eastern Africa, predominantly in Djibouti, Eritrea, 
Ethiopia, Somalia and Sudan (Yoder & Khan, 2008). Type IV is any other alteration to the 
female genitalia that is not classified as I, II or III. It is important to note that a woman who 
has undergone infibulation will require defibulation for childbirth (i.e., incision to the vulva 
to open the vagina) and re-infibulation post birth (i.e., re-suturing of the vulvar opening).  
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According the Royal College of Obstetricians and Gynaecologists’ (RCOG) 
guidelines on FGM/C, the procedure is usually performed between infancy and 15 years, and 
it is usually performed by traditional practitioners with little or no medical training. The 
procedure is usually performed using crude instruments such as knives, scissors or razor 
blades and without anaesthetics. The term medicalization of FGM/C is used to refer to cases 
where a trained healthcare provider performs the FGM/C procedure or reinfibulation as 
reported by the United Nations Children's Emergency Fund (UNICEF, 2013). The 
medicalization of the procedure is becoming more prevalent especially in Egypt, Sudan and 
Kenya (RCOG, 2015).  
 
Table 3.2.1.  
WHO classification of FGM/C  
Type  Definition  
Type I Clitoridectomy; partial or total removal of the clitoris (a small sensitive and erectile 
part of the female genitals) or, in rare cases, only the prepuce (the fold of skin 
surrounding the clitoris) 
Type II Excision; partial or total removal of the clitoris and labia minora with or without 
removal or the labia majora (the labia are “the lips” that surround the vagina) 
Type III Infibulation; narrowing of the vaginal opening through the creation of a covering seal. 
The seal is formed by cutting and repositioning the labia minora or majora with or 
without removal of the clitoris 
Type IV Other; all other harmful procedures to the genital for non-medical reasons e.g. 
pricking, piercing, incision, scraping and cauterising the genital area 
Note. WHO = World Health Organization; FGM/C = Female Genital Mutilation/Cutting  
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Figure 3.2.1. FGM/C procedure as classified by WHO. Figure from 
https://en.wikipedia.org/wiki/File:FGC_Types.svg Copyright by WHO. 
Reprinted with permission  
 
 
Although awareness about FGM/C and its impact on female health has increased over 
the past 20 years this has yet to translate into measurable changes in prevalence (Toubia & 
Sharief 2003). The practice of FGM/C may have stemmed from a patriarchal structure of 
social control of sexuality and fertility and women are the primary social group to suffer from 
it, but it also appears that women are also the perpetuators of the practice (Toubia & Sharief 
2003). The prevalence of female circumcision in Africa differs from population to population 
as reported by the joint program of the United Nations Population Fund and UNICEF 
(UNFPA-UNICEF, 2014). Prevalence is highest in North East Africa, with the highest 
reported rate in Somalia (98%), followed by Egypt (91%) and Sudan (88%), see Figure 3.2.2. 
The prevalence is also very high in Northern West African countries like Guinea (97%) and 
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Mali (89%), while it is much lower in countries like Nigeria (25%) and almost non-existent 
in southern Africa (USAID, 2008; UNFPA-UNICEF, 2014).  
Information sheets that summarize evidence on the different types of violence against women 
published by the WHO’s Department of Reproductive Health Research (RHR) and the Pan 
American Health Organization (PAHO) in 2012 include data on FGM/C. This material 
includes information on cultural, religious and social factors that predispose girls to FGM/C 
i.e. factors that influence their families to subject them to the procedure (WHO, RHR &
PAHO, No. 12.41, 2012).  Factors include social pressure form extended family/society, rural 
living, being uneducated, being Muslim, having undergone FGM/C themselves and having 
no exposure to mass media. Attitudes that perpetuate the practice include the idea that 
FGM/C preserves purity and cleanliness and the belief among some women that it improves 
sexual pleasure for their husbands. It is also noted that the education of the mother has a 
protective effect for her daughters, which is similar to that seen in other cases of violence 
against women. However, this positive impact of education is not always evident. In some 
locations the effect was reversed with the more educated mothers more likely to subject their 
daughters to FGM/C (WHO, RHR & PAHO, No. 12.41, 2012). These mixed results are also 
reported in a study in Sudan that shows that even within the same country education of the 
family/mother could have a different impact depending on region (Mazharul Islam & Uddin, 
2001). The authors interviewed women from different regions within Sudan on attitudes and 
included factors such as education and socio-economic status (SES) of the family and 
whether the mother was cut. Results indicated that in the rural area sampled education had a 
protective effect while in the urban (low income) suburb of the capital more education was 
linked to more FGM/C (Mazharul Islam & Uddin, 2001). These mixed results signify the 
importance of considering the effect of education and SES in any analysis of the effects of 
FGM/C to help understand if such factors have a mediating and/or protective effect.  
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Figure 3.2.2. Percentage of girls and women aged 15 to 49 years who have undergone 
FGM/C, by country. Figure from 
http://www.who.int/reproductivehealth/topics/fgm/prevalence/en/ Copyright by WHO. 
Reprinted with permission 
Plausible Mechanisms to Explain why FGM/C Could be Associated with Fertility
Problems 
Fertility problems have been reported as long-term health consequences of FGM/C in 
numerous publications including guidelines such as the RCOG, the Canadian Clinical 
Practice Guidelines, and the WHO (RCOG, 2015; Perron, Senikas, Burnett, & Davis, 2013; 
A Systematic Review of the Health Complications of Female Genital Mutilation, WHO, 
2000). Injuries or infections to the female reproductive tract have been proposed historically 
Chapter 3 Systematic Reviews 
113 
as possible biological pathway through which FGM/C (any form) may lead to difficulty 
becoming pregnant or carrying a pregnancy to term since the late 1960s (Shandall 1967; 
Lenzi 1970; Belsey 1979).  
Based on information obtained from the literature it was clear that the impact of 
FGM/C on fertility was likely to be through an indirect effect. Several plausible mechanisms 
have been suggested in the literature: (1) ascending pelvic infection, at the time of the 
FGM/C procedure or later in life (not at the time of the procedure) that causes tubal damage, 
(2) lack of intercourse due to difficult or painful penetration, and (3) obstetric complications
e.g. prolonged labour (Obermeyer, 2005; RCOG, 2015; Reisel & Creighton, 2015; WHO
study group on female genital mutilation and obstetric outcome, 2006). These mechanism 
were used to conduct a potential pathways model depicted in Figure 3.2.3.  
In the first mechanism, infection at the time of the procedure appears to be plausible because 
the vagina of the prepubescent girl is low in oestrogen and the epithelium is thin, making the 
girl more susceptible to infection (Farrington, 1997; Mroueh & Muram, 1999). In the absence 
of this protective hormonal environment the infection can then ascend to the uterus and 
fallopian tubes and, if left untreated, can lead to pelvic inflammatory disease (PID) and 
subsequently tubal factor infertility (TFI). PID is an infection of the female reproductive tract 
and adjacent pelvic structures that is unrelated to previous surgery or pregnancy 
(McCormack, 1994). If PID is left untreated then the infection can ascend from the uterus to 
the upper genital tract i.e. the fallopian tubes causing obstruction and consequently TFI (Land 
& Evers, 2002; Sciarra, 1997). PID has been reported to be primarily caused by STIs e.g. 
chlamydia and gonorrhoea (Rhoton-Vlasak, 2000). 
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Figure 3.2.3. Proposed pathways for the impact of FGM/C on fertility. Solid line = Recent 
evidence; Dashed line = Proposd pathway/historic evidence; Dashed-Dotted line = Well 
established; FGM/C = female genital mutilation/cutting; TFI = tubal factor infertility 
In addition to infection at the time of the procedure, infection later in life (long-term 
consequence) seems plausible due to change in anatomy (suturing forms a skin fold that is 
not accessible for cleaning that may harbour harmful microorganisms) that may render the 
woman at an increased risk of gynaecological infections that, if left untreated, may in turn 
ascend and cause tubal damage. This causal pathway would be supported by the higher 
incidence of bacterial vaginosis, herpes and other infections in cut women that is documented 
in the literature (Reisel & Creighton, 2015; RCOG, 2015; Obermeyer, 2005; Morison et al., 
2001; De Silva, 1989; Jones, 1999). However, there is little evidence to support an increased 
susceptibility to STIs specifically (only one study reported on FGM/C and STIs: Elmusharaf, 
2006), which can also be a precursor to the development of PID and ensuing TFI.   
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In the second and third pathways difficulties appears to be due to the injury to the 
female genitalia that causes narrowing from infibulation (Type III) or the formation of scar 
tissue (more likely with more extensive cutting). In the second pathway, sexual problems 
seem plausible because the anatomical changes can make penetration physically difficult, not 
possible, or painful. In the third pathway obstetric complications also appear to be plausible 
due to the fact that the anatomical changes could lead to prolonged and difficult labour 
ultimately resulting in complications such as haemorrhage, foetal complications and 
emergency C-sections as supported by the literature (Berg & Underland, 2013; Obermeyer, 
2005; RCOG, 2015; Reisel & Creighton, 2015; WHO, 2000).  
From Figure 3.2.3 it can be seen that the three potential pathways are impacted by the 
severity of the FGM/C and/or the type of circumciser. In essence what this means is that 
whether or not FGM/C leads to an infection, sexual problems or obstetric complications is 
impacted by whether the FGM/C was severe and/or if the circumciser was a lay person. 
Severe FGM/C (as defined by Type or amount of tissue) potentially increases susceptibility 
to infection because of the amount of tissue excised or the suturing. Alternatively, the 
suturing or excessive amount of tissue removed (scar tissue that occurs) involved in the 
severe forms of FGM/C can lead to difficult or painful intercourse and increase the likelihood 
of obstetric complications. Infections and reduced or non-existent intercourse would hinder 
ability to become pregnant, while obstetric complications could lead to having less live 
births. The effect of infection on fertility seems to be impacted by the outcome of the 
infection e.g. untreated infection can ascend to the tubes and cause tubal blockage, which 
would in turn preclude pregnancy, while a treated infection would not have an impact on 
fertility. 
If these propositions are true then the risk of fertility problems would be related to the 
extent of FGM/C, where women with Type III FGM/C would be at greater risk than Type II, 
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and they in turn would be at even greater risk than Type I or no FGM/C groups. However, 
there have not yet been many studies that report on Type III (Obermeyer, 2005) and ones that 
do often mix Types in analysis (e.g. II and III see Larsen, 2002; I, II and IV see Yount, 2001). 
It is important to separate the effect of the different types or extents of cutting on fertility 
problems as a way to disentangle the complex causal mechanisms involved. With regard to 
infertility some studies have been able to compare different types of FGM/C, such as the 
study in Egypt comparing women with Type I and II, where women with TFI had higher 
adjusted odds of having undergone Type II than their fertile counterparts (Inhorn & Buss, 
1993).  
Reproductive Health Consequences of FGM/C 
  A summary of the health consequences of FGM/C in the reviewed literature is 
presented in Table 3.2.2. These five reviews were subjected to quality evaluation using the 
“Critical Appraisal of Systematic Reviews” published by the WHO (Abalos, Carroli, Mackey 
& Bergel, 2001). Results of the reviews and quality assessment are briefly described next.  
Three of five reviews were systematic in design (Berg & Underland, 2013; 
Obermeyer, 2005; WHO, 2000) and one reported results of meta-analyses (Berg & 
Underland, 2013). Search strategies were reported for four of the five reviews (Berg & 
Underland, 2013; Obermeyer, 2005; RCOG, 2015; WHO, 2000), all four searched major data 
bases (e.g. Medline, Embase) one searched grey literature (Berg & Underland, 2013) and two 
searched low resource databases (Berg & Underland, 2013; RCOG, 2015). Four of the five 
reviews were of high quality, but an evaluation of the quality of one review (Reisel & 
Creighton, 2015) was not possible because search methodology was not reported.  
The reviews included studies that reported on different outcomes that were separated 
into short and long-term consequences. Consequences can be short-term (occur at the time of 
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the procedure) or long-term (do not occur immediately following the procedure). Long-term 
consequences encompass infertility, gynaecological, sexual and obstetric complications. The 
most serious long-term consequences included labour complications and foetal death, while 
the most serious short-term consequences reported included haemorrhage and death. Long-
term consequences were reported in all five reviews, whereas short-term consequences were 
reported in only one review (Reisel and Creighton, 2015). Exact figures on the short-term 
complications were not well documented in the literature and this was attributed to the 
difficulty obtaining data because of the sensitive nature of the topic (Reisel & Creighton, 
2015). Of the long-term outcomes obstetric complications were included in all reviews, while 
sexual problems, gynaecological infections and infertility were included in three of the five 
reviews (RCOG, 2015; Reisel and Creighton, 2015; Obermeyer, 2005).  
In addition to data from these reviews, in a prospective study the WHO reported on 
the relative risk of obstetric complications in cut and uncut women in six African countries 
(Burkina Faso, Ghana, Kenya, Nigeria, Senegal, and Sudan) (WHO study group on female 
genital mutilation and obstetric outcome, 2006). Results indicated that cut women were 
significantly more likely to experience harmful obstetric outcomes such as postpartum 
haemorrhage and stillbirth. The risks appeared to be greater in the more severe forms of 
cutting, see Table 3.2.2.  
Table 3.2.2 summarises the outcomes that were correlated with FGM/C. The 
percentage of women who experienced complications such as primary and secondary 
infertility, urinary infections, hepatitis, reduced sexual desire, emergency C-section and still 
births, was higher in cut than uncut women. Additionally, odds ratios indicated higher 
likelihood of outcomes such as bacterial vaginosis, herpes, discharge, abdominal pain, genital 
ulcers and some obstetric complications (most notably post-partum haemorrhage, difficult 
delivery and pre-labour foetal death) in cut women. Overall it can be concluded that FGM/C 
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is related to gynaecological consequences such as infections, primary and secondary 
infertility and some obstetric complications. 
Table 3.2.2.  
Summary of Reproductive Health Consequences of FGM/C Reported in the Literature 
Reproductive 
outcome 
Effect of FGM/C Statistics reported (where 
available) 
Review 
Percentage Odds ratio 
Short-term 
Traumatic bleeding, 
infection, damage to other 
adjacent organs, incomplete 
healing and death 
NR Reisel & Creighton, 
2015 
Long-term 
Infertility Childless for more than 
seven years 
2-7 vs 2-6 Obermeyer, 2005 
Primary infertility  1.4-3.3 vs 
1.7 
Secondary infertility 12.7-17.3 
vs 15.5 
Gynaecological 
(Infection)  
Bacterial vaginosis 1.7 RCOG, 2015; 
Obermeyer, 2005; 
Morison et al., 2001 Herpes 4.7 
Urinary infections 11 vs 6 De Silva, 1989; Jones, 
1999 Genital infections 1.7 
Chronic genital abscesses, 
vaginal infections, Hepatitis 
B and HIV 
NR Reisel & Creighton, 
2015 
Discharge  1.7-2.8 Obermeyer, 2005 
Genital ulcers 4.4 
Lesions 7 vs 5 
Damaged perineum 62 vs 56 
Cysts 3 vs 2 
Chronic pelvic infection  13 vs 6 El Dareer, 1982 
Abdominal pain  1.5 Okonofua, 2002; 
Obermeyer, 2005 
STIs NR Elmusharaf, 2006 
Sexual No sexual desire  42 vs 16 Obermeyer, 2005 
no orgasm 43 vs 18 
Reduced arousal, 
lubrication, orgasm, 
satisfaction, sexual quality 
of life, and dyspareunia and 
absence of sexual desire 
NR Reisel and Creighton 
(2015) 
Obstetric Prolonged labour  1.69 WHO, 2000; Reisel & 
Creighton, 2015; Berg 
& Underland, 2013 
Obstetric/post-partum 
haemorrhage (PPH) 
2.04 
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Reproductive 
outcome 
Effect of FGM/C Statistics reported (where 
available) 
Review 
Percentage Odds ratio 
RR: Type I 
(1.03), Type II 
(1.21), Type III 
(1.69) 
WHO, 2006 
Emergency C-section 15.4 vs 6.5 Obermeyer, 2005; 
Reisel & Creighton, 
2015 
RR: Type I 
(1.03), Type II 
(1.29), Type III 
(1.31) 
WHO, 2006 
Difficulty in delivery 2.28-2.57 Obermeyer, 2005; Berg 
& Underland, 2013 
Foetal distress  2.6 WHO, 2000; 
Obermeyer, 2005 
Still birth 15 vs 11 
RR: Type I 
(1.15), Type II 
(1.32), Type III 
(1.55) 
WHO, 2006 
Pre-labour foetal death 2.5 WHO, 2000; 
Obermeyer, 2005 
Early neonatal death NR 
Obstetric lacerations 1.38 Berg & Underland, 
2013 Instrumental delivery 1.65 
Pain during and after 
deinfibulation (anterior 
episiotomy), maternal death 
postpartum, postnatal 
genital wound infection and 
fistulae formation  
NR WHO, 2000 
Episiotomies and perineal 
trauma  
NR WHO, 2000; Reisel & 
Creighton, 2015 
Obstetric complications NR RCOG, 2015 
Note. NR= data not reported 
Table 3.2.2 also summaries results from individual studies on gynaecological 
infections. Infection that occurs after the initial procedure is labelled as ‘later in life’ to 
distinguish it from infections that occur at the time of the procedure itself. Studies that 
demonstrated higher rates of infections in cut women were reported in Table 3.2.2. First, 
urinary and genital infections were higher in circumcised women, in a sample of Sudanese 
women in Saudi Arabia (De Silva, 1989). Second, chronic pelvic infection was more 
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prevalent among infibulated than uncircumcised women in a sample of Sudanese women in 
five states in Sudan (El Dareer, 1982). Third, in rural Burkina Faso in a study comparing cut 
and uncut women, genital infection was found to be higher among circumcised than 
uncircumcised women (Jones, Diop, Askew & Kabore, 1999). Fourth, in Edo State, Nigeria a 
study comparing circumcised (type unspecified) and uncircumcised women showed higher 
odds of lower abdominal pain in circumcised women (Okonofua, Larsen, Oronsaye, Snow, & 
Slanger, 2002). Fifth, in Farafenni, Gambia, women with FGM/C were found to have higher 
odds of bacterial vaginosis and herpes simplex virus than uncut women (Morison et al., 
2001). The majority of these studies did not indicate the type of FGM/C in the sample so 
conclusions on an association of infection with a specific type or extent of FGM/C could not 
be drawn.  
The increased risk of STI transmission with FGM/C has not been well documented in 
the literature. However, one study examined the association between STIs and the type of 
FGM/C/anatomical extent in Sudan (Elmusharaf, Elkhidir, Hoffmann & Almroth, 2006). 
This was a multi-centred hospital based case-control study on a sample of 222 women. Of 
the 222 women, 26 tested positive for an STI (gonorrhoeae, chlamydia or Syphilis) and 196 
controls tested negative for STIs. The results while non-significant indicated that 85% of 
women who tested positive for an STI had undergone the severest form of FGM/C (Type III/
labia majora) compared with 78% of controls, and 15% of cases had undergone the milder 
form involving just the clitoris (Type I) compared with 5.6% of controls.  It is important to 
note that of all 222 women only 3 had not undergone FGM/C while 175 (78.8%) had 
undergone the most extensive form (Type III). The lack of significance may have been due to 
the relatively small sample size that would have made it difficult to detect rare complications, 
the overwhelming number of Type III, or to the lack of an effect, all issues that warrant 
further investigation in future research. Thus the association 
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between FGM/C and STIs cannot be confirmed nor denied until unequivocal research is 
conducted.  
It is unclear whether it is the amount of tissue removed or the suturing done that has a 
pivotal role in the causal pathway to fertility problems, or if there are confounding factors 
such as the type of circumciser, and education and socio economic status (SES) of the family. 
One study attempted to disentangle the issue of FGM/C classification by comparing analysis 
separated by Type (WHO classification) with analysis done by extent of cutting (Almroth, 
2005). In this study there were two groups of women, primary infertile women, defined by 
the authors as younger than 35 and unable to get pregnant after two years of regular 
unprotected intercourse (n=99) and fertile controls which were pregnant women who had 
achieved pregnancy in less than two years of regular sexual intercourse (n=179). Analyses 
were done by comparing the same group of infertile women and fertile controls in two 
separate analyses, first using WHO classification of FGM/C where the distinction between 
Type II and III relates to suturing not to the parts excised, and second by comparing the same 
group of women who have had removal of labia minora versus majora regardless of suturing. 
The separation of women based on which parts were removed (labia majora, minora) is 
distinct from the WHO classification (suturing or not) and was done to demonstrate whether 
it is the parts removed or the suturing that is related to infertility (Almroth, 2005). This 
distinction can help shed light on the mechanism involved.  
Results of the Almroth (2005) study indicated that in the analysis using WHO 
classification, FGM/C Type III was not significantly associated with infertility (defined as 
inability to become pregnant after 12 months of unprotected intercourse) whereas in the 
analysis using anatomical extent of the cutting, FGM/C involving labia majora was 
significantly associated with infertility. The results indicated that the amount of tissue 
removed may be more culprit than suturing per se. The amount of tissue removed may 
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increase the likelihood of infection or scar tissue due to a larger wound at the time of the 
cutting. Therefore, it may be that infection at the time of the procedure rather than later in 
life, or difficult intercourse (more likely with suturing) is involved in the causal pathway to 
fertility problems. Confounding variables such as SES, education, and STIs were included in 
multivariate analysis and results indicated that these variables did not change the effect size 
significantly. It is important to note that the difference between WHO classification versus 
anatomical extent was smaller in the infertile group; Type III (92%), Majora (93%) compared 
to the fertile control group, Type III (85%), Majora (73%). Therefore, it appears that in the 
fertile group the severe form (Type III) is overestimated by the WHO classification relative 
to the anatomical extent classification (Majora). This difference can impact the interpretation 
of results in the following way: for the infertile group there was hardly any difference 
between the two classifications (suturing or removal of labia majora) thus inferring which 
type is related to the infertility can be problematic, whereas in the fertile group there was a 
difference between the two classifications (smaller percentage involving labia majora than 
Type III) so it is unclear if this can be interpreted as the fact that the removal of the labia 
majora is less likely to be connected with infertility than suturing.    
In addition to severity of the FGM/C, the type of circumciser has also been suggested 
to influence the effect of FGM/C on fertility. Inhorn and Buss (1993) examined the effect of 
type of circumciser (medical professional versus lay person). The results indicated that the 
adverse effect of Type II FGM/C had a synergistic relationship with having a non-medical 
circumciser. The issue of traditional practitioners performing the procedure of FGM/C using 
crude instruments such as knives, razor blades or scissors can impact the likelihood of 
infection and as indicated previously the majority of circumcisers are traditional practitioners 
(RCOG, 2015). The lack of use of antiseptics and anaesthetics by traditional practitioners has 
not been well documented but two articles report a possible link between asepsis and FGM/C 
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complications but exact figures were not reported (Puri, Kumar & Ramesh, 2011; Inhorn & 
Buss, 1993). 
Rational, Aim and Objectives 
It is evident from the literature cited previously that FGM/C has negative 
consequences on the reproductive health of women, most notably obstetric complications. 
However, as yet a systematic review for other fertility problems has not been performed. 
Therefore, the presence of an association between FGM/C and fertility problems, the 
magnitude of this relationship and the link with type or extent of FGM/C needs to be 
systematically evaluated. It is important to determine whether reports of fertility problems 
from FGM/C are due to obstetric complications that lead to fewer live births or to anatomical 
changes in the female reproductive system (damage to external genitalia or tubes) that lead to 
an inability to become pregnant. 
The biological plausibility of the effect of FGM/C on the reproductive process 
coupled with the high prevalence in some developing countries and the results of the survey 
of physicians [FGM/C endorsed as a potential risk factor by 54.2% of responders] (Chapter 2, 
pp 25), highlighted the need to investigate whether FGM/C should be included as a risk 
factor in the adapted FertiSTAT. The present study reports on results of a systematic review 
and meta-analyses of studies on FGM/C. The objective of the review was to examine whether 
FGM/C was associated with fertility problems in women, the scale of this impact and at what 
point in the reproductive process FGM/C might exert its impact (ability to achieve a 
pregnancy or a live birth). The review also intended to identify the presence of an association 
between fertility problems and the extent or type of FGM/C. The population of interest for 
the review was women, the exposure was FGM/C (different types) and the outcome of 
interest was fertility problems. In the present review meta-analyses were performed 
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according to outcomes available in the included studies and subgroup analyses were planned 
according to outcomes and type of exposure (FGM/C), to identify whether the effect of 
FGM/C was on ability to become pregnant or post implantation (ability to have live birth) 
and if impact was associated with level of exposure. The overall aim of this review was to 
determine whether FGM/C should be included as a risk factor in the adapted FertiSTAT. 
Materials and Methods 
Search Strategy 
The search terms included words related to FGM/C, for a complete list of MeSH 
terms see Appendix K. Studies were excluded if FGM/C referred to corrective or feminizing 
surgery, congenital abnormalities or the acronym FGM/C meant something other than female 
genital mutilation.  
Data Extraction and Quality Assessment 
The data extraction form (Appendix H) was adapted to include information relevant 
to FGM/C. Specifically to include the type of FGM/C, as per WHO classification, see Table 
3.2.1 and to include method of ascertainment of FGM/C: self-report, clinical examination or 
medical/hospital records. The NOS form was adapted to reflect quality criteria for the 
assessment of FGM/C and additional confounders. FGM/C was adequately assessed if there 
was independent validation of the degree of cutting as determined by clinical examination or 
if ascertained from hospital or other medical records. The primary confounder was the type of 
circumciser.  
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Data Synthesis and Analysis 
Meta-analyses were computed separately for the outcomes reported in the studies and 
where necessary data were calculated as previously described (pp. 65).
Results 
Study Selection 
Figure 3.2.4 shows the flowchart for number, reason and stage of exclusion of 
articles. A total of 244 records were identified (after duplicates removed) and most studies 
(144 of 244, 59.0%) were excluded because they did not report on fertility problems or did 
not report the relationship between FGM/C and fertility problems. Of the 244 articles 11 were 
non-English, and sufficient translations were obtained for all using Google translate 
(https://translate.google.com/). Search of the reference lists of the included studies and 
contact with authors resulted in no additional studies. Of the 17 full text articles assessed for 
inclusion, seven met inclusion criteria and were included in meta-analyses. 
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Figure 3.2.4. PRISMA Flow Diagram for FGM/C. Figure shows the exclusion of articles at 
the different stages and the reasons for exclusion. Records identified through datbase 
searching of Medline and Embase includes original search, an update from the time of 
original search and a search using new MeSH terms. FGM/C = Female Genital 
Mutilation/Cutting 
Characteristics and Design of Included Studies 
Table 3.2.3 shows selected sample characteristics of the included studies. All of the 
studies were conducted in Africa and only three included average age at time of study, 
whereas the other four studies included information related to participant age in range. Table 
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3.2.4 shows methodological characteristics of included studies. The majority of the studies 
were cross-sectional design (5 of 7) and two were case-control, see Table 3.2.4. In the cross-
sectional studies data was collected from community or household interviews in three studies 
and from demographic surveys in two. FGM/C was reported as cutting of the female genitalia 
as classified by the WHO as Type I, II, III or IV in all of the studies. In one study analyses 
were conducted based on WHO classification as well as ‘anatomical extent regardless of 
suturing’ (Almroth, 2005). Type III was not included in three of the studies (Inhorn, 1993; 
Yount, 2006; Klouman, 2005), while two had very low rates (1% and 8.2%), Morison (2001) 
and Larsen (2000) respectively. Conversely, the two studies from Sudan had very high rates 
of Type III (85.1% and 87%), Larsen (2002) and Almroth (2005) respectively.  
As shown in Table 3.2.4, fertility problems outcome measures in the included studies 
were: ‘trying-to-conceive for 1 year or more’ in two studies (one of which had a TFI 
subcategory), ‘trying-to-conceive for 2 years or more’ (TFI only) in one study, ‘unable to 
become pregnant after 1 year living with partner’ in one study (where primary indicated no 
pregnancy and no live birth and secondary indicated no pregnancy 1 year after a live birth) 
and ‘childless after seven-years marriage’ in two studies.  One study reported ‘never had live 
birth after five years’.  
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Table 3.2.3.  
Sample Characteristics Reported in the Seven Included Studies 
Location Sample (n) N N 
 Age a 
Women 
Cross-sectional Studies FGM/C No-FGM/C (control) FGM/C No-FGM/C 
Klouman, 
2005 
Tanzania 969 women 670 299 Mean age (SD) 27 (8) 
Larsen, 
2000 
Central African Republic, Cote 
d'Ivoire, and Tanzania 
16361 women 6124 10237 NR NR NR 
Larsen, 
2002 
Sudan 4218 women 3747 471 NR NR NR 
Morrison, 
2001 
Gambia 776 women 420 356 NR NR NR 
Yount, 
2006 
Egypt 1729 women 1700 29 Range Percentage (n) 
< 25 9.2 (156) 
25-34 39.1 (664) 
35-44 34.9 (593) 
45 + 16.9 (287) 
Case-control studies Infertile b Fertile (control) Infertile b        Fertile 
Almroth, 
2005 
Sudan 279 women 99 180 Mean age (SD) 27.2 (3.9) 24.7 (4.4) 
Range  Percentage (n) Percentage (n) 
Inhorn, 
1993 
Egypt 125 women 39 86 0-19 2.2 (2) 2 (2) 
20-29 41.4 (37) 47 (47) 
30-39 49.5 (44) 40 (40) 
40+ 7.1 (6) 11 (11) 
Note: a Age for women at the beginning of the study; b Unable to become pregnant after 12 months of unprotected intercourse; FGM/C=women who have undergone Female 
Genital Mutilation. SD=Standard deviation NR= data not reported  
Chapter 3 Systematic Reviews 
129 
Table 3.2.4. 
Characteristics of the Design of the Seven Included Studies 
Study 
design 
Data collection Study 
period 
FGM/C assessment FGM/C self-report 
or clinical 
examination  
Fertility Problems outcome measure 
(and duration, where relevant) 
Klouman, 
2005 
Cross-
sectional 
Community-based survey in 
rural area 
1991-
1992 
 Type I and II Self-report & Clinical 
examination 
Not able to become pregnant after 1 year 
living together (primary)  
Subsequent infertile (secondary) not 
being able to become pregnant after 1 
year from last birth  
In the analysis combined  
Larsen, 
2000 
Cross-
sectional 
Demographic and Health 
Survey (Household 
interviews) 
1995, 
1995, 
1997 
Type I, II and III for 
Tanzania only. For others 
only cut v uncut  
Self-report Childless after more than 7 years of 
marriage, and subsequent infertile defined 
as still childless 5 years from last birth 
Larsen, 
2002 
Cross-
sectional 
Demographic and Health 
Survey (Household 
interviews) 
1989-
1990 
Type I, II and III Self-report Childless after more than 7 years of 
marriage and subsequent infertile (5 years 
from last birth) 
Morrison, 
2001 
Cross-
sectional 
Community based survey in 
17 villages (3 tribes) 
Jan-July 
1999 
Type I, II and III Self-report & Clinical 
examination  
1 year trying to conceive 
Yount, 
2006 
Cross-
sectional 
Household interviews in 
rural area 
1995-
1997 
Type I, II and IV Self-report Never had live birth after 5 years of 
marriage 
Almroth, 
2005 
Case-
control 
Hospital based (urban) 2003-
2004 
Anatomical extent and 
Type I, II and III 
Clinical 
examination 
2 years trying to become pregnant (TFI 
subcategory) 
Inhorn, 
1993 
Case-
control 
Hospital based (urban and 
rural) 
1988-
1989 
Type I, II and III Self-report & 
medical records 
1 year trying to become pregnant, 
(TFI only) 
Note. FGM/C = female genital mutilation/cutting; TFI = tubal factor infertility 
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Study Quality, Fertility Problems Outcome Measure and Bias 
Table 3.2.5 shows the results of quality assessment (see table footnote for criteria).  
The FGM/C group was representative of the population in all studies. FGM/C was adequately 
assessed (clinical examination) in only three of the seven included studies. The non-FGM/C 
group (controls) were well defined, selected from the same population and exclusions were 
adequately reported. Comparability of at least one confounder in the case-control (FGM/C 
versus non-FGM/C groups) was reported in all of the studies, and four studies reported on 
‘circumciser’. Only two of the studies adequately evaluated the included confounders, the 
majority (5 of 7) used only self-report to assess confounders. Additionally, matching for 
confounders or including them in analysis was done in three of the studies. Fertility problems 
outcome was adequately measured in all of the included studies, as indicated by blind or 
independent assessment. Overall the majority of studies had high or average quality as per 
quality assessment. 
As shown in Table 3.2.6, higher percentages were reported for all outcomes (infertile, 
childless and TFI) in the exposed (FGM/C all Types or severe Types II and III) group than 
the none/minimally exposed (No-FGM/C or Type I) group.
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Table 3.2.5. 
Quality Ratings for the Seven Included Studies on the Basis of an Adapted Newcastle-Ottawa Quality Assessment Scale 
Study 
Quality Criterion 
Overall rating g 
Adequacy of 
FGM/C 
(exposed) 
assessmenta 
Max 2 points 
Adequacy of 
control (non-
exposed), 
definition and 
selection b 
Max 2 points 
Comparabil
ity of 
control c 
Max 2 
points 
Confounders 
adequately 
assessed  
Max 2 points d 
Adequacy of 
outcome 
Fertility 
Problems 
measure e 
Max 1 point 
None 
response rate 
or loss to 
follow-up f
Max 1 point 
Klouman, 2005 2 2 0 2 1 High 
Larsen, 2000 1 2 1 2 1 High 
Larsen, 2002 1 2 1 1 1 Average 
Morrison, 2001 2 2 1 1 1 High 
Yount, 2006 1 2 2 2 1 High 
Almroth, 2005 2 2 2 1 1 High 
Inhorn, 1993 1 2 2 2 1 High 
Note. 
a FGM/C was adequately assessed when independent validation of the degree of cutting was assessed (e.g. clinical examination and/or hospital/medical records) and it was representative of the 
cohort i.e. drawn from the same population (up to 2 points) 
b Controls were adequately assessed when selection was comparable to cases, and FGM/C was excluded properly in the control population (up to 2 points) 
c Comparability of controls was achieved if exposed/non-exposed were matched or adjustment during analysis conducted. One point for circumciser and one point for any other confounder (up 
to 2 points) 
d Confounders were adequately assessed if they were obtained from records or a blind interview, and one point was given if the same method was used for both groups (up to 2 points) 
e Fertility problems outcome was adequately assessed if independent or blind assessment was stated in the paper, or confirmation of the outcome by reference to secure records (medical records, 
etc.) (up to 1 point)  
f Point given if same rate for both groups and <20% loss to follow up reported  
g The overall quality rating was low (0 to 3 points), average (4 to 6 points), or high (7 to 10 points). 
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Table 3.2.6. 
Number and Percentage of Women with Infertility Childlessness and TFI (n) in the FGM/C 
and No-FGM/C groups in the included studies (k=7) 
Outcomes Number of women (%) 
FGM/C Non-FGM/C 
Infertile (>12 months no 
pregnancy)  
117 of 1090 (10.7) 61 of 655 (9.3) 
Childlessness 352 of 9903 (35.5) 251 of 7760 (32.3) 
TFI (infertile, >12 months no 
pregnancy) 
Type II and III 
72 of 276 (26.1) 
Non-FGM/C and Type I 
15 of 76 (19.7) 
Note. FGM/C = Female Genital Mutilation/Cutting; TFI = Tubal Factor Infertility 
Results of Meta-analyses 
The first meta-analysis compared two studies reporting an ‘infertility >12 months’ 
(only primary in one study [Morrison, 2001] and primary combined with secondary in the 
other [Klouman, 2005]). Figure 3.2.5 shows the meta-analysis had non-significant pooled 
effect (OR 1.17, 95% CI 0.84 to 1.63) and non-significant heterogeneity (I² = 0%, p = 0.54). 
The results indicated that the risk of an episode of infertility was not significantly different 
between the FGM/C and non-FGM/C groups (comparable fertility problems).  
Figure 3.2.5. Odds ratio for proportion of ‘infertile > 12 months’ in the FGM/C and non-
FGM/C groups  
Figure 3.2.6 shows the forest plot and meta-analysis result for the second meta-
analysis on the three studies investigating the proportion of ‘childless’ women. The meta-
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analysis showed a significant pooled effect size (OR 1.23, 95% CI 1.02 to 1.48), with non-
significant heterogeneity between studies (I² = 3%, p = 0.36). The results indicated that 
women in the FGM/C group were significantly more likely to be childless (more likely to 
have fertility problems) than the non-FGM/C group.  
Figure 3.2.6. Odds ratio for proportion of ‘childless’ women in the FGM/C and non-
FGM/C groups  
The third analysis compared two studies with calculated data representing the 
proportion of infertile (>12 months) women in the exposed and none or minimally exposed 
women.  Infertility was 12 months in one study and 24 months, and one study included data 
only on tubal factor infertility (TFI), while the other reported on TFI as well as other 
aetiologies, thus the meta-analysis only included TFI. In both studies due to the very small 
number of non-FGM/C participants, the non-FGM/C participants were grouped with Type I 
as the minimally exposed group. One study reported on all types of FGM/C [but mainly Type 
III, 85%] (Almroth, 2005), whereas the other only reported on Type I and II (Inhorn, 1993), 
therefore in the meta-analysis exposure was Type II or III grouped together. Figure 3.2.7 
shows this meta-analysis indicated a significant pooled effect size (OR 2.06, 95% CI 1.03 to 
4.15), and non-significant heterogeneity (I² = 0%, p = 0.68). The results indicated that 
women who had undergone FGM/C Type II and/or III were significantly more likely to have 
TFI 
(more likely to have fertility problems) compared to Type I or no-FGM/C.  
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Figure 3.2.7. Odds ratio for proportion of women with TFI in the severe FGM/C and mild 
FGM/C groups 
Subgroup analyses were planned to consider heterogeneity due to outcomes and type 
of exposure (FGM/C), however, there was no heterogeneity in any of the analyses.  
Publication bias assessment. 
Publication bias was assessed using funnel plots, Eggers test and trim and fill 
procedures for one of the analyses (proportion ‘childless’), but this was not possible for the 
other analyses because they comprised too few studies.  Egger’s tests performed for the meta-
analysis was not significant at P<0.05, indicating the lack of publication bias. Trim and fill 
was used to estimate the number of ‘missing’ studies and if there were any changes to the 
magnitude of the pooled effect size if ‘missing’ studies were included. Figure 3.2.8 shows 
that the procedure revealed two ‘missing’ studies in the percentage ‘childless’ analysis, the 
pooled effect size changed from (OR 1.22 95% CI 0.99 to 1.52) to (OR 1.17 95% CI 0.98 to 
1.4), indicating that inclusion of the two ‘missing’ studies would have reduced the difference 
between the FGM/C and non-FGM/C groups but the FGM/C group would still be more 
infertile than the non-FGM/C group.   
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Figure 3.2.8. Funnel plot with trim and fill procedure to impute ‘missing’ studies (missing 
studies in red) for the proportion ‘childless’ analysis  
Discussion 
Principal Findings 
The results of the present set of meta-analyses suggest that severe forms of FGM/C 
are a relevant factor for the prediction of achieving pregnancy (infertile as indicated by 12 
months without pregnancy), specifically via TFI. The implication of these results for couples 
is that women with FGM/C can become pregnant unless they develop TFI. Evidence from the 
current meta-analyses can be used to confirm the first pathway (TFI) in Figure 3.2.3 (pp 114), 
but no information was available to determine whether the infection developed at the time of 
cutting or later in life. No studies were available to confirm the second pathway (problems 
with intercourse). No new studies to confirm the third pathway (obstetric complications) were 
found, however, extant literature suggests such an association exists. 
Pathways one and two in Figure 3.2.2 would lead to an inability to become pregnant 
due to lack of intercourse and/or tubal damage (Reisel & Creighton, 2015; RCOG, 2015), 
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however, current results support pathway one. Results of this review suggest that although 
FGM/C does not decrease the likelihood of pregnancy, severe types (II and III) were found to 
be associated with TFI and the link between the two would likely be via the mechanism of 
infection that ascends to the tubes causing TFI. This finding is corroborated by research 
proposing that FGM/C may be a contributing factor to tubal damage, possibly via increased 
likelihood of infection (Shandall 1967; Lenzi 1970; Belsey 1979; Reisel & Creighton, 2015; 
RCOG, 2015).  The fact that there was no difference in ability to become pregnant between 
cut and uncut women in the first analysis (not exclusively TFI) would suggest that if infection 
is involved it occurs after the women has had a chance to become pregnant (at some point). 
Therefore, suggesting that post-operative infection occurred later in life (e.g. STIs) rather 
than at the time of the procedure. Whether the ascending infection was due to the amount of 
tissue excised or to suturing cannot be determined from this review and should be addressed 
in future research. 
The comparable likelihood of childlessness would suggest that what impact FGM/C 
has on fertility through TFI does not ultimately render a woman childless. It would also seem 
that obstetric complications documented in the literature (WHO, 2000; Obermeyer, 2005; 
Berg & Underland, 2013; Reisel & Creighton, 2015; RCOG, 2015) may not have an effect on 
childlessness, potentially due to reproductive compensation. Obstetric or perinatal outcomes 
should be targeted in future investigations of the impact of FGM/C on overall fertility to 
better understand the third pathway of obstetric complications that can affect the mother and 
child’s health.  
Type of FGM/C. 
The impact of the specific types of FGM/C on fertility problems was demonstrated by 
the fact that the severe Type II and III as compared to Type I or no FGM/C were found to be 
significantly associated with TFI. This supported the hypothesis that the degree of cutting 
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influences the extent of effects on reproduction (Reisel & Creighton, 2015; WHO, 2000; 
Obermeyer, 2005; Berg & Underland, 2013). At this time, inferences cannot be made about 
the difference in impact between Type II and III (effect of suturing) due to the lack of 
relevant data. It was not possible to identify if amount of tissue removed or suturing is 
implicated in the causal pathway. Inferences about the effect of type of FGM/C on the other 
casual mechanism namely, difficult or painful intercourse, could not be made because this 
consequence is especially profound in the case of infibulation Type III [suturing] (Reisel &, 
Creighton 2015) and data on Type III was limited in the current study. It could be that the 
impact of FGM/C is only the extent of cutting or only the suturing or an interaction between 
the two, this can only be determined by an examination of different types separately. 
Unfortunately the data in this review did not allow one to disentangle this relationship but 
that should be the goal of future research.  
Circumciser. 
In addition to the type of FGM/C another factor that may influence the impact of 
FGM/C on fertility is the type of circumciser who performs the procedure. The RCOG (2015) 
guidelines indicated that although medicalization of the procedure is increasing it is still 
largely performed by traditional practitioners in conditions that might not be aseptic. The 
consideration of type of circumciser was conducted in the majority of primary studies but it 
was only included in the analysis in two studies. In one of these studies (Inhorn, 1993), the 
effect of FGM/C on TFI was found to be augmented by having been performed by a 
traditional circumciser. The inclusion of type of circumciser in a subgroup analysis in the 
current review was not possible due to insufficient data, thus it should be one of the goals of 
future research.  
In the present study the effect of FGM/C on fertility was examined in a set of meta-
analyses of observational studies. Although this systematic approach demonstrated that
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FGM/C was not associated with infertility or childlessness, the severe forms of cutting were 
found to be associated with TFI. However, a causal relationship could not be confirmed, nor 
could a specific mechanism of action be specified.  Therefore, if we apply the ‘Bradford Hill 
criteria’ noted in the General Methods (pp. 55), we can see that four of the nine apply to the 
current review and enhance confidence in the causal relationship between FGM/C and 
fertility problems.  
The criterion of ‘specificity’ was met because the association between FGM/C and 
infertility was only found with a specific type of infertility involving the tubes. This is 
consistent with the literature (see, Elmusharaf et al., 2006). The criterion of ‘Biological 
gradient’ was also met because only a specific type of FGM/C, that involving more 
extensive cutting, was found to be related to infertility consistent with the literature (see, 
Kraemer et al., 2001). The criterion of ‘temporality’, was met since FGM/C is performed in 
early childhood before sexual activity and the correlated STIs, PID and tubal damage could 
have occurred. Finally, the criterion of ‘plausibility’ is met because the model set forth in 
the literature about how the extent of the cutting can increase likelihood of infection is 
biologically sound.    
Justification for including FGM/C in FertiSTAT. 
The current meta-analyses indicated that inclusion of FGM/C in FertiSTAT as a new 
risk factor was warranted, since knowledge of FGM/C could possibly increase prediction of 
the inability to become pregnant in women.  In the analysis comparing women with severe 
FGM/C with women with mild or no FGM/C, those with severe type were more likely to 
have infertility and the infertility was TFI. Therefore, women should be made aware of the
potential associated between the severe types of FGM/C and TFI.  
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Implications of Findings 
Results of the current study indicated that FGM/C could potentially improve 
prediction of fertility problems such as TFI, therefore, awareness of the risks associated with 
it should be communicated to women.  The results of the review cannot support reports in the 
literature of increased likelihood of obstetric and perinatal complications that may impair 
maternal and child health because these outcomes were not found in the current search but 
need to be systematically examined (WHO, 2000; Obermeyer, 2005; Berg & Underland, 
2013; Reisel & Creighton, 2015; RCOG, 2015). The implications of these results is that 
women and health care providers should be made aware of potential risks that women who 
have undergone Type II and III FGM/C face with regard to increased likelihood of TFI. 
These results augmented with extant literature can be used to inform women of the adverse 
effects of FGM/C on childbearing as well as the health risks to mother and child during 
labour and delivery. The negative impact of FGM/C can be used by anti-FGM/C campaigns 
that aim to reduce this practice. It is hoped that mothers who are informed of the deleterious 
impact on their daughters’ future health and on their ability to have children will persuade 
them to stop putting their daughters at risk.   
Policy makers and healthcare workers hoping to educate people about the impact of 
FGM/C on reproductive health can use these results by the implementation of FGM/C care 
within an inclusive pre-pregnancy care package. The WHO has outlined recommendations 
about how to address the impact of FGM/C on reproductive health as part of their 
comprehensive pre-pregnancy care programme (WHO, 2013). Within this package guidelines 
included; discouraging the practice of FGM/C, screening women to detect complications 
before pregnancy, educating couples about potential complications, deinfibulation before or 
during pregnancy to prevent labour complications and treating cysts and other complications 
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(WHO, 2013).  The effectiveness of these interventions should be examined and implemented 
accordingly where the prevalence of FGM/C is high (e.g., Sudan, Somalia, Egypt). 
Due to the large number of migrant populations from countries practicing FGM/C to 
countries in western nations, health care practitioners in developed countries must also be 
informed of the potential labour and delivery complications and informed of various aspects 
of how to prevent maternal and child mortality and morbidity related to FGM/C. FGM/C is 
already being considered in some countries as evidenced, for example in the UK the RCOG 
practice guidelines recognise complications of FGM/C (RCOG, 2015). These guidelines 
include recommendations about training doctors and midwives on the management of 
FGM/C in gynaecological and obstetric practice e.g. how to carry out gynaecological 
examination without causing damage, performing deinfibulation before delivery and 
appropriate suturing after delivery (RCOG, 2015). The guidelines also include information 
about the legal implications and obligations related to FGM/C for doctors practicing in the 
UK.  Although FGM/C is more prevalent in specific world regions, migrations means it can 
influence practice in many more countries. 
Strength and Limitations in Included Studies 
The heterogeneity in study methodology, outcome measures and sample size in 
included studies could affect the comparability of these studies, and the generalizability of the 
results of this review. Heterogeneity in FGM/C measure (type and extent), fertility problems 
outcome (different duration of childlessness, inability to become pregnant), study design 
(case-control and cross-sectional) and data collection methods (medical examinations and 
interviews), can affect the practical applicability of the results.  However, there was no 
statistically significant heterogeneity in any of the meta-analyses conducted in this review, 
indicating that issues of methodological heterogeneity were no longer substantial when 
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analyses were separated by outcome, study design and duration. The quality of each study 
independently does not appear to affect the overall results of the review since the majority of 
studies were of sound quality. 
Bias relating to the primary studies included selection bias, information bias and 
recall bias. In the case-control studies the selection of participants based on hospital 
attendance can reduce the generalizability of the results. However, because the same 
sampling procedures were used for both cases and controls, we can assume that selection bias 
may not be substantial. It can be assumed that since the selection of participants was from the 
same sample and information was gathered using the same method for both the exposed and 
non-exposed groups in all the studies, that selection and information bias may not affect 
results considerably. Recall bias can affect the internal validity of results where data was 
collected in interviews that require recall of old events, but this is more substantial for recall 
of details (Hassan, 2005). Thus, recall bias might not have been considerable because the 
interviews did not require recall of details e.g. period of childlessness or type of FGM/C. The 
recall or type of FGM/C may not be problematic, however, the identification of type/extent 
may reduce the reliability of studies that relied solely on self-report, which was the case in 
four of the seven included studies (Snow, Slanger, Okonofua, Oronsaye, & Wacker, 2002; 
Klouman, Manongi & Klepp, 2005). Bias due to confounder is a major limitation of the 
studies included, because matching the groups for confounders or including confounders in 
the analysis was reported in only three of the included studies. The most important 
confounder ‘circumciser’ which may be linked to an increase in the likelihood of infection 
was only included in the analysis of three studies. There could have been an unequal 
distribution of other confounders in the exposed and non-exposed groups but this was not 
reported in the included studies. The effect of confounders like age, age at FGM/C, education 
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and SES might have influenced the relationship between FGM/C and fertility problems 
reported in these studies.  
Another limitation relating to the primary studies is the use of observational designs, 
as discussed in the consanguinity review. As in the case of consanguinity randomization 
would not have been possible or ethical, for FGM/C, therefore the most rigorous design 
would be cohort studies, followed by case-control and then cross-sectional (Mann, 2003). 
This study comprised of two case-control and five cross-sectional studies which can be a 
good starting point to identify associations that can then be followed by more rigorous studies 
(Mann, 2003), therefore, the results of this review can only be used to infer association.  
Future Research 
Methodological considerations for research in FGM/C. 
Although the negative impact of FGM/C on the health of women and girls has been 
explored in the literature, the sensitive nature of the topic and the varied ways of defining the 
different forms of FGM/C may have affected the quality of existing data and evidence (Reisel 
& Creighton, 2015). In their review, Reisel and Creighton (2015) discussed some of the 
methodological problems in the field of FGM/C and made recommendations as to how these 
hurdles can be overcome to produce sound research. Reisel and Creighton recommended that 
because RCTs were not possible the best research design to study the consequences of 
FGM/C would be prospective cohort studies. Unfortunately, none of the included studies in 
this meta-analysis were prospective or retrospective cohort in design (follow over time). The 
RCOG guidelines (2015) also concluded that research in FGM/C “has been hampered by 
patchy methodology” (RCOG, 2015, p. 9) as well as the fact that in Africa maternal and 
perinatal mortality and morbidity are very high due to other variables. Consequently it 
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becomes difficult to determine the casual role of FGM/C and to state definitively if the 
FGM/C caused the pregnancy or labour complications.  
Obermeyer (2005) reported on the main methodological problems in the field of 
FGM/C. First, it was noted that while the serious complications may be frequent from a 
public health perspective, they were statistically rare thus large population-based studies were 
required to carry out tests of significance. In this review the average sample size across the 
seven included studies was 3499 (range 190-16,361) with the larger samples in the five 
demographic studies, and smaller samples in the two case-control studies. Second, many 
studies used clinic samples that may not be representative of the population because they tend 
to represent more educated people from high socioeconomic classes. This was not the case in 
the studies included in this meta-analysis, were the majority of studies were 
household/community based (5 of 7) and only two were clinical samples, furthermore one of 
the clinical studies used both urban and rural samples (Inhorn, 1993) while the other used 
only an urban sample (Almroth, 2005). This would suggest that the overall sample used in the 
meta-analyses is representative of the population. Third, finding an appropriate control group 
may be problematic in populations where the prevalence of the practice is very high. This 
was especially true for studies from Egypt and Sudan, e.g. the two case-control studies had 
zero to 3% uncut women in the samples (Inhorn, 1993; Almroth, 2005) respectively, while 
the demographic study in Sudan had 11% uncut women (Larsen, 2002) and the demographic 
study in Egypt had no uncut women (Yount, 2006). As can be seen from Figure 3.2.2, the rate 
of uncut women in the populations from which these samples were derived were 12% in 
Sudan and 9% in Egypt. Thus only the Larsen (2002) study had a rate of uncut women in the 
study sample representative of the population prevalence. In the other three studies the rate of 
uncut women was between 31-63%. The rate of the different types of FGM/C also differed 
from study to study making causal links with type of FGM/C very difficult, e.g. there were no 
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Type III women in the Inhorn (1993) study and very few Type II (3%) in the Almroth (2005) 
study. Consequently reducing the ability to make inferences about which Type of FGM/C is 
related to fertility problems. Fourth, confounders such as ethnicity, education, access to 
health care and SES should be taken into consideration because these confounders could also 
explain ill effects of FGM/C. In the current review matching for confounders or including 
them in analysis was done in three of the studies. In the two case-control studies that 
considered the relationship between TFI and FGM/C, one included the confounders: age, SES 
and education in multivariate analysis, all were found not to be significantly associated with 
TFI (Almroth, 2005) while the other included the type of circumciser (traditional vs medical) 
and found the traditional circumciser to be significantly associated with TFI (Inhorn, 1993). 
In the cross-sectional study in Egypt (Yount, 2006) confounders that were included in 
multivariate analysis were: age, age at marriage, age and procedure, type of circumciser, 
education, rural-urban, religion and contraceptive use. Results indicated that only religion and 
contraceptive use were significantly associated with fertility outcomes (never pregnant, 
childless). These results are not surprising, given that FGM/C practice is predominantly 
performed by Muslims and contraceptive use reduced the chance of getting pregnant and 
having live births.  
Finally, the issue of exposure to FGM/C and how the extent of the procedure was 
defined and categorized could affect study quality. Physical examination to ascertain the 
anatomical extent of the procedure may not always be feasible. Studies that compare self-
report and clinical examination seem to show mixed results, and this could be because some 
women may be able to identify the extent of the FGM/C while others are not (Obermeyer, 
2005). Reliance on self-report may further reduce the reliability of studies (Snow, Slanger, 
Okonofua, Oronsaye, & Wacker, 2002; Klouman, Manongi & Klepp, 2005). In the current 
review the WHO classification was used in all studies as it is the most widely used 
Chapter 3 Systematic Reviews 
145 
classification system, but one study used WHO classification as well as amount of tissue 
excised to disentangle the relationships between suturing or tissue excised and TFI (Almorth, 
2005). The ascertainment of FGM/C was based on self-report in six of the included studies, 
and it was augmented with clinical examination in two of those studies (Klouman, 2005; 
Morison, 2001) but one study used clinical examination only (Almroth, 2005). In the Almroth 
(2005) study, the clinical examination allowed a comparison of suturing with amount of 
tissue removed to be analysed, however, since self-report was not used an analysis of 
discrepancy between clinical and self-report was not possible. In Morison (2001) there was 
only 3% disagreement between clinical and self-report of Type of FGM/C. While in Klouman 
(2005) there was 7% disagreement between clinical and self-report of FGM/C, with higher 
rate of FGM/C being reported by clinical exam than self-report, which may be a reflection of 
reluctance to self-report rather than an inability to identify it in oneself. The effect of 
classification on the association with infertility was only performed in one study (Klouman, 
2005), where the rate of infertility was higher in the clinically observed group (12.7%) than 
the self-report group (9.5%). Similar rates of clinical and self-report with minimal 
discrepancy in the included studies (were such information was available), would suggest that 
this method of ascertainment has little impact on the results of the current review. On the 
other hand, issues of classification and their impact on the relationship between FGM/C and 
fertility problems were only examined in one study (Almroth, 2005). Results of this study 
indicated that there is indeed a difference in the classification systems; using anatomical 
extent (parts removed) to operationally define FGM/C was found to be significantly 
associated with infertility, whereas using WHO classification (amount of surturing) was not 
(Almroth, 2005). Altogether methodological issues will need to be addressed in future 
research to produce more robust evidence, as discussed in the next section.  
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New research.
Future research to disentangle the effect of FGM/C on fertility problems would 
require RCTs, however, for FGM/C that would be unethical therefor the next best design 
would be prospective cohort studies to investigate the causal mechanisms that are involved 
in the different types of FGM/C and which aspects of the reproductive process are affected. 
It is especially important to investigate the effect of Type II and III separately. Studies 
should clinically examine the difference between the effect of which parts are removed 
versus suturing, to understand if the amount of tissue excised renders the women at increased 
risk of infection and/or scar tissue or if the skinfold caused by suturing leads to more 
infection and/or difficult penetration.  Future research should be directed at understanding 
the reasons for the lower live birth rate, to definitively ascertain if gestational or perinatal 
complications are implicated. Finally, it’s important to investigate the hypothesis of 
increased likelihood of infection and reduced intercourse frequency, as well as factors that 
maybe moderating the effect of FGM/C on fertility problems such as circumcisers, 
education, age at FGM/C and SES.  
Ideally, longitudinal cohort studies following women who have undergone FGM/C 
and reporting on infections at the time of FGM/C or later in life with follow-up after 
marriage (reporting on fertility problems outcomes) should be used to help identify if the 
time of infection is significant. Further, outcomes throughout the reproductive pathway (from 
occurrence of sexual intercourse to delivery) need to be investigated to build up knowledge 
of where FGM/C exerts its effects.  More research considering women with non-tubal 
infertility and different types of FGM/C is also required to ascertain if mechanical difficulties 
are also implicated. Although we have a convergence of results from outcome with duration, 
the caveat is that the studies from which this information is derived are cross-sectional and 
few in number.  Ideally to study the effect of FGM/C and to understand the biological 
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mechanisms involved a large population-based prospective cohort study with a sufficiently 
large control group should be conducted. The study should assess the different types of 
FGM/C using verification of type of FGM/C with clinical examination/medical records and 
the distinction between amounts of tissue excised versus suturing. Confounders such as 
circumciser, age, age at circumcision, ethnicity, education, access to health care and SES 
should be included by matching the groups or in multivariate analysis. The study should 
report on outcomes such as infection (at the time of FGM/C and later in life), STIs, HIV, 
sexual frequency, pregnancy rates, perinatal and obstetric complications as well as live birth 
rates for the different types of FGM/C.  
Conclusion 
Fertility problems have been reported as a negative consequence of FGM/C in the 
literature but evidence to support this claim has been limited. Results of the current meta-
analyses indicate that cut women were no more likely to experience infertility or 
childlessness. However, women with severe cutting (Type II and III) were more likely to be 
diagnosed with TFI. Therefore, results support the hypothesis that fertility problems increase 
with the degree of cutting as identified by the WHO classification. In light of the results, 
inclusion of ‘severe FGM/C’ as a new risk factor in the adapted FertiSTAT could potentially 
be justified since it is associated with increased likelihood of TFI.  It is important to note that 
this area of research should be re-examined due to the methodology and the small number of 
included studies in the meta-analyses.  
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Study 3.3: Systematic Review and Meta-analysis of Observational Studies Examining 
the Association of HIV and Fertility Problems 
Introduction 
The human immunodeficiency virus (HIV) was one of the risk factors identified 
through the process of adapting the FertiSTAT and was endorsed by the experts in Study 2.1 
(Chapter 2, pp. 25). The validity of this risk factor as a predictor of fertility problems was 
examined in the current systematic review using the operational definitions of fertility 
problems and risk factor applied in the original development of FertiSTAT (Bunting & 
Boivin, 2010). 
Description of HIV 
 HIV is a viral infection that impairs the immune system by attacking a type of white 
blood cell known as CD4 cells (WHO, Case Definitions of HIV, 2007). Once infected with 
HIV the person’s immune system continues to deteriorate leading to immune deficiency. The 
compromised immune system then renders the body more susceptible to other infections 
known as opportunistic infections that a healthy immune system is able to fight off. The more 
advanced stage of the HIV infection is known as Acquired immunodeficiency syndrome 
(AIDS). A person is said to have AIDS when they have experienced certain cancers, 
infections, or other severe medical complications (WHO, Case Definitions of HIV, 2007). 
The most common opportunistic infection and the number one cause of death in HIV infected 
individuals in Africa is tuberculosis (TB). There are several stages that have been classified 
for the progression of HIV/AIDS. The WHO classifies the progression of HIV into four 
stages based on clinical symptomatology, see Table 3.3.1 (WHO, Case Definitions of HIV, 
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2007). Stage 1and 2 are milder forms of the disease, whereas 3 and 4 are more severe and are 
characterized by more infections and marked weight loss known as wasting syndrome 
(WHO, Case Definitions of HIV, 2007). HIV wasting syndrome is a condition where the 
individual losses more than 10% of their body weight and the condition does not improve 
with increased caloric intake; it can be accompanied by diarrhoea and/or fever (WHO, Case 
Definitions of HIV, 2007). On the other hand, the CDC’s classification is based on CD4 
count, where category one (lowest severity) is greater than or equal to 500 cells/mL, category 
two is 200-499 cells/mL and category three is less than 200 cells/mL, category three is also 
classified as AIDS (Centres for Disease control and Prevention, 2008).  
The diagnosis of HIV can be made using various blood tests, usually a combination of 
antibody testing such as enzyme immunoassay (EIA) or enzyme-linked immunosorbent assay 
(ELISA) and confirmation using Western Blot, all of which are indirect tests used in the 
diagnosis of infectious agents by detecting antibodies to these agents (Fearon, 2005). These 
tests are referred to as indirect tests because they measure the effect of the infectious agent on 
the immune system rather than the agent itself.  Western blot is difficult to perform but 
produces less false positive results, thus it is used to confirm results of ELISA test. Western 
blot has been the gold standard in confirming HIV diagnosis since 1989 (CDC and 
Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV 
Infection, 2014). If the HIV infection is confirmed, the person is said to be HIV positive 
(HIV+), and if it is not confirmed then the person is said to be HIV negative (HIV-).  
At the end of 2014 there were 36.9 million people living with HIV worldwide, with 
2.0 million new infections in the year 2014 (The Joint United Nations Programme on 
HIV/AIDS (UNAIDS), 2015).  With 70% of all cases occurring in Sub-Saharan Africa (25.8 
million), it is the region with the highest prevalence of HIV globally (UNAIDS, 2015). Sub-
Saharan Africa has a reported prevalence of 4.5% of the population infected with HIV, see 
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Figure 3.2.1. More than half the total number of cases of HIV infection in sub-Saharan Africa 
are women (UNAIDS, 2015). STIs are reported to be among the risk factors for contracting 
HIV.  
Drug therapy for HIV/AIDS consisted of antiretroviral drugs (ARV) in the late 
1980’s and more recently (1995-1996) using a combination of at least three ARTs known as 
highly active antiretroviral therapy (HAART) has been used (Palmisano & Vella, 2011). 
HAART prevents the virus replicating and can slow the progression of the disease by 
decreasing the viral load i.e. amount of virus in an infected person’s blood (UNAIDS, 2015). 
The use of HAART has changed the prognosis of HIV from a deadly disease to a chronic 
manageable disease (UNAIDS, 2015).  
Table 3.3.1.   
WHO Clinical Staging of HIV/AIDS for Adults and Adolescents 
Clinical Stage Clinical Conditions or Symptoms 
Primary HIV 
Infection 
 Asymptomatic
 Acute retroviral syndrome
Clinical Stage 1  Asymptomatic
 Persistent generalized lymphadenopathy
Clinical Stage 2  Moderate unexplained weight loss (<10% of presumed or measured body weight)
 Recurrent infections (respiratory, Herpes, oral ulceration, Seborrheic dermatitis
 Fungal nail infections)
Clinical Stage 3  Unexplained severe weight loss (>10% of presumed or measured body weight)
 Unexplained chronic diarrhea for >1 month
 Unexplained persistent fever for >1 month (>37.6°C, intermittent or constant)
 Persistent oral candidiasis (thrush), Oral hairy leukoplakia
 Pulmonary tuberculosis (current)
 Severe presumed bacterial infections (e.g., pneumonia, empyema, pyomyositis, bone or
joint infection, meningitis, bacteremia)
 Unexplained anemia (hemoglobin <8 g/dL)
 Neutropenia (neutrophils <500 cells/µL)
 Chronic thrombocytopenia (platelets <50,000 cells/µL)
Clinical Stage 4  HIV wasting syndrome 
 Recurrent infections (severe bacterial pneumonia, Chronic herpes, Esophagea
candidiasis, Extrapulmonary tuberculosis, Cytomegalovirus infection)
 Cancer (Kaposi sarcoma, Lymphoma, Invasive cervical carcinoma)
 Central nervous system toxoplasmosis
 Other severe infections and cancers
Note. Table adapted from Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and 
Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd edition. WHO, 2016. 
https://www.ncbi.nlm.nih.gov/books/NBK374293/ Copyright by WHO [2016]. Reprinted by permission. 
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Figure 3.3.1. Prevalence of HIV (15-49 years) in 2013 by WHO region. Figure from: 
http://www.who.int/gho/hiv/epidemic_status/prevalence/en/ Copyright by WHO. Reprinted 
with permission 
Plausible Mechanisms to Explain why HIV Could be Associated with Fertility Problems
Evidence from the literature suggests that the causal mechanism involved in the effect 
of HIV on fertility may be a multifactorial chain of events. There are potential factors that 
affect the impact of HIV on fertility in general, including age, weight loss (wasting), systemic 
illness, stage of disease, STIs, a history of intravenous drug use and other substance abuse as 
well as sociodemographic factors (Lo & Schambelan 2001; Kushnir & Lewis, 2011). 
However, the exact biological pathway for the effect of HIV infection on reproductive 
outcomes may be difficult to uncover for several reasons, one such reason is that being 
diagnosed with HIV may be followed by a decline in sexual activity (Lo & Schambelan 
2001). Based on the information obtained from the literature a model was constructed to 
depict the potential casual pathways, see Figure 3.3.2.   
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Figure 3.3.2. Proposed pathways for the impact of HIV on fertility. Solid line = Recent 
evidence (imaging); Dashed line =Proposd pathway/historic evidence; Dashed-Dotted line 
= Well established; SES = socioeconomic status; POI = primary; ovarian insufficiency; 
STIs = sexually transmitted infections; PID = pelvic inflammatory disease; TFI = tubal 
factor infertility, IUAs = intrauterine adhesion 
As can be seen in Figure 3.3.2, anovulation (not ovulating) is a factor in two of the 
pathways, the first is via weight loss and/or systemic illness and the second via of primary
ovarian insufficiency (POI). The stage of disease is a precursor for weight loss/systemic
illness and POI. Although, hormonal dysfunction (endocrinological and/or ovarian) has been 
indicated in several reviews (Waters, et al., 2007; Kushnir & Lewis, 2011), a direct inhibitory 
effect of HIV on ovarian function has not been supported. However, POI has been implicated 
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as a factor in the potential pathway for the impact of HIV on fertility in several studies 
(Kushnir & Lewis, 2011). Menstrual irregularities and amenorrhea may be a direct result of 
ovarian dysfunction or result as a consequence of complications/comorbidities of HIV (e.g., 
weight loss). Factors that have been described to be associated with menstrual irregularities 
reported in HIV (without wasting) include; drug abuse, marijuana, chronic alcohol 
consumption, low SES (Lo & Schambelan 2001), low CD4 count and high HIV viral load 
(Waters, et al., 2007).  
POI is a condition that affects about 1% of women and is characterised by premature 
menopause, i.e. before the age of 40, compared to 51 for normal menopause (Cox & Liu, 
2014). When a women’s hormones change prematurely to resemble those of menopause, 
regardless of the eitiology of the change a diagnosis of POI is made. POI has been used to 
encompass several hormonal disorders including premature ovarian failure (POF), 
hypergonadotropic hypogonadism and ovarian dysgenesisis, and is thus used to describe 
compromised ovarian function on a continuum rather than a specific endpoint (Cox & Liu, 
2014).  The diagnosis of POI can be confirmed by detecting follicle-stimulating hormone 
(FSH) levels greater than 30U/L in the presence of amenorrhea for 4-6 months (Cox & Liu, 
2014). In the 2015 European Society of Human Reproduction and Embryology (ESHRE) 
guidelines for the management of POI, it was concluded that FSH is the gold standard for 
diagnosis of POI, however there hasn’t been consensus as to an exact cut-off (ESHRE, 2015).  
Cut-offs include 25, 30, 40 and 50, but the etiology of POI contributes to the level of FSH, 
where women with autoimmune causes have been found to have lower levels of FSH while 
women with idiopathic POI had higher levels. Therefore, the ESHRE guidelines state that a 
cut off level of FSH > 25 IU/l would be more inclusive. More recently anti-Mullerian 
hormone (AMH) has been used as a marker for POI (La Marca, et al., 2006), however women 
with regular cycles and low ovarian reserve may also have low AMH, thus on its own AMH 
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should not be used to diagnose POI (ESHRE, 2015). Decreased ovulation or anovulation 
occurs in POI due to a congenital decline in follicles, accelerated follicular degeneration or an 
inability to recruit follicles (Nelson, 2009), whereas in menopause there is permanent 
cessation of menses due to the complete depletion of follicles. In contrast to menopause it is 
reported that 50% of patients with POI will have varying degrees of ovarian function and that 
5-10% are able to achieve unassisted conception (Cox & Liu, 2014; Nelson, 2009).
The second pathway in Figure 3.3.2, depicted the suspected increased susceptibility to 
STIs and severity of pelvic infections (Kushnir & Lewis, 2011; Lo & Schambelan 2001; 
Waters, et al., 2007). In the third pathway, reduced penetrative sexual intercourse and/or use 
of barrier contraceptives e.g. condoms can potentially explain how HIV affects fertility (Lo & 
Schambelan 2001; Kushnir & Lewis, 2011). In the fourth pathway, class A drugs have been 
depicted because the use of class A drugs is correlated with HIV and class A drugs have a 
proven independent impact on fertility (Mueller et al., 1990; Hassan & Killick, 2004). In the 
final pathway, increased miscarriage is depicted as a factor that could lead to reduced ability 
to have live birth (Kushnir & Lewis, 2011).  
Reproductive Health Consequences of HIV 
The negative impact of HIV on women’s reproductive health and specifically fertility 
problems has been explored in the literature over the past few decades. A summary of the 
consequences in the reviewed literature is presented in Table 3.3.2, and these will be 
discussed next. The four reviews summarized were subjected to quality evaluation using the 
“Critical Appraisal of Systematic Reviews” published by the WHO (Abalos, Carroli, Mackey 
& Bergel, 2001). 
Specific figures for prevalence of health consequences were not reported in all of the 
reviews. In a commentary about research on reproductive function and HIV, Lo and 
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Schambelan (2001), discussed ovarian function as well as other markers of fertility in HIV 
infected women. In a narrative review of the literature on HIV and subfertility, Waters, 
Gilling-Smith and Boag (2007) conducted a search of PubMed, however, no details on search 
methodology were reported to allow adequate quality assessment of the review. The results of 
the review indicated that some studies have shown an association between HIV and fertility 
problems. In another narrative review of the literature on the impact of HIV on fertility 
problems PubMed was searched, but search methodology and exact figures were not reported 
(van Leeuwen, et. al., 2007). Results of this review indicated that HIV can be detected in the 
female reproductive tract, however, evidence for the impact of HIV on reproduction was 
inconsistent. Most of the studies cited in this review were conducted in Africa and may not be 
generalizable to other populations (van Leeuwen et. al., 2007). In a more recent systematic 
review and meta-analysis on HIV and infertility, Kushnir and Lewis (2011), conducted a 
search on PubMed for studies pertaining to how subfertility is affected by HIV infection, 
comorbidities (e.g. STIs, drug use) and HIV drug treatment (antiretroviral therapy).  
Overall the reviews included 24 primary studies with each review mainly updating 
new primary studies. However, the two most recent reviews (van Leeuwen et al. 2007; 
Kushnir & Lewis, 2011) included several studies that were published prior to the previous 
reviews suggesting different search methodologies and/or inclusion criteria may have been 
used.   
The summary of evidence presented in Table 3.3.2 suggests that HIV has been found 
to be associated with reproductive functioning, but results were inconsistent across the 
literature. For effects on ovarian reserve, the evidence was mixed, with some studies 
reporting an association between HIV and reduced ovarian function (including elevated FSH 
levels), and other studies reporting no difference. Similarly, with regards to amenorrhea the 
evidence was mixed with some studies reporting an association with HIV while others 
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reporting no such association.  With regard to menstrual irregularities, the majority of 
evidence pointed to an association between HIV and menstrual irregularities that in some 
studies was shown to be related to stage of disease. Regarding the other outcomes (comorbid 
STIs, tubal blockage, reduced pregnancy and birth rates and increased abortion/miscarriage), 
all the cited evidence indicated an association with HIV. 
Table 3.3.2.  
Summary of Reproductive Health Consequences of HIV Reported in the Literature 
Reproductive 
outcome 
Effect of HIV Primary study Statistics 
reported 
(where 
available) 
Review 
Ovarian 
function 
Change in ovarian 
reserve in HIV+ women 
Mixed results  
Schoenbaum et al. (2005); Martinet 
et al. (2006) reported normal 
ovarian reserve 
NR van 
Leeuwen et 
al. (2007) 
Clark et al. (2001); Englert et al. 
(2004) reported dramatically 
reduced ovarian function i.e. 
Primary ovarian insufficiency (POI) 
NR 
FSH level Clark et al. (2001) report higher 
rates of elevated FSH 
8% of HIV+ 
women (20-
42yrs) had 
FSH level 
indicative of 
menopause 
Kushnir and 
Lewis 
(2011) 
Cejtin et al. (2006) reported no 
difference in FSH in women with 
amenorrhea  
NR Kushnir and 
Lewis 
(2011) 
Seifer et al. (2007) found no 
evidence that HIV infection 
influences ovarian aging (FSH and 
AMH levels) 
NR Kushnir and 
Lewis 
(2011) 
Ovaries susceptible to 
HIV and secondary 
infections  
Not well studied but hypothetically 
i.e. no specific evidence
NR Lo and 
Schambelan 
(2001) 
Menstrual 
cycle 
Menstrual irregularities 
(very short and very 
long) in HIV+ women 
without AIDS 
Chirgwin et al. (1996) NR van 
Leeuwen et 
al. (2007); 
Lo and 
Schambelan 
(2001); 
Waters et al. 
(2007) 
Increased rate of 
menstrual irregularities 
in HIV infected women 
with AIDS (and the 
associated wasting). 
Harlow et al. (2000) NR van 
Leeuwen et 
al. (2007) 
Grinspoon et al. (1997) NR Lo and 
Schambelan 
(2001) 
HIV+ had little effect 
on menstrual 
irregularities (cycle 
Harlow et al. (2000) NR Lo and 
Schambelan 
(2001); 
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Reproductive 
outcome 
Effect of HIV Primary study Statistics 
reported 
(where 
available) 
Review 
length/ menstrual 
duration) 
Waters et al. 
(2007) 
Harlow et al. (2000); Chirgwin et 
al. (1996) 
NR Waters, et 
al. (2007); 
van 
Leeuwen et 
al. (2007) 
Among HIV+ women, 
increased cycle 
variability was 
associated with higher 
viral loads and lower 
CD4 cell counts 
Harlow et al. (2000) NR Lo and 
Schambelan 
(2001); 
Waters et al. 
(2007) 
Clark et al. (2001) NR Waters et al. 
(2007) 
Amenorrhea Prolonged amenorrhea 
without ovarian failure 
Cejtin et al. (2006) HIV+ 
women 3 
times more 
likely to 
have 
prolonged 
amenorrhea 
without 
ovarian 
failure 
Kushnir and 
Lewis 
(2011) 
Increased rate of 
amenorrhea 
Chirgwin et al. (1996) NR Lo and 
Schambelan 
(2001); 
Kushnir and 
Lewis 
(2011); 
Waters et al. 
(2007) 
Being HIV+ had little 
overall impact on 
amenorrhea 
Harlow et al. (2000) NR Lo and 
Schambelan 
(2001); 
Waters et al. 
(2007) 
Ellerbrock et al. (2007); Harlow et 
al. (2000) 
NR Kushnir and 
Lewis 
(2011) 
Comorbid 
STIs 
A high incidence of 
comorbid STIs in HIV+ 
Paxton et al. (1998); Gray et al. 
(1998); Wawer et al. (1998) 
NR Kushnir and 
Lewis 
(2011) 
Frankel et al. (1997); Sobel (2000) NR van 
Leeuwen et 
al. (2007) 
Tubal 
blockage 
Higher rates of tubal 
blockage 
Frodsham et al. (2006) NR Waters et al. 
(2007) 
Higher STIs suggesting 
that women who are 
HIV+ may be at 
increased risk of tubal 
damage. 
Frankel et al. (1997); Sobel (2000) NR van 
Leeuwen et 
al. (2007) 
Tubal occlusion  Coll et al. (2007) 27.8% 
among 
HIV+ 
women 
Kushnir and 
Lewis 
(2011) 
Pregnancy 
rate 
Lower pregnancy rate in 
HIV+ women  
Zaba  et al. (1998) [Africa] fertility was 
25% to 40% 
lower in 
HIV+ 
Kushnir and 
Lewis 
(2011) 
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Reproductive 
outcome 
Effect of HIV Primary study Statistics 
reported 
(where 
available) 
Review 
women in 
Sub-
Saharan 
Africa 
Massad et al. (2004) [USA] NR 
Stephenson et al. (1996); Thackway 
et al. (1997); De Vincenzi et al. 
(1997) 
NR Lo and 
Schambelan 
(2001) 
Zaba and Gregson (1998) 
(Regardless of STIs) 
NR van 
Leeuwen et 
al. (2007) 
Dramatic decline in 
pregnancy rate in HIV+ 
women with increased 
progression of the 
disease  
Sedgh et al. (2005) NR van 
Leeuwen et 
al. (2007) 
Birth rate Lower birth rate in 
HIV+ women 
Stephenson et al. (1996); Thackway 
et al. (1997); De Vincenzi et al. 
(1997) 
NR Lo and 
Schambelan 
(2001) 
Abortions/mi
scarriage 
Pregnancy loss was 
more common among 
HIV+ 
women 
Gray et al. (1998) HIV+ vs. 
HIV- 
(18.5% 
vs.12.2%) 
Kushnir and 
Lewis 
(2011) 
Before HAART 
pregnancy loss was 
much more common 
among HIV+ women 
D’Ulbaldo et al. (1998) 67% higher 
among 
HIV+ 
Kushnir and 
Lewis 
(2011) 
Miscarriage rate 
remained 
constant from 1990 
through 2006 despite 
evolution of therapy 
during this period 
Townsend et al. (2008) Miscarriage 
rate of 4% 
Kushnir and 
Lewis 
(2011) 
Higher rates of abortion Stephenson et al. (1996); Thackway 
et al. (1997); De Vincenzi et al. 
(1997) 
NR Lo and 
Schambelan 
(2001) 
Note. NR = not reported; POI = Primary Ovarian Insufficiency; FSH = Follicle-Stimulating Hormone; AMH = 
Antimullerian hormone; CD4 = Type of white blood cell; STIs = Sexually Transmitted Infections; PID = Pelvic 
Inflammatory Disease  
In addition to the aforementioned reviews, there have been several studies that 
reported a reduced pregnancy rate in HIV+ women, without mention of period of exposure to 
risk of pregnancy (Ryder et al., 2000; Ross et al., 1999; Ross et al., 2003; Sedgh et al., 2006; 
Glynn, 2000).  These studies can be used to demonstrate a possible association between HIV 
and reduced prevalence of pregnancy, but they cannot be used to ascertain the effect of HIV 
on rate of infertility (because that would require knowing that the period of exposure to 
pregnancy was more than one year). The lack of information about the period of exposure to 
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pregnancy precluded the inclusion of these studies in the current meta-analysis and may be 
the reason why these studies were not included in the abovementioned reviews.  
In a cohort of Ugandan women attending routinely at a rural AIDS clinic over a 
seven-year period it was found that pregnancy rate was 7% in HIV+ women and 9.5% in 
HIV- women (Ross et al., 1999).  However the duration of exposure to the risk of pregnancy 
was not reported and a proportion of the women in the study (13% of HIV+) and (18% of 
HIV-) had no sexual partners in the last year. In the same cohort of women followed over a 
longer period of time (11 years), reduced pregnancy rate with increased stage of disease 
(10.9% in HIV-, 8.5% in stage 1, 7% in stage 2, 5% in stage 3 and 1.1% in stage 4) was 
reported (Ross et al., 2003).  These results suggest that the severity of the disease (stage) 
impacts on ability to become pregnant, which may be related to the systematic illness and 
weight loss that become more pronounced with progressive stages of the disease.  A study 
comparing pregnancy rate in serodiscordant couples in the Democratic Republic of the 
Congo, found that pregnancy rate was lower in couples where the women was HIV+ (11.6%) 
than in couples where the woman was HIV- (15%), but there was no control group where 
both partners were HIV- (Ryder et al., 2000).  
There have been various studies that measured the prevalence of HIV in infertile 
populations including a study on stored frozen sera in a tertiary care center in the USA that 
found the prevalence of HIV to be 0.6% of women in a low-middle class infertile population 
(Bray, Soltes, Clarke, Minkoff, Sierra & Reyes, 1991). In another prevalence study among 
Spanish patients attending an infertility clinic in Barcelona, prevalence of HIV was found to 
be 0.3% in primary infertile women and spontaneous recurrent aborters (Balasch, Pumarola, 
Jove, Coll & Vanrell, 1991).  In a community survey in Gabon in the late 80s on prevalence 
of HIV in infertile women (primary and secondary) and fertile controls, it was found that 
9.3% of primary infertile (childless for more than two years), 2.1% of secondary infertile 
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(childless for more than two years following the last birth) and 0.7% of fertile controls were 
HIV+ (Schrijvers, 1991).  
Rational, Aim and Objectives 
The studies mentioned thus far indicate that HIV impacts negatively on aspects of 
female reproductive health, most notably amenorrhea, menstrual irregularities, decreased 
pregnancy rate and increased pregnancy loss (Waters, et al., 2007; van Leeuwen et. al., 2007; 
Kushnir & Lewis, 2011; Ryder et al., 2000; Ross et al., 1999; Ross et al., 2003, Schrijvers, 
1991). The negative impact of HIV on fertility problems has been suggested but there is a 
lack of unequivocal evidence to support this suggestion. The presence of an association 
between HIV and fertility problems, the magnitude of this relationship and the link with stage 
of HIV or CD4 count need to be explored. It is important to understand whether reports of 
fertility problems are due to hormonal changes (directly caused by HIV or indirectly by other 
factors such as weight loss), anatomical changes in the female reproductive system (damage 
to tubes) or behavioural changes (abstinence or use of condoms during penetrative sex) that 
could lead to difficulty becoming pregnant. It is unclear whether it is the HIV virus itself or 
the decreased immune response and ensuing increased susceptibility to opportunistic 
infections that impacts on fertility problems or if there are confounding factors such as age, 
STIs, stage of HIV, contraceptive use, education and SES.   
The biological plausibility of the effect of HIV on reproductive processes coupled 
with the high prevalence in some developing countries and the results of the survey of 
physicians [HIV endorsed as a potential risk factor by 75.9% of responders] (Chapter 2, pp 
25), highlights the need to investigate whether HIV should be included as a risk factor in the 
adapted FertiSTAT. The review also intended to examine hormonal changes and amenorrhea 
as plausible biological pathways. The present study reported on results of a systematic review 
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and meta-analyses of studies on HIV.  The objective of the review was to examine whether 
HIV was associated with fertility problems in women, the scale of this impact and at what 
point in the reproductive process HIV might exert its impact (ability to become pregnant or 
have a live birth).  The population of interest for the review was women, the exposure was 
HIV (seropositive) and the outcome of interest was fertility problems. The overall aim of this 
review was to determine whether HIV should be included as a risk factor in the adapted 
FertiSTAT. 
Materials and Methods 
Search Strategy 
The search terms included words related to HIV, for a complete list of MeSH terms 
see Appendix L. Studies were excluded if the acronyms HIV or AIDS referred to or meant 
something else. Due to the extensive amount of literature on HIV not relevant to this review 
the search was modified by only including some subject headings and by excluding studies 
using the ‘NOT’ Boolean to remove studies on topics such as cancer and ethics, see 
Appendix L for the complete search strategy. For the search term AIDS only the following 
subheadings were included: complications, diagnosis, disease management, drug resistance, 
drug therapy, epidemiology, etiology, radio therapy, rehabilitation and side-effects.  
Data Extraction and Quality Assessment 
The data extraction form (Appendix H) was adapted to include information relevant to 
HIV. Specifically to include stage of HIV and type of blood testing used for the diagnosis of 
HIV in included studies. The NOS form was adapted to reflect quality criteria for the 
assessment of HIV and additional confounders. HIV was adequately assessed if there was 
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blood testing using ELISA and/or Western Blot during clinical examination or from 
hospital/medical records. The confounder that was more important than others was age. 
Data Synthesis and Analysis 
Meta-analyses were computed for the outcomes reported in the studies. Data from 
case-control studies were calculated as previously described (pp. 65)
Results 
Study Selection 
Figure 3.3.3 shows the flowchart for number, reason and stage of exclusion of 
articles. A total of 741 records were identified (after duplicates removed) and most studies 
(522/741, 70.4%) were excluded because they did not measure fertility problems or report the 
relationship between HIV and fertility problems. Three studies were non-English, and 
translations were obtained using Goggle translate (https://translate.google.com/). Search of 
the reference lists of the included studies and contact with authors resulted in 2 additional 
studies. Of the 35 full text articles assessed for inclusion, nine met inclusion criteria.  
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Figure 3.3.3. PRISMA Flow Diagram for HIV. Figure shows the exclusion of 
articles at the different stages and the reasons for exclusion. Records identified 
through datbase searching of Medline and Embase includes original search, an 
update from the time of original search and a search using new MeSH terms. 
Characteristics and Design of Included Studies 
Table 3.3.3 shows selected sample characteristics of the included studies. The 
majority of the studies were conducted in Africa (7/10, 70%) and six included mean or 
median age at time of study, two studies included information related to participant age in 
range and two did not report on age. The average age in the HIV+ group (of studies that 
reported mean or median) was 28.9 (range 16.7-35) and in the HIV- group was 28.12 (range 
16.9-34.5).  
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Table 3.3.3. 
Sample Characteristics Reported in the Ten Included Studies 
Study Location Sample (n) N N       Age a 
Women 
Cohort/cross-
sectional studies 
HIV No-HIV HIV No-HIV 
Cejtin, 2006 USA 1431 women 1145 women 286 women Range Percentage (n) Percentage (n) 
16–39 59.1 (677) 63.6 (182) 
40–44 25.2 (288) 25.5 (73) 
45–49 11.4 (131) 8 (23) 
50–55 4.3 (49) 2.8 (8) 
Chirgwin, 1996 USA 330 women 248 women 82 women Mean (SD) 32.7 (6.2) 34.5 (6.9) 
Gray, 1998 Uganda 4497 women 953 women 3544 women Range Percentage (n) Percentage (n) 
15–19 23·9 (847) 7·1 (68) 
20–24 26·5 (938) 30·7 (293) 
25–29 16·3 (578) 30·6 (292) 
30–39 21·9 (775) 26·1 (249) 
>40 11·5 (406) 5·4 (51) 
Linas, 2011 USA 1412 women 941 women 471 women NR NR NR 
Willems, 2013 Burkina Faso 93 women 54 women 39 women Mean (SD) 35 (5) 29 (6.5) 
Ross 2003 Uganda 216 women 81 women 135 women NR NR NR 
Yaro 2001 Burkina Faso 912 women 63 women 849 women Mean (SD) 16.7 ±2 16.9±2 
Ezechi 2010 Markurdi, Nigeria 3473 women 2549 women 924 women Mean age 32.7± 4.9 33.2±5.7 
Case-control 
studies 
Infertile b Fertile (control) Infertile  Fertile 
De Muylder, 
1990 
Zimbabwe 331 women 227 104 Mean (SD) 28.4 (4.8) tubal 
27.1 (4.9) non-tubal 
NR 
Dhont, 2010 Rwanda 595 women 312 283 Median (IQR) 30 (27–35)  27 (24–31) 
Note. a Age for women at the beginning of the study; b Unable to become pregnant after at least 12 months of unprotected intercourse; NR= data not reported; SD=Standard 
deviation; IQR=inter-quartile range
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Table 3.3.4 shows methodological characteristics of included studies. Two studies 
were cohort design, information extracted in three studies was cross-sectional data embedded 
within a larger cohort study, two studies were cross-sectional and two were case-control.  
HIV was confirmed by a blood test in all of the studies (specified as ELISA and/or Western 
blot in half of the studies). 
Fertility problems outcome measures reported in the included studies were: 
‘pregnancy rate’ (calculated no-pregnancy) in two studies, ‘FSH level only’ in one study, 
‘amenorrhea only’ in one study, ‘FSH and amenorrhea’ in one study, ‘infertility >12 months’ 
in two studies (more than 12 months unprotected sex in one study and more than 18 in the 
other study). The two studies that reported ‘pregnancy rate’ reported levels of contraceptive 
use as follows; 84% of HIV+ and 79% of HIV- women used a contraceptive in the 6 months 
prior to the study (Linas, et al., 2011), while 14.3% of HIV+ and 10.7% of HIV- women used 
modern contraceptives and 6.7% of HIV+ and 5.7% of HIV- women used abstinence (Gray, 
et al., 1998). The Gray et al. (1998) study was a prospective cohort study reporting on 
pregnancy rate in HIV+ and HIV-. Pregnancy was determined at the being on the study at 
baseline and all the women who were not pregnant were followed over time to measure 
pregnancy rate but the final pregnancy rate was not given per woman rather it was given in 
women years, so it was not possible to use the prospective data in the current meta-analysis. 
Instead the baseline data regarding the number of women who were pregnant and those who 
were not pregnant in both the HIV+ and HIV- groups at the beginning of the study was 
extracted and used in the current meta-analysis (thus it was cross-sectional because it was 
obtained at one point in time). The data in Linas et al. (2011) on the other hand was 
prospective cohort since these women were followed over a 7-year period. In this study 766 
pregnancies occurred in 456 women, meaning some women had more than one pregnancy in 
the seven year period, therefore the number of women who became pregnant (456) was used 
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Table 3.3.4. 
Characteristics of the Design of the Ten Included Studies 
Study Study design Data collection Study period HIV self-report or Blood test Fertility Problems outcome measure 
(duration) 
Cejtin, 2006 Cross-sectional data 
embedded in a 
Cohort study 
Interagency HIV Study 
Hospital/clinic based 
1994-1997 Blood test (type not specified) Amenorrhea > 12 months 
And/or 
FSH > 25 (mUI/ml) 
Chirgwin, 1996 Cross-sectional data 
embedded in a 
Cohort study 
Hospital/clinic based 1991-1994 Blood test (type not specified) Amenorrhea > 3 months  
Gray, 1998 Cross-sectional data 
embedded in a 
Cohort study 
Community based 1994-1995 Blood test (Western-blot) Pregnancy rate per woman (we 
converted to no-pregnancy) 
Linas, 2011 Cohort Interagency HIV Study 
Hospital/clinic based 
2002-2009 Blood test (HIV RNA, CD4 count and 
Serology) 
Pregnancy rate per woman (we 
converted to no-pregnancy) 
Willems, 2013 Cross-sectional data Hospital/clinic based 2008 Blood test (ELISA and Western-blot) FSH > 40 (mUI/ml) 
De Muylder, 1990 Case-control Hospital based 1985-1987 Blood test (ELISA and Western-blot) More than 18 months unprotected sex 
Dhont, 2010 Case-control Hospital based & 
community 
2007-2009 Blood test (Rapid test) More than 12 months unprotected sex 
Ross 2003 Cohort study Clinic based 1990-2001 Records (CD4 count & WHO staging) Foetal loss- spontaneous abortion and 
still birth 
Yaro 2001 Cross-sectional Clinic based 1988 Blood test (type not specified) Live birth, still birth, abortion 
Ezechi 2010 Cross-sectional Research institute & 
medical centre 
2005-2007 Blood test (ELISA, Western bolt, CD4 
count and viral load) 
Amenorrhoea > 90 days 
Note. HIV = Human Immunodeficiency Virus; CD4 = cluster of differentiation 4; RNA = Ribonucleic Acid ; FSH = Follicle Stimulating Hormone; ELISA = Enzyme-
linked Immunosorbent Assay 
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in the meta-analysis. Additionally, there were problems with the contraceptive use data e.g. 
of the 766 reported pregnancies, 192 occurred at the same visit that hormonal contraception 
use was also reported by women, but it was unclear if this was due to contraceptive failure or 
to errors in reporting of contraceptive use (Linas, et al., 2011). 
Study Quality, Fertility Problems Outcome Measure and Bias 
Table 3.3.5 shows the results of quality assessment (see table footnote for criteria).  
HIV was representative of the population and adequately assessed in all included studies, see 
Table 3.3.4. The non-HIV group (controls) were well defined, selected from the same 
population and exclusions were adequately reported in all included studies. Comparability of 
at least one confounder in the HIV/non-HIV groups was reported in all of the studies, and the 
majority of studies (6 of 7) reported on ‘age’. The majority of the studies adequately 
evaluated and included confounders in the analysis (5 of 7).  ‘Fertility problems’ outcome 
was adequately measured in all of the included studies, as indicated by blind or independent 
assessment. Overall the majority of studies had high quality as per quality assessment.  
Heterogeneity was significant in only one analysis, however, publication bias was not 
explored using funnel plots, Eggers test or trim and fill procedures because that analysis 
included two studies only, thus computation was not possible.  
Percentages reported in Table 3.3.6 indicated that pregnancy occurred similarly in the 
HIV+ and HIV- women. However, more HIV+ women had amenorrhea, levels of FSH > 25 
IU/l, infertility (>12months) and miscarriage that HIV- women. 
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Table 3.3.5.   
Quality Ratings for the Ten Included Studies on the Basis of an Adapted Newcastle-Ottawa Quality Assessment Scale 
Study 
Quality Criterion 
Overall 
rating g 
Adequacy of 
HIV (exposed) 
measure a 
Max 2 points  
Adequacy of control 
(non-exposed), 
definition and 
selection b 
Max 2 points  
Comparability of 
control c 
Max 2 points 
Confounders 
adequately assessed 
Max 2 points d 
Adequacy of 
outcome Fertility 
Problems measure e 
Max 1 point 
None response 
rate or loss to 
follow-up f
Max 1 point 
Cejtin, 2006 2 2 1 2 1 0 High 
Chirgwin, 1996 2 2 1 1 1 NA High 
Gray, 1998 2 2 1 2 1 NA High 
Linas, 2011 2 2 1 2 0 NR High 
Willems, 2013 2 2 1 2 1 NA High 
De Muylder, 1990 2 2 0 1 1 NA Average 
Dhont, 2010 2 2 1 2 1 NA High 
Ross 2003 2 1 1 2 0 NR Average 
Yaro 2001 2 2 1 1 0 NA Average 
Ezechi 2010 2 2 1 1 1 NA High 
Note. NA = not applicable; NR = not reported; a HIV was adequately assessed when independent validation of the diagnosis (e.g. blood testing and/or hospital/medical 
records) and it was representative of the cohort i.e. drawn from the same population (up to 2 points); b Controls were adequately assessed when selection was comparable to 
cases, and HIV was excluded properly in the control population (up to 2 points); c Comparability of controls was achieved if exposed/non-exposed were matched or 
adjustment during analysis conducted. One point for age and one point for any other confounder (up to 2 points); d Confounders were adequately assessed if they were 
obtained from records or a blind interview, and one point was given if the same method was used for both groups (up to 2 points); e Fertility problems outcome was 
adequately assessed if independent or blind assessment was stated in the paper, or confirmation of the outcome by reference to secure records (medical records, etc.) (up to 1 
point); f Point given if same rate for both groups and <20% loss to follow up reported; g The overall quality rating was low (0 to 3 points), average (4 to 6 points), or high (7 
to 10 points). 
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Table 3.3.6. 
Number and Percentage of Women with a Specific Outcome in the HIV+ and HIV- Groups 
in the Included Studies (k=9) 
Outcome Number of women (%) 
HIV+ HIV- 
Pregnancy 532 of 1894 (28.1) 1120 of 4015 (27.9) 
Amenorrhoea 173 of 3942 (4.4) 22 of 1292 (1.7) 
FSH >25 IU/l 60 of 1194 (5.0) 10 of 317 (3.2) 
Infertile > 12 months 107 of 146 (73.3) 432 of 780 (55.4) 
Miscarriage 26 of 155 (16.8) 99 of 948 (10.4) 
Note. FSH = follicle-stimulating hormone 
Results of Meta-analyses 
The first analysis compared two studies reporting ‘pregnancy’, see Figure 3.3.4. This 
meta-analysis showed a significant pooled effect size (OR 0.36, 95% CI 0.15 to 0.89) and 
significant heterogeneity (I² = 97%, p < 0.00001). The results indicated that the HIV+ women 
had significantly less pregnancies (more likely to have fertility problems) than HIV- women. 
Heterogeneity could not be explored with sensitivity or subgroup analysis because there were 
only two studies in this analysis.   
Figure 3.3.4. Odds ratio for women reporting ‘pregnancy’ in the HIV+ and the HIV- 
groups  
Figure 3.3.5 shows the forest plot and meta-analysis result for the three studies 
investigating the number of women who have had amenorrhea for more than 3 months. The 
meta-analysis showed a significant pooled effect size (OR 2.44, 95% CI 1.56 to 3.81), and 
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non-significant heterogeneity (I² = 0%, p = 0.46), see Figure 3.3.4. The results indicated that 
the HIV+ women had significantly more amenorrhea (more likely to have fertility problems) 
than the non-HIV group. 
Figure 3.3.5. Odds ratio for the proportion of women who have amenorrhea (>3 months) in 
HIV+ vs HIV- women 
The third analysis compared two studies reporting ‘FSH >25 IU/l’, see Figure 3.3.6. 
The meta-analysis showed a non-significant pooled effect size (OR 1.51, 95% CI 0.77 to 
2.94), and non-significant heterogeneity (I² = 0%, p = 0.39). The results indicated that the 
proportion of women who had ‘FSH > 25 IU/l’ did not differ significantly between the HIV+ 
and HIV- groups (comparable fertility problems).    
Figure 3.3.6. Odds ratio for proportion of women who have ‘Level of FSH >25 IU/l’ 
(indicative of POI) in the HIV+ and HIV- groups  
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The fourth analysis compared two studies with calculated data representing the
proportion of infertile (>12 months) women in the HIV+ and HIV- women, see Figure 3.3.7. 
The meta-analysis revealed a significant pooled effect size (OR 2.93, 95% CI 1.95 to 4.42), 
with non-significant heterogeneity between studies (I² = 0%, p = 0.43). The results indicated 
that there were more infertile women in the HIV+ group than the HIV- group (more likely to 
have fertility problems).  
Figure 3.3.7. Odds ratio proportion of women who are ‘infertile > 12 months’ in the HIV+ 
and HIV- women 
The fifth analysis compared two studies reporting on the proportion of women who 
had a ‘miscarriage’ in the HIV+ and HIV- groups, see Figure 3.3.8. The meta-analysis 
revealed a non-significant pooled effect size (OR 1.35, 95% CI 0.77 to 2.35), with non-
significant heterogeneity between studies (I² = 0%, p = 0.55). The results indicated that the 
two groups were equally likely to report miscarriages (comparable fertility problems).  
Figure 3.3.8. Odds ratio for the proportion of women who had a ‘miscarriage’ in the HIV+ and 
HIV- women 
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Publication bias assessment. 
Heterogeneity was only significant in one of the four analyses, however publication 
bias could not be assessed using funnel plots, Eggers test or trim and fill procedures because 
this analysis included only two studies, which precluded all computations.  
Discussion 
Principal Findings 
The results of the present set of meta-analyses suggest that HIV may be a relevant 
factor for the prediction of ability to become pregnant, due to the lower pregnancy rate and 
higher rate of infertility and amenorrhea. These results support an impact via the first four 
pathways (inability to achieve pregnancy) but not the fifth pathway (miscarriage) in Figure 
3.3.2 (pp. 152). Results support the first (anovulation) and third (contraception) pathways but 
not the second pathway (TFI). However, the second pathways was not examined due to a lack 
of primary studies reporting on STIs and TFI in HIV retrieved from current search. The first 
pathway appears more likely to be due to weight loss than POI because the results for the 
FSH analysis were not significant. The third pathway also requires more research to confirm 
the exact use of contraception and abstinence and possible association with pregnancy.  
 Potential reasons for the decreased rate of pregnancy reported in HIV+ women, 
include hormonal problems (menstrual irregularities, POI), decreased sexual activity, 
increased use of contraceptives, and mechanisms pertaining to the disease, its symptoms and 
comorbidities like STIs (Waters, et al., 2007; van Leeuwen et. al., 2007; Kushnir & Lewis, 
2011). Significant results of ‘pregnancy-rate’ analysis need to be interpreted in light of the 
fact that a proportion of the sample were contracepting and that amenorrhea analysis was 
significant while FSH level was not. The difference in pregnancy rate across the two included 
studies should also be taken under consideration. In one study (Gray et al., 1998) the 
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pregnancy rate in both groups (HIV+ 13.4%, HIV- 21.4%) was lower than the other study 
(HIV+ 25.7%, HIV- 45%) [Linas et al., 2011]. This difference may have been due to 
methodological differences in the two studies, where data was collected at one point in time 
in the Gray et al. (1998) study and over time (7 years) in the Linas et al. (2011) study. Cross-
sectional studies may therefore underestimate the ability to eventually achieve pregnancy in 
both groups (HIV+ and HIV-), because they only capture current fertility problems rather 
than lifetime. Nevertheless, women with HIV were less likely to be pregnant overall.  
Overall it can be inferred from the results that what difference there is in infertility 
and pregnancy rate could be related to lack of period and/or contracepting. It seems plausible 
that the amenorrhea may be associated with low weight specifically and/or ill health in 
general (Lo & Schambelan 2001; Kushnir & Lewis, 2011). Amenorrhea does not appear to
be related to direct effect of HIV or other ‘opportunistic infections’ on ovarian 
function/hormones such as FSH, contradicting suggestions in the literature of ovarian 
impairment (van Leeuwen et. al., 2007; Kushnir & Lewis, 2011). Rather the results 
corroborate explanations in the literature indicating that amenorrhea may be an indirect effect 
of the subsequent wasting/weight loss, comorbid drug use, marijuana, chronic alcohol 
consumption, low SES (Lo & Schambelan 2001) or low CD4 count and high HIV viral load 
(Waters, et al., 2007).  The significant link between HIV and amenorrhea is not surprising 
given that weight loss starts at early stages of HIV and is not only limited to end stage or 
AIDS manifestation, see Table 3.3.1. The effect of stage of disease and related sequel could 
not be confirmed because analysis by stage was not feasible due to lack of relevant data.  
An understanding of how contraceptive use may have influenced the lower rate of 
pregnancy would have been gained from subgroup analysis based on only non-contracepting 
women. Although subgroup analysis was planned it was not possible because in one of the 
included studies the number of pregnancies exceeded the number of non-contracepting 
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women, indicating that some women became pregnant while using contraceptives, suggestive 
of misuse/failure of contraceptives or an over reporting of contraceptive use.  
In the present study the effect of HIV on fertility was examined in a set of meta-
analyses of observational studies. This systematic approach demonstrated that HIV was 
associated with infertility and reduced pregnancy rate but a causal relationship could not be 
confirmed, nor could a specific mechanism of action be specified.  Additionally, application 
of the ‘Bradford Hill criteria’ noted in the General Methods (pp. 55), lead to the conclusion 
that the available evidence does not meet any of the criteria, therefore the likelihood of a 
causal relationship between HIV and fertility problems could not be confirmed. It is possible 
that this is because there are numerous confounding factors such as comorbidities and 
lifestyle factors such as abstinence that need to be well controlled for to enable firm 
conclusions about causality.  
Justification for including HIV in the FertiSTAT. 
Although the results showed that HIV did not appear to be related to FSH levels 
suggestive of POI (FSH > 25) as can be inferred from the lack of significance of the analysis 
of FSH level, results cannot be used to confirm whether the impact was via amenorrhea 
exclusively. The similar levels of FSH in HIV+ and HIV- women further corroborates that 
the amenorrhea may be induced by side-effects of the disease such as weight loss or 
comorbidities such as drug use (Waters, et al., 2007; Kushnir & Lewis, 2011), thereby 
weakening the argument that ovarian dysfunction is the causal pathway involved. If the 
mechanism of action of HIV was only via amenorrhea, then it would not be an independent 
risk factor since amenorrhea is a risk factor in the current FertiSTAT and the inclusion of 
HIV would therefore not increase the predictive ability of the tool. If the mechanism of 
action had been via hormonal change indicative of ovarian dysfunction (POI), then HIV may 
have had an independent effect on fertility problems. Confirmation of the other two causal
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pathways (tubal damage, contraception) thorough which HIV may exert an impact on fertility
problems could not be ascertained from the available data as there were no studies examining 
tubal damage, rate of intercourse and abstinence found in the current search. The fact that the 
meta-analysis for ‘miscarriage’ showed no significant difference between HIV+ and HIV- 
women indicated that HIV may have little impact once pregnancy occurs.  Finally, the 
increased likelihood of being infertile in the HIV+ women indicated that HIV may be one of 
the factors contributing to the infertility, and the mechanism via which it contributes 
appeared to be via lack of period, abstinence or contraceptive use. Additionally, this 
association may be linked to increased susceptibility to, or comorbidities with STIs and PID 
(Waters, et al., 2007; van Leeuwen et. al., 2007; Kushnir & Lewis, 2011), unfortunately there 
was no data to corroborate this information.  
The current meta-analyses indicated that inclusion of HIV in FertiSTAT as a new risk 
factor could potentially increase prediction of fertility problems in LMICs. In the present
study the effect of HIV on fertility was examined according to the fertility dimension of 
outcome i.e. infertility, pregnancy rate, amenorrhea and FSH level. This systematic approach 
demonstrated that although HIV had an impact on infertility and pregnancy rate this impact 
could be affected both by lack of period and use of contraceptives. Given the significant 
result of the meta-analysis using ‘infertility’, ‘pregnancy rate’ and 
‘amenorrhea’ but not of FSH level, it can be inferred that HIV has an impact on menstrual 
cycle but that it does not appear to be associated with ovarian function. The effect on 
pregnancy rate has to be interpreted in light of the fact that a proportion of couples in those 
studies were contracepting making it difficult to disentangle the effect of HIV on ability to 
become pregnant. 
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Implications of Findings 
Results of the current study indicated that awareness of the risks associated HIV 
should be communicated to women.  The implications of these results is that women and 
health care providers should be made aware of potential risks to reproductive health that 
women who have HIV face. The results of the review lend support to reports in the literature
of increased likelihood of menstrual irregularities that can hinder a women’s ability to 
become pregnant (Lo & Schambelan 2001; Waters, et al., 2007; van Leeuwen et. al., 2007; 
Kushnir & Lewis, 2011). The repercussions of the accompanying amenorrhea for couples 
wanting to become pregnant are important because of its impact on childbearing. An 
understanding of whether the amenorrhea is related to the disease or side-effects/
comorbidities such as weight loss and drug use needs to be examined as the treatment will 
vary depending on what the amenorrhea is attributable to. The distinction between 
amenorrhea linked to decreased ovarian function and that which is related to weight/drug 
use, is that the former may not be reversible while the latter can potentially be remedied. 
Thus from a clinical perspective it is important to measure levels of FSH in HIV+ women 
who have amenorrhea and desire to have children to rule-out POI and advise the patient 
accordingly.  
HIV in pre-pregnancy care.
The importance of including HIV in pre-pregnancy care was underlined in the WHO 
report “Meeting to Develop a Global Consensus on Preconception Care to Reduce Maternal 
and Childhood Mortality and Morbidity” (WHO, Meeting report, 2012). Additionally, 
emphasis was placed on tailoring interventions to settings (before attempting 
implementation) depending on local prevalence, the existing interventions, and the available 
mechanisms and resources that can facilitate the delivery of additional care. With regard to 
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HIV specifically, the report included information on the association between HIV and 
infertility and effects of unprotected sexual intercourse on ability to get pregnant in 
populations at high risk of HIV/STIs. It was noted that due to limited access to infertility 
treatment people with fertility problems often resort to traditional methods of self-cure (e.g. 
unprotected sex with multiple partners to achieve pregnancy), which can result in the spread 
of HIV. It was also noted that in developing countries couples living with HIV have higher 
rates of infertility and spontaneous miscarriage (no data reported). One of the health 
problems contributing to maternal and child morbidity and mortality mentioned in the report 
was the lack of HIV/STI screening and the repercussion on future fertility (via PID, tubal
damage, see Figure 3.3.2). People living with HIV were mentioned in the report as a special 
segment of the population that should be targeted with pre-pregnancy care. However, specific 
recommendation, symptoms and effects of HIV that could potentially be mediating the impact 
on fertility problems were not mentioned. The results of the current meta-analysis indicated 
that HIV+ women were more likely to have amenorrhea (a potential consequence of HIV that 
impedes pregnancy), demonstrating the importance of including amenorrhea as an additional 
aspect of a comprehensive pre-pregnancy package.  
The inclusion of HIV in a comprehensive pre-pregnancy care package was further 
emphasized in the WHO’s publication: “Preconception care: maximizing the gains for 
maternal and child health” (WHO, Preconception care, 2013). It was reported that this can 
help prevent the vertical transmission of HIV/STIs. Interventions for HIV in the pre-
pregnancy care package include essential aspects such as the prevention of mother-to-child 
transmission of HIV, family planning and contraception but do not include how to safely 
become pregnant while HIV positive (especially important for serodiscordant couples to 
prevent the transmission of HIV).  
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Strength and Limitations in Included Studies 
The heterogeneity in study methodology, outcome measures and sample size in 
included studies could affect the comparability of these studies, and the generalizability of 
the results of this review. Heterogeneity in fertility problems outcome (inability to become 
pregnant, lack of period, hormonal changes), study design (case-control, cohort and cross-
sectional) and data collection methods (medical examinations and interviews), can affect 
the practical applicability of the results.  However, heterogeneity was only statistically 
significant in one meta-analysis in this review, indicating that overall issues of 
methodological heterogeneity may not be extensive. The quality of each study 
independently does not appear to affect the overall results of the review since all of studies 
were of sound quality. 
Bias relating to the primary studies included selection bias, information bias and 
recall bias. In the hospital based studies, the selection of participants based on hospital 
attendance can reduce the generalizability of the results. However, because the same 
sampling procedures were used for both cases (exposed) and controls (non-exposed), we 
can assume that selection bias may not be substantial. It can be assumed that since the 
selection of participants was from the same sample and information was gathered using the 
same method for both the exposed and non-exposed groups in all the studies, that selection 
and information bias may not affect results considerably. Recall bias can affect the internal 
validity of results where data was collected in interviews that require recall of old events, 
which is more substantial for recall of details (Hassan, 2005). Thus, recall bias might not 
have been considerable because the interviews did not require recall of old events e.g. 
information on last menstrual cycle. Bias due to confounder was a potential limitation of the 
studies included but it might not have been considerable given that matching the groups for 
confounders was reported in all of the included studies and including confounders in the
Chapter 3 Systematic Reviews 
179 
 analysis, was conducted in five of the seven studies. The most important confounder ‘age’ 
which is known to impact negatively on fertility was included in the analysis of five studies. 
There could have been an unequal distribution of other confounders in the exposed and non-
exposed groups but this was not reported in the included studies. However, the effect of 
confounders like weight, stage of HIV, education and SES that could have influenced the 
relationship between HIV and fertility problems was taken into consideration via either 
matching groups for confounders or entering them into analysis.  Another limitation relating 
to the primary studies is the use of observational designs, as discussed in previous reviews. 
As in the case of consanguinity randomization would not have been possible or ethical, for 
HIV, therefore the most rigorous design would be cohort studies, followed by case-control 
and then cross-sectional (Mann, 2003). This study comprised of three cohort studies, two
case-control studies and cross-sectional data in two studies, which are reasonably rigorous in 
identifying associations (Mann, 2003), thus the results of this review can only be used to infer 
association.  
Future Research 
Future research to disentangle the effect of HIV on fertility problems requires 
prospective cohort and case-control studies to investigate the causal mechanisms that are 
involved. Future research can be informed by the pathway diagram, Figure 3.3.2 (pp. 152), 
indicating that studies should examine the use of contraception and abstinence as well as 
STIs and TFI in HIV. Studies need to consider the different stages of HIV and ensuing side-
effects such as wasting and to determine which aspects of the reproductive process are 
affected.  Future research should be directed at understanding the reasons for the increased 
infertility and lower pregnancy rate, to definitively ascertain if it is related to abstinence, 
sexual frequency, use of condoms or menstrual irregularities and amenorrhea. 
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Finally, it’s important to investigate the link between HIV and POI due to the small 
number of included studies in the current meta-analysis. It is imperative that after more such 
studies are carried out that an update of the meta-analyses be conducted.  Ideally, 
longitudinal prospective cohort studies should be conducted to follow women who are HIV+ 
and HIV- controls, with measurements at baseline and follow-up of fertility problems 
outcomes such as pregnancy, childlessness, menstrual irregularities, and POI. The intent to 
conceive, use of contraceptives, frequency of sexual intercourse as well as the duration of 
exposure to sexual intercourse should be reported. Additionally, confounders such as age, 
stage of the disease (clinical staging and CD4 count), weight, comorbid STIs and drug use 
and SES should be considered (matching and/or included in the analysis).  
Conclusion 
Fertility problems have been reported as a negative consequence of HIV in the 
literature but evidence to support this claim has been limited. Results of the current meta-
analyses indicated that HIV may affect ability to become pregnant. Therefore, the results 
indicated that including HIV may increase the predictive ability of the FertiSTAT. It is 
important to note that this area of research should be re-examined due to the methodological 
limitations of primary studies and the small number of included studies in the meta-analyses. 
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Study 3.4: Systematic Review and Meta-analysis of Observational Studies Examining 
the Association of Genital Tuberculosis and Fertility Problems 
Introduction 
Genital tuberculosis was one of the risk factors endorsed by survey of fertility doctors 
(Chapter 2, pp. 25). The validity of this risk factor as a predictor of fertility problems was 
examined in the current systematic review using the operational definitions of fertility 
problems and risk factor applied in the original development of FertiSTAT (Bunting & 
Boivin, 2010). 
Description of GTB 
Tuberculosis (TB) is an infectious airborne disease caused by the bacillus 
mycobacterium tuberculosis (WHO, Global TB report, 2015). TB is mainly prevalent in 
developing countries, with 75% of all cases occurring in only 13 developing nations (Haas, 
2000). According to WHO estimates, in 2014, 3.2 million women contracted TB (WHO, TB 
in women: factsheet, 2015). India has the highest incidence of TB in the world and Nigeria 
the highest in Africa, with very low incidence in developed countries (WHO, Global TB 
report, 2015).  According to the WHO (TB in women: factsheet, 2015), TB mostly affects 
vulnerable groups; those living in poverty, malnutrition and food insecurity, and the vast 
majority of TB deaths occur in the developing world.  
TB can manifest as pulmonary TB in the lungs and extrapulmonary TB occurring 
outside the lungs (WHO, Global TB report, 2015). In very rare cases maternal TB can pass to 
the foetus if there is rupture of part of the placenta or the infected endometrium, and this type 
is referred to as congenital TB (Hüseyin, Melike, Sevgi, Onur & Rahmi, 2009). 
Extrapulmonary TB occurs as a result of the spread of TB from the lungs to other organs 
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through the blood, which can transpire within hours of the initial infection (Varma, 2008). 
Genital tuberculosis (GTB) is one manifestation of extrapulmonary TB that happens as a 
result of the spread of TB to the genital tract through the blood or from neighbouring lesions 
(Gatongi et al., 2005; Varma, 2008). GTB represents between 15-20% of extrapulmonary TB 
and affects about 12% of people who have pulmonary TB (Aka & Vural, 1997). Estimates of 
the prevalence of GTB cannot be precisely ascertained because the disease can be 
asymptomatic and remain undetected for years (Gatongi et al., 2005; Chowdhury, 1996, 
Varma, 2008; Ghosh, Ghosh & Chowdhury, 2011), see Figure 3.4.1 for global incidence rate 
of TB. According to the WHO, GTB is a challenge to diagnose and has been recognised as an 
important cause of infertility in settings with high TB-incidence (WHO, TB in women: 
factsheet, 2015). The global prevalence of GTB in infertile women has been estimated to be 
between 5-10% (Figueroa, Martinez, Villagrana & Arredondo, 1996), as low as 1% in 
Australia and as high as 19% in India (Chowdhury, 1996). 
Figure 3.4.1. WHO estimates of the Global incidence rate of TB, 2015. Figure from 
http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1 
Copyright by WHO. Reprinted with permission 
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GTB can affect any of the organs of the female reproductive tract, but the fallopian 
tubes are the most susceptible site, from which it spreads to other parts (Varma, 2008). It is 
reported in the literature that the involvement of the fallopian tubes in nearly 100% of cases 
suggests that they may be the initial source of infection (Varma, 2008). GTB has been noted 
most commonly in the fallopian tubes (95–100%), endometrium (50–60%) and ovaries (20–
30%), with much less involvement of the cervix (5–15%), vulva/vagina (1%) and the 
myometrium [2.5%] (Schaefer, 1976; Varma, 2008; Ghosh et al., 2011). In some reports 
cervical involvement was reported to be higher, 43.1% (Samal, Gupta & Agarwal, 2000) and 
24% (Nogales-Ortiz, Tarancion & Nogales, 1979), endometrial involvement was higher, 79% 
(Nogales-Ortiz et al., 1979) and 60% (Onuigbo, 1979), while ovarian involvement was lower, 
11% (Nogales-Ortiz et al., 1979).  
The diagnosis of GTB can be performed via several tests including histology, culture, 
polymerase chain reaction (PCR), laparoscopy, hysteroscopy and hysterosalpingography 
depending on availability in the clinical setting. Histology refers to microscopic examination 
of tissues, while culture refers to growing a microbe in the lab to help identify it, both of 
which are not as specific as PCR, a test that analyses the DNA of the microorganism to 
identify it (Srivastava et al, 2014; Thangappah, Paramasivan & Narayanan, 2011). 
Laparoscopy is a surgical procedure that involves inserting a narrow tube with a light and 
camera through a small abdominal incision, while hysteroscopy involves using a similar
instrument inserted through the vagina into the uterus (NHS Choices, Hysteroscopy, 2016). 
Hysterosalpingography is an examination of the female reproductive tract using a specific 
type of x-ray that requires the use of contrast material (Baramki, 2005). The Centres for 
Disease Control (CDC) and National Institute for Health and Care Excellence (NICE) 
guidelines recommend that diagnosis should be confirmed by culture after initial microscopic 
identification of the microorganism (CDC, Diagnosis of TB, 2016; NICE, Guidelines 
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[NG33], 2016). In addition to culture, PCR has been used more recently to confirm the 
diagnosis as it is more specific (Varma, 2008) but it is yet to be included in guidelines. Not 
only is PCR more precise (high sensitivity and specificity) it is also faster (days or even 
hours) than culture [several weeks] (Gatongi et al., 2005; Varma, 2008; Ghosh et al., 2011). 
These confirmatory tests (culture, PCR) are usually limited in low resource countries where 
the prevalence of GTB is highest (Giannacopoulos et al., 1998; Lamba, Bryne, Goldin & 
Jenkins, 2002; Qureshi, Sammad, Hamd & Lakha, 2001), therefore, the diagnosis is done 
during hysteroscopy, laparoscopy or hysterosalpingography usually performed during 
preliminary infertility investigations (Gaur, Meheshwari & Lal, 1983; Samal et al., 2000; 
Margolis, Wranz, Kruger, Joubert, & Odendaal, 1992). Clinical examination of the 
reproductive tract shows that GTB manifests as a mass or lesion [adhesions, nodules, 
tubercles] (Ahmadi, Zafarani & Shahrzad, 2014; Gatongi et al., 2005; Varma, 2008; Ghosh et 
al., 2011). Laparoscopy and hysteroscopy provide visual assessment of such lesions and can 
be useful for obtaining tissue biopsy for culture and histology (Gogate, Joshi & Gogate, 1994; 
Thangappah et al., 2011). Tissue can also be obtained from menstrual fluid in the first day of 
menstruation to confirm diagnosis (Oosthuizen, Wessel & Hefer, 1990; Kirchoff, 1951). One 
of the major problems with diagnosing GTB is that it can remain asymptomatic (dormant 
state, or no observable symptoms) for one to ten years (Simon, Weinstein, Pasternak, Swartz 
& Kunz 1977; Daly & Monif, 1982; Burne, 1956) and is typically only discovered and 
diagnosed during routine infertility investigations (Figueroa et al., 1996; Gatongi et al., 2005; 
Varma, 2008). Therefore, a history of general ill health, weight loss, low-grade fever, fatigue 
or vague lower abdominal discomfort is the typical profile to alert healthcare providers to the 
presence of GTB (Varma, 2008).  
It has been reported that 20% of GTB patients have a family history of TB in their 
immediate family members, suggesting exposure during childhood (Schaefer, 1976) and that 
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approximately 50% have had other forms of TB in their lifetime (Varma, 1991; Tripathy & 
Tripathy, 1987; Schaefer, 1976). The majority (80-90%) of cases diagnosed in developing 
countries have been shown to be between the age of 20 and 40 years old (Schaefer, 1976; 
Falk, Ludviksson & Agren, 1980; Hutchins, 1977; Tripathy & Tripathy, 1987; Ojo & 
Unuigbe, 1987; Nogales-Ortiz et al., 1979). In developed countries reports have shown an 
older age, over 40 years (Falk et al., 1980; Hutchins, 1977). A delay in menarche in women 
with GTB (13.7 years old) has also been reported in a study where a group of women with 
GTB were compared with women with PID and endometriosis (12.8 years old) combined 
(Avan, Fatmi & Rashid, 2001). It has also been reported in a historical study using hospital 
records, that when pulmonary TB occurs close in time to menarche, this increases the 
likelihood of genital tract involvement (Burne, 1956).  
Plausible Mechanisms to Explain why GTB Could be Associated with Fertility
Problems 
In addition to an association between GTB and infertility, reports in the literature of 
laparoscopic and hysteroscopic findings confirm that GTB is associated with the formation 
of lesions in the tubes, endometrium and ovaries, leading to tubal blockage, endometrial 
destruction and ovarian masses (Ahmadi et al., 2014; Chavhan, et al., 2004; Ghosh et al., 
2011; Varma, 2008; Tripathy & Tripathy, 1998), see Figure 3.4.2. Since GTB can remain 
asymptomatic long after the initial infection and only exhibits symptoms once it has damaged 
the reproductive organs extensively (Figueroa et al., 1996; Gatongi, et al., 2005; Varma, 
2008; Ghont, et al., 2011), it is hard to extrapolate the exact biological pathway involved. 
However, it appears that there are three plausible mechanisms of change, see pathways 1, 2 
and 3 in Figure 3.4.2. The first through tubal blockage (Ahmadi et al., 2014; Chavhan, et al., 
2004) is the most probable pathway since fallopian tubes are the site of the majority of GTB 
(Schaefer, 1976) and the extent of damage to the tubes has been demonstrated in imaging 
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described in the literature (Ahmadi et al., 2014; Chavhan, et al., 2004; Malik, 2003; Tripathy 
& Tripathy, 1998).  
Figure 3.4.2. Proposed pathways for the impact of Genital Tuberculosis (GTB) on fertility. 
Solid line = Recent evidence (e.g. imaging); Dashed line = Proposed pathway/historic 
evidence; Dashed-Dotted line = Well established; TFI = tubal factor infertility; IUAs = 
intrauterine adhesion 
The second mechanism involving the endometrium, may have no impact if the 
damage is not extensive since the endometrial cells are shed with menstrual blood monthly 
(Nogales-Ortiz et al., 1979). Extensive endometrial damage on the other hand, can lead to 
menstrual disturbances and amenorrhea, due to the development of intrauterine adhesions 
(IUAs) and ultimately Asherman’s syndrome (Sharma, et al., 2008). Asherman’s syndrome is 
characterised by adhesions that occur in the uterine cavity or the cervix. Typically 
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Asherman’s occurs as a result of damage to the endometrium from curettage or infection but 
it has also been shown to be associated with GTB (Yu, Wong, Cheong, Xia, & Li, 2008).  
The syndrome can be diagnosed by ascertaining the presence of IUAs during hysteroscopy 
(Yu, et al., 2008). Clinical features of Asherman’s syndrome include menstrual disturbance 
(scanty or painful periods), amenorrhea, fertility problems, recurrent miscarriage and 
placental problems (Yu, et al., 2008).  
In the third mechanism, ovarian damage caused by lesions in the interior of the 
ovaries or encapsulation from the outside may result in the disruption of ovulation (ovarian 
failure), which would preclude pregnancy. The occurrence of amenorrhea in GTB can be due 
to ovarian failure, however complete destruction of the ovaries is rarely found (Varma, 2008). 
Therefore, amenorrhea in GTB has usually been attributed to extensive damage to the 
endometrium rather than ovarian damage (Malkani,1966; Nogales-Ortiz & Villar, 1957). 
Infertility in GTB can occur with or without amenorrhea and regardless of the cause of the 
amenorrhea. In cases without amenorrhea, the infertility is usually attributed to tubal damage 
(Varma, 2008). 
Reproductive Health Consequences of GTB 
It appears from the literature reviewed that the association between GTB and 
infertility is a well-established fact, however, an in depth evaluation of this literature would 
suggest that the evidence is not unequivocal. There are numerous studies and reviews 
reporting on the association of GTB with infertility, menstrual irregularities and other 
reproductive outcomes. A summary of the consequences reported in four narrative reviews 
(Malik, 2003; Gatongi et al., 2005; Varma, 2008; Ghosh et al., 2011) based on 29 primary 
studies, is presented in Table 3.4.1. The reviews summarized were subjected to quality 
evaluation using the “Critical Appraisal of Systematic Reviews” published by the WHO 
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(Abalos, Carroli, Mackey & Bergel, 2001). Table 3.4.1 presents information on the 
reproductive outcomes (infertility, pelvic pain, menstrual dysfunction, Asherman’s and TB in 
the neonate), how TB impacts the reproductive outcome and the percentages (prevalence of 
the problem) reported.  Reference for the primary studies cited and the reference for the 
review are also shown in the table. Generalizations about the health consequences noted in 
Table 3.4.1 need to be considered in light of the methodology of the reviews and the primary 
studies included. The most important methodological drawback of the reviews was the 
absence of a description of the search methodology (Malik, 2003; Gatongi et al., 2005; 
Varma, 2008). In the Ghosh et al. (2011) review, PubMed, Medline and Indian Indexing 
Software Medline were searched. However, search methodology was not reported in the other 
reviews. The most important flaw in the primary studies reviewed was the lack of control 
groups or the study of GTB in infertile women exclusively, making it difficult to infer 
causality or to determine statistical comparisons such as odds ratio.  
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Table 3.4.1. 
Summary of Reproductive Health Consequences of Genital Tuberculosis (GTB) Reported in the Literature 
Reproductive 
Outcome 
Effect of GTB Statistics reported 
(percentage of GTB 
patients) 
Primary study Review 
Infertility Infertility is the presenting or most common 
complaint 
40 to 50 Siegler, 1979; Sutherland, 1979; 1983, Bazax-
Malik, 1983; Sivanesaratnam, 1986; Punnonen, 
1983; Francis 1964; Govan, 1962; Russel, 1951 
Varma, 2008 
Infertility 64.2 vs. 22 control Tripathy & Tripathy, 1987 
54.4 Ojo & Unuigbe, 1987 
10 to 85 Schaefer 1976, Krishna, 1977; Tripathy & Tripathy, 
2002 
Ghosh, 2011 
NR Arora, 2003; Choudhary, 1996; Bukulmez, 1999; 
Bapna, 2005; Varma, 1991; Sharma, 2008; Chavan, 
2004; Dam, 2006 
Ghosh, 2011 
NR Dhillon, 1990; de Vynck, 1990 Varma, 2008 
Infertility (primary and secondary) 42.5 (78 and 22) Qureshi et al., 2001 Gatongi, 2005 
Tubal blockage (Peritubal adhesions and 
tuboovarian masses) 
47.2 deVynck et al, 1990 Malik, 2003 
Pelvic pain Is not usually severe and present for many 
months before presenting  
25 to 50 Falk et al., 1980; Francis, 1964; Sutherland, 1979; 
Sutherland, 1983 
Varma, 2008 
Progression of GTB increase severity of 
pelvic pain and is usually aggravated by 
coitus, exercise, and menses. 
NR Daly & Monif, 1982 Varma, 2008 
Chronic pelvic pain 42.5 Qureshi et al., 2001 Gatongi, 2005 
Chronic pelvic pain 15.8 Samal et al., 2000 Gatongi, 2005 
Menstrual 
dysfunction 
Abnormal uterine bleeding 10 to 40 Simon et al., 1977; Daly& Monif, 1982 Varma, 2008 
menorrhagia (very heavy) 19 Samal et al., 2000 Varma, 2008, 
Ghosh, 2011; 
Gatongi, 2005 
Oligohypomenorrhea 54 Samal et al., 2000 Varma, 2008; 
Gatongi, 2005 
Amenorrhea NR Sharma, 2008 Ghosh, 2011 
Chapter 3 Systematic Reviews 
191 
Reproductive 
Outcome 
Effect of GTB Statistics reported 
(percentage of GTB 
patients) 
Primary study Review 
Amenorrhea 14.3 Samal et al., 2000 Varma, 2008; 
Ghosh, 2011; 
Gatongi, 2005 
15 Qureshi et al., 2001 Gatongi, 2005 
Dyspareunia (painful sex) 5 Qureshi et al., 2001 
Dysmenorrhoea (painful period) 12.5 Qureshi et al., 2001 
Menstrual irregularities found cases of 
endometrial TB of which Amenorrhea was 
the most common 
85 and 43.6 Tripathy & Tripathy, 1987 Varma, 2008; 
Gatongi, 2005 
Asherman’s 
Syndrome 
Uterine adhesions can be the cause of 
infertility 
NR Sharma, 2008; Bukulmez, 1999 Ghosh, 2011 
TB in the 
neonate 
TB can be spread to fetus in utero/delivery 
from a mother who has GTB (referred to as 
congenital TB) 
NR Hamadeh,1992; Arora, 2003; Stark, 1997; 
Cantwell, 1994 
Note: NR=not reported
Chapter 3 Systematic Reviews 
192 
It can be inferred from the data reported in Table 3.4.1 that there is a range of 
problems that seem to be associated with GTB, however there is heterogeneity in the 
prevalence of these problems. Overall, the data strongly suggest that GTB was found to be 
associated with reproductive health consequences like infertility (approximately 50% of 
women with GTB), pelvic pain (approximately 30% of women with GTB) and menstrual 
disturbances (approximately 30% of women with GTB) in the primary studies. Inferences 
about the data in Table 3.4.1 need to be made cautiously due to mythological shortcoming 
such as lack of control groups and clear terminology, and inconsistent reporting of outcomes, 
which could affect the validity of the results. Although infertility is reported in approximately 
50% of GTB cases the validity of this association cannot be ascertained as none of these 
studies (except one) had control groups, highlighting the need to systematically evaluate the 
evidence and to perform meta-analyses were data is present.  
Rational, Aim and Objectives 
It was evident from the literature that GTB has negative consequences on women’s 
reproductive health, most notably infertility, menstrual dysfunction and pelvic pain (Malik, 
2003; Gatongi et al., 2005; Varma, 2008, Ghosh et al., 2011). However, the lack of 
unequivocal evidence to support an association between GTB and infertility suggests the 
need to verify the presence of such an association, its magnitude, the biological mechanism 
involved and the link with severity of GTB.  
The biological plausibility of the effect of GTB coupled with the results of the survey 
of physicians [GTB endorsed as a potential risk factor by 97% of responders] (Chapter 2, pp. 
25) highlighted the need to investigate whether GTB should be included in the adapted
FertiSTAT. The objective of the review was to examine whether GTB was associated with 
fertility problems in women, and at what point in the reproductive process GTB might exert 
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its impact.  The population of interest for the review was women, the exposure was GTB and 
the outcome of interest was fertility problems. In the present review meta-analyses were 
performed according to the outcomes available in the literature to determine the effect of 
GTB on ability to become pregnant. The overall aim of this review was to determine whether 
GTB should be included as a new risk factor in the adapted FertiSTAT. 
Materials and Methods 
Search Strategy 
The search terms included words related to GTB, for a complete list of MeSH terms 
see Appendix M. Studies were excluded if the TB was pulmonary or congenital only.  
Data Extraction and Quality Assessment 
The data extraction form (Appendix H) was adapted to include information relevant to 
GTB. The NOS form was adapted to reflect quality criteria for the assessment of GTB and 
additional confounders. GTB was adequately assessed if diagnosis was confirmed through 
culture or PCR. The confounder that was more important than others was rural vs. urban 
living (potentially affecting rate of infection and/or help-seeking).  
Data Synthesis and Analysis 
Meta-analyses were computed for the outcomes available in the included studies.  
Results 
Study Selection 
Figure 3.4.3 shows the PRISMA flowchart for number, reason and stage of exclusion 
of articles. A total of 451 records were identified (after duplicates removed) and most studies 
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(278 of 451, 61.6%) were excluded because they did not measure ‘fertility problems’, report 
on the relationship between ‘fertility problems’ and GTB, or did not have a control group. 
Twenty two articles were excluded because an abstract could not be located despite contact 
with authors, all of which were published more than 30 years, 18 of 22 were published in the 
50s and 60s. Of the 23 full text articles assessed for inclusion five met inclusion criteria and 
were included in meta-analyses. ‘Fertility problems’ outcomes available in the included 
studies were: infertility, amenorrhea, primary and secondary infertility. An examination of 
the impact of GTB on ability to have live birth was not possible due to the lack of primary 
studies measuring childlessness or rate of live births. In the primary studies, infertility was 
defined as inability to become pregnant after one year of unprotected sexual intercourse. 
‘Amenorrhea’ was defined as not having a period (duration not specified in included studies). 
The terms ‘primary’ and ‘secondary’ infertility were not well defined in primary studies. 
Therefore, it could not be ascertained whether these referred to an inability to achieve 
pregnancy or achieve a live-birth.  The most recent definitions of these terms, both refer to an 
inability to establish clinical pregnancy but the difference between them is that primary 
infertility refers to a women who has ‘never’ been able to establish clinical pregnancy, while 
secondary infertility to a women “who has previously been diagnosed with a clinical 
pregnancy” (Zegers-Hochschild et al., 2017). It was assumed that the definition of 
primary/secondary used in the study though not reported was applied consistently in the 
exposed and non-exposed groups. 
Chapter 3 Systematic Reviews 
195 
Figure 3.4.3. PRISMA Flow Diagram for GTB. Figure shows the exclusion of studies at 
different stages and the reasons for exclusion. Records identified through datbase searching 
of Medline and Embase includes original search, an update from the time of original search 
and a search using new MeSH terms. GTB = Genital Tuberculosis  
Characteristics and Design of Included Studies 
Table 3.4.2 shows selected sample characteristics of the included studies. Three of the 
five studies were conducted in India, four included mean age at time of study (30 years old) 
and one reported participant age in range. Table 3.4.3 shows methodological characteristics 
of included studies. In all studies cross-sectional data was collected. All samples were 
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hospital or clinic based and GTB diagnosis was confirmed by histology in all studies but 
using PCR/culture in only two of the five studies. 
Study Quality, Fertility Problems Outcome Measure and Bias 
Table 3.4.4 shows the results of quality assessment (see table footnote for criteria).  
GTB was representative of the population and adequately assessed (confirmed by medical 
testing or from medical records) in all included studies. The No-GTB group (controls) was 
well defined and selected from the same population in all studies, but exclusions were 
adequately reported in three studies. Comparability of at least one confounder in the 
GTB/No-GTB groups was reported in four of five studies. Matching or adjustment in analysis 
based on confounders was not performed in any of the studies. ‘Fertility problems’ outcome 
was adequately measured in only one of the five included studies, as indicated by blind or 
independent assessment. Overall the majority of studies (4 of 5) had average quality as per 
quality assessment.   
Numbers reported in Table 3.4.5 indicated higher percentage of infertility, 
amenorrhea and primary infertility amongst women with GTB than amongst women without 
GTB. However, secondary infertility was lower amongst women with GTB than amongst 
women without GTB. 
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Table 3.4.2.  
Sample Characteristics of the Seven Included Studies 
Study Location Sample (n) GTB (n) No-GTB (n) Age Women a 
GTB No-GTB 
Ali, 2012 Kassala, 
Sudan 
 44 women 25 19 Mean (SD) 34.8 (6.9) 34.7 (7.7) 
Bhanothu, 2014 India (south) 302 women 202 100 Mean (SD) 28.54 (4.46) 27.59 (4.62) 
Sharma, 2011 India 388 women 99 289 Mean (SD) 28.69 (4.83) 29.72 (9.58) 
Malhotra, 2012 India 208 women 104 104 Mean (SD) 28.7 (3.9) 28.2 (3.1) 
Kitilla, 2002 Ethiopia 268 women 67 201 Range Percentage (n) Percentage (n) 
15-19 0 0.5 (1) 
20-24 19.4 (13) 8.5 (17) 
25-29 38.8 (26) 31.3 (63) 
30-34 29.9 (20) 36.3 (73) 
35-39 11.9 (8) 19.9 (40) 
40-44 0 3.0 (6) 
45+ 0 0.5 (1) 
Note..a Age for women at the beginning of the study; GTB = Genital Tuberculosis, SD=Standard deviation; NR= data not reported 
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Table 3.4.3.  
Characteristics of the Design of the Seven Included Studies 
Study design Data collection Study 
period 
GTB measure Infertility outcome measure (duration) 
Ali, 2012 Cross-sectional Maternity 
Hospital 
Jan-Dec 
2010 
Clinical symptoms and 
Histology 
Infertility defined as failure to become pregnant despite 
unprotected sexual practice after one year of marriage. 
Bhanothu, 2014 Cross-sectional 2 Gynaecology 
clinics  
2006-2014 Clinical symptoms and 
Histology  
Amenorrhea (duration not specified) 
Sharma, 2011 Cross-sectional University 
Hospital 
2007-2010 PCR, Histology, culture, 
laparoscopy and hysteroscopy 
Primary infertility (inability to conceive spontaneously despite 
one year of regular (3-4 times a week) unprotected intercourse) 
AND 
Amenorrhea (duration not specified) 
Malhotra, 2012 Cross-sectional Outpatient 
Gynaecology 
clinic 
2007-2009 PCR, Histology, culture, 
laparoscopy and hysteroscopy 
Primary infertility  
Secondary infertility 
Kitilla, 2002 Cross-sectional University 
Hospital 
1995-2000 Surgical and Histology TFI (tubo-peritoneal) 
Primary infertility  
Secondary infertility  
Note. PCR = polymerase chain reaction; TFI = tubal factor infertility 
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Table 3.4.4.   
Quality Ratings for the Seven Included Studies on the Basis of an Adapted Newcastle-Ottawa Quality Assessment Scale 
Quality Criterion 
Overall rating g 
Adequacy of 
GTB 
(exposed) 
measurea 
Max 2 points 
Adequacy of control 
(non-exposed), 
definition and 
selection b 
Max 2 points  
Comparability of 
control c 
Max 2 points 
Confounders 
adequately 
assessed  
Max 2 points d 
Adequacy of 
outcome 
Infertility 
measure e 
Max 1 point 
None response 
rate or loss to 
follow-up f
Max 1 point 
Ali, 2012 2 2 0 0 0 NA Average 
Bhanothu, 2014 2 2 0 2 1 NA High 
Sharma, 2011 2 1 1 1 0 NA Average 
Malhotra, 2012 2 2 0 1 0 NA Average 
Kitilla, 2002 2 1 0 2 0 NA Average 
Note. a GTB was adequately assessed when diagnosis was confirmed by medical testing or hospital records, and it was representative of the cohort i.e. drawn from the same 
population (up to 2 points); b Controls were adequately assessed when selection was comparable to cases, and GTB was excluded properly in the control population (up to 2 
points); c Comparability of controls was achieved if exposed/non-exposed were matched or adjustment during analysis conducted. One point for rural-urban and one point for 
any other confounder (up to 2 points); d Confounders were adequately assessed if they were obtained from records or a blind interview, and one point was given if the same 
method was used for both groups (up to 2 points); e Infertility outcome was adequately assessed if independent or blind assessment was stated in the paper, or confirmation of 
the outcome by reference to secure records (medical records, etc.) (up to 1 point); f Point given if same rate for both groups and <20% loss to follow up reported; g The 
overall quality rating was low (0 to 3 points), average (4 to 6 points), or high (7 to 10 points). 
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Table 3.4.5. 
Number and percentage of women with infertility or amenorrhea in the GTB and No-GTB 
groups in the included studies (k=5) 
Outcome Number of women (%) 
GTB No-GTB 
Infertility  102/124 (82.3) 127/308 (41.2) 
Amenorrhea 24/301 (8.0) 12/389 (3.1) 
Type of infertility Primary 133/171 (77.8) 149/305 (48.9) 
Secondary 38/171 (22.2) 156/305 (51.1) 
Note. GTB = genital tuberculosis 
 Results of Meta-analyses 
Three meta-analyses were performed. Figure 3.4.4 displays the first analysis 
comparing the two studies reporting on ‘percentage infertile’ in women with GTB and those 
without GTB. This meta-analysis showed a significant pooled effect size (OR 8.91, 95% CI 
1.89 to 42.12) and significant heterogeneity (I² = 72%, p = 0.06). The results indicated that 
women with GTB were significantly more likely to be infertile (more likely to have fertility 
problems) than women without GTB.  
Figure 3.4.4. Odds ratio for the women who are infertile (>12 months) in the GTB and No-
GTB groups  
Figure 3.4.5 shows the forest plot and meta-analysis result for the two studies 
investigating the number of women who have had ‘amenorrhea’. The meta-analysis revealed 
a significant pooled effect size (OR 4.24, 95% CI 0.23 to 78.14) and significant heterogeneity 
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(I² = 75%, p = 0.05). The results indicated that the women with GTB were significantly more 
likely to have ‘amenorrhea’ (more likely to have fertility problems) than the women without 
GTB.  
Heterogeneity could not be explored with sensitivity or subgroup analysis because 
there was only two studies in the first two meta-analyses. 
Figure 3.4.5. Odds ratio for the women reporting ‘amenorrhea’ (duration not specified) in 
the GTB and No-GTB groups  
Figure 3.4.6 displays the third analysis comparing two studies reporting on ‘primary 
infertility’ in infertile women with GTB and those without GTB. The meta-analysis showed a 
significant pooled effect size (OR 2.94, 95% CI 1.89 to 4.56) and non-significant 
heterogeneity (I² = 0%, p = 0.71). The results indicated that in infertile women, those with 
GTB were significantly more likely to have primary compared to secondary infertility than 
women without GTB.  
Figure 3.4.6. Odds ratio for ‘primary infertility’ amongst infertile women in the GTB and 
No-GTB groups 
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Publication bias assessment. 
Publication bias was not explored using funnel plots, Eggers test or trim and fill 
procedures because each analysis included two studies only, thus computation was not 
possible.  
Discussion 
Principal Findings 
In the present study the association between GTB and fertility was examined 
according to the fertility outcomes (infertility, amenorrhea and primary vs. secondary 
infertility) found in the primary studies. This analytic approach demonstrated that GTB might 
be a relevant factor for the prediction of ability to become pregnant. A significantly greater 
number of women exposed to GTB had infertility (more than 12 months) generally and 
primary infertility specifically, but not amenorrhea. The results of the review lend support to 
reports in the literature of increased likelihood of infertility and especially primary infertility 
(Gatongi et al., 2005; Varma, 2008; Ghosh et al., 2011). These finding need to be interpreted 
in light of methodological considerations (described in detail on pp. 189), such as clinical 
sampling and the rate of infertility in exposed and control groups.  The rate of infertility was 
higher in the present review compared to population based estimates 
(Boivin, Bunting, Collins & Nygren, 2007). This indicated that perhaps the sample of women 
who were included in the primary studies were not representative of the population, therefore 
the association between infertility and GTB may be exaggerated.  
Results indicated that the percentage amenorrhea in women without GTB (3%) was
comparable to that in the general population [3-4%] (Pettersson, Fries, & Nillius, 1973; 
Bachmann & Kemmann, 1982). However, the percentage of amenorrhea in women with
GTB (8%) was lower than estimates in other samples of women with GTB [14.3-15%] 
(Samal et al., 2000; Qureshi et al., 2001).
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 It can be inferred from these two results combined that the greatly inflated rate of
infertility may be independent of amenorrhea, thus suggestive of tubal involvement.  
Results indicated that women in the GTB group were more likely to have primary 
infertility than secondary infertility. The higher rate of primary infertility in the GTB group 
(77.8%) and the lower rate of secondary infertility (22.2%), found in the current study were 
corroborated by similar estimates in the literature (Qureshi et al., 2001; Avan et al., 2001). It 
can be inferred from the higher rate of primary infertility that early onset may be more 
prevalent in the current samples. Early onset potentially damages the reproductive tract prior 
to having the opportunity to become pregnant leading to more primary infertility. Late onset 
manifesting later in the lifespan would have less impact on overall fertility, thus will be 
underrepresented in clinical samples compared to early onset.  
In the present study the effect of GTB on fertility was examined in a set of meta-
analyses of observational studies. Although this systematic approach demonstrated that GTB 
was associated with infertility generally and primary specifically, a causal relationship could 
not be confirmed, nor could a specific mechanism of action be specified.  However, if we 
apply the ‘Bradford Hill criteria’ noted in the General Methods (pp. 55), we can see that four 
of the nine criteria apply to the current review and enhance confidence in the causal 
relationship between GTB and fertility problems.  
The criteria of ‘strength’ was met because of the large size of the association between 
GTB and infertility in the current meta-analysis and in primary studies sited in other reviews 
(see, Gatongi, 2005; Ghosh, 2011; Varma, 2008). The criteria of ‘biological plausibility’, 
‘coherence’ and ‘consistency’ were satisfied for GTB due to the molecular level studies that 
included imaging of lesions (Ahmadi et al., 2014; Chavhan, et al., 2004; Gatongi, 2005; 
Ghosh et al., 2011; Varma, 2008; Tripathy & Tripathy, 1998) in the female reproductive 
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tract, bolstering results from observational studies citing high rates of infertility caused by 
these lesions.  
Justification for including GTB in FertiSTAT.
The results would suggest the inclusion of GTB in the adapted FertiSTAT could 
potentially be justified because it could increase prediction of fertility problems in LMICs.
The only observable signs of GTB reported in the literature are menstrual disturbance and/or 
pelvic pain (Gatongi et al., 2005; Varma, 2008; Ghosh et al., 2011). Since these observable 
signs and symptoms are included in the current FertiSTAT, GTB might not be an 
independent factor. However, GTB remains asymptomatic for long periods (Gatongi et al., 
2005; Varma, 2008; Ghosh et al., 2011), therefore it might be an independent RF.  
 In cases where GTB leads to tubal damage and there are no observable 
signs/symptoms, it remains undiagnosed until a woman is unable to become pregnant in 
which case it is diagnosed during routine infertility investigations (Gatongi et al., 2003; 
Varma, 2008; Ghosh et al., 2011). The woman would then be informed of the impact of GTB 
on fertility, reducing the utility of the FertiSTAT. If the inclusion of GTB is not found to 
increase the predictive ability of the tool, the wording of the ‘painful periods’ item could be 
modified, to incorporate pain from GTB that does not only occur during menstruation as the 
only observable sign of the disease.  
Implications for Practice 
Awareness of the risks associated with GTB highlighting its silent nature should be 
communicated to couples. Women who are at higher risk of contracting GTB (living in a 
region with high prevalence of TB, family member with TB) should be made aware of how 
GTB can affect their reproductive tract. Policy makers and healthcare workers can also 
utilized results when developing and implementing comprehensive pre-pregnancy care 
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packages that should include GTB screening. To the authors knowledge, GTB has not been 
included in any preconception package, but TB was reported as one of the preconception risk 
factors examined in “The Dutch national summit on preconception care” (2015). Healthcare 
practitioners in countries with high prevalence of TB should be informed of the potential 
impact of GTB and to the latent nature of the disease, which makes it pertinent to include 
GTB screening as part of a routine pre-pregnancy examination. Menstrual disturbances 
and/or pelvic pain should alert practitioners to test for GTB, to enable early detection before 
irreversible damage to the reproductive tract occurs.  
Strength and Limitations in Included Studies 
The heterogeneity in study methodology and outcome measures in included studies 
could affect the comparability of these studies and the generalizability of the results. 
Heterogeneity in GTB measure (different diagnostic tests), ‘fertility problems’ outcome 
(different duration of amenorrhea, different definition of primary or secondary infertility) and 
data collection methods (examinations and records), can affect the practical applicability of 
the results. Subgroup analysis could not be performed because there were too few studies. 
However, future research should endeavour to reduce heterogeneity by applying comparable 
methods (design and data collection), using best practice for diagnostic testing of GTB (at 
least culture, but preferably PCR) and by applying similar well defined outcomes e.g. 12 
months of inability to become pregnant.  The quality of each study independently did not 
appear to affect the overall results of the review since the majority of studies were of average 
quality. 
Another limitation of the primary studies was the exaggerated estimates of infertility 
in both the GTB and no GTB groups. In the current sample the rate of infertility in the No-
GTB group was 41.2% compared with a maximum population estimate of 15% (Boivin, et 
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al., 2007). Additionally, the rate of infertility in the GTB group (82.3%) was also higher than 
in GTB samples, approximately 50% (range 10-85%) see Table 3.4.1. The inflation in 
common can be explained by clinical sampling but the exaggerated infertility in the GTB 
group that is beyond that seen in the No-GTB group could be due to other reasons. First, the 
women in the GTB group that were presenting for treatment have become symptomatic 
(pelvic pain, infertility, amenorrhea etc.), indicative of severe disease. Second, the main 
presenting concern for care in women with GTB is the inability to become pregnant, see 
Table 3.4.1. Furthermore, the difference between the rate of infertility in the GTB sample in 
the current study and other clinical samples of GTB can be attributed to issues such as 
presentation time (how long women wait to seek help), the type of clinics sampled (general,
gynaecological, infertility), whether the sample was rural or urban and other economic and 
environmental barriers to help seeking. In the ‘prevalence of infertility’ meta-analysis, two 
studies were included, the rate of infertility was within the expected range in one of them 
(Ali, et al., 2012) [40%] but higher in the other one (Sharma et al., 2011) [92%]. In the 
Sharma et al., (2011) study the sample was from women presenting for hysteroscopy, and 
infertility is recognized as one of the main presenting complaints that warrants hysteroscopy 
(NHS Choices, Hysteroscopy, 2016). Therefore, it can be inferred that the inflated estimate 
reflects a difference in presentation for treatment and sampling. However, this does not 
negate the fact that there was a significant difference that could be indicative of the damage 
caused by lesions in the reproductive tract that hinders ability to become pregnant. 
Bias relating to the primary studies included selection bias, information bias and bias 
due to confounding. The selection of participants based on hospital attendance can inflate the 
rate of infertility because infertility is the presenting complaint, as was indicated previously. 
However, the selection of participants was from the same sample and information was 
gathered using the same method for both the exposed and non-exposed groups in all the 
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studies. Therefore, it can be assumed that selection and information bias may not affect 
results considerably, but care must be taken when generalizing the results of this review. Bias 
due to confounder is a major limitation of the studies included, because matching the groups 
for confounders or including confounders in the analysis was not reported in any of the 
included studies. The most important confounder, whether the participant was in a rural or 
urban setting was only reported in three studies. This is an important confounder because 
people living in urban areas (especially in poverty) tend to live in overcrowded residencies, 
which is linked to an increase in the likelihood of contracting TB (Schmidt, 2008; Baker, 
Das, Venugopal, & Howden-Chapman, 2008). Since overcrowding may not be reported 
separately or quantified appropriately, rural-urban living was taken as a proxy variable 
because it is closely correlated to overcrowding. In general urbanization leads to increased 
population density, overcrowding and more mobility among migrants seeking employment 
all of which impact the transmission of TB (Schmidt, 2008). The WHO reported that the link 
between poverty and TB is intermediated by factors such as poorly ventilated housing, 
overcrowding, smoking, malnutrition, stress, social deprivation and poor social capital, thus it 
would be important to consider all these factors (Figueroa-Munoz & Ramon-Pardo, 2008). 
There could have been an unequal distribution of other confounders (smoking, SES, 
education, access to healthcare) in the exposed and non-exposed groups, which might have 
influenced the relationship between GTB and ‘fertility problems’.  
Another limitation relating to the primary studies is the use of observational designs.  
As discussed in previous chapters observational designs are prone to biases, such as sampling 
bias that can invalidate results.  However randomization would not have been possible or 
ethical for GTB. This review comprised of five cross-sectional studies that can be a good 
starting point to identify associations but should be followed by more rigorous studies with a 
cohort design (Mann, 2003) as explained in the next section. 
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Future Research 
Since RCTs producing GTB would be unethical, future research to disentangle the 
effect of GTB on fertility problems would require prospective cohort studies, failing that 
retrospective cohort studies (Mann, 2003).  RCTs that examine risk of infertility in 
treated/untreated samples of GTB could also be examined.  Researchers should investigate 
the causal mechanisms involved in GTB, the impact of severity of the disease, which parts of 
the reproductive tract are affected, the differential impact on primary versus secondary 
infertility and the specific reasons for the increased prevalence of amenorrhea. Ideally, large 
population-based prospective cohort studies following women who are at increased risk of 
TB should be conducted to assess true rates of consequences such as infertility and 
amenorrhea. Additionally, household survey where identified women are then referred for 
treatment can be conducted. This survey can also compare women who have been vaccinated 
verses those who have not been vaccinated (by visually confirming through scare). The 
inclusion of control groups matched for confounders such as rural-urban living, 
overcrowding, poorly ventilated housing, SES, smoking, malnutrition, age, access to 
healthcare and education, should be included by matching the groups or in multivariate 
analysis. Realistically, prospective studies may not be ethical because once detected GTB or 
TB should be treated with antibiotics to prevent further disease progression, thus 
retrospective cohort studies may be the best option.  
Conclusion 
Fertility problems including infertility generally and primary infertility specifically as 
well as amenorrhea have been reported as negative consequence of GTB in the literature but 
evidence to support these claims has been fraught with limitations such as lack of control
and sampling infertile women only. Results of the current meta-analyses confirmed reports 
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in the literature that GTB was association with an inability to become pregnant. Therefore, 
inclusion of GTB in the adapted FertiSTAT could potentially increase the predictive ability
of the tool.  It is important to note that this area of research should be re-examined due to 
the methodological shortcoming of primary studies and the small number of included 
studies in the meta-analyses. The fertility implications of GTB should be communicated to 
women at risk for contracting GTB.
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Study 3.5: Systematic Review and Meta-analysis of Observational Studies Examining the 
Association of Bacterial Vaginosis and Fertility Problems 
Introduction 
Bacterial Vaginosis (BV) was one of the risk factors identified through the process of 
adapting the FertiSTAT and was endorsed by the experts in Study 2.1 (Chapter 2, pp. 25). 
The validity of this risk factor as a predictor of fertility problems was examined in the current 
systematic review using the operational definitions of fertility problems and risk factor 
applied in the original development of FertiSTAT (Bunting & Boivin, 2010). 
Description of BV 
BV is an infection of the lower female reproductive tract that is characterized by an 
imbalance in the naturally occurring microorganisms of the vagina (Mastromariano, et al., 
2014; Money, 2005). The imbalance is typically a depletion of normal lactobacillus and an 
overgrowth of anaerobes (Viniker, 1999). In healthy women lactobacilli are the dominant 
bacteria, there are small numbers of other bacteria, and the pH is retained below 4.5. The 
acidic environment provides protection from infection (Viniker, 1999). In BV the pH of the 
vagina becomes less acidic and can be elevated up to 6.0, lactobacilli are reduced in number 
and the flora is dominated by an overgrowth of anaerobic bacteria (up to a thousand-fold 
more than normal). This imbalance renders the genital tract at increased risk of an 
overgrowth of harmful bacteria (endogenous to the vagina) and more susceptible to 
exogenous infections such as STIs and HIV (Mastromariano, 2014; Money, 2005; Morris, 
Nicoll, Simms, Wilson & Catchpole, 2001; Allsworth & Peipert, 2007).  
According to the UK National Guideline for the management of Bacterial Vaginosis 
(Hay, Patel & Daniels, 2012), BV is the most common cause of abnormal vaginal discharge 
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in women of childbearing age. BV can present with various symptoms including vaginal 
discharge that is grey, yellow, odorous, abdominal pain, intermenstrual bleeding or prolonged 
menses (Morris, et al., 2001). The discharge may also be thin, white and homogenous (Hay, 
et al., 2012), with no signs of inflammation and up to 50% of cases may be asymptomatic 
(Hay, et al., 2012; Woodrow & Lamont, 1998). BV can be treated with antibiotics but 
reoccurrence is common (Hay, et al., 2012; Morris, et al., 2001; Money, 2005). A meta-
analysis of 43 observational studies reporting on BV and sexual behaviour has shown an 
increased susceptibility to BV linked to change of sexual partner, but was not shown to be 
independently related (Fethers, Fairley, Hocking, Gurrin & Bradshaw, 2008). BV has also 
been found to be associated with vaginal douching (Brotman, et al., 2008), use of intrauterine 
device (Avonts, et al;, 1999; Shoubnikova, Hellberg, Nilsson & Mardh, 1997), black race 
(Hay, et al., 1994; Goldeberg, et al., 1996; Llahi-Camp, Rai, Ison, Regan & Taylor-Robinson, 
1996) and smoking (Hay, et al., 1994; Llahi-Camp, et al., 1996; Jonsson, Karlsson, Rylander, 
Gustavsson & Wadell, 1997; Rahm, Odlind & Pettersson, 1991). Change of sexual partners 
and an increased number of sexual partners has been reported in some studies as a risk for 
developing BV (Hay, et al., 2012; Morris, et al., 2001, Money, 2005). However, BV is not 
classified as a sexually transmitted infection (STI) due to a lack of unequivocal evidence 
because the exact molecular level understanding is not complete (Hay, et al., 2012; Morris, et 
al., 2001, Money, 2005) and because it has been reported in virgins (Bump & Buesching, 
1988; Papanikolaou, Tsanadis, Dalkalitsis & Lolis, 2002).  
Since BV is not caused by an infection from an external organism, rather it is an 
imbalance of existing vaginal microorganisms, its diagnosis has been problematic because 
culture of vaginal swab can be positive even for women without BV i.e. false positive 
(Money, 2005; Hillier, 1993). There are currently two mechanisms for the diagnosis of BV: 
using clinical criteria of which the Amsel’s criteria (Amsel, et al. 1983; Money, 2005) are the 
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most widely accepted, or using laboratory-based testing, gram stain method using the Nugent 
scoring system (Nugent, Krohn, & Hillier, 1991). The gram stain method using Nugent 
scoring is currently the gold standard for the diagnosis of BV (Money, 2005; 
Mohammadzadeh, Dolatian, Jorjani & Majd, 2015), see Table 3.5.1. Although there is debate 
as to whether the Amsel criteria are as good as the Nugent test, it is noted in the literature that 
when lab equipment is not present the Amsel criteria is a good substitute for the Nugent test 
(Money, 2005; Mohammadzadeh, et al., 2015). 
Table 3.5.1. 
Clinical and Laboratory Approaches, Criteria and Evaluation for the Diagnosis of Bacterial 
Vaginosis   
 Approach Criteria Evaluation 
Amsel 
criteria 
(clinical) 
(1) Thin, white, homogeneous discharge
(2) Clue cells on microscopy of wet mount 5
(3) pH of vaginal fluid >4.5
(4) Release of a fishy odour on adding alkali (10% KOH)
At least three of the 
four criteria are present 
for the diagnosis to be 
confirmed 
Gram 
stained 
vaginal 
smear 
(laboratory) 
Grade 1 (Normal): Lactobacillus morphotypes predominate 
Grade 2 (Intermediate): Mixed flora with some Lactobacilli 
present, but Gardnerella or Mobiluncus morphotypes also 
present 
Grade 3 (BV): Predominantly Gardnerella and/or 
Mobiluncus morphotypes. Few or absent Lactobacilli 
To be evaluated with 
the Nugent criteria or 
the Hay/Ison criteria 
Note. BV = bacterial vaginosis; UK guidelines for the management of BV (Hay, Patel & Daniels, 2012) 
The prevalence of BV varies wildly depending on the population sampled. It has been 
reported to be as high as 50.9% in rural Uganda (Paxton, 1998), 35% of women attending 
STI clinics (Eschenbach, 1993), 29.2% of women ages 14–49 in a nationally representative
sample in the US (Koumans, et al., 2007), 29% of non-institutionalized American women 
(Allsworth & Peipert, 2007), 24.6% of women undergoing IVF (Ralph, Rutherford & 
Wilson, 1999) and as low as 10-20% of unselected population 
(Mead, 1993). The prevalence of BV in pregnant women also varies with the highest 
percentage reported being 32.5% of pregnant inner city American women (McGregor, et al., 
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1995), 28% of women undergoing pregnancy termination in the UK (Blackwell, Thomas, 
Wareham & Emery, 1993), 15-20% of pregnant women (Eschenbach, 1993) and as low as 
8.6% by Nugent’s method in a sample of pregnant women in rural India (Dadhwal, 
Hariprasad, Mittal, S. & Kapil, 2010).  
Plausible Mechanisms to Explain why BV Could be Associated with Fertility Problems 
An examination of the potential relationship between BV and infertility requires an 
understanding of PID. Authors of the UK guidelines for the management of PID indicated 
that infection ascending to the upper reproductive tract can cause inflammation of the 
different parts of the tract e.g. endometritis (endometrium), salpingitis (fallopian tubes) etc. 
(Ross & McCarthy, 2011). This inflammation of the reproductive tract is collectively known 
as PID. Infectious agents known to ascend through the vagina include exogenous bacteria like 
Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium and endogenous 
anaerobic bacteria like Prevotella, Atopobium and Leptotrichia. The authors indicated that 
infertility is one of the consequences of PID and that the risk of developing infertility 
increases in cases of delayed treatment and repeated episodes (Ross & McCarthy, 2011). The 
WHO estimates that 40% of women with untreated gonorrhoea or chlamydia will develop 
PID and that 25% of women with PID will develop infertility (WHO, 2007, Global strategy 
for the prevention and control of sexually transmitted infections: 2006–2015).  
The relationship between BV and reproductive processes has been reported in the 
literature and several attempts to explain the mechanism of action have been reported, see for 
example Figure 3.5.1. One pathway suggested in the literature was via increased 
susceptibility to infections (exogenous or endogenous) that lead to PID and consequently 
tubal damage (Mastromariano, et al., 2014), see Figure 3.5.2. A second pathway proposed 
that the overgrowth of endogenous microflora triggered an immune response which 
consequently hindered implantation (Hay, 2004; Hay, Patel & Daniels, 2012; Hillier et al., 
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1996; Korn, et al., 1995; Mastromariano, et al., 2014; Sweet, et al., 1987), see Figure 3.5.2. In 
addition to pathways that show the potential impact of BV on preimplantation and 
fertilization processes, there is a third pathway that helps explain the impact of BV on 
adverse pregnancy related outcomes and the consequent inability to have a live birth, see 
Figure 3.5.2. 
Figure 3.5.1. Potential impact of bacterial vaginosis on reproductive processes. 
Figure from “Biological control of vaginosis to improve reproductive health,” by 
P. Mastromariano, et al., 2014, Indian J Med Res, 140 (supplemental), 91-97.
Copyright by Indian Council of Medical Research [2014]. Reprinted with
permission
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Figure 3.5.2. Proposed pathways describing potential impact of Bacterial Vaginosis (BV) 
on fertility. Solid line = Recent evidence (molecular level laboratory); Dashed line = 
Proposed pathway/historic evidence; Dashed and dotted = Well established 
In the first pathway, the absence of vaginal lactobacilli characteristic of BV, renders 
the vagina more susceptible to external bacteria like Nesseria gonorrhoeae and Chlamydia 
trachomatis (Wiesenfeld, Hillier, Krohn, Landers & Sweet, 2003), and viral infections such 
as HIV, HPV and herpes simplex virus (Martin, et al., 1999; Cherpes, Meyn, Krohn, Lurie & 
Hillier, 2003). These harmful microorganisms can increase incidence of PID and 
consequently lead to TFI (Mastromariano, et al., 2014; Ross & McCarthy, 2011; WHO, 2007, 
Global strategy for the prevention and control of sexually transmitted infections), proposed 
‘Pathway 1(a)’ in Figure 3.5.2.  
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The absence of vaginal lactobacilli can also lead to an overgrowth of endogenous 
bacteria. Evidence for the involvement of an overgrowth of endogenous microflora comes 
from laboratory findings confirming that BV microflora ascend from the vagina to the uterus 
and the fallopian tubes (Hillier et al., 1996; Korn, et al., 1995; Sweet, et al., 1987). These 
studies reported laboratory findings confirming the presence of BV related bacteria in the 
endometrium and fallopian tubes of women with PID, more endometritis in symptomatic BV 
women and more BV microflora in the endometria of women with endometritis (Hillier et al., 
1996). These studies provide evidence for ‘Pathway 1(b)’ in Figure 3.5.2. In the second 
pathway it is proposed that endometritis due to BV could affect the implantation of the 
embryo and placenta, independent of tubal involvement (Hay et al., 2004; Mastromariano, et 
al., 2014; Hay, 2004), see Figure 3.5.2. A positive association between lactobacilli and live 
birth rate was demonstrated in women undergoing IVF in the US and the authors indicated 
that the lactobacilli create an environment in the endometrium that is favourable for 
implantation and placentation (Eckert, Moore, Patton, Agnew & Eschenbach, 2003). When 
lactobacilli are absent, normal microflora become pathogenic, which results in an immune 
response (production of proinflammatory cytokines) that alters the balance of immune cells 
(T-helper cells) and this imbalance can then result in failure of implantation (Moore, de Waal 
Malefyt, Coffman & O’Garra, 2001). In another study on women undergoing IVF, authors 
found that BV was associated with raised levels of mediators of immunity (interleukin-1b and 
interleukin-8 cytokines) in the cervix (Spandorfer, Neuer, Giraldo, Rosenwaks & 
Witkin,2001). The authors also reported that there were no significant differences in outcome 
of IVF; however, detecting lactobacilli on the catheter tip after implantation of the embryo 
was associated with high rate of success in IVF (Eckert, et al., 2003).  These studies suggest 
that the diminished lactobacilli levels result in bacterial overgrowth that triggers an immune 
response that could ultimately hinder implantation, supporting ‘Pathway 2’ in Figure 3.5.2. 
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The suggested mechanism of action in the third pathway for the effect of BV on 
preterm labour involves the release of cytokines and prostaglandins that initiate labour that is 
triggered prematurely by the toxins produced by the BV microflora (McDonald, O'Loughlin, 
Vigneswaran, Jolley, Harvey & McDonald, 1997; Morris, et al., 2001). Preterm labour can 
also be triggered by the release of enzymes (sialidases and mucinases) by bacteria, allowing 
penetration of mucus and weakening of the membranes (Howe, et al., 1999; McGregor, et al., 
1994). Cases where preterm labour was due to chorioamnionitis (an infection of the foetal 
membranes) were found to be related to organisms associated with BV identified in the 
membranes more often than any other putative infective agent (Hillier, et al., 1988; Heller, 
Moorehouse-Moore, Skurnick & Baergen, 2003; Goldenberg, Hauth & Andrews, 2000; 
Sebire, 2001). This evidence suggests that the BV microflora release chemicals that affect the 
membranes or initiate the natural labour cascade, in both cases leading to preterm birth.  
Reproductive Health Consequences of BV 
The negative impact of BV on women’s reproductive health and specifically fertility 
problems has been reported in the literature. A summary of the consequences in the reviewed 
literature is presented in Table 3.5.2. The reviews summarized were subjected to quality 
evaluation using the “Critical Appraisal of Systematic Reviews” published by the WHO 
(Abalos, Carroli, Mackey & Bergel, 2001). 
Morris et al. (2001) conducted a narrative review of the literature on the prevalence of 
BV, associated factors, consequences and interventions. The search was limited to English 
language publications since 1984 on both Medline and the Cochrane database.  The authors 
noted that BV was associated with considerable morbidity in women of reproductive age, 
however, they noted that the majority of the studies investigating the consequences of BV 
include in their review were cross-sectional, restricting the inference of a causal relationship.  
The authors reported the following consequences: preterm delivery, miscarriage, pelvic 
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inflammatory disease (PID), tubal factor infertility (TFI), cervical intraepithelial neoplasia 
(CIN) and increased susceptibility to STIs, HIV and human papilloma virus (HPV), see Table 
3.5.2. Morris et al. (2001) noted that the association between BV and preterm delivery has 
been well established, but there is not yet enough evidence to establish a concrete association 
for other consequences like PID, TFI and first trimester miscarriage. The authors suggested 
that the biological similarity in vaginal microflora in BV and PID in the absence of STIs 
makes the association between BV and PID and the progression from BV to PID biologically 
plausible (Morris, et al., 2001). 
Hay (2004) reviewed the literature to summarize knowledge on the relationship 
between BV and miscarriage. The author did not report on methods of the review process, but 
presented a summary of the possible mechanism of action of BV on negative pregnancy 
outcomes including first and second trimester loss, see Table 3.5.2 for studies included. The 
author noted the following consequences: adverse pregnancy outcomes e.g. preterm delivery 
and second trimester loss, and negative IVF outcomes e.g. first trimester loss. The author 
reported that the risk of miscarriage and preterm labour persists even when BV resolves 
during pregnancy (Hay, 2004). The evidence in the Hay (2004) review was supported by two 
subsequent reviews (McDonald, et al, 2007; Brocklehurst, Gordon, Heatley & Milan, 2013). 
Evidence from these reviews indicated that if treatment of BV occurred before 20 weeks 
gestation treatment could reduce the risk of preterm birth, but only if the group of women 
with BV included those with abnormal microflora categorized as intermediate flora 
(McDonald, et al, 2007; Brocklehurst et al, 2013). Treatment was also beneficial in women 
who had a history of preterm birth (McDonald, et al, 2007; Brocklehurst et al, 2013). Hay 
(2004) also noted that studies examining types of infertility and BV in women undergoing 
IVF reported significantly more BV in women with TFI and anovulation than, male factor, 
endometriosis and unexplained infertility, see Table 3.5.2.  
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Table 3.5.2. 
Summary of Reproductive Health Consequences of Bacterial Vaginosis Reported in the 
Literature  
Reproductive 
outcome 
Effect of BV Primary study Statistics reported Review 
Preterm labour/ 
delivery  
Women with BV at increased risk 
of preterm birth 
Hillier, et al., 1995 ORs between 1.8 and 6.9 Hay, (2004) 
McGregor, et al., 1995 
Hay, et al., 1994 
Hay, (2004) 
Hay, et al., (2012) 
Hillier, et al. 1995 
Hauth, Goldenberg, 
Andrews, DuBard & 
Copper, 2001  
Attributable risks 
between 2-10 for BV in 
pregnancy leading to 
preterm delivery (women 
with no previous history) 
and over 30 (women with 
a history of a previous 
preterm birth) 
Morris et al., (2001) 
The strong association between 
BV and loss before 20 weeks was 
confirmed in women examined at 
less than 14 weeks’ gestation 
(Belgium) 
Donders, et al., 2000 RR= 5.4 Hay, (2004) 
The overall risk of preterm 
birth for women with BV was 
determined in meta-analysis of 
20 232 pregnancies  
Leitich, et al., 2003 Studies that screened 
before 16 
weeks’ gestation OR= 
7.55,  
Studies that screened 
before 20 weeks gestation 
OR= 4.20  
Hay, (2004) 
Preterm labour due to 
chorioamnionitis found to be 
related to organisms associated 
with BV  
Hillier, et al., 1988 
Heller, Moorehouse-
Moore, Skurnick & 
Baergen, 2003 
Sebire, 2001 
Goldenberg, Hauth & 
Andrews, 2000  
NR Hay, (2004) 
Hay, et al., (2012) 
Release of enzymes by bacteria, 
allowing penetration of mucus and 
weakening of the membranes, 
leading to preterm labour  
Howe, et al., 1999  NR Hay, (2004) 
Alterations in vaginal 
microbiology associated with late 
miscarriage and 
premature birth 
Koumans, Markowitz & 
Hogan, 2002 
NR Mastromarino, et al., 
(2014) 
Miscarriage Higher risk for preclinical 
pregnancy loss in women who had 
BV than those who didn’t 
(conceived by IVF) 
van Oostrum, et al., (2013)  
Meta-analysis 
 (OR 2.36, 95% CI 1.24 
to 4.51). 
van Oostrum, et al., 
(2013)  
Even if BV resolves during 
pregnancy, that doesn’t reduce 
risk of miscarriage and preterm 
labour 
Riduan, et al., 1993 
Lamont, Duncan, Mandal 
& Bassett, 2003 
NR Hay, (2004) 
More first trimester miscarriage in 
women with BV in a sample of 
women who conceived with IVF 
treatment, even after adjusting for 
factors known to increase risk of 
miscarriage 
Ralph, Rutherford & 
Wilson, 1999  
First trimester 
miscarriage was 31.6% 
for those with BV 
compared with 18.5% for 
those with normal vaginal 
flora (crude odds ratio 
2.49, 1.21 to 5.12) 
Hay, (2004)  
Morris et al., (2001) 
In study on natural conception BV 
was associated with miscarriage 
early in the second trimester 13-15 
weeks, but not at 10-12 weeks 
Oakeshott, et al., 2002 13–15 weeks’ gestation 
(OR 3.5; 1.2–10.3) 
10 and 12 weeks 
gestation (OR 1.32; 0.67–
2.62) 
Hay, (2004) 
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Reproductive 
outcome 
Effect of BV Primary study Statistics reported Review 
PID BV found to be more common in 
women with PID.   
Moi, 1990 
Taylor, 1997 
Soper, Brockwell, Dalton 
& Johnson, 1994 
Larsson, Platz-Christensen, 
Thejls, Forsum & Pahlson, 
1992 
NR Morris, et al., (2001) 
Hay, et al., (2012) 
BV related organisms have been 
isolated from the endometrium 
and 
fallopian tubes of women with 
PID 
Sweet, 1987 NR Hay, (2004) 
Increased risk of PID in women 
with BV (using only clinical 
diagnosis for PID) 
Eschenbach, et al., 1988 Nine-fold Morris, et al., (2001) 
Increased risk of PID in women 
with BV (using gold standard 
laparoscopy to diagnose PID) 
Peipert, Montagno, Cooper 
& Sung, 1997 
Three-fold Morris, et al., (2001) 
BV associated with a 
markedly increased risk for  
development of PID 
Ness, et al., 2005 NR Hay, et al., (2012) 
Endometritis Endometritis more in women with 
BV than without 
Hillier, et al., 1996  (OR 15, 95% CI 2-686) Morris, et al., (2001) 
Microorganisms associated 
with BV were isolated more from 
the endometria of women with 
than without plasma cell 
endometritis 
Korn, et al., 1995  (OR 12.4) Morris, et al., (2001) 
Hay, (2004) 
BV associated with post-partum 
endometritis 
Watts, Krohn, Hillier & 
Eschenbach, 1990 
NR Hay, et al., (2012) 
Infertility  Significantly moreBV in women 
attending infertility clinic  than 
attending antenatal clinic  
van Oostrum, 2013 
Meta-analysis 
 (OR 3.32, 95% CI 1.53 
to 7.20) 
van Oostrum, et al., 
(2013)  
In women undergoing IVF more 
BV in women with TFI than those 
with non-TFI 
Gaudoin, Rekha, Morris, 
Lynch & Acharya, 1999  
Liversedge, et al., 1999 
NR Morris, et al., (2001) 
Preclinical pregnancy loss 
following IVF higher in infertility 
patients with BV than those with 
no BV 
van Oostrum, et al., (2013)  (OR 2.36, 95% CI 1.24 to 
4.51). 
van Oostrum, et al., 
(2013)  
BV more common in women with 
TFI than other types of  infertility 
in sample of women undergoing 
IVF 
Liversedge, et al., 1999 BV more common in 
women with TFI (31.5%) 
than non-TFI (19.7%) 
infertility (OR 1.87) 
Hay, (2004) 
Wilson, Ralph & 
Rutherford, 
2000. 
Compared with 
endometriosis (OR 3.63, 
95% CI 1.52–8.67), male 
factor (OR 2.98, 95% CI 
1.80–4.90), and 
unexplained infertility 
(OR 2.20, 95% CI 1.35–
3.59) [adjusted ORs] 
Morris, et al., (2001) 
Hay, (2004) 
Significantly more BV in women 
with TFI as compared to other 
causes of infertility in sample of 
women undergoing IVF 
van Oostrum, et al., (2013)  (OR 2.77, 95% CI 1.62 to 
4.75) 
van Oostrum, et al., 
(2013)  
Significantly more BV in women 
with anovulation than other types 
of  infertility (but less than TFI)  
in sample of women undergoing 
IVF 
Wilson, Ralph & 
Rutherford, 
2000. 
Compared with 
endometriosis (OR 3.77, 
95% CI 1.28–11.08), 
male factor (OR 3.09, 
95% CI 1.37–6.96), and 
unexplained infertility 
(OR 2.29, 95% CI 1.02–
5.12) [adjusted ORs] 
Morris, et al., (2001) 
Hay, (2004) 
A correlation between bacterial 
vaginosis, immune response and 
idiopathic infertility demonstrated 
in sample of women undergoing 
IVF 
Spandorfer, Neuer, 
Giraldo, Rosenwaks & 
Witkin, 2001 
NR Mastromariano, et al., 
(2014) 
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Reproductive 
outcome 
Effect of BV Primary study Statistics reported Review 
Increased 
susceptibility to 
infections  
More HIV+ in women with severe 
BV (score of 9-10 on a Gram 
stain) than those with normal 
vaginal flora in Uganda 
Wawer, et al., 1999 
Sewankambo, et al., 1997 
(OR 2.08, 95% CI 1.48-
2.94)  
Morris, et al., (2001) 
Women with BV significantly 
more likely to seroconvert before 
giving birth and after giving birth 
(Malawi) 
Taha et al., 1998 (OR 3.7, P = 0.03) before 
giving birth  
(OR 2.3, P = 0.04) after 
giving birth  
Morris, et al., (2001) 
Hay, et al., (2012) 
Women with abnormal flora on 
Gram's stain at increased risk of 
HIV acquisition (Kenya) 
Martin, et al., 1999  (HR = 1.9, 95% CI 1.1-
3.1) 
Morris, et al., (2001) 
Absence of lactobacilli, 
characteristic of BV and 
associated with an increased risk 
of HIV 
Martin, et al., 1999  (HR = 2.0; 95% CI 1.2-
3.5)  
Morris, et al., (2001) 
Mastromariano, et al., 
(2014) 
Pregnant women with abnormal 
vaginal flora at increased risk of 
HIV seroconversion (North 
Carolina, USA) 
Royce, Thorp, Granados & 
Savitz, 1999 
 (RR 4.0, 95% CI 1.1-
14.9)  
Morris, et al., (2001) 
BV is associated with a 
markedly increased risk for 
acquisition of HIV 
Cu-Uvin, et al., 2001  
Schwebke, 2003 
Atashili, Poole, Ndumbe, 
Adimora & Smith, 2008 
NR Hay, et al., (2012) 
BV risk factor for female to male 
HIV transmission  
Cohen, et al., 2012 adjusted OR (3.06, 1.35-
6.95) 
Hay, et al., (2012) 
BV associated with a markedly 
increased risk for acquisition STIs 
Martin, et al., 1999 
Cherpes, Meyn, Krohn, 
Lurie & Hillier, 2003 
Harmanli, Cheng, 
Nyirjesy, Chatwani & 
Gaughan, 2000 
NR Mastromariano, et al., 
(2014) 
Abnormal vaginal flora lacking 
lactobacilli facilitates infection by 
parasites e.g. Trichomonas 
vaginalis and bacteria e.g. 
Neisseria gonorrhoea and 
Chlamydia trachomatis  
Wiesenfeld, Hillier, Krohn, 
Landers & 
Sweet, 2003  
NR Mastromariano, et al., 
(2014) 
Absence of vaginal lactobacilli, is 
an independent risk factor for 
acquisition of herpes simplex 
virus  
Cherpes, Meyn, Krohn, 
Lurie & Hillier, 2003 
NR Mastromariano, et al., 
(2014) 
Cervical 
intraepithelial 
neoplasia 
(changes in the 
squamous cells 
of the cervix.) 
Association between BV and CIN 
(suggested to be caused by 
nitrosamines produced by the 
abnormal vaginal microflora)  
Hudson, Tidy, McCulloch 
& Rogstad, 1997 
Pavic, 1984  
NR Morris, et al., (2001) 
Significantly more BV in 
women with CIN 
Uthayakumar, Boyle, 
Barton, Nayagam & Smith, 
1998 
NR Morris, et al., (2001) 
Note: BV = bacterial vaginosis; OR = odds ratio; RR = risk ratio; NR = not reported; IVF = in vitro fertilization; 
PID = pelvic inflammatory disease; TFI = tubal factor infertility; HIV = human immunodeficiency virus; 
STIs=sexually transmitted infections; CIN = Cervical intraepithelial neoplasia 
Hay et al. (2012) conducted a review as bases for the UK guidelines for the 
management of BV that included a search of Medline, Embase, Centers for Disease Control 
and prevention (CDC) STD Treatment Guidelines, European (IUSTI/WHO) Guidelines and 
Cochrane Databases. Articles were evaluated and recommendations provided and categorized 
according to best available evidence (Hay, Patel & Daniels, 2012). The authors reported the 
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following as potential complications of BV: increased risk of acquisition of HIV in pregnant 
women, increased prevalence of BV in women with PID, late miscarriage, preterm delivery, 
preterm premature rupture of membranes, and postpartum endometritis (Hay et al., 2012), see 
Table 3.5.2.  
In a narrative review of the literature, Mastromariano, et al. (2014), reported on the 
effect of BV on reproductive processes in women and men. The authors noted consequences 
such as increased susceptibility to STDs, PID and other infections, complications during 
pregnancy e.g. late miscarriage and preterm delivery, and neonatal infections. Although this 
review covered a wide range of literature and areas where BV has been shown to have an 
impact, the authors did not report search methodology, and pooled estimates were not 
calculated.   
Van Oostrum and colleges (2013) conducted a systematic review and meta-analysis to 
assess the association of BV with the cause of infertility in women in general and the effect 
on conception rates and early pregnancy losses in women undergoing IVF specifically (van 
Oostrum, Sutter, Meys & Verstraelen, 2013). The authors reported that BV was significantly 
more prevalent in women attending infertility clinics than antenatal clinics (OR 3.32, 95% CI 
1.53 to 7.20), significantly more prevalent in women with TFI as compared to other causes of 
infertility in samples of women undergoing IVF (OR 2.77, 95% CI 1.62 to 4.75) and 
associated with higher risk of preclinical pregnancy loss, following IVF (OR 2.36, 95% CI 
1.24 to 4.51). The authors reported that BV was not significantly associated with decreased 
conception rates, or elevated risk of first trimester miscarriage, in women who had conceived 
by IVF. The methodology of this review was high as gauged by “Critical Appraisal of 
Systematic Reviews” (Abalos, et al., 2001). However, there are methodological issues with 
the representativeness of the samples included in this review that could potentially limit 
generalizations that can be made. First, there were four studies that were published before the 
review that were not included in the review and meta-analysis. Second, more than half (7 of 
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12, 58%) of the included studies were reporting on the prevalence of BV in infertile women 
undergoing IVF. Contact with authors indicated that studies reporting on infertile women not 
undergoing IVF were not excluded rather this was the data that was available at the time. 
Historically IVF was used to treat women with TFI (Wang & Sauer, 2006).  More recently, 
and especially after the advent of ICSI (intracytoplasmic sperm injection), IVF has been used 
in male factor infertility as well (Palermo, Joris, Devroe & Van Steirteghem, 1992; Sullivan 
et al., 2013; Wang & Sauer, 2006). It is possible that IVF samples could be over represented 
by certain types of diagnoses namely, TFI, male factor and unexplained infertility (Wang & 
Sauer, 2006). As such the IVF sample is not representative of the broader infertile population. 
Therefore generalizations to infertile women not undergoing IVF cannot be made.  
There were other studies not included in the previously mentioned reviews that also 
reported an association between BV and adverse reproductive outcomes. Such outcomes 
included: miscarriage, preterm birth, premature rupture of the membranes and post-partum 
endomitritis (Krohn, et al., 1995; Koumans & Kendrick 2001). Endomitritis is an 
inflammation of the lining of the uterus due to an infection that is likely a precursor for 
adverse pregnancy outcomes like miscarriage, and preterm labour due to chorioamnionitis, an 
infection of the foetal membranes (Hay, 2004). In a study on adverse pregnancy outcomes 
and enzyme-producing microorganisms, BV was found to be associated with increased risk 
of preterm birth (RR 3.3, 95% CI 1.2 to 9.1, p = 0.02) and premature rupture of membranes 
(RR 3.8, 95% CI 1.6 to 9.0, p = 0.002) (McGregor, et al., 1994). In an examination of BV and 
recurrent pregnancy loss, BV was found to be twice as common in women who had had at 
least one late miscarriage (27/130; 21%) as in women who had had only first trimester 
pregnancy losses (31/370; 8%) (P < 0.001) (Llahi-Camp, et al., 1996).  
The epidemiological and molecular level evidence summarized thus far lends support 
to the different pathways in Figure 3.5.2, with more definitive evidence available for the 
preterm pathway (‘Pathway 3’) via which fewer live births occur. However, evidence for the 
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other two pathways is more equivocal with some reports of associations between BV and 
STIs, endogenous infections and PID. Given the lack of RCTs and molecular level evidence 
to substantiate the exact mechanism of action of BV and the methodological weaknesses in 
extant research a meta-analysis of available studies would help provide more concrete 
evidence until such time as there is more substantial evidence. Although, van Oostrum and 
colleagues (2013) conducted such a study, and an update from 2013 to present might have 
been enough, their review examined effects in samples of women undergoing IVF only and 
some studies conducted prior to the review were not included. A new review is therefore, 
necessary to include all evidence.  
Rational, Aim and Objectives 
The biological plausibility of the effect of BV on reproductive process coupled with 
the association with adverse reproductive outcomes like preterm labour and TFI noted in the 
literature and the results of the survey of physicians [BV endorsed as a potential risk factor by 
44.4% of responders] (Chapter 2, pp. 25), highlight the need to investigate whether BV 
should be included as a risk factor in the adapted FertiSTAT. BV has been noted as one of the 
long term consequences of FGM/C by the WHO (WHO, 2017, Female genital mutilation: 
Fact sheet), and a significantly higher odds of having BV was reported in women who had 
undergone Type II FGM compared with uncut women in Gambia (Morison, et al., 2001). 
This is especially relevant to regions where the prevalence of FGM/C is very high e.g. Sudan 
(88%; UNFPA-UNICEF, 2014). The WHO also noted BV as one of the conditions that 
increase an individual’s risk of contracting HIV (WHO, HIV/AIDS: Fact Sheet). It is 
therefore important to investigate the nature and magnitude of the impact of BV on female 
fertility, regardless of whether it is an independent risk factor for infertility or impacts via 
other known risks.   
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The aim of the current systematic review was to determine whether BV should be 
included as a risk factor in the adapted FertiSTAT. To achieve this aim the present study 
sought to uncover evidence to determine whether BV has a negative impact on female 
fertility, the scale of this impact and whether the effect was on ability to become pregnant or 
have a live birth. The objective of the review was to examine whether BV was associated 
with fertility problems in women, and at what point in the reproductive process BV might 
exert its impact.  The population of interest for the review was women, the exposure was BV 
and the outcome of interest was fertility problems.  
Materials and Methods 
Search Strategy 
The search terms included words related to BV, for a complete list of MeSH terms see 
Appendix N. Studies were excluded if the acronym BV indicated something other than 
bacterial vaginosis, or only a specific species of bacteria.  
Data Extraction and Quality Assessment 
The data extraction form (Appendix H) was adapted to include information relevant to 
BV. The data-extraction form was adapted to include method used for the diagnosis of BV in 
included studies. The NOS form was adapted to reflect quality criteria for the assessment of 
BV and additional confounders. BV was adequately assessed if there was laboratory testing 
using the Nugent test during clinical examination or from hospital/medical records. The 
confounder that was more important than others was comorbid STIs.  
Data Synthesis and Analysis 
Meta-analyses were computed for the outcome found in the studies. Since these were 
all case-control studies data were calculated as previously described (pp. 65)
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Subgroup analyses were planned to compare studies reporting on different types of 
infertility and studies using different outcomes. Since STIs might be an important aspect of 
the pathway (Figure 3.5.2), a subgroup analysis of women with STIs and those without was 
planned to enable conclusions to be drawn about the exact pathway.  
Results 
Study Selection 
Figure 3.5.3 shows the PRISMA flowchart for number, reason and stage of exclusion 
of articles. A total of 184 records were identified (after duplicates removed) and most of 
those studies (123 of 184, 66.8%) were excluded because they did not measure fertility 
problems, no association between BV and fertility problems was reported or the association 
was reported following ART only.  Of the 15 full text articles assessed for inclusion, eleven 
met inclusion criteria.  
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ability to have live births was not possible.  Table 3.5.3 shows selected sample characteristics 
of the included studies. Almost half of the studies were conducted in Africa (5 of 11, 45.5%). 
Nine reported mean, median or range of age at time of study which was between 20 and 40, 
and two studies did not report on participant age. Table 3.5.4 shows methodological 
characteristics of included studies. Ten studies were case-control design and one was cross-
sectional.  Recruitment and biological sample collection (i.e., vaginal swabs) were carried out 
in hospitals or clinics in all 11 studies. BV was confirmed using Amsel clinical criteria in 
only one study, laboratory-based testing in 10 of the 11 studies, eight of those by means of 
gram staining using Nugent's scoring system, one using bacterial culture and one using 
culture or microscopy.   
The primary outcome reported in the included studies was the diagnosis of BV 
(exposure to BV) in infertile (cases) and fertile (controls) women as noted (Chapter 3 
Methods, pp. 65) the raw data were used to calculate the number of infertile women in the
BV and No-BV groups. The definition of infertility varied in the included studies: four 
studies reported one-year duration of inability to become pregnant (of those, three were 
primary infertility and one was secondary infertility), two studies reported two years of 
inability to become pregnant, one study reported 36 months of inability to become pregnant 
(primary and secondary), two studies reported on TFI, one study reported idiopathic 
infertility and one study reported female factor infertility. The control groups also differed; 
three studies included pregnant controls, three studies included women who were reported to 
be fertile, two studies included women who had recently delivered (within 6 to 18 months) 
and two studies included women attending family planning clinic.
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Table 3.5.3.  
Sample Characteristics Reported in the Eleven Included Studies 
Study  Location Sample (n) 
 
N N                                             Age a 
                           Women 
Case-control 
studies  
  Infertile b Fertile (control)   Infertile Fertile 
Aboul Enien, 2005 Egypt 60 women 40 20 Mean (SD) NR NR 
Adamson, 2011 India 897 women 113 784 Mean (SD) 24.0 (3.4) 26.1 (3.0) 
Almanza, 2011 Cuba 189 women  89 100 Mean 30.4 24.3 
Dhont, 2010  Rwanda  571 women 307 264 Median (IQR) 30 (27–35) 27 (24–31) 
Dhont, 2011 Rwanda 396 women  177 219 Median (IQR) 32 (28-37) 28 (25-32) 
Durugbo, 2015 Nigeria 356 women 178 178 Mean (SD) 28 (5) NR 
<20 0 6 (3.4) 
20-24 20 (11.2) 20 (11.2) 
25-29 77 (43.3) 66 (37.1) 
30-35 60 (33.7) 60 (33.7) 
>35 21 (11.8) 26 (14.6) 
Kildea, 2000 Australia (Indigenous 
Women)  
342 women 241 101 Mean (CI)  30.4 (95% CI, 29.7-31.1) 
Mania-Pramanik, 
2009 
India 214 women 112 102 Mean (SD) In BV+ women 27.7 (5.2)  
Morgan, 1997 UK 1578 women  199 1379  NR NR 
Salah, 2013 Egypt 1256 women  874 382 Mean (SD) 27.1 (2.2) 25.8 (3.1) 
Tomusiak, 2013 Poland 161 women  101 60 Range  20-40 
Note. a Age for women at the beginning of the study; b Unable to become pregnant after 1 or 2 years of unprotected intercourse, a specific diagnosis e.g. idiopathic, female 
factor; NR = not reported; SD = Standard deviation; IQR = inter-quartile range 
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Table 3.5.4.  
Characteristics of the Design of the Eleven Included Studies 
Study Study design Recruitment 
and data 
collection 
Study 
period 
BV self-report or lab test Fertility Problems outcome measure 
(duration) 
Control 
Aboul Enien, 2005 Case-control Hospital based Gram staining for the presence of 
BV using Nugent's scoring system 
Diagnosed idiopathic infertility  Fertile women 
Adamson, 2011 Case-control Hospital based 2005-
2006 
Gram staining for the presence of 
BV using Nugent's scoring system 
Primary infertility: married (or partnered) for more than 
two years, sexually active, not using modern 
contraception, and without children 
Sexually active, not using modern 
contraception fertile women (not 
explicitly stated that they have a 
child, but only that they are fertile) 
Almanza, 2011 Case-control Hospital based 2009  Bacteriological culture techniques Diagnosed tubal obstruction  Currently pregnant women about to 
deliver   
Dhont, 2010 Case-control Hospital based 2007-
2009 
Gram staining for the presence of 
BV using Nugent's scoring system 
and Amsel criteria 
Infertility: having regular unprotected intercourse for 1 
year or more without conception with at least one regular 
partner, and included both primary and secondary 
infertility. TFI subcategory 
Non-pregnant women recently 
delivered (within past 6 to 18 
months) 
Dhont, 2011 Case-control Hospital based 2007-
2009 
Gram staining for the presence of 
BV using Nugent's scoring system 
and Amsel criteria 
Secondary infertility: having regular 
unprotected intercourse for one year or more with at least 
one regular partner without conception in women who 
conceived at least once before 
Non-pregnant women recently 
delivered (between 6 and 18 months 
ago) 
Durugbo, 2015 Case-control Hospital based 2014 Visual assessment of discharge, 
then pH test, then ‘whiff test’ then 
microscopic examination (‘fourth 
Amsel  criteria’) 
TFI previously diagnosed by hysterosalpingography Fertile women attending the family 
planning clinic 
Kildea, 2000 Cross-sectional  Medical records 1996 Culture or microscopy Primary infertility: never given birth to a live child 
despite 36 months of unprotected sexual intercourse. 
Secondary infertility: given birth to one or more live 
children in the past but now unable to become pregnant 
after 36 months of unprotected intercourse 
Women who had been able to 
conceive within 36 months of 
unprotected intercourse 
Mania-Pramanik, 
2009 
Case-control Hospital based NR Gram staining for the presence of 
BV using Nugent's scoring system 
Women who did not conceive within two years of 
marriage but were trying to conceive 
Currently pregnant antenatal cases 
(first trimester, 2-3 months) 
Morgan, 1997 Case-control Clinic based Gram staining for the presence of 
BV using Nugent's scoring system 
Women attending at a specialist infertility clinic (trying to 
conceive for at least one year)  
Currently pregnant (antenatal clinic) 
Salah, 2013 Case-control Hospital based 2009-
2011 
Gram staining for the presence of 
BV using Spiegel’s criteria 
Women diagnosed with female factor infertility Attending family planning 
Tomusiak, 2013 Case-control Hospital/clinic 
based 
NR Gram staining for the presence of 
BV confirmed based on pH, 
Nugent score and quantitative 
culture results 
Women in the infertile group had been treated for 
infertility for at least one year. Anatomical, hormonal 
abnormalities, endometriosis and abnormal sperm 
parameters ruled out 
Women who had no history of 
fertility problems and at least one 
child 
Note. BV = Bacterial vaginosis; TFI = tubal factor infertility; NR = not reported 
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Study Quality, Fertility Problems Outcome Measure and Bias 
Table 3.5.5 shows the results of quality assessment (see table footnote for criteria). 
Infertility was adequately assessed in all the studies, as pre-specified in the quality 
assessment form (see Appendix H) but whether it was representative of the population could 
only be determined in six of the 11 included studies, see Table 3.5.4. The controls were 
adequately assessed in 10 of the 11 studies, but the adequacy of selection (selected from the 
same population) was reported in only five of the studies. Adequate assessment of 
confounders in the infertile/fertile groups was reported in six of the 11 the studies, but only 
three studies used the same method for both groups.  Confounders were included in the 
analysis in six of the 11 reviewed studies, but only two (Durugbo, 2015; Kildea, 2000) 
included STIs.  In addition to Durugbo (2015) and Kildea (2000), six other studies reported 
on ‘STIs’ but did not include STIs in the analysis. BV was adequately measured in eight of 
the included studies, as indicated by gram stain evaluated by Nugent’s criteria, not bacterial 
culture or clinical criteria. Overall the majority of studies (10 of 11) had high or average 
quality as per quality assessment. Follow-up criteria were not applicable to the included 
studies because they were case-control and cross-sectional, therefore there was no follow-up.   
Heterogeneity was significant and publication bias was explored using funnel plots, Eggers 
test, trim and fill procedures as well as subgroup analysis. Although a subgroup analysis was 
planned for the outcome ‘childlessness’, because only one study reported that outcome it 
could not be computed, instead the study was removed in a sensitivity analysis.  
Percentages reported in Table 3.5.6 indicated that there were more infertile women in 
the BV group than in the No-BV group regardless of type of infertility. Additionally, the 
highest percentage of infertility was reported in the BV group in the exclusively TFI studies 
subgroup, see Table 3.5.5.  
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Table 3.5.5.   
Quality Ratings for the Eleven Included Studies on the Basis of an Adapted Newcastle-Ottawa Quality Assessment Scale 
Study 
Quality Criterion 
Overall 
rating g 
Adequacy of 
infertility 
(exposed) 
measurea 
Max 2 points 
Adequacy of control 
(non-exposed), 
definition and 
selection b 
Max 2 points  
Comparability 
of control c 
Max 2 points 
Confounders 
adequately assessed 
Max 2 points d 
Adequacy of 
outcome BV 
measure e 
Max 1 point 
Loss to 
follow-up f
Max 1 point 
Aboul Enien, 2005 2 1 0 0 1 NA Average 
Adamson, 2011 1 1 1 2 1 NA Average 
Almanza, 2011 1 1 1 1 1 NA Average 
Dhont, 2010 1 2 1 2 1 NA High 
Dhont, 2011 1 2 1 1 1 NA Average 
Durugbo, 2015 2 1 2 1 0 NA Average 
Kildea, 2000 2 2 2 2 0 NA High 
Mania-Pramanik,2009 1 2 0 0 1 NA Average 
Morgan, 1997 
0 2 0 0 1 NA Low 
Salah, 2013 
2 1 0 0 1 NA Average 
Tomusiak, 2013 2 1 0 0 1 NA Average 
Note. NA= not applicable; a Infertility was adequately assessed when independent validation of (e.g. laboratory testing and/or hospital/medical records) and it was 
representative of the cohort i.e. drawn from the same population (up to 2 points); b Controls were adequately assessed when selection was comparable to cases, and infertility 
was excluded properly in the control population (up to 2 points); c Comparability of controls was achieved if exposed/non-exposed were matched or adjustment during 
analysis conducted. One point for STIs and one point for any other confounder (up to 2 points); d Confounders were adequately assessed if they were obtained from records or 
a blind interview, and one point was given if the same method was used for both groups (up to 2 points); eFertility problems outcome was adequately assessed if independent 
or blind assessment was stated in the paper, or confirmation of the outcome by reference to secure records (medical records, etc.) (up to 1 point); f Point given if same rate for 
both groups and <20% loss to follow up reported; g The overall quality rating was low (0 to 3 points), average (4 to 6 points), or high (7 to 10 points). 
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Table 3.5.6. 
Number and Percentage of Infertile Women in BV and No-BV Groups in the Included 
Studies (k=11) 
Studies included Number of women (%) 
BV No-BV 
All studies 
k=11 
846 of 1421 (59.5) 1443 of 4597 (31.4) 
Exclusively TFI (subgroup) 
k=2 
114 of 159 (71.7) 153 of 386 (39.6) 
Not only TFI (subgroup) 
k=9 
732 of 1262 (58.0) 1290 of 4211 (30.6) 
Note. BV = bacterial vaginosis; TFI = tubal factor infertility 
Results of Meta-analyses 
The first analysis compared 11 studies with calculated data representing the
proportion of infertile women in the BV and No-BV (control) groups, see Figure 3.5.4. 
This meta-analysis showed a significant pooled effect size (OR 2.81, 95% CI 1.85 to 4.27) 
and significant heterogeneity (I² = 83%, p < 0.00001). The results indicated that being in 
the BV group was associated with higher odds of being infertile (more likely to have 
fertility problems) than the No-BV control group.  
Figure 3.5.4. Odds ratio for women who are infertile in the BV and No-BV groups 
Figure 3.5.5 shows the forest plot and meta-analysis result for the sensitivity analysis 
conducted by removing the one study reporting ‘inability to have a child’, and pooling the 
results of the 10 studies reporting ‘inability to become pregnant’. The meta-analysis showed a 
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significant pooled effect size (OR 3.12, 95% CI 2.03 to 4.79), but heterogeneity remained 
significant (I² = 82%, p < 0.00001), see Figure 3.5.5. The results indicated that although both 
analyses were significant, the odds of being infertile in the BV group were higher if only 
women who were unable to achieve a pregnancy were included than if women who were 
unable to have a child were also included. Whether the difference between these two analyses 
was significant was not determined.   
Figure 3.5.5. Sensitivity analysis by outcome (removed one study reporting childlessness 
and compared only studies retorting inability to become pregnant) for the comparison 
‘Odds ratio for women who are infertile in the BV and No-BV groups’  
Figure 3.5.6 shows the subgroup analysis comparing the probability of being infertile 
in the BV and No-BV (control) groups in studies with ‘only TFI’ diagnoses compared with 
studies that were ‘not only TFI’ (multiple types of infertility). The subgroup that included the 
two studies reporting ‘only TFI' showed a significant pooled effect size (OR 5.11, 95% CI 
3.27 to 7.99), and non-significant heterogeneity (I² = 0%, p = 0.63). The subgroup that 
included the nine studies reporting ‘not only TFI’ showed a significant pooled effect size (OR 
2.42, 95% CI 1.53 to 3.84), and significant heterogeneity (I² = 84%, p < 0.00001).  The test 
for subgroup difference was statistically significant (P=0.02), indicating that the odds of an 
association between BV and ‘only TFI’ was significantly more than the odds of an 
association between BV and ‘not only TFI’. The results indicated that when only women 
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diagnosed with TFI were considered the odds of being infertile were higher in the women 
with BV than those without, as compared to lower odds if the infertile women had multiple 
types of infertility (not only TFI). 
Figure 3.5.6. Subgroup analysis by outcome (with studies that are exclusively TFI, and 
studies that are not only TFI) for the comparison ‘Odds ratio for women who are infertile 
in the BV and No-BV groups’  
Publication bias assessment. 
Publication bias was assessed using funnel plots, Eggers test and trim and fill 
procedures for the analysis ‘Odds ratio for women who are infertile in the BV and No-BV 
groups’. Egger’s test performed for the meta-analysis was not significant at P<0.05, 
indicating the lack of publication bias. Trim and fill was used to estimate the number of 
‘missing’ studies and if there were any changes to the magnitude of the pooled effect size if 
‘missing’ studies were included. Figure 3.5.7 shows the procedure revealed one ‘missing’ 
study and the pooled effect size changed from (OR 2.81, 95% CI 1.85 to 4.27) to (OR 2.75, 
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95% CI 1.82 to 4.15), indicating that inclusion of the one ‘missing’ study would have reduced 
the difference between the BV and No-BV (control) groups but the BV group would still 
have significantly higher odds of infertility than the No-BV group.  
Figure 3.5.7. Funnel plot with trim and fill procedure to impute ‘missing’ studies 
(missing studies in red) for the ‘odds ratio for women who are infertile in the BV and 
No-BV groups’  
STIs and Sexual History Reported in the Included Studies 
Data were not available to enable a subgroup analysis of women with STIs and those 
without. Only a summary of percentages of women with STIs in the BV and No-BV groups 
was possible.  Of the 11 studies included in the current meta-analysis, eight reported on STIs 
and four on sexual history, see Table 3.5.7. More STIs were found in the infertile women in 
all eight studies, except for more chlamydia found in the fertile group in one study 
(Tomusiak, 2013). Seven studies reported on the percentage of STIs in the infertile and fertile 
groups regardless of exposure to BV, see Table 3.5.7. In two of the included studies an 
association between BV and STIs was reported (Durugbo, 2015; Mania-Pramanik, 2009). In 
the first study, a history of STIs was significantly associated with BV (Durugbo, 2015). The 
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infertile group in this study included only women with a diagnosis of TFI. Of the 50 infertile 
women who had BV, 38 (74%) women had a history of STIs and of the 14 fertile controls 
that had BV, 11 (79%) women had a history of STIs. A history of STIs was more commonly 
found in the women with BV in both the infertile and fertile controls than in women without 
BV, see Table 3.5.7. In the second study, of the 29 infertile women who had BV, 5 (17.2%) 
women had comorbid STIs (Chlamydia and HPV) but none of the six pregnant controls who 
had BV had comorbid STIs (Mania-Pramanik, 2009). However, the significance of the 
differences between the infertile groups and the controls was not reported. 
Table 3.5.7.  
Percentage of Women with Comorbid STIs or a History of STIs in Infertile Versus Fertile 
Women in Eight of the Eleven Included Studies (k=8) 
Study Type of infection Percentage of STIs 
Infertile 
(%)
Fertile (control) 
(%)
Adamson, 2011 HSV 22/113 (19.5) 81/784 (10.3) 
Almanza, 2011 Chlamydia 41/89 (46) 2/100 (2) 
Mycoplasma hominis 15/89 (16.9) 10/100 (10) 
Ureaplasma urealyticum 38/89 (42.7) 2/100 (2) 
Dhont, 2010 HIV 98/312 (32) 39/283 (14) 
HSV 180/312 (59) 115/283 (41) 
Chlamydia 57/312 (19) 44/283 (16) 
Dhont, 2011 HIV 74/177 (42) 35/219 (16) 
HSV 121/177 (70) 99/219 (45) 
Chlamydia 31/177 (18) 33/219 (15) 
Kildea, 2000 Chlamydia 36/101 (36) 68/241 (28) 
Gonorrhoeae 42/101 (42) 51/241 (21) 
Trichomonas vaginalis 64/101 (63) 95/241 (39) 
Tomusiak, 2013 Chlamydia 0/101 (0) 2/60 (3) 
Mycoplasma hominis 4/101 (4) 0/60 (0) 
Ureaplasma urealyticum 9/101 (9) 5/60 (8) 
Durugbo, 2015 History of STIs 64/178 (36) 35/178 (19.7) 
Infertile/BV Infertile/no-BV Fertile/BV Fertile/no-BV 
38/50 (74) 26/128 (20.3) 11/14 (79) 24/164 (14.6) 
Mania-Pramanik,2009 Chlamydia and HPV 5/29 (17.2) NR 0/6 (0) NR 
Note: HSV = herpes simplex virus; HIV = human immune deficiency virus; HPV = human papilloma virus; 
STIs = sexually transmitted infections; NR = not reported 
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Four studies also reported on sexual history. Infertility was significantly associated 
with younger age at sexual debut, risky sexual behaviour (e.g. unprotected sex) and increased 
number of lifetime sexual partners in three studies (Adamson, 2011; Dhount, 2010; Durugbo, 
2015), and factors like unsafe abortion and pregnancy with a previous partner were associated 
with secondary infertility in the fourth study (Dhount, 2011). Additionally, having only one 
sexual partner was reported to be a protective factor against BV (Durugbo, 2015). 
Discussion 
Principal Findings 
The results of the present set of meta-analyses suggest that BV may be a relevant 
factor associated with ability to become pregnant. One potential reason for the higher odds of 
infertility in women with BV proposed in the literature was increased susceptibility to other 
infections e.g. STIs (Wiesenfeld, Hillier, Krohn, Landers & Sweet, 2003) that lead to PID 
and consequently TFI (van Oostrum, et al., 2013; Morris, et al., 2001; Hay, 2004; 
Mastromariano, et al., 2014), ‘Pathway 1 (a)’ in Figure 3.5.2. The PID could also occur in the 
absence of STIs due to increased endogenous bacterial overgrowth typical of BV microflora 
(Korn, et al., 1995; Sweet, et al., 1987), ‘Pathway 1 (b)’ in Figure 3.5.2. Another potential 
pathway could be that the lack of lactobacilli characteristic of BV can lead to endometritis 
(Hillier et al., 1996) that could hinder implantation because of an immune response (Moore, 
et al., 2001; Spandorfer, et al., 2001; Hay, 2004), ‘Pathway 2’ in Figure 3.5.2.  The difference 
between the subgroup analysis comparing women with ‘only TFI’ with those with ‘not only 
TFI’ was significant. This difference is clinically plausible and supported by evidence from 
the literature (Mastromariano et al., 2014; Morris, et al., 2001; Hay et al., 2012; van Oostrum, 
et al., (2013); Hay, 2004). The final arm of ‘Pathway 1 (a)’ that indicates tubal damage leads 
to infertility was supported by the finding of significantly higher odds of TFI compared to 
multiple types of infertility in women with BV than in women without BV. 
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However, the mechanism of how this blockage occurs remains unclear. The tubal blockage 
could be due to STIs leading to PID (Mastromariano et al., 2014), or it could be due to PID 
independent of STIs (Morris, et al., 2001; Hay et al., 2012), but the current results cannot 
support either mechanism. Additionally, the fact that the ‘not only TFI’ subgroup which 
included multiple types of infertility was also significant, suggested that either this sample 
included some women who had TFI, or that BV is also associated with other types of 
infertility e.g. anovulation, as reported in the literature (Morris, et al., 2001; Hay, 2004). This 
association could be examined by excluding all women with TFI from the ‘not only TFI’ 
subgroup and reassessing the meta-analysis. However, this was not possible in the current 
study because the type of infertility was not specified in all the include studies.  
Other sub-group analyses could have helped provide evidence to the exact 
mechanism of action (e.g., types of infertility, comorbid STIs and PID) however, this was 
not possible from the current data. Although the second pathway in Figure 3.5.2 is 
biologically plausible, data from the current study could not be used to corroborate it. 
Evidence for the third pathway was not considered in the current review but is more concrete 
and therefore, requires less additional evidence.   
It is important to note that two studies (Almanza, 2011; Dhount, 2010) reported 
percentage of BV in the infertile and fertile groups (72% and 52% respectively) that were 
higher than the highest estimate of BV reported in the literature, 50.9% in rural Uganda 
(Paxton, 1998). The higher percentage in Almanza (2011) can be explained by the fact that 
the bacterial culture method used to diagnose BV in this study is known to be less sensitive 
and can include many false positives (Money, 2005; Hillier, 1993). In the other study 
(Dhount, 2010), the fact that the study was conducted in Rwanda where the predominant 
race is black can be used to explain this high percentage, as black race has been found to be 
associated with higher percentages of BV (Hay, et al., 1994; Goldeberg, et al., 1996), and the 
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highest estimates of BV in the literature (50.9%) was reported in rural Uganda (Paxton, 
1998). 
An understanding of whether BV was associated with inability to achieve pregnancy 
or to have a child would have been gained from subgroup analysis based on a comparison of 
studies reporting inability to become pregnant with studies reporting inability to have a child. 
However, this was not possible because only one of the included studies reported inability to 
have a child (Adamson, 2011). Therefore, only a sensitivity analysis was conducted by 
removing the one study reporting childlessness. This analysis resulted in a larger pooled 
effect size, with higher odds of being infertile when only studies that considered the 
percentage of BV in women who were unable to become pregnant were included. However, 
making generalizations about the association of BV with childlessness are difficult at this 
time and would require more such studies. 
In almost all the included studies the infertile women had more STIs (comorbid or 
history) than the fertile women. However, the association between STIs and BV was only 
reported in two studies (Durugbo, 2015; Mania-Pramanik, 2009). It can be inferred from the 
results of the first study (Durugbo, 2015) that a history of STIs was more commonly found in 
thewomen with BV in both the infertile and fertile controls than in women without BV. 
However, the results of the second study (Mania-Pramanik, 2009) indicate that BV was 
associated with STIs in the infertile women but not the fertile controls. The difference in the 
percentage of women with comorbid/history of STIs between these two studies could be 
related to the fact that in the first study (Durugbo, 2015) a history of STIs was measured 
while in the second study (Mania-Pramanik, 2009) a current STI was measured. Another 
reason for the difference could be the prevalence of STIs in the populations from which the 
studies were sampled. Durugbo (2015) was conducted in Nigeria and the prevalence of STIs 
in Africa is 7.2%, while Mania-Pramanik (2009) was conducted in India, and the prevalence 
in South-East Asia is 2.2% (WHO, 2012, Global incidence and prevalence of selected 
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 curable sexually transmitted infections).  Regardless of the reasons for the different 
percentages of STIs, these conflicting results make it difficult to draw conclusions to 
determine the involvement of STIs in ‘Pathway 1 (b)’ suggested in Figure 3.5.2, pp. 215. It 
can be inferred  from the two studies that reported more cases of BV occurred with a history/
comorbid STIs than without, regardless of fertility status, that STIs were also associated with 
BV. This data supports claims of increased susceptibility to, or comorbidities with STIs (van 
Oostrum, et al., 2013; Morris, et al., 2001; Hay, 2004; Mastromariano, et al., 2014); 
however, this requires more systematic evidence to be confirmed. 
Overall it can be inferred from the results that exposure to BV was associated with 
infertility and that this association was stronger when only studies reporting on TFI were 
considered. The results indicated that women with BV were more likely to be infertile than 
women without BV. The results also indicated that the mechanism via which BV acts may be 
partially due to tubal damage, corroborating that the suggested mechanism of action may 
include the involvement of the fallopian tubes (van Oostrum, et al., 2013; Morris, et al., 
2001; Hay, 2004). Whether the mechanism of tubal blockage was due to STIs and PID could 
not be   established from current meta-analyses but data from the reviewed studies indicated 
higher percentage of STIs in infertile women, which is not surprising given that STIs are a 
well-established risk factor for infertility (NHS, April 2015; CDC, October 2016).   
The criteria of ‘biological plausibility’, ‘coherence’ and ‘consistency’ were satisfied 
for BV due to the molecular level studies indicating the change in vaginal microflora, the 
consequential susceptibility to infection and immune response triggered by the abnormal 
microflora (see, Eckert et al., 2003; Hillier et al., 1996; Korn, et al., 1995; Moore et al., 2001; 
Spandorfer et al., 2001; Sweet, et al., 1987). These studies provide evidence for the first and 
second pathways in Figure 3.5.2.  Molecular level evidence exists to support the first arm 
(weakening of membranes and/or labor cascade) of the third pathway in Figure 3.5.2 (Hillier, 
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et al., 1988; Heller et al., 2003; Goldenberg et al., 2000; Sebire, 2001) and epidemiological 
evidence for the rest of the pathway (preterm labor), see (Hay, 2004; Hay et al., 2012; 
Mastromarino et al., 2014; Morris et al., 2001).  
There is systematic evidence that shows that although treatment of BV during 
pregnancy does not prevent preterm birth, in women with abnormal flora (intermediate flora 
and BV) treatment helps reduce the risk of preterm birth (McDonald et al., 2007), suggestive 
of a dose-response effect, thus satisfying the ‘biological gradient’ criteria. The evidence from 
these studies combined with the fifth criteria ‘strength’ of the relationship found in the current 
meta-analysis (more than double chance of being infertile in the BV group and a fivefold 
increase when the infertility was TFI only), should bolster the likelihood that there is a causal 
relationship between BV, infertility generally and TFI specifically. However, more evidence 
is necessary to identify whether the increased susceptibility is due to STIs or to endogenous 
infections that could affect treatment protocols in infertile patients with BV. 
Justification for including BV in the FertiSTAT.
The current meta-analyses indicated that inclusion of BV in FertiSTAT as a new risk factor 
could potentially increase the predictive ability of the tool in LMIC. If the mechanism of 
action of BV was only via tubal blockage caused by STIs or PID, then it would not be an 
independent risk factor since STIs and PID are risk factors in the original tool and the 
inclusion of BV would not increase the predictive ability of the tool. However, the fact that 
significantly higher odds of being infertile in the BV versus No-BV group even when the type 
of infertility was not limited to TFI, indicated that there may be more than one mechanism via 
which BV operates. Had an analysis been performed that excluded all women with TFI it 
would have been possible to draw conclusions about the pathways that do not involve PID 
and the consequential tubal damage. However, as previously mentioned, this was not possible 
due to lack of data. Additionally, the involvement of post-pregnancy outcomes (e.g., preterm 
birth) were not examined since such outcomes were not used in the primary studies identified 
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in the current review. Therefore, the results of the current study do not allow confirmation of 
the second and third causal pathways which involved post implantation and preterm birth, 
see Figure 3.5.2.  
Implications of Findings 
Results of the current study indicated that there was sufficient evidence to determine 
that BV is associated with infertility generally and TFI specifically. Whether this effect is 
mediated or moderated by other factors such as STIs could not be determined from the 
current data, nevertheless, awareness of the risks associated with BV should be 
communicated to women.  
The main implication of the results of this review is that women and health care 
providers should be made aware of potential risks to reproductive health that women who 
have untreated BV (including intermediate level microflora) face. The results of the review 
lend support to reports in the literature of an association between BV and TFI that can hinder 
a women’s ability to become pregnant (van Oostrum, et al., 2013; Morris, et al., 2001; Hay, 
2004). The repercussions of the potential damage to the fallopian tubes due to untreated BV 
and the potential increased susceptibility to STIs and/or PID for couples wanting to become 
pregnant are important because of its impact on childbearing. An understanding of whether 
the tubal damage results directly from the BV leading to PID or to intermediate infections 
like STIs that lead to PID needs to be examined as the treatment and management guidelines 
may vary depending on the mechanism of action.
With regard to BV specifically, the WHO report on pre-pregnancy care (see WHO, 
Meeting report, 2012), did not include information on the association between BV or about 
the management of BV before pregnancy or during pregnancy (WHO, Meeting report, 
2012).  However, the results of the current meta-analyses strengthen the evidence base 
required to include BV screening as an additional aspect of a comprehensive pre-pregnancy 
package. NHS guidelines for BV recommend that women should consult a GP if they notice
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abnormal vaginal discharge, especially if pregnant (NHS, October 2015), however, in the 
UK, screening for BV is not part of pre-pregnancy care. UK guidelines for the management 
of BV indicate that the evidence for screening and treating BV during pregnancy is 
conflicting and therefore make no recommendations about screening (Hay, et al., 2012). 
With regards to treating women with BV, UK guidelines recommend that based on the 
evidence currently available treatment should be as usual for symptomatic pregnant women 
(Hay, et al., 2012). However, they note that there is insufficient evidence for the treatment of 
asymptomatic pregnant women, but that pregnant women at additional risk of preterm birth 
could benefit from treatment before 20 weeks’ gestation (Hay, et al., 2012). This 
recommendation was based on a Cochrane review (McDonald, Brocklehurst & Gordon, 
2007), but a recent update of that review revealed that the risk of preterm birth was not 
reduced with treatment for BV (Brocklehurst et al., 2013).  The authors recommend that 
there is little value in screening or treating all pregnant women in preventing preterm birth, 
however, if screening criteria include women with abnormal flora (broader than BV) there 
was a significant reduction of preterm birth (Brocklehurst, 2013). All these recommendations 
are for preterm birth, whether there is value in screening women for BV before pregnancy to 
prevent STIs and PID to avoid complications like TFI and impaired implantation remains to 
be examined.  
Strength and Limitations in Included Studies 
The heterogeneity in study methodology, outcome measures and sample size in included 
studies could affect the comparability of these studies, and the generalizability of the results 
of this review. Heterogeneity in fertility problem outcomes (inability to become pregnant, 
being childless, TFI) and data collection methods (diagnosis of BV and infertility, subtypes 
of infertility), can affect the practical applicability of the results.  Heterogeneity remained 
statistically significant in subgroups and sensitivity analyses indicating that overall issues of
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methodological heterogeneity persisted, suggesting that uniformity in study methodology is 
required before pooled estimates are recalculated. The quality of each study independently 
does not appear to affect the overall results of the review since all of studies were of sound 
quality as determined by the Newcastle-Ottawa quality assessment scale. Bias relating to the 
primary studies included selection bias and information bias. In hospital and clinic based 
studies, the selection of participants based on hospital attendance can reduce the 
generalizability of the results. However, because the same sampling procedures were used 
for both cases (exposed) and controls (non-exposed), we can assume that selection bias may 
not be substantial. It can be assumed that since the selection of participants was from the 
same sample and information was gathered using the same method for both the exposed and 
non-exposed groups in all the studies, that selection and information bias may not affect 
results considerably. Bias due to confounder was a potential limitation of the studies 
included because matching the groups for confounders was reported in five of the included 
studies. The most important confounder ‘comorbid STI’ which is known to impact 
negatively on fertility was reported in eight of the elven studied but included in the analysis 
of only two studies. There could have been an unequal distribution of other confounders in 
the case and control groups. However, the effect of confounders e.g. sexual history, marital 
status, age, that could have influenced the relationship between BV and fertility problems 
was taken into consideration via either matching groups for confounders or entering them 
into analysis in five studies.  
Another limitation relating to the primary studies is the use of observational designs, 
as discussed in previous reviews. The fact that all of studies included in this review were 
case-control in nature, which are reasonably rigorous in identifying associations (Mann, 
2003), limits the determination of a causal relationship between BV and infertility.  As in 
the case of consanguinity, randomization for exposure to BV would not have been possible 
or ethical, but randomization might be possible for screening for BV. Alternatively, the most
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rigorous design to compare exposed and non-exposed individuals would be cohort studies, 
followed by case-control and then cross-sectional (Mann, 2003).  
Future research 
Future research to disentangle the effect of BV on fertility problems requires, RCTs 
and prospective cohort studies to investigate the causal mechanisms that are involved. 
Additionally, molecular level studies need to consider the specific microflora changes 
typical of BV and the associated consequences such as increased susceptibility to STIs, to 
support the first part of 
‘Pathway 1 (a)’ in Figure 3.5.2.  Ideally, RCTs that examine risk of infertility in samples of 
women screened and treated versus unscreened for BV should be conducted. Such a study 
would assess the benefit of screening women for BV, STIs and PID and measuring 
outcomes like pregnancy, infertility generally and TFI specifically and other reproductive 
outcomes. Additionally, longitudinal prospective cohort studies should be conducted to 
follow women exposed (at risk) to BV and non-exposed (not at risk) women as well as 
women treated/untreated, with measurements at baseline and follow-up of reproductive 
outcomes such as STIs, PID, tubal blockage, pregnancy rate (clinical versus biochemical), 
pregnancy outcomes e.g. first and second trimester losses, preterm labour, preterm birth and 
premature rupture of membranes. Additionally, confounders such as sexualhistory, 
comorbid STIs and PID should be considered in study methodologies (e.g. included in 
statistical analysis).  It will be important to determine which aspects of the reproductive 
process are affected to determine whether implantation is being impacted or if tubal 
blockage is occurring, and whether it was preceded with PID (with or without STIs).  Future 
research should be directed at understanding the reasons for the higher odds of being 
infertile (TFI compared with multiple types of infertility) in women with BV, to definitively 
ascertain if it is related to blocked tubes. Studies sampling only women with TFI should be 
compared
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with studies that exclude TFI. It is important to investigate BV during pregnancy to 
determine the nature of the relationship between BV and the different stages of pregnancy. 
This would help identify the exact biological mechanisms involved, which would in turn 
determine the differential management required. It is imperative that after more such 
studies are carried out that an update of the current meta-analyses be conducted.  
Conclusion 
 Fertility problems have been reported as a negative consequence of BV in the 
literature but evidence to support this claim has been equivocal. Results of the current 
meta-analyses indicated that BV was associated with an inability to become pregnant, and 
this appeared to be related to tubal blockage. The results were not sufficient to rule-out an 
association between BV and non-TFI. Therefore, there appear to be several pathways 
through which BV can impact fertility and evidence from molecular level studies, and 
previously reviewed epidemiological studies lend support to the three pathways suggested 
in this review. In light of these results the inclusion of BV in the adapted FertiSTAT could 
potentially increase the predictive ability of the tool. It is important to note that this area of 
research should be re-examined when more research is accumulated. 
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Study 3.6: Systematic Review of Observational Studies Examining the Association of 
Repeated Dilatation and Curettage and Fertility Problems 
Introduction 
Repeated dilatation and curettage (D&C) was one of the risk factors endorsed by 
participants in the survey of international fertility doctors (Chapter 2, pp 25). The validity of 
this risk factor as a predictor of fertility problems was examined in the current systematic 
review using the methodology reported in the General Methods of Chapter 3 (pp. 58). 
Description of D&C and reproductive health consequences 
D&C is a gynaecological procedure performed to remove tissue from the uterus for 
various clinical indications (see below) (NHS Suffolk Public Health Team, 2013). The D&C 
procedure involves dilation of the cervix with an instrument or medication and the scraping 
of the inside of the uterus with a curette, a metal instrument, see Figure 3.6.1 and 3.6.2.  
To understand the body of evidence some medical terminology used in the literature 
needs to be clarified. ‘Repeated D&C’ refers to having the procedure more than once over 
time (weeks, months, years), not twice on the same occasion. Abortion indicates induced 
abortion not miscarriage unless otherwise specified. An induced abortion is defined as 
intentional loss of intrauterine pregnancy through medical or surgical intervention (Zegers et 
al., 2017).  Medical management is used to indicate non-surgical treatment with medicines 
such as misoprostol and prostaglandins. Retained products of conception (RPOC) refers to 
placental or foetal tissue that remains in the uterus after birth, miscarriage or abortion. 
Negative pregnancy outcomes refers to any outcome of pregnancy that does not lead to a 
healthy live birth including gestational problems like miscarriage, ectopic pregnancy and still 
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birth. Obstetric history is a medical term indicating all previous obstetric events, for example, 
pregnancy, miscarriage, abortion, live birth, post-partum infection and premature birth. 
It is also important to consider these three factors when reviewing the literature: 
clinical indications for the procedure, type of procedure(s) and outcome after the 
procedure(s). First, the clinical indications for D&C include (but are not limited to) to: (1) 
treatment of abnormal uterine bleeding, (2) induce abortion, (3) ensure miscarriage is 
complete, (4) remove RPOC after miscarriage, abortion or birth, and (5) endometrial 
sampling necessary for diagnoses of diseases like cancer. There is also anthropological 
evidence that D&C was historically used to ‘cure’ infertility or to enhance a woman’s ability 
to become pregnant (Inhorn and Buss, 1993). It is important to consider the clinical 
indications because they could have different impact due to the difference in gynaecological 
and obstetric history, for example previous infections, or miscarriages, abortions or births 
could have led to biological alteration to the reproductive system.   
Second, some of the procedures used in control groups compared to D&C include but 
are not limited to: (1) hysteroscopy or hysteroscopic resection, the insertion of a thin lighted 
tube (telescope) to examine the cervix and uterus and to remove tissue using a surgical loop 
at the end of the hysteroscope (2) vacuum aspiration, dilatation and evacuation (D&E), both 
procedures use suction to remove materials from the uterus (not a curette), (3) medical 
management with misoprostol or prostaglandins (medications that cause uterine 
contractions), and (4) expectant/conservative management (waiting). It is important to note 
that in some studies surgical procedures are grouped together. These surgical procedures are 
D&C, vacuum aspiration, D&E and hysteroscopy, and all involve a form of surgical 
intervention. Figure 3.6.1 shows the different equipment used in these surgical procedures 
and Figure 3.6.2 compares the metal instrument used to remove tissue. The procedures could 
have different impact for the following reasons: (a) all procedures other than medical and 
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expectant management that use dilatation have the potential to damage the cervix, (2) in 
medical and expectant management there is the risk of incomplete evacuation of products of 
conception, which could lead to complications such as bleeding, (3) the difference between 
D&C and all procedures using suction is that scraping of the uterus with a sharp instrument is 
done in D&C, (4) the difference between all procedures and hysteroscopic resection is that 
hysteroscopy allows for visualization of the procedure, while all other surgical interventions 
such as D&C are blind, see Figure 3.6.2.  
Figure 3.6.1. Instruments used in D&C, vacuum aspiration/D&E and hysteroscopy. 
D&C=dilatation and curettage, D&E=dilatation and evacuation  
Figure 3.6.2. Instruments used to remove tissue in curettage as compared to hysteroscopy.  
D&C=dilatation and curettage, the surgical loops are found at the end of the hysteroscope  
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Third, regarding outcomes, all outcomes reported are complications that occur after 
the management (surgical, medical or waiting) that are considered a deviation from the 
normal post-operative sequel. Some studies report on short-term consequences such as 
prolonged bleeding that occur immediately after the procedure and others report on long-term 
consequences such as intra uterine adhesions (IUAs) and pregnancy rate that occur sometime 
in the future not immediately after the procedure.  Short and long-term outcome could also be 
linked, for example prolonged bleeding right after the procedure might be linked to 
developing IUAs. Since the literature is not extensive all available evidence was reviewed 
and conclusions about the impact of repeated D&C on fertility, inferred from an evaluation 
of the consolidation of all the available evidence. An examination of the literature would 
enable inferences to be made about whether: (a) it is the D&C or the clinical indications for 
its use that has negative reproductive consequences, (b) a single D&C can cause harm, (c) 
other types of surgical interventions such as vacuum aspiration are equally harmful, more so 
than medical treatment (misoprostol) or waiting, (d) short-term consequences can predict 
long-term outcomes and consequently the appropriate treatment of short-term problems can 
lead to better prognosis, (e) there are other confounding variables that moderate, mediate or 
completely explain the effect of D&C (e.g. post-operative care or experience of the 
professional conducting the D&C).  
Negative reproductive outcomes after the procedure of D&C have been reported 
historically and in more recent literature, a summary of these findings is presented in Table 
3.6.1. In older research (Pre 2000, see Table 3.6.1), the negative consequences reported after 
a single D&C included IUAs, secondary infertility and negative pregnancy outcomes (e.g. 
spontaneous abortion). In the same literature, repeated D&C was associated with negative 
pregnancy outcomes (e.g. ectopic pregnancy) and infertility (in cases where PID occurred 
after D&C). Specifically, in a review, Hogue and colleagues (1983) reported that the 
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evidence for the effect of multiple induced abortions whether using D&C only or D&C and 
Vacuum aspiration, on reproductive problems was inconclusive (Hogue, Cates & Tietze, 
1983). The authors reported that some outcomes such as ectopic pregnancy were reported in 
some primary studies but not others, and that this could be due to the method used for the 
abortion but also whether the abortion was legal or not (Hogue, Cates & Tietze, 1983). It is 
important to note that the results in this review pertain to the exposure to ‘multiple abortions’ 
rather than the specific procedure performed (Hogue, Cates & Tietze, 1983). 
Table 3.6.1. 
Summary of Long-term Negative Reproductive Outcomes Reported as a Consequence of 
D&C in the Literature 
Reproductive 
outcome 
Long-term negative reproductive outcome Primary study or 
review  
Historical literature 
(up to 2000) 
Single D&C Intrauterine adhesions (IUAs), Asherman’s syndrome (30.9% of 
women who had D&C after miscarriage) 
Schenker & 
Margalioth, 1982; 
Schenker, 1996 
Secondary infertility (after spontaneous miscarriage as a 
complication of the intrauterine surgery) 
Schenker & 
Margalioth, 1982; 
Schenker, 1996 
Recurrent miscarriages (after spontaneous miscarriage as a 
complication of the intrauterine surgery) 
Schenker & 
Margalioth, 1982; 
Schenker, 1996 
Negative pregnancy outcomes* after D&C (e.g. higher rates of 
spontaneous abortion), incompetent cervix**, preterm labour, preterm 
rupture of membranes, early neonatal death, and ectopic pregnancy) 
Madore, Hawes, 
Many & Hexter, 1981; 
Linn et al., 1983; 
Kalish, Chasen, 
Rosenzweig, 
Rashbaum & 
Chervenak, 2002 
Repeated D&C Negative pregnancy outcomes after repeated D&C (e.g. first 
trimester bleeding, abnormal presentations, placenta abruption, foetal 
distress, low birth weight, short gestation, and major malformations) 
Linn, 1983 
Primigravida abortion was only associated with infertility in cases 
where infection was present and consequently PID occurred 
Hogue et al., 1983 
(review) 
D&C as compared to vacuum aspiration was associated with negative 
reproductive outcomes (ectopic pregnancy, mid-trimester 
spontaneous abortion and low birth weight) 
Hogue, 1986 (review) 
Current literature 
(2000-present) 
Single D&C Significantly more IUAs were found after D&C compared with 
hysteroscopic resection*** (30% vs. 13%) 
Hooker et al., 2016 
(review) 
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Reproductive 
outcome 
Long-term negative reproductive outcome Primary study or 
review  
More postpartum haemorrhage in pregnancy following D&C (as 
compared to the literature) 
Lohmann-Bigelow et 
al., 2007 
Repeated D&C Odds of developing IUAs after repeated (>1) D&C were greater than 
after one D&C (OR 2.05, 95% CI 1.35–3.12, P=0.0008) 
Hooker et al., 2014 
(review) 
Note: D&C= dilatation and curettage, IUAs= intrauterine adhesions, PID=pelvic inflammatory disease, 
*Negative pregnancy outcomes are all the outcomes of a pregnancy that do not lead to a live birth (e.g.
gestational problems, stillbirth) **incompetent cervix = cervical insufficiency i.e. weak cervical tissue
contributes to premature birth. ***hysteroscopic resection is the removal of tissue from the uterus using a
hysteroscope.
More current literature such as a Cochrane review of RCTs have shown that 
differences in short-term complications like blood loss of first trimester termination of 
pregnancy using D&C compared to vacuum aspiration were not statistically significant 
(Kulier, Cheng, Fekih, Hofmeyr & Campana, 2001). The authors reported that long-term 
outcomes (such as fertility) were not available in the 11 included studies (Kulier et al., 2001). 
In a more recent Cochrane review of seven RCTs of expectant management (EXP) 
versus surgical treatment (vacuum aspiration or D&C) for miscarriage, the authors reported 
that women in the EXP group were significantly more likely to experience short-term 
consequences (require surgery after the initial treatment, prolonged bleeding and need for 
transfusion) (Nanda, Lopez, Grimes, Peloggia & Nanda, 2012). The two groups were not 
reported to differ significantly with regards to infection. Additionally, pooled effects for long-
term outcomes such as future pregnancy or live births were not computed (Nanda et al., 
2012). These Cochrane reviews were included to provide evidence for the short-term 
consequence of D&C and other procedures because the link between short and long-term 
outcomes has not been examined but may prove to be important.  
In a systematic review, the odds of developing IUAs after repeated (>1) D&C were 
greater than after one D&C (OR 2.05, 95% CI 1.35–3.12, P=0.0008) (Hooker et al., 2014). 
Additionally, the effect of D&C on long-term reproductive outcomes like future pregnancy 
and live birth was summarized but pooled estimates were not reported in the review (Hooker 
Chapter 3 Systematic Reviews 
255 
et al. 2014). The summary comprised five studies reporting on live birth and/or pregnancy 
rates after miscarriage in women who had undergone D&C as compared to women who had 
had other management (i.e., EXP or medical management with misoprostol [MED]).  From 
the summary of these studies it was concluded that the future pregnancy or live birth rate 
after miscarriage in women treated with D&C as compared to EXP or MED management did 
not differ. However, an examination of these primary studies, proposed by Hooker et al. 
(2014) to be reporting on D&C, indicated that four were in fact studies using surgical 
interventions that involved suction not D&C (Blohm, et al., 1997; Graziosi et al., 2004; Smith 
et al., 2009; Tam et al., 2005). Only Ben-Baruch et al. (1991), reported on D&C and therefore 
was included in the current study.  
In a systematic review examining the long-term outcomes after management of 
retained products of conception (RPOC), Hooker and colleagues (2016) reported significantly 
more IUAs were encountered after D&C compared with hysteroscopic resection (30% vs. 
13%) (Hooker, Aydin, Brolmann & Huirne, 2016). It was also reported that women treated 
for RPOC (D&C compared to hysteroscopic resection) had a similar rate of pregnancy and 
live birth. Of the three studies reporting long-term consequences summarized in this review, 
one used D&E (ultrasound-guided evacuation) not D&C (Rein et al., 2011), one used D&C 
but in some cases they went back and did hysteroscopy so it is not possible to identify which 
outcomes are related to D&C (Cohen et al., 2001) and the third (Ben-Ami, 2014) was 
obtained from the original search (details in results section, pp 265).
The evidence presented thus far suggests the need for a systematic review and makes 
clear that the relationship between D&C and future reproductive outcomes is complicated by 
several factors. First, the clinical indication for the procedure differs within and between 
studies making the effect of D&C difficult to separate from that of the indication. Second, the 
number of times the procedure is performed could determine its impact on fertility outcomes. 
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Finally, there is heterogeneity in control groups, outcomes and follow up periods (short and 
long-term) reported. The lack of compelling evidence for or against the impact of D&C on 
long-term reproductive outcomes (infertility, pregnancy and live birth rates), coupled with the 
heterogeneity in primary study methodologies supports the need to conduct the current 
systematic review.  
Plausible Mechanisms to Explain why D&C Could be Associated with Fertility 
Problems  
All the evidence from the literature summarized thus far would suggest that D&C 
could impact fertility as a result of a single procedure or as a result of multiple procedures 
(more than one D&C).  Figure 3.6.3 shows the proposed pathways and the level of evidence 
available for each. It can be seen from Figure 3.6.3 that IUAs (pathways 3 and 4) and 
gestational problems (pathways 2 and 5) are associated with single procedure and multiple 
procedures. A single procedure is also associated with secondary infertility (pathway 1), 
while multiple procedures are associated with infection and PID (pathway 6).  
The biological plausibility of the effect of D&C on reproductive processes coupled 
with the association with adverse reproductive outcomes like increased IUAs noted in the 
literature, highlight the need to investigate whether D&C should be included as a risk factor 
in the adapted FertiSTAT.  
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Figure 3.6.3. Proposed pathways for the impact of dilatation and curettage (D&C) on 
fertility. Solid line = Recent evidence; Double solid line= Recent Meta-analysis; Dashed 
line = Proposd pathway/ historic evidence; Dashed-Dotted line = Well established; Solid 
arrow = Moderator; D&C = dilatation and curettage; IUAs = intrauterine adhesion; 
gestational problems = any problem that occurs during pregancy that does not lead to a 
healthy live birth 
 
 
 
Rational, Aim and Objectives  
The aim of the current systematic review was to determine whether repeated D&C 
should be included as a risk factor in the adapted FertiSTAT. This was achieved by 
systematically reviewing the literature to determine whether repeated D&C was associated 
with fertility problems in women, and at what point in the reproductive process the impact 
occurs.  The population of interest for the review was women, the exposure was to the 
procedure of D&C more than once and the outcome of interest was fertility problems.  
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Materials and Methods 
Search Strategy 
The search terms included words related to D&C, for a complete list of MeSH terms 
see Appendix O. The search was limited to humans due to the large number of animal 
studies. Studies were excluded if the acronym D&C referred to or meant something else.  
Data Extraction and Quality Assessment 
The data extraction form (Appendix H) was adapted to include information relevant to 
D&C. Specifically, data about ‘obstetric history’ (e.g. pregnancy, miscarriage, abortion, live 
birth, post-partum infection and premature birth). The NOS form was adapted to reflect 
quality criteria for the assessment of D&C and additional confounders. D&C was adequately 
assessed if there were medical/hospital records indicative of the procedure performed. The 
confounder that was more important than others was ‘obstetric history’.  
Data Synthesis and Analysis 
As noted in General Methods (pp. 58), studies that could not be combined in a meta-
analysis, due to different outcomes and methodologies, were reviewed narratively.  
Results 
Study Selection 
Figure 3.6.4 shows the flowchart for number, reason and stage of exclusion of 
articles. A total of 347 records were identified (after duplicates removed) and most studies 
(281 of 347, 81%) were excluded because they did not report fertility problems or did not 
report on the association between D&C and fertility problems.  
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Figure 3.6.4. PRISMA Flow Diagram for D&C. Figure shows the exclusion of articles at 
the different stages and the reasons for exclusion. Records identified through datbase 
searching of Medline and Embase includes original search, an update from the time of 
original search and a search using new MeSH terms. D&C = Dilatation and Curettage 
Of the 18 full text articles assessed for inclusion, four met inclusion criteria and 
reported on the association of D&C on future fertility. One of those four studies was obtained 
from the search of reference lists of the studies screened at full text stage (Ben-Baruch et al., 
1991, retrieved from Hooker et al., 2014). Only studies reporting on ‘single’ D&C were 
found in the current search. The indication for D&C was different in all four studies: routine 
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investigation for infertility, spontaneous abortion (miscarriage), induced abortion and RPOC. 
The outcomes available in the included studies were: ‘PID, endometriosis and fibroids’ 
(Taylor, 1982), ‘gynaecological diseases and menstrual dysfunction’ (Sotnikova, 1986), 
‘infertility’ and pregnancy (Ben-Ami, 2014; Ben-Baruch, 1991) following D&C compared 
with other management. The two studies reporting on long-term fertility outcomes of interest 
(infertility, pregnancy) could not be combined in meta-analysis because they defined 
reproductive outcomes differently, used different indications for the procedure and different 
comparators in the control groups.  
Characteristics and Design of Included Studies 
Table 3.6.2 shows selected sample characteristics of the four included studies.  Only 
two included mean age at time of study that ranged between 28.6 and 30.5 years.  Table 3.6.3 
shows methodological characteristics of included studies. Three of the four studies were 
cohort design and one was cross-sectional, all data were collected from hospitals or clinic 
records.  
The control groups were heterogeneous with two being untreated (Ben-Baruch, 1991; 
Taylor, 1982) and the other two being treated with hysteroscopy (Ben-Ami, 2014) or 
prostaglandins and/or vacuum aspiration (Sotnikova, 1986). The outcome ‘infertility’ was 
reported in two studies, but defined as mechanical infertility, included tubal damage and 
IUAs (Ben-Ami, 2014) and as 12 months of inability to become pregnant despite trying (Ben-
Baruch, 1991). 
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Table 3.6.2.   
Sample Characteristics Reported in the Four Included Studies 
Study  Country  Sample (n) 
 
N N                                        Age a 
                         Women 
   D&C No-D&Cx  D&C No-D&C 
Ben-Ami, 2014 Israel 177 women 94 women 83 women Mean (SD) 30.4 (6.3) 30.5 (5.9) 
 
Sotnikova, 1986 Moscow 650 women 350 women 300 women NR NR NR 
 
Taylor, 1982 N/A 195 women 53 women 142 women NR NR NR  
Ben-Baruch, 1991 Israel 86 women 52 women 35 women Mean (SD) 28.6 (6.1) 29.2 (5.0) 
Note. x type of control group described in Table 3. a Age for women at the beginning of the study; b Unable to become pregnant after at least 12 months of unprotected 
intercourse; D&C= dilatation and curettage; NR= data not reported; SD=Standard deviation; Shaded study from search of reference list
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Table 3.6.3.  
Characteristics of the Design of the Four Included Studies 
Study Study design  Data collection Study 
period  
Control Group (no-D&C) Indication for procedure  Fertility Problems: 
outcomes reported in 
primary studies 
Ben-Ami, 
2014 
 
Retrospective 
cohort study 
Hospital based 2000-
2010 
Hysteroscopic resection  RPOC Infertility, time to conception 
in months, conception rate 
 
Sotnikova, 
1986 
Retrospective 
cohort study 
NR NR PG & vacuum suction  Induced abortion  Gynaecological diseases (e.g. 
salphingophoitis, 
endometriosis), menstrual 
dysfunction (e.g. biphasic 
menstrual cycle, insufficient 
luteal phase) 
 
Taylor, 
1982 
Cross-
sectional 
study 
Hospital based NR Did not undergo D&C  Routine investigation for 
infertility  
PID, endometriosis and 
fibroid 
 
 
Ben-
Baruch, 
1991 
Prospective 
cohort study 
Hospital based 19983-
1988 
Expectant management  Spontaneous abortion 
(miscarriage)  
Infertility (attempted 
conception > 12) months after 
abortion or stopping 
contraception. Future 
pregnancy, miscarriage and 
normal delivery.  
 
Note: D&C= dilatation and curettage; NR= data not reported; RPOC = retained products of conception; PG = prostaglandins; PID = pelvic inflammatory disease.  Shaded 
study from search of reference list 
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Study Quality, Fertility Problems Outcome Measure and Bias 
Table 3.6.4 shows the results of quality assessment.  The majority of studies (3 of 4) 
were of high or average quality and only one study (Sotnikova, 1986) was rated lower quality 
as per quality assessment. D&C was adequately assessed, the non-D&C group (controls) 
were well defined, selected from the same population and exclusions were adequately 
reported in all but one of the included studies (Sotnikova, 1986). Comparability of at least 
one confounder in the D&C/non-D&C groups was reported in three studies and one reported 
on ‘obstetric history’. One study adequately evaluated and included confounders in the 
analysis (Ben-Ami, 2014).  ‘Fertility problems’ outcome was adequately measured in only 
one study (Taylor, 1982), the rest were self-report. Response rate or loss to follow-up was not 
reported in one study (Sotnikova, 1986) and did not meet criteria in the other studies.  
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Table 3.6.4.   
Quality Ratings for the Four Included Studies on the Basis of an Adapted Newcastle-Ottawa Quality Assessment Scale 
Study 
Quality Criterion 
Overall rating g 
Adequacy of D&C 
(exposed) measure a 
Max 2 points 
Adequacy of control 
(non-exposed), 
definition and 
selection b 
Max 2 points 
Comparability of 
control c 
Max 2 points 
Confounders 
adequately assessed 
Max 2 points d 
Adequacy of 
outcome Fertility 
Problems measure 
e
Max 1 point 
None 
response rate 
or loss to 
follow-up f
Max 1 point 
Ben-Ami, 2014 2 2 2 2 0 0 High 
Sotnikova, 1986 0 0 0 0 1 0 Low 
Taylor, 1982 1 2 1 1 2 NA High 
Ben-Baruch, 1991 2 2 1 0 0 0 Average 
Note. a D&C was adequately assessed when hospital/medical records were available and sample was drawn from the same population (up to 2 points); b Controls were 
adequately assessed when selection was comparable to cases, and D&C was excluded properly in the control population (up to 2 points); c Comparability of controls was 
achieved if exposed/non-exposed were matched or adjustment during analysis conducted. One point for ‘obstetric history’ and one point for any other confounder (up to 2 
points); d Confounders were adequately assessed if they were obtained from records or a blind interview, and one point was given if the same method was used for both 
groups (up to 2 points); e Fertility problems outcome was adequately assessed if independent or blind assessment was stated in the paper, or confirmation of the outcome by 
reference to secure records (medical records, etc.) (up to 1 point); f Point given if same rate for both groups and <20% loss to follow up reported, NA: not applicable; g The 
overall quality rating was low (0 to 3 points), average (4 to 6 points), or high (7 to 10 points). Shaded from search of ref list
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Narrative Results of Systematic Review 
Four studies met inclusion criteria but could not be included in meta-analysis because 
of differences in methodology (indication for procedure, control group and outcomes 
measured), see Table 3.6.5 for summary of methodology and results of the four included 
studies. The first, compared impact on future reproductive outcomes of hysteroscopy versus 
D&C in women who had RPOC (Ben-Ami, 2014). This was a retrospective cohort study of 
the medical records of women who had undergone surgery to remove RPOC after a 
reproductive event (birth, spontaneous or induced abortion). Medical records or contact with 
the women who had undergone these procedures were used to ascertain the following 
reproductive outcomes: desire for pregnancy, became pregnant, time to pregnancy, new 
infertility problem, and gestational outcomes (delivery, abortion, placental complications, 
birth weight and gestational age at delivery). Reproductive outcomes were analysed for 177 
women, however follow-up duration was not reported.  
The hysteroscopy and D&C groups were similar in demographic characteristics, 
obstetric history and mode of conception preceding the RPOC.  However, more women 
underwent hysteroscopy after birth and more women underwent D&C after abortion 
(unspecified if induced or spontaneous or both) to remove RPOC. The D&C group were 
more likely to comprise women who presented with abdominal pain and the hysteroscopy 
group were more likely to have had longer time from delivery/abortion to diagnosis of 
RPOC.  
Results of this study indicated that the occurrence of an infertility problem was 
significantly higher in women who had undergone D&C, 23/94 (24.5%) than hysteroscopy 
10/83 (12%) (P= 0.034). The aetiology of the infertility was tubal blockage and IUAs. The 
women in the hysteroscopy and D&C groups were equally likely to have a desire for 
pregnancy and to become pregnant. However, the time to pregnancy was significantly shorter 
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in women who had undergone hysteroscopy than D&C (7.4 ± 7 Vs 12.9 ± 16.8 months, 
respectively; P = 0.037). The fact that the average duration to pregnancy in the D&C group 
was more than 12 months, indicating that even the women who got pregnant did so after the 
12 months, could explain why there are more infertile women but equal number of 
pregnancies in the D&C group.  
Table 3.6.5. 
Summary of Methodological Considerations and Results of the Four Included Studies 
Study Indication 
for 
procedure 
Control 
Group (no-
D&C) 
Other factors Follow up 
period 
Results: 
Outcomes reported in primary 
studies 
Significant 
difference 
No 
significant 
difference 
Ben-Ami, 
2014 
RPOC after 
birth, 
spontaneous 
or induced 
abortion 
Hysteroscopic 
resection 
(HR) 
More HR after 
birth and more 
D&C after 
abortion 
D&C group 
more 
abdominal pain 
(before 
procedure), HR 
group longer 
time from 
birth/abortion 
to RPOC 
NR More infertility in 
the D&C group 
Longer time to 
pregnancy 
(months) in the 
D&C group 
Desire for 
pregnancy 
Achieve 
pregnancy 
Ben-
Baruch, 
1991 
Spontaneous 
abortion 
(miscarriage) 
Conservative 
management 
(waiting) 
Which 
treatment 
would be 
performed was 
decided by 
treating 
physician 
28 months 
(range 12-
68) in the
D&C
group
26 months
(range 12-
72) in the
control 
group 
Achieve 
pregnancy, 
miscarriage 
and normal 
delivery. 
Infertility 
(including 
existing and 
new cases) 
Sotnikova, 
1986 
Induced 
abortion 
Group 1- PG 
OR vacuum 
suction 
Gynaecological 
history (e.g. 
age at 
menarche, 
genital 
inflammation) 
was reported 
One year More 
gynaecological 
diseases (e.g. 
inflammation of 
fallopian tubes, 
endometriosis) in 
the D&C group 
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Study Indication 
for 
procedure 
Control 
Group (no-
D&C) 
Other factors Follow up 
period 
Results: 
Outcomes reported in primary 
studies 
Significant 
difference 
No 
significant 
difference 
Group 2 - PG 5 years More menstrual 
dysfunction (e.g. 
anovulation, 
oligomenorrhea, 
insufficient luteal 
phase) in the 
D&C group 
Taylor, 
1982 
Routine 
investigation 
for infertility 
Did not 
undergo D&C 
Excluded 
women with 
history of PID, 
pelvic surgery 
abnormal 
menstruation 
History of 
D&C or 
no-D&C 
More PID in the 
D&C group 
Endometriosis 
and fibroid 
Note: D&C = dilatation and curettage; RPOC = retained products of conception; HR = Hysteroscopic resection; 
PG = prostaglandins; PID = pelvic inflammatory disease; NR = not reported.  
The second study reported on the impact on future reproductive outcomes of D&C 
compared with conservative management (waiting) after miscarriage (Ben-Baruch, 1991). 
This was a prospective cohort study that included women who were treated surgically (D&C) 
within 24 hours or conservatively (waiting) after a spontaneous miscarriage. The choice of 
treatment modality was determined by the treating physician. Of the 114 women, 68 
underwent D&C and 46 were managed conservatively (control). Only those who tried to 
achieve pregnancy were followed up, 52 of the 68 in the D&C group and 35 of the 46 in the 
control group. The following reproductive outcomes were reported: future pregnancy, normal 
delivery, miscarriage and infertility. Infertility was defined as not achieving pregnancy after 
12 months of trying from the time of the miscarriage or after stopping contraception. The 
women were followed up on average after 28 months (range 12-68) in the D&C group and 26 
months (range 12-72) in the control group.  
Results indicated that the two groups were not statistically different in age, parity, 
gestational age and previous miscarriage. None of the women experienced short-term 
complications like prolonged bleeding. During follow-up, the differences in number of 
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pregnancies, normal deliveries, miscarriages and infertility were not statistically significant. 
Pregnancy was reported by 39 (75%) of the 52 women in the D&C group, and 27 (77.1%) of 
the 35 women in the control group. Normal delivery was reported by 22 (42.3%) of the 52 
women in the D&C group, and 14 (40%) of the 35 women in the control group. Miscarriage 
was reported by 11 (21.2%) of the 52 women in the D&C group, and 5 (14.3%) of the 35 
women in the control group. Infertility was reported by 13 (25%) of the 53 women in the 
D&C group, and 8 (22.9%) of the 35 women in the control group. However, a history of 
infertility prior to the miscarriage (treated in the study) was reported in 8 (61.5%) of the 13 
infertile women in the D&C group and 5 (62.5%) of the 8 infertile women in the control 
group.  
The third study reported on the effect of different methods of abortion on short and 
long-term gynaecological outcomes (Sotnikova, 1986). Two groups of women who had 
undergone termination of pregnancy using different methods (D&C, vacuum aspiration and 
prostaglandins) were followed for one year or five years. The study comprised two 
comparisons. In the first comparison 250 women were followed for one year, of whom 100 
had had D&C only and 150 had had other procedures (vacuum aspiration or prostaglandins).  
The results showed that more gynaecological disease (i.e., uterus not returning to its normal 
size after delivery, endometriosis, inflammation or infection of the tube and ovaries, irregular 
uterine bleeding) was reported by more women in the D&C group (12/100 (12%), than 
women who had vacuum aspiration and/or prostaglandins, 4/150 (2.6%). The second 
comparison comprised 400 women who were followed for five years, of whom 250 had 
instrumental termination (D&C) and 150 had termination with prostaglandins. Results of the 
second comparison showed menstrual irregularity (e.g. anovulation, oligomenorrhea) were 
reported by more women in the D&C group 20/100 (20%) than women treated with 
prostaglandins, 15/150 (10%) (Sotnikova, 1986).  
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The fourth study reported on the impact of D&C versus no-D&C on PID, 
endometriosis and fibroids (Taylor, 1982). This was a retrospective study of 195 women with 
unexplained infertility about to undergo laparoscopy and hysteroscopy as part of routine 
investigation, some of whom had also undergone D&C in the past as part of infertility 
investigation. The women who had not undergone a D&C in the past were the control group 
and the women who had undergone a D&C in the past were the exposed group. Women were 
excluded if they had a previous history of appendectomy, pelvic surgery, intrauterine 
contraceptive device usage, hysterosalpingography, episodes of PID or abnormal 
menstruation. Results indicated that the two groups were comparable in age, SES and 
duration of infertility. The group that had a history of undergoing D&C as part of past 
infertility investigation had significantly more cases of PID than the group that had no such 
history. Both groups were equally likely to have endometriosis and fibroids (Taylor, 1982). 
Discussion 
Principal Findings 
There is a belief that D&C (single or repeated) as compared to other treatment 
modalities for examination or removal of tissue from the uterus compromises future 
reproductive ability. The results of the present study indicated that there is some evidence to 
support this belief but its reliability could be compromised by methodological 
inconsistencies of the primary studies. Consequently, there are some lingering questions 
about possible effects of the indication for the procedure and type of control group that could 
not be disentangled from the D&C procedure itself. Future research should aim to unravel 
these effects through integrity of control groups and indication for the procedure. Despite the 
lack of evidence in the current study of reduced pregnancy rate, and contradictory evidence 
regarding infertility after D&C, these results should not be considered to promote D&C as a 
safe procedure. Women should be informed of the potential increased time to pregnancy and 
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infertility that could occur as a result of undergoing D&C.  It seems clear that D&C has an 
impact on women’s future reproductive capacity as indicated by the increased time to 
pregnancy and new cases of infertility, gynaecological and menstrual problems. However, 
there are caveats to interpreting these findings: (a) the indication for performing the D&C 
was to remove RPOC, after spontaneous miscarriage, to induce abortion and as part of 
routine infertility investigation (Ben-Ami, 2014; Ben-Baruch, 1991; Sotnikova, 1986; 
Taylor, 1982, respectively), (b) three of the four studies were conducted more than 25 years 
ago (Ben-Baruch, 1991; Sotnikova, 1986; Taylor, 1982), (c) D&C was compared to different 
procedures in each study: hysteroscopy, conservative management, vacuum aspiration and 
prostaglandins or no procedure (Ben-Ami, 2014; Ben-Baruch, 1991; Sotnikova, 1986; 
Taylor, 1982, respectively). 
The newer study (Ben-Ami, 2014) that showed a longer time to pregnancy and more 
new cases of infertility (TFI, IUAs) used hysteroscopy as the control group. Hysteroscopy 
differs from D&C not only in the way material is removed (see Figure 3.6.2) but also 
because D&C is blind and hysteroscopy allows for visual assessment, which maybe more 
accurate and therefore may lead to less complications. The difference between Ben-Ami 
(2014) and Ben-Baruch (1991) with respect to infertility could be due to difference in 
follow-up duration, because most women, achieve pregnancy after 24 months (100% of 
‘super fertile’ and ‘normal fertile’, see Evers, 2002) and therefore if the follow-up duration is 
more than 24 months then this might reduce the number of women diagnosed as infertile and 
increase the number of women who achieved pregnancy.  This appears to be the case in Ben-
Ami (2014) because despite the longer time to pregnancy and more cases of infertility, there 
is ultimately no difference in the number of pregnancies, indicating that a longer follow up 
period might have been used, but this was not reported. In light of these caveats it could be 
that the effects seen are obsolete (e.g. the procedure is much safer than 25 . years ago and/or 
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it is no longer conducted as part of routine infertility investigation), or that effects are not 
permanent and resolve over time.   
Justification for not including D&C in the FertiSTAT.
The results of the current review alone would lead to the conclusion that D&C should 
not be included in the adapted FertiSTAT because of the lack of pooled estimates regarding 
future reproductive outcomes like infertility, pregnancy and live births after single or 
repeated D&C. However, extant reviews and primary studies have tested a broader set of 
pathways that could suggest otherwise.  The arm of the proposed pathway depicting the 
association between repeated D&C and IUAs (Pathway 4, Figure 3.6.1) has been reported 
historically (Schenker & Margalioth, 1982; Schenker, 1996) and corroborated with a recent 
meta-analysis (Hooker et al., 2014) that showed repeated (>1) D&C was correlated with 
increased IUAs (Hooker et al., 2014).
The arm of the pathway depicting the association between a single D&C and IUAs 
(pathway 3, Figure 3.6.1) was supported by a recent systematic review reporting more IUAs 
after a single D&C compared to hysteroscopic resection (Hooker et al., 2016).  The high 
quality of the Hooker et al. (2014 and 2016) reviews and the fact that the current search did 
not produce newer primary studies to update the meta-analysis on repeated D&C and IUAs 
or the systematic review on single D&C and IUAs, indicates that these results are the most 
current statement of available evidence.  
As noted in chapter 3.4, Asherman’s syndrome occurs mainly as a consequence of 
trauma (e.g. termination of pregnancy, miscarriage and postpartum curettage) to the uterine 
cavity that results in IUAs, and has been reported to be associated with infertility (see Yu, et 
al., 2008; Schenker & Margalioth, 1982).  Therefore, if D&C is more likely to lead to IUAs 
as evidenced  by the Hooker at al. (2014) meta-analysis and the Hooker et al., (2016) 
systematic review then it is likely that D&C could be expected to lead to infertility via this 
path (Pathways 3 and 4, Figure 3.6.1) if it causes damage. The fact that the increased cases 
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of infertility reported in one of the primary studies (Ben-Ami, 2014) in the current review are 
tubal and/or IUA further corroborates the meta-analysis in Hooker et al., (2014).  
Evidence for the other pathways suggested in Figure 3.6.1 come from primary studies 
or reviews published prior to 2000 and mostly indicates IUAs, gestational problems and 
secondary infertility, therefore, more data is required to validate these pathways. It is noted 
that cases where infection occurred and consequently PID are the only ones that lead to tubal 
infertility (Hogue et al., 1983). This was also corroborated by one of the included studies in 
the current review that indicated more cases of PID in women who had a history of D&C as 
part of routine investigation for infertility than those who did not (Taylor, 1982). However 
this evidence is over 30 years old, therefore replication is required to clarify if there were 
confounding factors that were involved such as septic conditions that increase the chance of 
infection and PID, that may no longer be relevant.  
However, if we apply the ‘Bradford Hill criteria’ noted in the General Methods (pp. 
55), we can see that three of the nine apply to the current review and enhance confidence in 
the causal relationship between D&C and fertility problems.  
The criteria of ‘consistency’ was met because IUAs have been consistently found to 
be associated with D&C.  The criteria of ‘specificity’ was met since the association of D&C 
with fertility seemed specifically related to IUAs which implies that there may be a more 
causal relationship between D&C and IUAs. The criteria of ‘biological gradient’ was met 
because the number of D&C procedures was found to be related to whether an effect was 
detected or not. The criteria of ‘plausibility’, ‘coherence’ and ‘experiment’ could be informed 
by biological evidence because that is currently lacking in the literature. Such evidence 
would enable a more accurate illustration of what aspects of the procedure itself or its 
repetition can cause damage, for example, is it the type of instruments used, the professional 
performing the procedure (level of training and experience), factors predisposing to the 
formation of adhesions (e.g., being more prone due to hormonal levels), clinical indication 
Chapter 3 Systematic Reviews 
273 
(miscarriage, abortion, lost products of conception) and so on. It can be inferred from the 
application of the Bradford Hill criteria that inclusion of repeated or single D&C in 
FertiSTAT as a new risk factor could potentially increase prediction of fertility problems in 
LMIC. 
Implications of Findings 
Results of the current review indicated that D&C leads to more infertility and longer 
time to pregnancy, but has no impact on future ability to become pregnant, however, this is 
not based on pooled estimates. Nevertheless, an integration of recent empirical evidence and 
the application of the Bradford Hill criteria would suggest that the association between 
repeated and single D&C and IUAs needs to be considered in the adapted FertiSTAT and 
clinical guidelines for D&C and infertility investigation. One such recommendation would be 
that where preservation of future fertility is desired, D&C should be used sparingly and other 
alternatives such as hysteroscopy, should be considered especially when there is a history of 
past D&C and/or IUAs.  
Strength and Limitations in Included Studies 
The heterogeneity in study methodology, outcome measures and control groups in included 
studies affects the comparability of these studies, and the generalizability of the results of this 
review. Heterogeneity in fertility problems outcome (infertility, pregnancy rates, 
gynaecological and menstrual problems, PID, endometriosis, fibroids, IUAs), study design 
(cohort and cross-sectional) and data collection methods (different duration of follow-up after 
medical procedures and retrieving information from medical records), can affect the practical 
applicability of the results. Furthermore a lack of consistency in the definition of outcomes 
such as infertility (12 months trying compared with mechanical infertility) precluded the 
calculation of pooled estimates. 
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  However, the quality of each study independently does not appear to affect the 
overall results of the review since the majority (3 of 4) of studies had at least moderate 
quality score. 
Bias relating to the primary studies included selection bias, information bias and bias 
due to confounder. In hospital-based studies, the selection of participants based on hospital 
attendance can reduce the generalizability of the results. However, samples exposed to D&C 
can only be obtained from sampling in clinical settings because D&C is a clinical procedure. 
Bias due to confounder was a potential limitation of the studies included but it might not 
have been considerable given that matching the groups for confounders was reported in three 
of the four included studies and the most important confounder ‘obstetric history’ was 
included in one  study. There could have been an unequal distribution of other confounders in 
the exposed and non-exposed groups but other confounders were not reported in the included 
studies. Additionally, the effect of confounders like clinical indication for the procedure, 
symptom presentation (abdominal pain prior to procedure) that could have influenced the 
relationship between D&C and fertility problems was not taken into consideration via either 
matching groups for confounders or entering them into analysis.  
Future Research 
Future research to disentangle the effect of D&C on fertility problems requires 
biological research, RCTs and prospective cohort studies to investigate the causal 
mechanisms that are involved. More biological examination of the uterus during and after the 
procedure (using technology like hysteroscopy and laparoscopy) could enable an 
examination of what aspects of the procedure are problematic. RCTs randomly assigning 
women to D&C and other treatment and/or prospective cohort study designs that follow 
women over time to measure both short and long-term outcomes should be performed. 
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To measure the effect of repeated D&C, a stratified RCT can be conducted where the 
sample all have a history of only one D&C, they are then randomly assigned to either an 
additional D&C or other treatment. In this case the D&C group would have in fact been 
exposed to more than one D&C. The factors that need to be considered in such research 
include: (a) clinical indications for D&C (e.g. miscarriage, abortion, RPOC), (b) nature of the 
control group (other procedures e.g. vacuum aspiration, prostaglandins or waiting/no 
treatment), (c) number of times (repetition) of D&C, (d) confounders like professional 
conducting the procedure (training and experience), post-operative care, obstetric history 
(e.g. previous pregnancy, miscarriage etc.), and (e) nature of the relationship between short 
and long-term consequences.  
Ideally, an RCT that randomly assigns women to different treatment modalities (e.g. 
D&C, hysteroscopy, vacuum aspiration, misoprostol, and expectant/conservative 
management) stratified by clinical indications (miscarriage, abortion, RPOC, etc.) that 
measures both short-term (e.g. uterine bleeding) and long-term (e.g. IUAs, pregnancy etc.) 
outcomes, should be conducted. Measurements at baseline and follow-up should include: 
fertility problem outcome, obstetric history (e.g. number of previous pregnancies, 
miscarriages, abortions), demographics and other confounding factors (e.g. post-operative 
care). Follow-up periods should be well defined and not arbitrary (e.g. 12 and 24 months). 
An investigation of the association between the short-term outcome like prolonged bleeding 
and long-term outcomes like IUAs could elucidate the exact biological mechanism. For 
example, it could be that women who bleed more post-operatively are more likely to develop 
IUAs or that women who require further surgery (medical attention) are more likely to 
develop long-term consequences. 
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Alternatively, a longitudinal prospective cohort study could be conducted to follow women 
who have undergone D&C (once and more than once) with women who have not 
undergone any procedure and women who have undergone different treatment modalities 
(EXT, MED etc.).  Research should also be directed at understanding the reasons for the 
incongruencey between more IUAs and infertility but similar rate of pregnancy and to 
definitively ascertain if it is related to the repetition, the severity of the IUAs the 
development of Asherman’s syndrome, the duration of follow-up or other reasons not 
currently known. Finally, it is imperative that after more such studies are carried out that 
an update of the review be conducted and pooled estimates calculated.  
Conclusions 
 Fertility problems have been reported as a negative consequence of D&C in the 
literature but evidence to support this claim has been limited. Results of the integration of 
the current systematic evidence and empirical literature corroborated past evidence. A 
single D&C procedure was found to be associated with longer time to pregnancy, more 
mechanical infertility and more gynaecological and menstrual dysfunction. Repeated D&C 
may affect ability to become pregnant, but this appeared to be via the development of 
IUAs. Since IUAs do not always lead to infertility, and pooled estimates were not 
calculated for the other effects, inclusion of D&C at this time as an independent risk factor 
for fertility problems in the adapted FertiSTAT cannot be justified. It is important to note 
that this area of research should be re-examined due to the small number of available 
studies and the methodological short comings of the studies included in the systematic 
review.  
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Study 3.7 Additional endorsed risk factors: water-pipe smoking, vitamin D 
deficiency and cervical electrocautery 
General Introduction 
Three other RFs were endorsed in the survey of international doctors (Chapter 2, pp. 
25): water-pipe smoking, vitamin D deficiency and cervical electrocautery (CE).  The 
relevance of these factors was assessed in the present chapter.  
Water-pipe smoking 
The methods for using tobacco differ worldwide e.g. cigarettes, chewing tobacco, and 
water-pipe use, to name a few.  According to the WHO, the impact on the human body is 
similar across methods of intake (WHO, Tobacco: deadly in any form or disguise, 2006). The 
water-pipe is a devise used to smoke tobacco that involves passing the smoke through water 
before inhaling it (WHO, Tobacco regulation, Advisory note, 2015). There is a pervasive 
belief that smoking tobacco through the water-pipe is safe (WHO, Tobacco regulation, 
Advisory note, 2015).  
The WHO advises that water-pipe smoking is as hazardous to human health as 
cigarette smoking. Specifically, a one-hour water-pipe session was assessed to be equivalent 
to inhaling 100-200 times the volume of smoke in a single cigarette (WHO, Tobacco 
regulation, Advisory note, 2015). Given this link and the strong evidence of the effect of 
smoking on fertility (Dechanet et al., 2011), conducting a systematic review on the impact of 
water-pipe smoking on fertility was not deemed necessary. However, an adapted version of 
the FertiSTAT should consider the inclusion of critical thresholds for water-pipe smoking to 
help a broader group of users recognise what level of consumption could be problematic for 
their fertility health. In the original FertiSTAT the critical threshold was smoking more than 
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10 cigarettes a day, consistent with empirical evidence (Axmon, Rylander, Albin, & Hagmar, 
2006; Hull, North, Taylor, Farrow & Ford, 2000). Establishing comparable critical thresholds 
for other smoking methods (e.g., water-pipe, chewing tobacco) requires further study. 
Vitamin D deficiency 
Introduction 
The Scientific Advisory Committee on Nutrition (SACN) in the UK recently 
published a report on vitamin D and health (SACN, Vitamin D and Health, 2016). The cut-off 
level of serum metabolite of vitamin D (the standard way to measure level of vitamin D) to 
protect musculoskeletal health should be above 25 nmol/L. It is noted in the report that the 
evidence for a causal relationship between non-musculoskeletal health and vitamin D is weak 
because it comes from observational studies only and the reported beneficial effects could be 
related to confounding or reverse causality. It is further noted that results of RCTs examining 
vitamin D supplementation for non-musculoskeletal conditions have produced inconsistent 
results (SACN, Vitamin D and Health, 2016). The Endocrine society guidelines indorse the 
following serum concentrations: (a) sufficiency: greater than 30 ng/ml, (b) insufficiency: 20-
29.9 ng/ml, (c) deficiency: less than 20 ng/ml (Holick et al., 2011).   
The motivation to evaluate the impact of vitamin D deficiency on fertility comes from 
a review of molecular level evidence in non-human animal and human studies suggestive of a 
role of vitamin D in supporting reproductive processes (see Lerchbaum & Obermayer-
Pietsch, 2012; Anagnostis, Karras & Goulis, 2013).  The aim of the current study was to 
examine whether there was evidence linking vitamin D deficiency and fertility problems.  
Methods 
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The need for a review on Vitamin D and fertility was examined using the approach 
described in Figure 3.2 (step 2, pp. 59). A recently published review was obtained 
(Muscogiuri et al., 2017). The review summarised the literature on the potential impact of 
vitamin D deficiency on fertility. The review was quality assessed as per Figure 3.2 (step 3, 
pp. 59) and found to be current and of sound quality as critically apprised by the “Critical 
Appraisal of Systematic Reviews” published by the WHO (Abalos, Carroli, Mackey & 
Bergel, 2001), making an update redundant. Another recent review was obtained but not used 
this review was based on primary studies considering the impact of vitamin D levels on 
outcome of Assisted Reproductive Treatment (ART) only (Chu et al., 2017), therefore 
generalizations to individuals not in treatment would be limited.  Consequently, the present 
chapter only summarizes (Figure 3.2, step 4, pp. 59) the evidence reported in the Muscogiuri 
et al. (2017) review and provides an assessment of the review methodology.  
Results 
Muscogiuri and colleagues (2017) reviewed molecular and epidemiological evidence 
for the relationship between vitamin D deficiency and female fertility. The outcomes 
examined were ovarian reserve, PCOS and endometrioses.  
Muscogiuri et al., (2017) reviewed more than a hundred primary studies, however the 
exact number of studies and search methodology were not reported. Unfortunately, more 
details about methodology were not available despite contact with author. The evidence 
reviewed included molecular and observational studies, and interventional studies on the 
effects of vitamin D supplementation. Extant meta-analyses in the following areas were also 
examined: (a) physiologic effect of vitamin D level on female reproduction (molecular), (b) 
vitamin D level and ovarian reserve markers (molecular and cross-sectional), (c) vitamin D 
level and female reproduction in animal studies (molecular), (d) vitamin D level and PCOS 
Chapter 3 Systematic Reviews 
280 
(molecular, observational and meta-analyses), (e) vitamin D level and endometriosis 
(molecular and observational), and (f) vitamin D supplementation and female fertility 
(guidelines and cut-offs, no primary studies).  
Three of the main conclusions reached were relevant to the current report. First, 
molecular and epidemiological evidence suggested that normal physiological processes in 
markers for ovarian reserve such as anti-Mullerian hormone (AMH) involved vitamin D 
(Muscogiuri et al., 2017). Second, there was inconsistency in results of studies reporting on 
molecular, epidemiological and meta-analyses regarding a relationship between Vitamin D 
level and PCOS diagnosis (Muscogiuri et al., 2017). Some studies reported an association 
between vitamin D deficiency and fertility problems in PCOS, and in PCOS with obesity 
populations, while others did not. One meta-analysis (Jia, et al., 2015) showed that women 
with PCOS had markedly reduced vitamin D as compared to controls, while another meta-
analysis found only a non-significant trend of vitamin D deficiency in women with PCOS 
(He, Lin, Robb and Ezeamama, 2015). Intervention studies showed no impact of vitamin D 
supplementation in women with PCOS (Muscogiuri et al., 2017). Third, molecular evidence 
suggested that vitamin D could modulate inflammation and proliferation in endometriosis. In 
contrast, the epidemiological evidence for an association between Vitamin D level and 
endometriosis has been inconsistent. Muscogiuri and colleagues (2017) concluded that 
inconsistency in results for PCOS and endometriosis reflected methodological shortcomings 
in primary studies.  
Discussion 
Principal findings. 
It can be inferred from the results of evidence summarized from Muscogiuri and 
colleagues (2017) that vitamin D is involved in physiologic reproductive processes, but its 
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involvement in PCOS and endometriosis is not confirmed. In light of this review, three 
potential pathways for associations between Vitamin D and fertility can be proposed, as 
shown in Figure 3.7.1.  
Figure 3.7.1. Proposed pathways for the impact of Vitamin D deficiency on fertility. Solid 
line = Recent evidence (primary molecular studies); Double solid line = meta-analytic 
evidence; Dotted line = inconsistency in results of primary studies and/or meta-analyses; 
Dashed line =Proposed pathway/historic evidence; Dashed-Dotted line = Well established 
Muscogiuri et al., (2017) proposed that sample size limitations and diversity in study 
design (observational, molecular) explained inconsistency in evidence for associations 
between Vitamin D and PCOS or endometriosis.  However, other limitations could also 
explain mixed findings. First, the expression of the molecular relationship between vitamin D 
and PCOS or endometriosis (physiologic processes) may be more complex and therefore 
more difficult to measure than a simple direct relationship as seen in musculoskeletal health. 
The molecular role of Vitamin D in the utilization of calcium in musculoskeletal tissue is 
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simple and well established (Wolff, Jones & Hansen, 2008). Second, there could be 
confounding effects associated with Vitamin D level (e.g. better nutrition and health overall) 
that are not consistently measured or reported (SACN, 2016 report).  
An application of the Bradford-Hill criteria (pp. 55) to the evidence in the Muscogiuri 
et al., (2017) review would indicate that the criterion of biological ‘plausibility’ is fulfilled 
through molecular evidence showing that vitamin D is involved in physiologic process in 
reproduction. The criterion of ‘coherence’ between molecular and epidemiological results is 
also met. However, the criterion of ‘consistency’ of results is not met, which would suggest 
that either the relationship between vitamin D deficiency and PCOS or endometriosis is weak 
or is mediated or moderated by confounding variables.  Consequently, the mixed evidence 
presented thus far indicates that the inclusion of Vitamin D deficiency in the FertiSTAT 
would not be justified.  
Implications of findings and future research. 
Muscogiuri and colleagues (2017) recommend more rigorous research such as RCTs 
to study the effect of supplementation on fertility and studies that could help identify the 
exact molecular pathways. This research should examine the relationship between complex 
molecular processes linking vitamin D and PCOS and the outward expression of this 
relationship, studies should also ensure control of the primary confounders associated with 
Vitamin D.   
A recommendation to have vitamin D supplementation to enhance/promote fertility is 
not yet warranted.  Vitamin D supplementation has been recommended by the Endocrine 
society for all women between 18 and 70 years, and for pregnant and lactating women due to 
the depletion of vitamin D during these processes (Holick et al., 2011). These 
recommendations follow the proven beneficial effect of vitamin D supplementation for 
musculoskeletal conditions (of the muscles and skeleton) like osteoarthritis (Allan et al., 
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2016), during pregnancy (Hollis, Johnson, Hulsey, Ebeling & Wagner, 2011; Kovacs, 2008) 
and for breast-feeding women (Kovacs, 2008).  However, evidence for the benefit of 
supplementation for non-musculoskeletal health has not been as consistent, for example, 
supplementation does not prevent occurrence or reduce recurrence of cancer, or respiratory 
tract infections (see Allan et al., 2016). This inconsistency also seems to be the case with 
fertility problems because supplementation for PCOS was not shown to be effective (see 
Muscogiuri et al., 2017). The fact that vitamin D deficiency is correlated with numerous non-
musculoskeletal medical conditions (see Peterlika, 2012) including fertility problems, but that 
supplementation is not beneficial (Allan et al., 2016), potentially suggests that the Vitamin D 
deficiency thresholds and optimal amount of supplementation required may be different than 
those for good non-musculoskeletal health. It could also be that for non-musculoskeletal 
conditions there are confounding factors such as overall nutrition and health mediating or 
moderating the impact of vitamin D levels. These findings need to be explored further to 
inform guidelines about whether and how much vitamin D supplementation to recommend 
for non-musculoskeletal conditions including fertility health.   
The results of the Muscogiuri review and additional suggestions in this chapter would 
not affect the Endocrine Society recommendations because their supplementation is proposed 
for overall health and not specific to fertility. However, if new research can determine 
definitively that supplementation has a positive impact on women with PCOS or 
endometriosis or women at risk for these diseases then clinical recommendations should 
change to accommodate these new findings. 
Cervical electrocautery (CE) 
Introduction 
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CE is a gynaecological procedure that uses electricity to destroy tissue in the cervix 
(CE, “Cervical Cauterization,” 2017). It is used to treat inflammations, cysts and cancerous or 
precancerous tissue.  Anecdotal reports from Egyptian doctors conducting CE suggested it 
was used to ‘cure’ infertility in LMIC (e.g., Egypt, Inhorn and Buss, 1993). Based on that 
anecdotal evidence Inhorn and Buss (1993) proposed that using CE to treat infertility could 
paradoxically cause tubal damage due to infection from septic conditions during the 
procedure. To test this prediction, a case-control study of 190 women in Egypt (100 infertile 
and 90 fertile) was conducted (Inhorn and Buss, 1993). The potential risk factors for 
infertility were extracted from medical and other sources and grouped according to the 
following categories: methods of ‘genital purification and hygiene’ (e.g. FGM, douching), 
sexual practices (e.g. number of sexual partners, use of prostitutes), ‘nutritional and 
consumption practices’ (e.g. obesity, diabetes, eating raw meat) and ‘iatrogenesis’ (e.g. 
postpartum infection, D&C, CE) which referred to past adverse reproductive events or 
biomedical procedures performed to treat infertility that could have unintended adverse 
effects on fertility. The authors proposed that these risks, as well as a composite of the latter 
category (all allegedly iatrogenic events and biomedical procedures) could lead to TFI. To 
test this hypothesis, cases with TFI and cases with other types of infertility were compared on 
this composite score. The results showed that CE was not associated with TFI in univariate 
analysis but in multivariate analysis, the ‘composite of iatrogenic risk’ was found to be 
associated with TFI (Inhorn and Buss, 1993).  Important limitations of this work were a non-
systematic data collection approach, poorly defined risk factors, and confounding of risks and 
outcomes. Data were obtained from medical records, research records and verbal reports from 
treating doctors at diverse times throughout the study introducing a high potential for bias. A 
clear justification for risk categories was not provided making it difficult to understand why 
proposed risks were perceived to be risks (e.g., genital depilation) or infer what shared causal 
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mechanisms could underpin risks within categories (e.g., depilation and female genital 
cutting). The risk categories also confounded potential risks (e.g., CE) with potential adverse 
consequences (e.g., infection) increasing the likelihood that categories would be associated 
with fertility problems but not individual risks. 
Despite the lack of substantial evidence, it was thought that a review of CE was 
warranted due to the paper often being cited as evidence of adverse effects of CE, and 
endorsement of the procedure as a potential risk factor by 56% of the fertility experts in the 
cross-sectional survey (chapter 2, pp. 25).  
Methods and Results 
The need for a further review on CE and fertility was examined using the approach 
described in Figure 3.2 (step 2, pp. 59). In the present study, the search (step 1) resulted in no 
reviews, therefore the results of the search were screened (step 5). Screening resulted in no 
primary studies that reported on any association between CE and fertility. Additionally, there 
were no studies reporting on a potential impact or mechanism of action to indicate whether or 
how CE could affect fertility.  
Discussion 
Principal findings. 
The only evidence for CE effects on fertility problems is the data provided in Inhorn 
and Buss (1993). This evidence is weak and does not warrant the inclusion of CE in the 
FertiSTAT.   
Several explanations could be offered for the lack of further studies and reviews on 
CE effects on fertility. First, it could be that the Inhorn and Buss (1993) study was 
sufficiently compelling that the practice was abandoned to cure infertility or much improved 
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to address the problem identified (e.g., done in aseptic conditions) such that new research was 
not required. However, there were many important limitations to the Inhorn & Buss study 
that call into question the validity of their original conclusion or its possible effect on 
practice. Second, it could be that the Inhorn and Buss (1993) study was not disseminated 
among medical practitioners who could have been interested in carrying out more research 
because it was published in a social science journal. This could be true because many of the 
subsequent research citing Inhorn & Buss (1993) were from social science journals. Third, it 
could be that the premise for the Inhorn and Buss (1993) study was not generalizable, being 
based on anecdotal evidence from doctors in one clinic, and using CE for curative purposes 
not widely used in other clinics and countries. Finally, it could be that this practice is not 
done openly, therefore, researchers cannot study it.    
An application of the Bradford-Hill criteria (pp. 55) to CE would suggest that only the 
criteria of ‘analogy’ (effect of similar factors e.g. other gynaecological procedures) could be 
met, but even gynaecological procedures like D&C have not been found to be definitively 
associated with fertility problems (Chapter 3.6). Therefore, the lack of evidence indicates that 
the inclusion of CE in the FertiSTAT is not justified. 
Implications of findings and future research. 
The need for research into the effects of CE is not known because its use in practice 
is not known (in LMICs).  Therefore the recommendation of the current study is that more
audit research about the use of CE in women presenting with fertility-related complaints 
should be conducted to determine need for research into effects. If this prevalence work 
reveals that that the procedure is still being conducted to ‘cure’ infertility then there should 
be more primary studies to test the hypothetical association with infertility because the 
existing evidence is too weak. Inclusion of CE in an adapted version of FertiSTAT could 
then be reconsidered.   
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General Discussion 
Water-pipe smoking, Vitamin D deficiency and CE were endorsed in the survey of 
fertility doctors (Chapter 2, pp. 25) but none should be included as separate risk factors in the 
adapted FertiSTAT. Water-pipe should not be included as an independent RF but this method 
and its critical thresholds should be noted as one of the methods used to consume tobacco. 
Vitamin D deficiency should not as yet be included because of the lack of convincing 
evidence to determine definitively that vitamin D deficiency has an impact on female fertility.  
However, the existing evidence compels further research to investigate the potential nature, 
magnitude and confounding factors in this relationship. CE should not be included due to the 
lack of studies and therefore evidence to support its potential impact on fertility. The reasons 
for the lack of studies needs to be investigated as it is unclear whether CE is an abandoned 
procedure not worth investigating, or one that is routinely used but not investigated. 
Depending on the outcome of such investigation, the use of CE and the potential impact on 
female reproductive processes should be studied.  
The examination of factors endorsed but not included in the FertiSTAT highlights the 
need to determine a strategy for how best to identify and assess new risks that should be 
further investigated for potential inclusion in FertiSTAT. In the present chapter, clinician 
endorsement, and historical and anecdotal evidence were used. However, for CE the evidence 
proved to be based on anecdotal hypotheses and no new evidence was found. For vitamin D, 
despite the extensive body of evidence, results proved to be inconsistent for an association 
with PCOS or endometriosis.  It seems clear from the present and previous chapters that 
many reasons (anecdotal reports, primary studies and comparability to other risks) could 
prompt the need to investigate associations between a risk and fertility, but such reasons may 
not equally compel action. This diversity suggests a need to systematically utilize a method 
for the selection of risks such as that proposed by Ezzati and colleagues (2002), noted in 
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General Methods (pp. 58).  For both vitamin D deficiency and CE an application of these 
criteria for risk selection would suggest that both are potentially modifiable. Additionally, for 
vitamin D there is data on risk levels for other diseases but not specific to fertility problems. 
A probability of causality and prevalence or hazardous nature of the RF were established 
from an aggregate of evidence for vitamin D deficiency but for CE these criteria were 
fulfilled only from anecdotal evidence and expert endorsement.  
Therefore, from the present chapter it seems it can be concluded that investigation of 
a risk should only be pursued when there is compelling evidence that fulfils these criteria (or 
other selection criteria). This type of approach should be applied systematically and should 
become the standard prior to adaptation of current recommendations and tools.  
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Chapter 3 
General discussion for all systematic reviews 
Reducing risk has been a human preoccupation, and at the turn of the century the 
WHO emphasized that health promotion and communicating accurate information about risks 
has the potential to enhance people’s adoption of healthier behaviors and lifestyle choices 
(WHO, World Health Report, 2002). Current patterns of fertility in LMIC, declining fertility 
rates, higher contraceptive use, lower maternal and child mortality, achieved through 
sustained progress on millennium goals suggest there now is space for a broader reproductive 
agenda that incorporates fertility health and the complex LMIC risk profile related to 
communicable and non-communicable diseases, cultural practices and overburdened 
healthcare systems. Some of these risks apply globally, such as HIV, while others might only 
have a regional impact, such as FGM/C. 
Principal Findings 
The original FertiSTAT was not found to be comprehensive for LMIC and therefore 
needs to be updated with risks relevant to LMIC. The RFs to be included in the adapted 
FertiSTAT were FGM/C, HIV, GTB, BV and CSG.  The RFs that do not need to be included 
were D&C, Vitamin D deficiency and CE, at least until further evidence is accumulated. 
Information about the different methods for using tobacco should include critical thresholds 
for water-pipe smoking in addition to cigarettes. The RFs investigated were associated with 
fertility through multiple biological, behavioural and clinical pathways and meta-analytic 
results were consistent for the most part with past narrative reviews. The methodological 
rigor of the systematic review process adopted enhanced reliability, however, the small number 
of primary studies and inconsistencies in outcome measures were limitations.  
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To date many risk factors have been proposed in narrative reviews to impair fertility 
in women living in LMIC. The eight systematic reviews and five meta-analyses produced in 
this review showed that some but not all of these factors were associated with fertility 
problems.  People living in LMIC could have a much more complex risk profile than is 
suggested by risks presented in the FertiSTAT or other awareness tools.  A focus on prevalent 
risks in higher income countries or single risks could obscure the multifactorial risks to which 
people in LMIC could be exposed. This risk complexity should be reflected in fertility 
education and awareness tools, and the FertiSTAT should be adapted accordingly. What can 
and should be done about risk exposure needs to be determined within countries and regions 
utilizing a global health framework. The findings of multifactorial risk also reinforced the 
need to put fertility as an agenda in global health initiatives. Future research needs to 
determine what is the best method of selecting risk factors (RFs), methods to systematically 
evaluate pathways leading to reduced fertility, particularly more rigorous prospective designs 
or RCTs aimed at modifying risks (where possible). 
 Elaboration on main findings. 
Table 3.3 provides a summary of the evidence reviewed, the outcomes reported, the 
number of studies included in each meta-analysis and the pooled effects estimate for those 
meta-analyses.  As shown in Table 3.3, the RFs that would need to be included in FertiSTAT 
were FGM/C, HIV, GTB and BV to inform women of risk to ability to achieve pregnancy. 
CSG should also be included if the adapted FertiSTAT was to be used to inform women of 
fertility problems beyond ability to achieve pregnancy (e.g. stillbirth). As can be see the 
potential impact of these RFs is significant with largest effect size being a 9 fold risk in 
reduced fertility (i.e., GTB). These RFs have evidence from current meta-analysis, extant 
literature and met the Bradford-Hill criteria (except for HIV) providing strong evidence for 
their inclusion in the FertiSTAT.  However, for FGM/C, HIV and BV data used in the meta-
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analyses were calculated from case-control studies with clinical samples, potentially
increasing sampling bias (Mann, 2003), but the conversion was methodologically sound 
(Kirkwood & Sterne, 2003, Chapter 16; Mann, 2003). 
Table 3.3 
Summary of evidence reviewed, outcomes reported, number of studies in each meta-analysis 
and pooled effects estimate. 
RF Evidence reviewed Outcome reported Number of 
studies 
included in 
MA 
Pooled effect 
estimates 
OR (95% CI)/ Mean 
Difference (95% CI) 
CSG 451 records 
retrieved, 24 
studies included in 
MA 
Time to first birth 2 MD 0.24 (-0.39-0.87) 
p=0.46 
Miscarriage 5 1.1 (0.93-1.30) 
p=0.25 
Never-pregnant 3 0.66 (0.45-0.98) 
p=0.04  
Childlessness 5 0.83 (0.67-1.03) 
p=0.09 
Mean # pregnancies 5 MD 0.40 (0.10-0.71) 
p=0.009 
Mean # live-births 7 MD 0.24 (0.05-0.43) 
p=0.01 
Stillbirth 5 1.28 (1.04-1.57) 
p=0.02 
Neonatal Death 4 1.57 (1.22-2.02) 
p=0.0005 
FGM/C 244 records 
retrieved, 7 studies 
included in MA  
Infertile > 12 months no 
pregnancy 
2 1.17 (0.84-1.63) 
p=0.36 
Childlessness 3 1.22 (0.99-1.52) 
p=0.07 
Infertile 2 yrs (TFI)* 2 2.06 (1.03-4.15) 
p=0.04 
HIV 741 records 
retrieved, 9 
included in MA 
Cumulative Pregnancy rate 2 0.36 (0.15-0.89) 
p=0.03  
Miscarriage 2 0.03 (-0.03-0.09) 
p=0.35 
Amenorrhea 3 2.44 (1.56-3.81) 
p<0.00001 
FSH >25 IU/l 2 1.51 (0.77-2.94) 
p=0.23 
Infertile > 12 months no 
pregnancy* 
2 2.93 (1.95-4.42) 
p<0.00001 
GTB 451 records 
retrieved, 5 
included in MA 
Infertile >12 months no 
pregnant 
2 8.91 (1.89-42.12) 
p=0.006 
Amenorrhea 2 4.24 (0.23-78.14) 
p=0.33 
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RF Evidence reviewed Outcome reported Number of 
studies 
included in 
MA 
Pooled effect 
estimates 
OR (95% CI)/ Mean 
Difference (95% CI) 
Primary infertility 2 2.94 (1.89-4.37) 
p<0.00001 
BV 184 records 
retrieved, 11 
included in MA 
Infertile > 12 months no 
pregnancy* 
11 2.81 (1.85-4.27) 
p<0.00001 
Narrative reviews 
D&C 347 records 
retrieved, 4 
included in 
narrative review 
Infertile > 12 months no 
pregnancy  
1 Significantly more 
than hysteroscopy 
group 
Time to pregnancy 1 Significantly longer 
than hysteroscopy 
group 
Gynaecological diseases 
(e.g. inflammation of 
fallopian tubes, 
endometriosis) 
1 More in the D&C 
than vacuum 
aspiration of 
prostaglandins.  
PID More in the D&C 
than no treatment 
group 
CE 484 records 
retrieved, none 
met inclusion 
criteria  
NA 0 NA 
Vitamin D 
Deficiency 
No review 
necessary  
NA 0 NA 
Water-
pipe 
No review 
necessary  
NA 0 NA 
Note. * = data calculated from case-control studies. RF = risk factor; OR = odds ratio; NA = not applicable; MA = meta-
analysis; CSG = consanguinity; FGM/C = female genital mutilation/cutting; GTB = genital tuberculosis; BV = bacterial 
vaginosis; D&C = dilatation and curettage; CE = cervical electrocautery; PID = pelvic inflammatory disease. 
Results of meta-analyses were also aggregated with extant evidence and used to 
construct a model that depicts how reviewed RFs impact fertility using outcomes reported in 
the primary studies, see Figure 3.3.  Figure 3.3 shows that RFs could have multiple ways of 
impacting fertility. In Figure 3.3 the solid black lines are supported directly by meta-analysis 
from the current studies, while the dashed black line is supported by meta-analytic evidence 
from other studies and the grey lines are supported by primary studies (no meta-analytic 
evidence). However, primary studies do not systematically investigate all paths, therefore an 
incomplete picture is garnered from the literature.  
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RFs such as BV and FGM/C seem to have an impact at several points in the reproductive 
process. In the case of BV this could be due to the fact that infection that occurs before 
pregnancy and reaches the tubes will compromise ability to achieve pregnancy, while 
infection that occurs during pregnancy could damage the amniotic sac and lead to preterm 
birth. In the case of FGM/C, it is likely that the TFI occurs as a result of infection related to 
the more severe types of cutting where the anatomy is altered drastically. It should be noted 
that even if the cutting did not lead to infection, a women could still be at risk of obstetric 
complications if the altered anatomy made delivery difficult, which could lead to negative 
outcomes such as stillbirth as noted in the literature (Obermeyer, 2005; RCOG, 2015; Reisel 
& Creighton, 2015; WHO study group on female genital mutilation and obstetric outcome, 
2006). Therefore, it can be inferred that timing and extent of exposure to RFs would affect 
fertility in different ways.  
Some RFs have common pathways, for example HIV, BV and D&C were all related 
to infection and PID. Although with FGM/C there was no direct link with infections and PID 
(no data available), it can be assumed that would be the case because of the association with 
TFI.  These risks could affect fertility due to the underlying trajectory or progression of 
infection producing that similarity, namely that any infection to the reproductive tract if left 
untreated could lead to PID, ascend to the tubes, or lead to tubal damage and therefore 
inability to achieve pregnancy (Ross & McCarthy, 2011; WHO, 2007, Global strategy for the 
prevention and control of sexually transmitted infections: 2006–2015). However, there were 
no consistent findings to suggest that infections always led to inability to achieve pregnancy. 
This is probably because the impact would only appear if the infection were untreated. 
Infections treated before they lead to PID would have no impact on the female reproductive 
tract and hence future ability to achieve pregnancy (Ross & McCarthy, 2011). Furthermore, 
not all infections lead to PID and not all cases of PID lead to tubal damage (WHO, 2007, 
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Global strategy for the prevention and control of sexually transmitted infections: 2006–2015). 
Future research should ensure that data about treatment of infection is collected. 
What can be clearly gleaned from Figure 3.3 is that the RFs that included infection, PID 
or TFI in their pathways (e.g. BV, HIV and FGM/C) were found to be associated with an 
inability to achieve pregnancy, affirming reports in the literature about infection being the 
leading cause of infertility in Africa and other LMIC (see, Cates, Farley, Rowe, 1985; 
Ericksen & Brunette, 1996; Leke, Oduma, Bassol-Mayagoitia, Bacha & Grigor, 1993; 
Odukogbe & Ola, 2005). One of the pathways of the effect of D&C noted in the literature 
was via infections (Hogue et al., 1983). However, these were historical data and it can be 
assumed that modern clinical care would be more aseptic than it used to be, thus not 
associated with fertility problems.  The available evidence would suggest that whilst infection 
is a shared pathway its potential causes are multiple and clinicians need to be mindful of all 
of the risks for infection and not just STIs and unsafe procedures (abortion, delivery) as has 
typically been the case (Ericksen & Brunette 1996; WHO, Infections, pregnancies, and 
infertility, 1987). 
The caveat to interpreting this diagram is that none of these results were obtained 
from RCTs. Therefore the causal nature of the relationships cannot be definitively 
ascertained. One way to address this limitation was using the Bradford-Hill criteria to 
determine the likelihood that there was indeed a causal relationship. Application of these 
criteria confirmed that a causal relationship is more likely in the case of BV, GTB, FGM/C, 
CSG and D&C in that order (more criteria met), see Table 3.4. However, there was no 
support for a causal relationship for HIV. The lack of support for HIV could be due to the 
numerous confounding factors such as abstaining from sexual intercourse, the use of barrier 
contraceptives or comorbid illness such as STIs, to name a few.  Suggestions for improving 
research designs in HIV were made in Chapter 3.3.  Additionally, future correlational 
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research on risk factors should be designed with consideration of how the design could 
inform these criteria. 
 
Table 3.4 
Summary of which Bradford-Hill Criteria were met for each of the six Risk Factors included 
in Systematic Review 
Criteria Risk Factor 
CSG FGM/C HIV GTB BV D&C 
Strength    X X  
Consistency    X X X 
Specificity  X    X 
Temporality X X     
Biological 
gradient 
X X   X X 
Plausibility X X  X X  
Coherence    X X  
Experiment       
Analogy       
Note. Bradford-Hill Criteria from Hill, 1965. CSG = consanguinity;  
FGM/C = female genital mutilation/cutting; GTB = genital tuberculosis;  
BV = bacterial vaginosis; D&C = dilatation and curettage 
 
Strengths and Limitations of the Study  
There were several review strengths that increased confidence in study findings. The 
review process used rigorous systematic review methodology that will be replicable. Two 
independent researchers duplicated screening and data extraction. Meta-analyses were 
possible for five of the nine RFs, not necessary for two RFs (vitamin D deficiency and water-
pipe smoking) and not possible for only two risk factors (D&C no data, CE no primary 
studies). The use of best-practice guidelines in the design, assessment and reporting of 
methodology also helped bolster the trustworthiness of the results.  
The decision to separate outcomes in meta-analysis also meant that more studies 
could be included in the reviews of each RF. This led to a more comprehensive review, with 
specific understanding of mechanism of action and identification of gaps in the literature, 
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which is the objective of systematic reviews (CRD, 2008). However, the small number of 
studies in each meta-analysis limited the generalizability of results.  
The main limitation of the review process for all of the reviews was that sources of 
grey literature were not included, potentially increasing publication bias. However, 
assessment of publication bias for all meta-analyses using visual assessment of funnel plot 
asymmetry, trim and fill procedures and Egger’s tests, did not alter the results.  
Another limitation was how best to select RFs for the systematic review.  The 
considerations used by the WHO (World Health Report, WHO, Chapter 2, 2002) and Ezzati 
et al. (2002) to select RFs were used (Chapter 3, General Methods, pp. 46) and were helpful 
in informing which RFs could be relevant to LMIC.  However, the WHO and Ezzati et al. did 
not publish a decision rule for number of considerations needed to be satisfied to declare risk 
relevance. Due to the lack of cut-off points, the author decided that the more considerations 
were satisfied the more likely the RF should be selected.  However, this decision rule ignores 
any weighting that could be applied to the risk. This was also the case for the Bradford-Hill 
criteria (Chapter 3, General Methods, pp. 55) used to ascertain the causal nature of the 
relationship. The validity of these assumptions can only be tested in future more controlled 
longitudinal evaluations. 
In total 18 different outcomes that were markers of fertility problems were found and 
included in the reviews. This heterogeneity and additional lack of consistency with regards to 
measuring fertility problems and diverse research methodology adds complexity and 
limitations to making generalizations about the impact of exposure to said RFs. The 
implications of the heterogeneity in outcomes reported is that all primary studies could not be 
included in a single meta-analysis to evaluate the pooled estimate of the effect of exposure to 
any given RF on fertility.  
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Regardless of how rigorous the review process was results could only be as strong as 
the primary studies included. Three limitations of the primary studies were similar across 
RFs. First, was the recruitment at fertility clinics, possibly limiting selection to women at 
higher risk of infertility (applicable to GTB, FGM/C, BV). Second, the definition of 
outcomes, period of exposure or type of infertility were often not reported (applicable to 
CSG, BV, HIV). Third, was the lack of inclusion of confounders potentially moderating the 
effect of the risk.  For example, the type of circumciser in FGM/C could be linked to an 
increase in the likelihood of infection and comorbid STIs (applicable to HIV and BV). Other 
limitations were specific to RFs, and reported in the respective chapters. 
Despite limitations of the review process and of primary studies, the aggregation of 
available empirical evidence and the application of the Bradford-Hill Criteria to evaluate the 
causal nature of the relationship enabled conclusions to be made about the association 
between RFs and fertility problems. This was bolstered by the fact that the results of the 
current study supported evidence from narrative reviews for the most part. Exceptions were 
that past reviews and primary studies indicated more obstetric complications that could 
potentially lead to less live birth for FGM/C (Obermeyer, 2005; RCOG, 2015; Reisel & 
Creighton, 2015; WHO study group on female genital mutilation and obstetric outcome, 
2006). However, in the current meta-analysis FGM/C was not found to be associated with 
more childlessness. Evidence in the literature indicated an association between HIV and more 
miscarriages and levels of FSH indicative of POI (Kushnir & Lewis, 2011) and GTB with 
more amenorrhea (Gatongi, 2005; Ghosh, 2011; Varma, 2008) but such associations were not 
corroborated in the current reviews.  The lack of effect could be due to the methodological 
issues mentioned, but could also indicate genuine lack of association and reconsideration of 
the pathways through which these risks have effects. 
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Implications of Findings 
Targeting communicable and non-communicable diseases is not only a priority to 
reduce the effects of these conditions but also their impact on childbearing and the morbidity 
experienced with that needs to be addressed. GTB was shown to have a nine fold increase in 
ability to become pregnant, HIV and BV both being global risks and found to have an almost 
threefold risk to inability to become pregnant within 12 months. While others that lead to 
smaller impact but are highly prevalent in some regions, such as FGM/C (Type II and III) a 
twofold increased risk of TFI (~90% in some African nations, UNFPA-UNICEF, 2014) and 
CSG, detrimental effects such as post-natal mortality (50% of marriages in some nations, 
Bittles, 2014).  
The findings strongly support the movement toward having a more global 
understanding of risk for disease, and its extension to include a global view about RFs. This 
understanding would ultimately translate into more effective early detection of fertility 
problems in LMIC. Furthermore, it would allow health promotion to encompass culturally 
relevant health education and promotion. Clinical implications of these findings include 
education about the impact of these RFs that should be disseminated widely and in the most 
culturally appropriate manner. In addition to health promotion efforts, these results should be 
disseminated to clinicians who can have discussions with individuals about these RFs that 
can lead to better choices to protect reproductive capacity and to ensure that there is informed 
decision-making about fertility health.  
The findings have specific implications for clinicians and women, and wider 
implications for the integration of fertility within the global reproductive health agenda.  
Awareness of the risks associated with reviewed RFs should be communicated to couples, 
especially where the threat of the RF is increased (e.g. high prevalence such as FGM/C in 
some countries, family member with TB, increased susceptibility to BV in black women and 
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smokers). Specifically healthcare practitioners and couples should be aware of the following.  
The closer the biological relationship between father and mother the more likely their 
progeny will inherit recessive genes that may be harmful (Bittles et al. 1991; Bittles & Black 
2010; Hamamy et al. 2011; Hamamy, 2012) and genetic screening should form a part of 
routine pre-pregnancy examination. The potential impact of GTB, the latent nature of its 
effects, and TB screening should form a part of routine pre-pregnancy communication and 
examination. Menstrual disturbances and/or pelvic pain should alert practitioners to test for 
GTB, to enable early detection before irreversible damage occurs. For FGM/C, risks such as 
TFI need to be communicated and current guidelines should be followed to avoid labor 
complications such as fetal distress, emergency C-section and post-partum hemorrhage noted 
in the literature (Berg & Underland, 2013; Obermeyer, 2005; Reisel & Creighton, 2015; 
WHO, 2000), until pooled estimates of obstetric outcomes can be assessed. Current results 
concur with extant inclusion of HIV in pre-pregnancy care, emphasized by the WHO (WHO, 
Meeting report, 2012), and women need to be informed of the increased risk of infertility and 
amenorrhea associated with HIV. For BV, women should be advised to seek help for vaginal 
infections and health care providers should screen women for BV as part of routine 
gynecological examinations when risk for BV is present. For D&C women should be advised 
of the increased risk of developing IUAs and about safer options like hysteroscopy. For 
vitamin D, existing standard guidelines about supplementation that include all women 
between the age of 18 and 70 years, and for pregnant and lactating women (Holick et al., 
2011) should be followed, as these apply to overall health of women. For water-pipe 
smoking, clinicians should advise women of the potential hazards of tobacco use regardless 
of method of use.  For all RFs, practice guidelines should be updated regularly as more 
evidence is accumulated. 
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More general implications include how fertility should be integrated in the global 
reproductive health agenda because these RFs affect significant numbers of people. Even 
though each RF is a target for other campaigns (e.g., GTB, HIV, FGM/C), the impact of these 
RFs on fertility health unites these conceptually.  The results can be used to inform a separate 
platform for fertility health in reproductive health or they can be used to inform separate 
platforms for each of these diseases, cultural practices or medical procedures. For example 
fertility problems can be communicated as possible sequel of GTB in TB campaigns or of 
FGM/C in anti-cutting campaigns. Alternatively a comprehensive holistic approach can be 
utilized such that clinicians and users would benefit more from an integration of fertility 
health and other campaigns in a comprehensive reproductive health approach.  Whether 
fertility health is emphasized as a separate agenda within reproductive health or it is included 
within individual disease campaigns ultimately enhancing fertility awareness about RFs can 
potentially lead to more prevention of fertility problems. 
Unanswered Questions and Future Research 
The specific examples of what research needs to be conducted for each RF were 
informed from the gaps in primary studies and the models constructed and have been 
discussed in each RF discussion section. These included using more rigorous methodology 
like RCTs were that is possible and longitudinal cohort studies were RCTs would be 
impossible or unethical. It also encompassed the inclusion of well-defined and consistent 
outcomes and the inclusion of confounders. Future research should also target gaps in the 
primary literature regarding these RFs such that causal pathways are investigated in more 
detail, for example more molecular level investigations. The implications of the uncovering 
of the exact causal pathways would be that more specific clinical recommendations and best 
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practice guidelines could be established. Furthermore, research endeavors can be enhanced 
with the adoption of a more systematic approach to studying fertility health globally.  
Future research should also be targeted at developing and updating standardized 
protocols to include the following. First, how to select RFs to be studied, for example existent 
criteria and models for the selection of RFs can be standardized with specific cut-offs. 
Second, how to examine the evidence for said RFs, for example through systematic review 
and meta-analysis of extant literature and the development of standardized methods for 
primary studies to include consistent outcome definitions. Third, how to apply and implement 
new evidence to clinical practice, guidelines and policies, for example adhering to minimum 
level of evidence that qualifies for best practice in the development and implementation of 
clinical care, guidelines and policies.  
Conclusion 
Nine RFs identified through literature search, survey and expert opinions (Chapter 2) 
were subjected to systematic review and where data permitted meta-analyses in the current 
chapter. Results lead to an understanding of the association of these RFs with fertility 
problems through an examination of outcomes available in the literature. These results 
indicated that FertiSTAT is not comprehensive for a global audience and should be adapted 
to include FGM/C, HIV, GTB and BV. Furthermore, if FertiSTAT is to be used to inform 
women about fertility problems beyond achieving pregnancy then CSG should also be 
included. The results were used to make recommendations for health promotion, clinical 
practice and best practice guidelines to ensure that providers and users are aware of the 
potential impact of these RFs and can then make the best informed decisions. Additionally, 
other fertility education materials should undergo a similar process of adaptation if they are to 
be used globally.   
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The reliability of the results was bolstered by the rigor of the systematic review 
process but was limited by methodological shortcomings of the primary studies found in the 
literature. The current study can be used as an example of how the systematic review process 
can only be as strong as the primary studies included.  Therefore, the main recommendation 
would be for more rigorous and consistent standardized methodology of primary studies to 
reinforce extant literature.  Overall the study also contributed to an understanding of the 
processes necessary in an exploration of risk for disease.  
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Chapter 4 
Patient Interviews to Determine Need for Fertility Health Information and the 
Acceptability and Feasibility of Administering the FertiSTAT from the user’s 
Perspective in a Sample of Sudanese Infertility Patients  
Introduction 
The cross-cultural adaptation of FertiSTAT for use in Sudan and the Middle East 
began with an exploration of the comprehensiveness of the RFs in the tool (Chapter 2, Study 
2.1) and systematic review of identified risks (Chapters 3). This exploration was followed by 
an examination of the views of multiple stakeholders about the cultural acceptability and 
feasibility of implementing all versions of the adapted tool in the region (Chapter 2, Study 
2.2). These activities underscored the need to include the perspective of potential users to 
provide a comprehensive investigation of the cultural sensitivity of the tool, which is the aim 
of the present chapter.   
Fertility Knowledge in Sudan
It is important to note the lower literacy and education rates for Sudan to better 
understand how fertility knowledge fits within a broader education perspective. Education in 
Sudan is free and compulsory for children aged 6 to 13 years. In 2001 the World Bank 
estimated that primary and secondary school enrolment in Sudan was only 46% and 21% 
(respectively) of eligible pupils. It is also worth noting that although Sudan has 19 
universities instruction is primarily in Arabic. That combined with the general lack of English 
language education limits the ability of people to obtain information from international 
sources such as the internet and English language publications. The population literacy rate, 
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which is the proportion of people who can read and write, is 70.2% of the total population 
(men 79.6%, women, 60.8%, see Library of Congress, 2004, pp. 65). 
People in Sudan also have poor fertility knowledge. Anecdotal evidence drawn from a 
1978 anthropological study conducted in Sudanese societies regarding reproductive and 
sexual beliefs (Nadel, 1978, as cited in Khalifa and Ahmed, 2012) suggested that Sudanese 
men and women believed many myths and misconceptions about reproductive and sexual 
behaviours. For example, sexual intercourse during menstruation can lead to venereal disease 
and sterility (Nadel, 1978). An example from this sample was that one female participant (age 
38 years and university educated, residing in rural area) was unaware of basics of sexual 
intercourse, such as why the penis becomes erect.  More recent research would seem to 
suggest that knowledge has not improved much.  Al Safi (2007) reviews the literature in 
Sudan about reproductive knowledge, practices and the use of traditional healers. Al Safi 
(2007) reported that knowledge of reproductive functions such as the fertile period is vague at 
best. It is common knowledge that fertility is required in both partners and that the man’s role 
in the process is to ejaculate his fluid within the woman’s vagina.  However, what actually 
occurs in the female after that is largely unknown (Al Safi, 2007).  These results concur with 
other research on LMIC indicating poor fertility knowledge (Dyer, 2008; and Ali et al. 2011). 
Poor knowledge also extends to other areas of reproductive health such as family planning. In 
a study in rural Sudan, it was found that the unmet need for family planning was significantly 
associated with educational level of both partners (Ali & Okud, 2013). Unmet need for family 
planning was defined as those women who were not using contraception but who wanted to 
postpone or stop having children (Ali & Okud, 2013).  
In addition to the challenges of low literacy and fertility knowledge in Sudan, there 
are cultural factors that impact understanding of fertility education.  According to the latest 
(and only) data available, the average age of first marriage for women was 22.7 in 1993 and 
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21.9 in 2010 (United Nations, Department of Economic and Social Affairs, Population 
Division, 2015) and the average age of first births was 23.5 in 1993 (United Nations, 
Department of Economic and Social Affairs, Population Division, 2013).  Therefore there is 
close correspondence between marriage and having a child.  According to Al Safi (2007), in 
Sudan there are strong gender norms when it comes to reproductive health.  Society places 
the blame of infertility and the burden of help-seeking on women, consequently women also 
bear the social stigma for childlessness and are obligated to accept divorce or polygamy as a 
result of infertility. Male contribution to infertility is rarely addressed and male competence 
should not be questioned which is especially in northern Sudanese society. Conventional 
knowledge in Sudan about male fertility assumes that male virility and sexual ability are 
indicators of fertility. Society expects that women should seek help and treatment, as well as 
bear the social stigma of infertility. This emphasizes the importance of increasing knowledge 
and awareness of infertility RFs among Sudanese women generally and women from low 
resource nations that share similar gender norms.  
Views on infertility and IVF in Sudan also demonstrate stigmatization after treatment. 
In a prospective study Gaily et al. (2010) compared 96 babies born after IVF in Sudan and 
their mothers to controls conceived naturally using gestational assessment and an interview. 
The authors reported that 74.2% of couples that conceived with IVF/ICSI, hid the fact from 
their community (Gaily et al., 2010). The reasons cited by couples for hiding the fact 
included fear of child being ostracized (12.9%), to avoid social problems (21%) and to avoid 
family problems (19.4%) regarding blame for infertility and the cost of treatment (Gaily et 
al., 2010). 
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Cultural Sensitivity in Health Promotion 
The importance of cultural appropriateness and sensitivity of interventions has been 
recognised as necessary in the adaptation of tools to new contexts. Cultural appropriateness 
and sensitivity are used synonymously in the literature. These concepts refer to the 
consideration of ethnic and cultural characteristics of a target population such as norms, 
values, beliefs as well as experiences (historical, social and environmental) in the design, 
delivery and evaluation of health promoting activities (Resnicow, Baranowski, Ahluwalia & 
Braithwaite, 1999).   Making tools culturally sensitive therefore aims to go beyond merely 
adapting interventions that are targeted at a specific population via simple linguistic changes 
(e.g. modified language or translations) (Kreuter, Lukwago, Bucholtz, Clark and Sanders-
Thompson, 2002; Betsch et al., 2016). Historically, cultural targeting has been used to 
achieve cultural sensitivity. Targeting involves modification of an intervention taking into 
consideration characteristics of the target population (Kreuter et al., 2002, Betsch et al., 
20162). For example using the FertiSTAT in Sudan would require considering the literacy of 
the target audience so that if they are largely illiterate a self-administered tool would not 
work, and instead a provider tool would be required. The reason for investing in making tools 
culturally appropriate is that cultural sensitivity is linked with the impact of interventions 
especially when sensitivity is achieved through consideration of both the surface structure 
and deep structure (nature) of a population (Resnicow et al., 1999). Surface structure refers to 
matching interventions to the ‘observable’ nature of the target population (e.g. using similar 
language), while deep structure refers to the factors that impact on the behaviour of interest in 
the target population (e.g. social, environmental, historic factors) (Resnicow at al., 1999). 
Resnicow and colleagues (1999) noted that while surface structure may enhance acceptability 
and feasibility of interventions, deep structure is expected to determine the effect of such 
interventions. For example, in the latest Ebola outbreak in West-Africa, the WHO enforced 
guidelines for the proper disposal of corpses infected with Ebola including cremation 
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(Manguvo & Mafuvadze, 2015). Because these guidelines were in direct violation of 
traditional burial and funeral rituals of the target populations, they were not adhered to 
making the intervention ineffective (Manguvo & Mafuvadze, 2015). Instead, families of the 
deceased continued the traditional burial practices in secrecy and corpse collectors were 
bribed to forge death certificates to falsely certify that the deceased did not die of Ebola 
(Manguvo & Mafuvadze, 2015). In hindsight, the WHO should have targeted the 
management to the target population by taking into consideration the specific burial practices 
and convincing the people of the need to deviate from such practices to save lives (Manguvo 
& Mafuvadze, 2015).  
Widely used and accepted guidelines for cross-cultural adaptation such as Guillemin 
et al. (1993) and Beaton et al (2000), provide thorough explanations of steps necessary for 
translation and cultural adaptation. However, these guidelines neglect to consider the deep 
structure proposed to be essential for effective impact of interventions because they mainly 
involve cultural targeting, as described previously.  Kreuter et al. (2002) and Resnicow et al. 
(1999) suggest that adaptations could better link to deep structures via cultural tailoring.  The 
difference between cultural targeting and cultural tailoring lies in the fact that targeting is 
aimed at the target population whereas tailoring is aimed at each individual within the target 
population and is based on characteristics of that specific person (Kreuter & Skinner, 2000). 
An example of cultural targeting in the FertiSTAT would be to use sensitive terminology 
when asking about sexual history (e.g. using the word ‘relations’ instead of ‘sexual 
intercourse’). In contrast, an example of cultural tailoring in the FertiSTAT would be to have 
instructions for the provider to gauge the level of religiosity of each user and based on that 
information to discuss the sexual history in a way most suitable to the religiosity of that 
specific user.  Kreuter and colleagues (2002) suggest that although culture is shared amongst 
a target group the individuals within that group can have different levels of cultural beliefs 
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like degrees of religiosity (Kreuter et al., 2002). Govender (2005) suggested that health 
promotion efforts in Africa should not view culture as a barrier, rather cultural dimensions of 
health should be embraced within initiatives and interventions, consistent with the idea of 
culture as a building block of understanding (Betsch et al., 2016). Healey et al. (2017) 
conducted a systematic review of studies comparing health and mental health services with 
cultural adapted interventions and ones without such adaptations. Results of the review 
indicated that groups who received culturally adapted interventions showed better outcomes 
than those who received standard interventions (Healey et al., 2017). Specifically, groups that 
received culturally tailored interventions showed better outcomes, for example, lower 
subjective distress, more HIV tests, decreases in alcohol-induced problem behaviour, 
increases in daily fruit and vegetable intake (Healey et al., 2017).   
Aim of current study 
Results of the studies carried out thus far (Chapters 2 and 3) led to the conclusion that 
cross-cultural adaptation of FertiSTAT would require deeper understanding of user 
perspective. To achieve this understanding qualitative methodology was selected. Qualitative 
research can be used to ascertain subjective experience of individuals as it allows inquiry 
about and documentation and interpretation of human experiences (Patton, 2014). Knowledge 
generating contributions of qualitative inquires include but are not limited to the process of 
meaning-making, understanding peoples’ perspectives and experiences from their personal 
stories and comparing cases to discover patterns and themes (Patton, 2014). According to 
Bowen et al. (2009) feasibility questions relating to whether the intervention can be used in a 
new target population (i.e. will it be found acceptable) and the most appropriate methods of 
delivering the intervention, can be best answered through qualitative research. These 
processes are necessary to identify modifications for the adaptation of FertiSTAT to address 
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cultural sensitivity and appropriateness informed by an understanding of the deep structures 
of Sudanese culture.  
A thematic analysis was carried out to understand from the participants’ perspective 
issues regarding the implementation of FertiSTAT. A semantic approach was used to 
understand the themes related to specific opinions on issues such as language used in 
FertiSTAT, and a latent approach was used to uncover the underlying motivations and ideas 
about the acceptability of FertiSTAT and related issues. Semantic themes are those that 
reflect explicit or surface meaning, while latent themes are those that reflect underlying ideas, 
assumptions and ideologies (Braun & Clarke, 2006). The meaning-making and subjective 
experiences with the tool as well as the patterns that arise from interviews was appropriate 
because to date experiences of people in Sudan with fertility education tools have not been 
documented.  
The first aim of this study was to elicit views on the need for fertility education in 
Sudan and the second aim was to assess acceptability and feasibility of implementing the 
adapted FertiSTAT among Sudanese people with infertility attending a private fertility clinic. 
Tackling these broad aims allowed consideration of the specific queries and 
recommendations of stakeholders from Study 2.2 (Chapter 2, pp. 36), such as exploration of 
topics perceived as taboo.  
Materials and Methods 
Study Design 
Semi-structured interviews embedded within a cross-sectional pilot questionnaire 
study were conducted with Sudanese men and women experiencing fertility problems and 
attending a fertility clinic in an urban area.  A background information form and the Arabic 
FertiSTAT were administered during the interview (see Appendix P for all materials). 
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The fertility quality of life tool (FertiQoL) was also administered for use in an independent 
study, therefore data on FertiQoL was not presented in this thesis.  Figure 4.1 shows the
stages of the interview component of the study. Interviews rather than focus groups were 
used to gauge the level of difficultly discussing sensitive topics like sex and drugs form 
each individual’s perspective. Focus groups tend to be problematic because they can foster 
self-disclosure issues, limiting the understanding of personal thoughts, feelings and 
experiences (Hollander, 2004).  Social desirability bias is the tendency to underreport 
socially objectionable activities and over report socially desired ones (Krumpal, 2013). 
Figure 4.1. Steps following for all semi-structured interviews 
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Participants and Recruitment 
Patients attending a semi-private infertility clinic in Khartoum, Sudan were recruited 
from January to March 2017. Convenience sampling was used to recruit participants from 
patients attending a fertility clinic. Patients were recruited because the fertility topic would be 
of relevance to them, which would increase the likelihood of participation (Patton, 2014). 
There were no exclusion criteria. Ethical approval was sought and provided by the School of 
Psychology, Cardiff University (see Appendix Q). In this clinic (and most clinics in Sudan)
the patients are seen on a first come first serve basis without prior appointment. Therefore, 
the patients spend many hours in the waiting room until they are seen by the doctor. This long 
waiting period provided an opportunity to approach patients while they were waiting. Of the 
22 patients approached in the waiting room of the clinic, 20 (91%) agreed and completed the 
study. Recruitment continued until saturation of data was reached, and there was data 
replication and redundancy i.e. the point of diminishing returns in data was reached (Bowen, 
2008).  
Materials 
Appendix P shows the materials for the study, which included the consent (including
briefing), background information form, the tentative adapted FertiSTAT checklist, interview 
topic guide containing questions about the FertiSTAT and debriefing.  
Background information: The 16-item Background Information Form was used to ascertain 
demographic and reproductive characteristics (e.g., age, past fertility history). 
Fertility Status Awareness Tool: The tentative adapted FertiSTAT checklist was used to elicit 
understanding of fertility health issues (see Chapter 2, pp. 31).  It was translated to Arabic 
(see translation section below).  
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Interview topic guide (questions about FertiSTAT): There were two components to the 
interview.  First, participants were asked about their fertility knowledge.  These questions 
concerned what they knew about the signs, symptoms and preventable causes of fertility 
problems and whether they knew when to seek help.  Their desire for this type of information 
was also assessed. The second component of the interview concerned reactions to an 
awareness tool, specifically the FertiSTAT checklist.  Participants were asked about 
acceptability of the tool referring to its topics, potential format of administration (e.g., 
specific format, setting, source and time required for administration), and finally, perception 
of the potential drawbacks, benefit and utility of the tool. Due to the fact that this was a semi-
structured interview, some participant answers were responses to interviewer questions, while 
participants generated other answers spontaneously in response to more open-ended 
questions.  
Translation 
Materials, interview transcripts, and illustrative quotes were translated to Arabic, 
which is the national language in Sudan. RB in collaboration with local fertility experts in 
Sudan translated the adapted FertiSTAT checklist to Arabic. A bilingual Arabic-English 
linguist from a UK-based translation company (Business Language Solutions) verified the 
initial translation completed by RB. Interviews were audio recorded and RB transcribed and 
translated these. Translation of relevant quotes was checked via back-translation conducted 
by an independent research assistant Dr Kawther Mohamed (KM).  
Procedure 
Patients were approached in the waiting room and invited to participate in the study. 
Interested participants were briefed about the study. Those who agreed to participate were 
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asked to review and sign the informed consent form, including information about 
confidentiality, and were interviewed in a private room, individually or as a couple. Research 
assistants first collected demographic data after which RB conducted the interview questions.  
Interviews were conducted in a quiet, private room adjacent to the central clinic area.  
Interviews lasted approximately half an hour. At the end of the interview participants were 
thanked for participation and debriefed.  
Data Analysis 
RB and Dr. Emily Koert (EK) conducted thematic analysis (as coders) (Braun & 
Clarke, 2006). EK is a psychologist and post-doctoral researcher in the Cardiff Fertility 
Studies Research Group with clinical and research experience in fertility awareness and 
education. Dr. Koert has received extensive training in qualitative research and has conducted 
qualitative studies in infertility (e.g., Koert, & Daniluk, 2016; Boivin, Bunting, Koert, ieng & 
Verhaak, 2017). The coders followed these thematic analysis steps: (1) familiarisation with 
the data, (2) generating initial codes, (3) searching for themes, (4) reviewing themes, (5) 
defining and naming themes and (6) producing the report (Braun & Clarke, 2006).  Using 
inductive coding, each coder derived initial codes from interview data for half of the 
participants.  The other coder then reviewed the initial set of codes and the meaning of codes 
was discussed through analytic process memos. Coders discussed and reached agreement on 
whether each code communicated a unique meaning or fit with other existing codes.  Each 
coder organized codes into main themes independently. The preliminary thematic groupings 
of codes were discussed between coders to deepen the analytic process, enhance 
trustworthiness of the findings and to ensure cohesiveness of each theme and consistency 
with the overall meanings in the dataset.  
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The use of parentheses within quotations (TEXT) indicates text added for clarity, 
while omitted text is represented using suspension points (…). Quotes are identified with the 
participant identification number (ID). Quotes are provided for latent themes when clearly 
illustrative of the idea, whereas when the idea was an integration of several quotes or analytic 
process memos, no illustrative quote was provided. Coders documented the thematic analysis 
process including analytic process memos and reflective notes creating an audit trail. To 
ensure trustworthiness of the findings, the data collection, analysis and presentation of 
findings was guided by best practice guidelines for qualitative research presented in the 
Critical Appraisal Skills Program (CASP; Critical Appraisal Skills Program, 2017) and 
Meyrick (2006).  
Results 
Demographics 
One patient was briefed about the study, signed the consent form, asked to be excused 
and did not return to complete the study. Of the 20 patients who completed the study, three 
(15%) were men and 17 (85%) were women. The majority (65%, n=13) were educated 
beyond high school. The average age of the sample was 32.8 (SD=9.26, range 22-62) years, 
average duration of marriage was 4.9 (SD=3.58) years and average duration of infertility was 
4.1 (SD=2.88) years.  The reason for infertility was female factors only in 12 cases (60%), 
male factor only in two cases (10%) and both male and female factor in three cases (15%). 
The reason was unknown in one case (5%) and still not diagnosed in two cases (10%). Five 
(25%) women had previous pregnancies, but only two (10%) had live births, and one (5%) 
was currently pregnant (first trimester) as a result of treatment.  
Results of Thematic Analysis 
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As shown in Table 4.1 thematic analysis resulted in six semantic themes, two latent 
themes and two meta-themes. For a more detailed record of quotes please see Appendix R.
Table 4.1. 
Themes that emerged from thematic analysis from patient interviews in Sudan 
Themes Description of theme 
Semantic themes 
Desire for fertility information Fertility information that was desired and was it generated 
or endorsed 
State of fertility knowledge in this sample 
 What is known
 What is not known
 Misconceptions/myths
Current fertility knowledge, gaps in knowledge and 
misconceptions or myths about fertility  
Benefits of fertility education 
 Perceived personal benefit (to
self)
 Perceived general benefit (to
others)
 Utility of the tool: addresses
knowledge gap and encourage
behaviour change
Potential benefits of implementation of the tool to the 
participants (self), to people in Sudan generally (other) and 
what could be the potential uses of the tool  
Specific suggestions for the tool 
 Content: taboo topics
 Format: print Vs seminar
 Setting: schools, home etc.
 Source: doctor, specialist etc.
 Timing: puberty, before marriage
etc.
Specific comments/suggestions about aspects of the tool 
and its implementation  
Factors influencing implementation 
 Endorsed:
o Personal preferences
o Perceived benefit
Factors affecting tool implementation endorsed by the 
participants  
 Participant generated:
o Acknowledging the
benefit of
education/information
o The appropriate method
of distribution
o Persistence
Factors affecting implementation generated by the 
participants 
Challenges and barriers to implementation 
 ‘Others’ will not accept taboo
topics
 Openness to health education in
general and fertility specifically
 Implementation may be
dependent on level of
understanding, knowledge,
education and religiosity
 Source not trusted
Challenges and barriers to successful implementation of 
the tool  
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Themes Description of theme 
Latent themes 
Self-disclosure Factors that affect self-disclosure, e.g. social norms, social 
desirability, demographics 
How issues of self-disclosure were resolved internally: 
self-other as a resolution for internal conflict of modern-
traditional, cultures in transition, pull between modern vs 
traditional values  
When is self-disclosure important (practice vs research) 
Understanding of being at risk Aspects that affect our understanding of being at risk, e.g. 
demographics, previous knowledge and experience, 
culture (social norms, religion)  
Meta-themes 
Compatibility with worldview Compatibility of info with worldviews, social norms, 
beliefs and values that affect the acceptability and feasibly 
of using the tool in Sudan and the issues related to self-
disclosure and understanding risk  
Cultural tailoring How the tool could be tailored to fit the a culture, i.e. 
according to gender, age, level of education or 
understanding and religiosity 
Note. Tool refers to FertiSTAT 
Semantic themes. 
Six semantic themes emerged from the data. The first sematic theme was the desire 
for fertility information. The data provided evidence of unanimous endorsement of a desire 
for information about fertility. A few participants also indicated that they were actively 
looking for information, ID5: “yes, I’m currently searching (for information).”  
The second sematic theme was the state of fertility knowledge in this sample. The 
participants’ level of fertility knowledge regarding signs, symptoms, preventable risk factors 
and when to seek help was gauged based on endorsement of information provided by the 
interviewer or generated by the participants. Most of the participants seemed to be aware of 
the impact of age on female fertility, ID20: “yes after 35 the chance is weak, very weak”, and 
to know that after a couple has been trying for one or two years they should go to the doctor, 
ID13: “I would say a year is good.” However, when participants were asked if they had 
fertility knowledge many stated that they didn’t, ID1: “I feel I have little information”, ID2: 
“No, I don’t know” and ID17: “no I didn’t know, especially the specific age I didn’t know 
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that.” There were also misconceptions/myths held by some participants regarding risk factors 
for infertility, ID13: “cleanliness and things like that” and isolating certain factors as the only 
cause of infertility such as, ID16: “(ovarian) cysts always.” 
The third semantic theme was the benefits of fertility education. The benefit to self 
was expressed by most of the participants, ID2: “yes I would look at it, I would find it 
beneficial.” Most participants also reported benefit to others, ID17: “our society is in need of 
lots of raised awareness, A LOT!!” The utility of the tool was seen as both to addresses 
knowledge gaps, ID13: “to see where there are gaps and to fill them” and to encourage 
behaviour change, ID16: “from early on is better so I can avoid things like drinking too much 
coffee and tea and things like that.” 
The fourth semantic theme was the specific suggestions for the tool which related to 
the content, best context for FertiSTAT and timing of its delivery to people. Endorsed or 
suggested changes about specific aspects of FertiSTAT that could influence acceptability and 
feasibility of implementation in Sudan were identified.  The content of FertiSTAT could be 
an issue but suggestions for making it appropriate were provided.  When asked about whether 
they thought the sensitive topics (sex, alcohol and drugs) would hinder acceptability, one 
participant stated, ID19: “maybe in the olden days maybe, but now it’s ‘aadee’ (normal)” and 
she noted that it would depend on how the provider was viewed: “if you introduce yourself 
properly in the beginning and they see you are a doctor, a professional,” then they would be 
more willing to accept these taboo topics. Most of the participants suggested that the 
interviewer just ask, using the Arabic word ‘aadee’ meaning normally, or casually, ID7: 
“people should talk about it ‘aadee’ (normally), because it’s for their benefit” and ID3: “a 
person should explain ‘aadee’ (normally) no problem.”  
The best context for FertiSTAT referred to comments about format, setting and 
provider. All the participants endorsed a magazine version and some generated format 
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examples including seminars and print materials, although there was disagreement about print 
materials, ID19: “something printed the boys will not read it (…) if its lectures or seminars 
(…) they will accept it, they will listen, because a boy by nature wants to hear not to read.” 
The most suitable setting suggested by most participants was educational institutions (schools 
and universities), although some suggested that the home might be more appropriate, ID13: 
“I imagine the home to be the best context, I mean the most important role, one sees their 
father and their mother and how they are, it’s better that they show them.” The participants 
stated that the most suitable source to provide this fertility information was a doctor, a 
professional or specialist. Responses demonstrated that the source being perceived as 
knowledgeable, ID1: “a person who understands the issue” was more important than the 
profession or gender, ID19: “the real difference lies in whether the information was given by 
a specialist, not man or woman.” Some participants felt that a same gender source would be 
better, ID12: “it could be specifically for women, a seminar just for women so they can ask”. 
Several participants also thought that a family member, a parent or older sibling should 
convey this type of information, ID10: “your mother, older sister at home” and ID12: “the 
responsible ‘al gehat’ [entities], the mother.” 
The timing and, relatedly, the most appropriate audience for using FertiSTAT were 
also discussed with specific suggestions provided. The majority of participants stated that the 
most suitable time to provide this information was at an early age. Specifically, participants 
stated puberty (same as ‘adolescence’ in Arabic) and the engagement period (before 
marriage) as the most suitable timings, ID18: “I think at puberty they should be made aware 
of these things” and ID19: “when they are in the engagement period, approaching marriage.” 
These suggestions were thought to be the time they can make changes to safeguard their 
fertility and to seek early treatment, ID16: “from early on is better so I can avoid things like 
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drinking too much coffee and tea and things like that” and ID15: “every girl MUST go and 
get checked out before she gets married.”  
The fifth semantic theme concerned factors influencing implementation. This theme 
related to the factors influencing the acceptability and feasibility of implementing FertiSTAT 
in Sudan. Most participants felt that personal preferences would dictate whether FertiSTAT 
was acceptable, ID1: “it’s choices, you don’t like the page, you turn it.” It was also 
considered that the perceived benefits of the tool would influence its acceptability in Sudan, 
ID4: “the topic is not that difficult, it’s just information that one can benefit from.” And more 
generally, ID1: “clear and direct questions so that the answer is clear and direct, you benefit 
and I benefit.”  Selecting the method of distribution would affect acceptability, ID14: “if it 
(FertiSTAT) is distributed right”.  Finally, it was considered that acceptability would be 
improved through persistence in providing the information:  
RB: so, you’re saying even if they say they don’t accept it we should give it 
anyway? 
ID14: I told you, he will calculate it (risk level) in his head. He might think 
maybe this is right, he will do it himself (fill out the FertiSTAT). 
The sixth and final semantic theme was challenges and barriers to implementation. 
Four potential barriers or challenges to implementing FertiSTAT in Sudan emerged. The 
possibility that ‘others’ would not accept taboo topics (sex with multiple partners, alcohol and 
drugs) was mentioned. Most participants stated that they would find it acceptable to talk 
about taboo topics but that ‘others’ would not. When asked if she would accept the materials 
ID5 responded: “yes acceptable” but when asked if others would accept it her response was 
different “some people will consider it and others will not”. Similarly, ID4: people may not 
accept these subjects, and:  
ID1: cons, there are no cons for me, the topic is normal 
RB: do you think people will respond authentically?  
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ID1: no (…) from the beginning you will get a sense of whether this person is 
willing to accept things, or not accept, for example, this sex question, most 
people will say ‘enough I don’t want to (continue)’ 
The lack of openness to health education in general and fertility specifically was 
expressed as a possible barrier by ID11:  
…you will face difficulties, you will face unacceptance of the idea itself. I’ve 
done village work (working outside the capital city), acceptance of things like 
this was problematic for people. To communicate to them about family 
planning and to prevent circumcision of females and things like that, we faced 
problems, only God knows. Our problem is our customs.  
Implementation was also seen to be dependent on level of understanding, knowledge, 
education and religiosity, ID14: “it will depend on their level of understanding, they may not 
accept it. Not everyone will accept, everyone has a different level of understanding” and ID1: 
“the religious one, in a religious way (…) God has forbidden certain things because they (the 
forbidden actions) can harm us”.  
Finally, the source might not be trusted and this could be a challenge, ID13: “it seems 
that it’s always the case that if you trust the source (person) that the information is coming 
from, that’s better. But if it comes from someone I don’t trust, I will just leave him and go.” 
Latent themes. 
Latent themes were the constructs perceived to influence the explicit content
participants expressed. From this data set it was inferred that the latent themes (constructs) of 
‘self-disclosure’ and ‘understanding of being at risk’ were influencing the behaviour of the 
participants.   
The evidence for the latent theme of ‘self-disclosure’ comes from several 
observations. First, participants were unwilling to self-disclose about behaviours that were 
against social norms in Sudan (e.g. premarital sex in women). For example, RB noted that 
none of the 17 women reported sexual activity before marriage, which seemed unlikely. 
Second, participants were 
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unwilling to self-disclose their true perceptions of the fertility information provided or the 
FertiSTAT and many mainly agreed with what the interviewer said.  
Agreeableness, wanting to be sociable or aiming to please others also emerged  
because most participants just endorsed FertiSTAT as it was. For example, when asked “is 
there anything else you could add that you think would help us, or something to add about the 
information, or a specific way to talk about this topic?” ID1 responded: “no, your way is 
nice”.  Agreeableness between spouses was also observed; as they did not contradict each 
other. For example, a wife and husband interviewed together:  
ID19 (wife): yes it makes no difference, the real difference lies in whether the 
information is given by a specialist, not man or woman.  
ID18 (husband): yes, I agree, the most important thing is that they have to be a 
specialist. 
Agreeableness, was also expressed, for example by a participant who repeatedly 
denied any problem with the questions which were known to contain taboo topics:   
RB: so these questions didn’t bother you?  
ID9: no. 
RB: no problem at all?  
ID9: no, no. 
RB: OK, do you think there is something we can do to improve this work?  
ID9: no, no. 
RB: so you feel this is a good or bad thing, I mean it’s beneficial, or it’s just 
useless? What do you think?  
ID9: no, no it’s good. 
Third, the participants who felt able to self-disclose (i.e. not affected by social 
desirability or agreeableness) were those that in Sudanese society would be allowed to violate 
norms, that is, those who would be perceived as higher up in the social hierarchy. From 
observations it was determined that male participants and more educated people could 
disclose or opine without worry. For example, an educated woman, ID19 (graduate level 
education): “OK you really have to write this (more research on varicocele) in the 
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recommendations!!” and an older male participant with female interviewer emphatically 
demonstrated more authority and confidence:  
RB: so it’s not a problem, for example we say ‘this area, people should not 
talk about’? 
ID8 (62 years old): it’s WRONG not to talk about it!! 
RB: so we should talk about all of this? 
ID8: YES, YES!! 
Another latent theme that seemed to be influencing observations about FertiSTAT was 
understanding of being at risk.  Information in the data about how risk was understood in this 
sample and in general led to the identification of several factors that affected understanding 
of being at risk. One participant’s understanding of being at risk seemed to be informed by a 
combination of religious doctrine and previous knowledge of disease transmission: 
ID7: everyone knows what can harm them and can help them, and they are 
still doing the (behaviour that is) wrong, like, for example, sex, they know it 
can transmit diseases but they still do it. They use protection and say ‘I won’t 
get a disease’. They know everything but they try in different ways to do 
things, but this thing (premarital sex) is haram (forbidden by Islam) and 
wrong. 
The coders agreed that the understanding of being at risk could differ by age, for example 
younger people appeared to feel more invincible, as this quote from a person reflecting on 
their younger self before marriage expressed, ID1: “before marriage I didn’t have information 
about sexual education. Before marriage, I felt like I didn’t want to educate myself.” There 
appeared to be gender norms about behaviour and risk taking too, as demonstrated:  
ID14: They should show this to the men too, so they don’t say it’s just from 
the woman (the fertility problem), they have to, they have to know it, this 
thing especially, boys will be boys, so you know boys can have relations (sex) 
as much as he wants before marriage and stuff, and then he comes and then, I 
mean after marriage he will have repented to God (no longer engages in sex 
with anyone other than his wife) and they have no problem (no extramarital 
affairs). 
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These quotes reflected the participants’ understanding that although social norms 
allow premarital sex for men this still may be a risk, thus the understanding of being at risk 
was partially based on gender.  
The data demonstrated that understanding of being at risk could be informed by 
previous knowledge, information (e.g. media, socially) and personal experience of infertility 
specifically (disease specific) or medical issues more generally (across disease): RB: “was the 
information beneficial? And was there any information you were not aware of before?” ID6: 
“yes, useful, I’ve seen it before”. Another participant expressed that had she known about the 
signs of fertility problems like irregular periods, she would have sought treatment when she 
developed these problems, rather than waiting after marriage, ID15: “every girl MUST go 
and get checked out before she gets married, to get herself checked, I had problems with my 
period, and I was not bothered with it.”  
Understanding of being at risk was also informed by what is forbidden by social 
norms, laws or religious doctrine, ID1: “God has forbidden certain things because they can 
harm us.” Understanding of being at risk can also affect behaviour, as one participant 
outlined ID13: “So, knowing about this, awareness about such things especially here in 
Sudan, here the girl won’t go to the doctor no matter what. For example, if her period is late 
she should find out, if her period she could have a problem, go to the doctor.”  
Meta-themes. 
In addition to the two latent themes, two meta-themes emerged, ‘compatibility with 
worldview’ and ‘cultural tailoring.’ The participants’ responses demonstrated that if health 
information/education was perceived to be compatible with a personal worldview (values, 
beliefs, philosophy, e.g., Islamic teaching) then it was more likely to be taken up and 
assimilated. When information was not congruent with personal worldviews, it could be 
disregarded or discredited. For example, several participants expressed the general Muslim 
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society belief about the value of knowledge, ID5: “this is a type of education and (education) 
is not wrong.”  
Participants stated that Islam forbids some of the risk factors for infertility identified 
in the FertiSTAT. One female participant explained, ID1: “sex outside marriage is haram 
(forbidden by Islam), God has forbidden certain things because they can harm us.” However, 
another participant shared that people in Sudan continue to engage in haram behaviours 
despite being forbidden: 
ID7: And I tell you something, in this day and age, they all know, they know 
wrong from right. And they are doing the wrong (regardless). Everyone knows 
what can harm them and can help them. And they are still doing the wrong, 
how, like, for example, sex, they know it can transmit diseases but they still do 
it. They use protection and say ‘I won’t get a disease’. They know everything 
but they try in different ways to do things, but this thing (premarital sex) is 
haram (forbidden by Islam) and wrong. 
 
RB: but if she is unwilling to accept; this information is important for them to 
know, they should know that unprotected sex with multiple partners can affect 
their ability to have kids in the future, it can lead to diseases that can infect the 
spouse, so how can I convey this information, what if I get a really shy or 
religious patient?  
ID1: the religious one, in a religious way, that sex outside marriage is haram 
(forbidden by Islam), God has forbidden certain things because they can harm 
us, you reach her at her level of understanding; each person at their level of 
understanding. 
 
ID13: yes, early is one year, some people wait 4 or 5 years to get tested, no I 
mean you have just wasted time like this. It’s better that they find out, so that 
even if God did not will it (meaning you can’t have babies), you can separate. 
Sometimes there are people that God gives them (a baby) with someone else, 
it was not meant to be here (in the first marriage). 
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Another meta-theme that emerged from the data was the idea that tailoring the health 
messages of an educational tool like the FertiSTAT to make them more compatible with the 
user’s worldview would make the tool more acceptable. For example a female participant 
provided the following ideas in order to reach people (ID1) “Each person at their level of 
understanding”: 
ID14: (…) printed materials, posters, pamphlets that can reach the mum or the 
aunt at home, they read it. People who can’t read (illiterate) can get it at the 
mosque, you give the information to the imam (priest) and tell him to convey. 
This way the people at the mosque will know something and the mums will 
get the printed material.  
Tailoring was suggested according to several factors. First, religiosity, some 
participants stated that information should be tailored to the extent of the individual’s 
religiousness, ID1: “the religious one, in a religious way, that sex outside marriage is haram 
(forbidden by Islam), God has forbidden certain things because they can harm us.” Second, 
gender, some participants stated that when the source of information was of the same gender 
as the audience this might lead to more acceptability of the materials: 
RB: Ok, so is it better from a woman or a man? 
ID10: it’s better from a woman of course! 
RB: so it’s better if a woman comes and talks to the girls and she can tell them 
and show them? 
ID10: why not, a man, for example, I can’t ask him questions, but you are a 
woman like me so I can ask you questions. 
Third, to the education or level of understanding, several participants stated that 
information should be provided at the individual’s level, ID1: “you reach her at her level of 
understanding, each person at their level of understanding” and ID14: “people who can’t read 
(illiterate) can get it at the mosque, you give the information to the imam (priest) and tell him 
to convey.” 
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  The coders’ integration of semantic, latent and meta-themes with the aims of the 
study lead to the development of the map depicted in Figure 4.2. As demonstrated in Figure 
4.2, the semantic themes of desire for more information, benefit of fertility education and the 
state of fertility knowledge all seem to inform the need for fertility education. The figure also 
shows the challenges and solutions regarding the acceptability and feasibility. Challenges 
include the latent themes of self-disclosure, understanding of being at risk and the perceived 
unacceptability of materials by ‘others’. The potential solutions include the semantic theme 
related to the specific tool changes noted in the data as well as the meta-themes of tailoring to 
be compatible with world views.  
Figure 4.2. Map of themes and how they apply to aims. Need = need for fertility education; 
Acceptability and feasibility of administering FertiSTAT; Challenges = factors viewed as potential 
challenges to implementation of FertiSTAT; Solutions = solutions to enhance implementation of 
FertiSTAT; Desire = desire for fertility education; Benefit = perceived benefit of fertility education; 
State = state of fertility knowledge; Understanding Risk = Understanding of being at risk; Tool 
specifics = changes to the tool; Worldview = compatibility  with worldview; Tailoring = cultural 
tailoring  
Discussion 
Principal findings 
Although the FertiSTAT checklist was in Arabic and included culturally relevant 
items such as FGM/C, meaning it was culturally targeted, issues of acceptability remained.  
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Thematic analysis of the data indicated that for this sample fertility education was perceived 
to be necessary and beneficial.  FertiSTAT would be acceptable and its implementation 
would be feasible only if challenges were addressed in a culturally sensitive manner. 
Challenges included the difficulty of accepting communication about sensitive topics such as 
sex and drugs, issues of self-disclosure and understanding of being at risk. Approaches to 
address said challenges included changes to the format of delivery (e.g. all women seminars) 
that would reduce the social hierarchy and could facilitate self-disclosure.  In addition, 
cultural tailoring to make materials compatible with individual worldviews was inferred to be 
a solution both to generate a personalized understanding of being at risk and to enhance 
acceptability of sensitive topics.  
Elaboration on main findings. 
Results showed a need for fertility education stemming from a lack of fertility 
knowledge among people in Sudan that was consistent with reports in the literature both in 
developed (Bunting, Tsibulsky and Boivin, 2013) and developing countries (Ali et al., 2011; 
Ola, Aladekomo and dan Oludare, 2010). The data confirmed that this Sudanese sample 
wanted to know more about their fertility as inferred from their expressed desire for 
information and given their current knowledge was fairly basic and they had significant 
knowledge gaps and believed common myths about fertility.  
It was inferred from the data that the tool as presented would only be acceptable and 
feasible if it was compatible with the Sudanese culture. This need was congruent with reports 
in the literature emphasising that successful implementation of health promotion in culturally 
diverse settings hinges on achieving accurate cultural sensitivity in health messaging (Betsch 
et al., 2016; Kreuter et al., 2002; Resnicow et al., 1999). Beyond cultural targeting it was also 
inferred that the materials needed to be compatible with the each user’s specific level of 
cultural attributes. One way to achieve this compatibility, ascertained from the results, was to 
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tailor the materials with an understanding of the deep structure of the society to fit each user’s 
specific level of socio-cultural factors such as religiosity and education, consistent with 
reports in the literature (Kreuter et al., 2002; Resnicow et al., 1999). Some challenges were 
identified and specific changes to the tool were suggested to tackle these challenges.  
Challenges to implementation. 
There were three main challenges ascertained from the data. First, its potential 
unacceptability to some members of Sudanese society, second, variable willingness to self-
disclosure and third, complex ways of understanding of being at risk.   
The main challenge garnered from the data was that although all the participants 
expressed that they accepted the materials for themselves, some felt that other people in 
Sudan might not accept the tool.  This self versus other dichotomy could reflect several 
processes.  First, it could be that people were not willing to disclose openly their own views 
of the tool and projected objections onto others.  This would not be surprising given that in 
Sudan being agreeable, cooperative and helpful is valued.  Second, this dichotomy between 
acceptability for ‘self’ and ‘other’ could be a manifestation of the pull between modern and 
traditional values inherent in cultures in transition, as is the case for Sudan. Participants most 
often highlighted the self-other dichotomy when considering the acceptability of addressing 
taboo topics in the tool. An example of this would be that many of the participants accepted 
the need to ask about taboo topics for themselves but stated that ‘others’ might not be as 
accepting. In this way, the participants could convey a modern view of self while projecting 
the negative ‘traditional’ beliefs onto the ‘other’ as a way of maintaining aspects of both 
tradition and modernity within one’s persona. Therefore, it appeared that this sample may be 
liberal and willing to engage in premarital sex (more modern), but yet still feel hampered in 
disclosing sexual history due to fear of being judged according to traditional social norms 
forbidding premarital sex (laws and religious doctrine). These findings highlighted the need 
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to address such dichotomies when tailoring health promotion tools to individual preferences 
and worldviews (Kreuter & Skinner, 2000).  
The second challenge was willingness to self-disclose less favourable aspects of the 
self. Results suggested that Sudanese users might not be as willing to self-disclose as they 
could be about their lack of knowledge or exposure to particular risks, congruent with the 
literature (Gerbert et al., 1999; Krumpal, 2013). This unwillingness to disclose seemed to be 
mainly due to worry about creating bad impressions with others (spouse, doctor). The 
consequence of lack of self-disclosure in clinical contexts is obvious, for example not being 
forthcoming about smoking, alcohol consumption and other issues that can impact fertility 
were noted by fertility doctors as challenges to accurate diagnosis of a fertility problem (Five 
little white lies that can impact fertility, 2016).  It can be inferred that self-disclosure to the 
provider matters most when disclosure will lead to research or clinical findings that can be 
skewed, however there does not appear to be a difference in self-disclosure to a researcher or 
a physician (Gerbert et al., 1999). Given that self-disclosure may be uncertain in formats that 
lead to social desirability bias, for example survey and interview (Krumpal, 2013) the 
question then becomes, ‘to what extent can self-disclosure impact research, clinical and 
educational outcomes for participants and providers?’ The answer would depend on the 
purpose of the survey or interview, such that research purposes would suffer immensely from 
lack of self-disclosure as would clinical screening because recommendations based on false 
or missing information would in turn be inaccurate or incomplete. Self-disclosure is critical in 
clinical practice because it could lead to more accurate management and in research because 
results of said research could be used to inform clinical practice and guidelines (Gerbert et 
al., 1999). Self-disclosure can also be viewed as a challenge to health education since it 
would reduce the provider’s assessment of perceived comprehension in the user (Krumpal, 
2013). When self-disclosure is about being forthcoming with information giving to the 
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provider then some suggestions made by the participants in this study could help, for example 
an all-female seminar and same gender source. An example of areas where self-disclosure 
may be less essential are educational programs, as on participant stated: “a person, even if he 
is taking (drugs) he will tell you this is none of your business. So when he reads it even if 
they don’t accept it, they will still know the levels (critical thresholds) the effects and such.” 
A third challenge to risk communication was perceived understanding of being at risk. 
It has been reported that to avoid hazards such as smoking people need to understand what it 
means to be at risk (Weinstein, 1999), and this perception of risk is influenced by several 
factors including psychological and cultural factors such as attitudes and values (Boholm, 
1998; Sjoberg, 2000). It was inferred from the data that understanding of risk was moderated 
by person characteristics further reinforcing the need for tailoring materials to individual 
needs.  The data in the current study speak to the recognition of personal risk or susceptibility 
being influenced by several features like age and gender but also by social norms and culture, 
congruent with the literature (Boholm, 1998; Sjoberg, 2000; Weinstein, 1999). It could be 
inferred from the data that youngsters are perceived to be uninterested in health education 
possibly linked to the idea of lack of perceived risk associated with age. The data suggested 
that perception of risk might be related to gender, for example, infections affect women only, 
and therefore sexual behaviours of women only are important. This was congruent with 
reports in the literature of women perceiving themselves as more at risk and men perceiving 
themselves as less at risk (Boholm, 1998; Fiuncane, Slovic, Mertz, Flynn & Satterfield, 
2000). Several participants emphasized the inclusion of men in fertility education that is 
congruent with the importance of addressing men in gender neutral health education noted in 
the literature (Östlin, Eckermann, Mishra, Nkowane and Wallstam, 2006). Integration of 
gender into health programs (inclusion of gender norms and taking into account gender-based 
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inequalities) has been reported as a way to achieve positive reproductive outcomes (Boerder 
et al., 2004; Robertson, Douglas, Ludbrook, Reid and van Teijlingen, 2008).  
Another example highlighting the complexity of understanding risk is the common 
belief that unmarried girls should not seek out treatment by a gynaecologist even if they are 
having menstrual problems. From RB’s experience as a Sudanese women, this could be due 
to two factors: young women do not understand that this is a risk and therefore do not seek 
help and the pervasive cultural/societal assumption that unmarried girls are not having 
premarital sex and thus they are not at risk and gynaecological services are not necessary. 
This could reflect on the one hand the lack of knowledge about non-sexually related 
gynaecological diseases that can affect fertility (e.g. anovulation) and on the other hand it 
reflects a denial about premarital sex in girls. One participant discussed that had she known 
about the impact of menstrual problems on fertility, she would have sought treatment before 
marriage (pp. 232). This showed that knowing the importance of seeking help early might 
help safeguard future fertility, demonstrating that a new understanding of being at risk could 
ultimately lead to behaviour change.  
Potential solutions to identified challenges. 
Implementation of a culturally sensitive version was not perceived to be a significant 
challenge. Participants generated multiple proposals for where and how the tool could be 
implemented for example information leaflets or same sex seminars, targeting adolescents 
and those about to embark on marriage in schools and universities. These results were in line 
with recommendations of the Sudanese Federal Ministry of Health that health promotion 
should focus on community-based interventions (e.g. homes, schools, workplaces, markets, 
hospitals, colleges, villages and cities) and that schools were a setting where child, parent and 
teacher involvement could enhance health promotion efforts (Elsubai, 2007). Many 
participants stated that a doctor would be the ideal source to disseminate the information, 
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because they were perceived to be knowledgeable and trustworthy, congruent with the idea 
that doctor-patient communication could be viewed as a basis for motivation, reassurance and 
support (Betsch et al., 2016) could be one  
Need for compatibility with worldview. 
The findings suggested that people might be more willing to accept health-based 
educational materials that are compatible with their worldview. This meta-theme related to 
the idea that information that is perceived to be compatible with ones worldview, beliefs, 
values and social norms is more acceptable and can be integrated into ones understanding of 
a concept. It may well be that participants found the materials to be acceptable because in 
Muslim society, “knowledge is good”, as one participant stated when discussing the sensitive 
and taboo nature of the topics, “this is a type of education and this is not wrong”. Findings 
demonstrated that when materials were perceived to be compatible with worldviews this 
enhanced the acceptability of fertility education, for example “sex outside marriage is haram 
(forbidden by Islam), God has forbidden certain things because they can harm us.” On the 
other hand if information is not congruent with one’s worldview then this information is 
simply discarded or discredited.  Making materials compatible with users’ worldviews would 
depend on the materials being, culturally sensitive and personally relevant. One way to 
achieve both would be through cultural tailoring and personalization of the materials.  
Need for cultural tailoring to be compatible with worldview.  
The participants’ recommendations underscored the need to tailor materials to the 
individual in order to be congruent with their abilities and views. The idea that enhanced 
effectiveness is related to congruency between the message and each user’s cultural attributes 
has been suggested in the literature (Betsch et al., 2016) and is consistent with the HBM 
(Rosenstock, 1990). Betsch and colleagues (2016) stated that “cultural congruency” i.e. 
equivalence between user’s cultural characteristics and health message led to better outcomes 
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and that choices about messaging should be consistent with informed values. The fact that the 
information about congruence and tailoring emerged from the data organically without 
actively being sought, confirms the legitimacy of such claims in the literature (Kreuter et al., 
2002; Govender, 2005; Timmerman, 2007).  
According to the HBM individuals may be less inclined to apply risk to themselves 
due to the erroneous belief that they are insusceptible to risk (Abraham & Sheeran, 2005; 
Rosenstock, 1966, 1990). Thus if a person does not perceive themselves to be at risk then 
they would not act to change their risky behaviour or to seek help (Rosenstock, 1990). 
Accordingly, they will lack appropriate motivation to adhere to doctor’s recommendations to 
reduce risk behaviours or to seek help (Abraham & Sheeran, 2005; Rosenstock, 1966, 1990). 
Personalized information as opposed to generic health messaging can increase the likelihood 
that people will reduce risk behaviours (Noar et al., 2007; Sohl & Moyer, 2007). Therefore, 
to enhance motivation to change behaviour, health messages need to be made personally 
relevant and of direct impact on a person’s life (Noar et al., 2007; Parkes et al., 2008; Petty & 
Cacioppo, 1986). The perception of personal risk is not enough to produce behaviour change 
because people may discredit the information in an attempt to decrease the fear evoked by the 
message (Witte & Allen, 2000).  Therefore, fertility education interventions need to go 
beyond personalization, to provide specific guidance about the action necessary to decrease 
risk (Witte & Allen, 2000).  
Behaviour change is not only affected by perceived risk but cultural variability can 
potentially influence actions after understanding personal risk. Different cultures have diverse 
interpretations of what to do when at risk, for example ‘western educated industrialized rich 
and democratic (WEIRD) societies’ may be more willing to act on risk to take action and 
seek help (Henrich, Heine and Norenzayan, 2010), but in other cultures risk may be 
interpreted as a state of being with no feeling of being compelled to take action. In Islam, 
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taking care of one’s health is encouraged, both in the hadith (Prophetic sayings) and the 
Quran. The Quran makes it explicit that one should not contribute to self-harm or destruction 
and the prophet Mohamed stated that people should seek treatment for disease because God 
has created a medicine for all ailments, except old age (Assad, Niazi and Assad, 2013). Given 
this strong belief in protecting one’s health and seeking treatment it may well be that in 
Muslim societies like Sudan, a perceived risk status would compel behaviour change and help 
seeking. The influence of culture and religion on the interpretations of what to do when at 
risk is an illustrative example emphasizing the need for cultural targeting and tailoring. 
However, even an understanding of personal risk and religious doctrine may not be enough to 
lead to behaviour change as suggested by one of the participants who said that even though 
people know premarital sex is wrong and harmful they continue to do it (pp. 323), as in all 
cultures.  Effective behaviour change would be a challenge in this field as it has been in 
others (e.g., cardiovascular disease). 
The FertiSTAT provides both the personalized information and the guidance about 
how to change behaviour (Noar et al., 2007; Parkes et al., 2008; Sohl & Moyer, 2007). 
However, cultural adaptation of the FertiSTAT needs to take a few extra measures, such as 
understanding the factors influencing behaviour change in that culture and the potential 
barriers and benefits of change in that culture. Once these factors are understood they can be 
used in the most culturally and individually relevant way. Activities of adaptation of the 
FertiSTAT reported thus far have followed methods of cultural targeting to address cultural 
sensitivity. However, the current study underscored that effective implementation of the 
FertiSTAT needs to go beyond cultural targeting that reflects an understanding of deep 
structures. Successful implementation of the adapted version of the FertiSTAT must include 
cultural tailoring based on each individual’s characteristics or level of cultural attributes to 
achieve maximum impact and not just personalisation to their level of risk.  
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It can be concluded from an integration of the data and the literature that successful 
health messaging that leads to behaviour change needs to evoke a perception of personal risk, 
provide guidance about what to do to address this risk, be culturally tailored to be congruent 
with each user’s worldviews and address barriers and benefits of behaviour change.  
Strengths and Limitations  
The main strength of this study was the methodology followed by the coders and the 
adherence to best practices guidelines of qualitative analysis (Braun & Clarke, 2006; CASP, 
2007; Meyrick, 2006), which included independent coding, double checking and discussion 
of coding, and thematic analysis with ongoing documentation of the analytic process which 
created an “audit trail”.  Issues of researcher bias and reflexivity were discussed between 
coders in order to enhance the trustworthiness of the findings. Another strength was the fact 
the interviewer and coder RB was from the target population which is consistent with 
‘Constituent-Involving Approaches’ that suggest that the inclusion of indigenous staff leads 
to awareness about cultural features that go beyond the obvious observable characteristics 
such as language and dress (Kreuter et al., 2002). 
Given that this was a very small Sudanese sample of mainly women, in treatment in a 
semi private facility in the capital city, the extent to which we can infer and generalize to the 
larger population from the findings is limited. However, the goal of qualitative research is not 
generalization, but rather understanding peoples’ perspectives and experiences from their 
personal stories and comparing cases to discover patterns and themes (Patton, 2014). 
Although the small sample would appear to be a limitation of the study, it is important to note 
that recruitment continued until saturation was reached (data replication/redundancy) i.e. 
similar findings were found in subsequent interviews indicating that the sample size was 
enough to fully capture the experience (Bowen, 2008). The representativeness of the sample 
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was another limitation because the proportion of male factor infertility was smaller than that 
reported globally, 25% and 40-50%, respectively (Kumar & Singh, 2015), because of the lack 
of male participants (n=3 of 20) and because the average age at marriage (average age minus 
average duration of marriage) for women in the sample (26.2) was older than the average age 
at marriage in Sudanese data [22.7] (United Nations, Department of Economic and Social 
Affairs, Population Division, 2015). These limitations would require duplication of 
interviews with more men and to ensure that the proportions of male to female factor 
infertility were reflective of true proportions.  
The fact that this study was conducted in Sudan with mostly urban, educated 
individuals necessitates further replication in other locations with more diverse samples to 
enable a greater understanding of the need for fertility education and the acceptability and 
feasibility of the screening tool with those not represented in the current study. The 
interviewer was female which could have impacted social desirability bias and self-
disclosure. Two of the men stated that they had engaged in premarital sex but none of the 17 
female participants stated that they had. While it is possible that the woman might have been 
telling the truth, it is more likely that they did not want to admit to engaging in premarital sex 
given that Sudanese social norms strictly prohibit this behaviour for women. The exception 
was the one man who reported not engaging in premarital sex, but he was interviewed in the 
presence of his wife, therefore his self-disclosure might have been related to her presence. 
Implications of Findings 
The findings of this study can be used to inform implementation of the FertiSTAT in 
Sudan and the Middle East (and used to inform adaptation in other regions) and to endorse 
knowledge about optimal messaging in fertility education and other health promotion 
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endeavours. The data can also be used to make recommendations and suggestions for future 
research to fill gaps in knowledge.  
Results of the current study lend support to the idea that culturally acceptable 
implementation of health promoting interventions like the FertiSTAT requires cultural 
sensitivity and tailoring of tools to the level of understanding and conservativism (modern v 
traditional) of not only the population but also of each individual. Cultural sensitivity can be 
achieved through a thorough understanding of the target audiences’ culture which can be 
enhanced by garnering the support of people from the culture as was the case of the 
interviewer and research assistants being Sudanese and more aware of cultural factors 
(Kreuter et al., 2002). Results and interpretations can then be translated to print materials and 
seminars for fertility education (and other health education campaigns). The findings 
indicated that although taboo topics may not be acceptable to everyone, this does not mean 
that discussions about them should be avoided, rather a culturally and individually sensitive 
way to communicate about them should be sought. Participants suggested that sensitive 
topics should be addressed directly. Beyond this recommendation, the overreaching idea 
about tailoring information to the individual’s level of religiosity or conservativism would 
suggest that sensitivity in provider version and appropriate titles to allow the provider to 
explain in the most appropriate way.  For example talking about sex in a more conservative 
society like Sudan would be to address sex within the context of marriage and in the service 
of achieving reproductive goals. One such way would be through an integrated awareness 
campaign that includes information about sexual education, contraception and infertility 
within one comprehensive pamphlet or poster. Such a campaign can be integrated within 
existing healthcare and referral systems by being available at all levels of healthcare (e.g. 
primary health clinics, larger public hospitals and smaller private tertiary clinics). It can also 
be disseminated in schools and public places (e.g. markets, mosques). Specifically with the 
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flipchart, cultural tailoring can be achieved by making questions on the provider side of the 
flipchart that can help the provider gauge level of understanding, education and 
religiosity/conservativism, and tailor the materials/questions to the individual’s specific level.  
The need for several versions noted by the stakeholders (chapter 2) was confirmed 
from the data in the current study. Most notably that versions need to be specific to the target 
audience and setting, for example adolescent boys might not respond to pamphlets but will be 
interested in seminars, young girls might be more willing to engage with a women provider 
and that provider administered versions would allow for tailoring to individual needs. In 
addition to being an educational tool (like the flip chart) FertiSTAT can be used as a screen 
(like the checklist noted in chapter 2) and as an ice-breaker, a tool to start communication, as 
a starting point for discussion between patient and provider (e.g. flip chart, or checklist), as a 
way for people to talk about their fertility issues with each other (e.g. pamphlet) and as a way 
to introduce sex education and contraception within a culturally sensitive and acceptable 
context (e.g. poster).  
Results of this study support reports in the literature about cultural sensitivity and 
cultural tailoring of health promotion tools for use in new contexts (Betsch et al., 2013; 
Kreuter et al., 2002). For example, the findings suggest that information which is compatible 
with worldviews is more readily acceptable and would lead to more efficient health education 
(as is the case with personalized information). That said, more research is need to confirm 
what the specific factors impacting behavioural change in different settings are (Betsch et al., 
2013, Kreuter et al., 2002). Consideration of level of self-disclosure could be important and 
can be based on social desirability as evidenced from the data and the literature (Krumpal, 
2013). Finally to enhance impact, fertility educational campaigns, in addition to providing 
information, should dispel common myths about the health behaviour or illness (Bunting and 
Boivin, 2008).  
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Future Research 
Future research specific to implementation of FertiSTAT in the Middle East requires 
more focus groups in other countries (in the Middle East) and different samples (e.g. men, 
rural), formal translation and back translation of tools into Arabic. Small scale roll out of 
Arabic version of tools in samples of about 100 participants or more in several locations (e.g. 
urban and rural), followed by large scale country wide roll out. Simultaneously, the protocol 
for cultural adaptation of the FertiSTAT could be replicated in other regions (e.g. Asia) 
including identifying additional RFs, conducting stakeholder meetings and focus groups as 
well as translation and back translation of FertiSTAT into other languages and pilot and 
large-scale testing. Most importantly it will be integral to conduct follow up studies to 
measure impact after roll out of FertiSTAT on outcomes such as behavioural change in the 
lifestyle RFs (e.g. less smoking, more condom use) and change in help seeking practices (e.g. 
visiting the gynaecologist for menstrual dysfunction and signs of infection like STIs and BV), 
as well as changes in guidelines, policies and provider behaviour (e.g. testing for GTB in 
areas of high TB prevalence).   
Conclusion 
The Arabic saying ‘no embarrassment in knowledge’ echoed in the data captures the 
importance of health promotion and cultural sensitivity. Successfully implementing the 
FertiSTAT in Sudan and the Middle East would require an integration of cultural targeting 
and tailoring and the specific suggestions (format, setting, source and timing) to address 
perceived challenges to its effective use, namely the transition between modern and 
traditional societies, issues of self-disclosure and understanding of being at risk.  These 
challenges highlighted the need for cultural tailoring that goes beyond culturally targeted 
materials that suit the entire culture to specific modifications to be compatible with each 
user’s worldview. It would appear that addressing the challenges identified through cultural 
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tailoring as suggested by the data and the literature would be the most effective way to 
achieve cultural sensitivity through congruence with worldviews.  An understanding of the 
deep structure of Sudanese culture would ultimately enhance the feasibility and acceptability 
of using this tool in Sudan. Cultural adaption of FertiSTAT based on cultural tailoring will be 
congruent with the theoretical bases for the development of the tool that emphasize that 
personalized risk and guidance enhance impact of health messaging. Finally, lessons learned 
extend beyond implementation of FertiSTAT to fertility awareness and health promotion in 
general.  
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Chapter 5 
General Discussion and the Adapted FertiSTAT 
The overall aim of the studies presented in this thesis was to culturally adapt the 
Fertility Status Awareness Tool (FertiSTAT) for use in Sudan and other LMIC. These studies 
addressed the importance of fertility health in LMICs, specifically preventative care within a 
multidisciplinary global perspective. Adaptation processes encompassed an evaluation of the 
comprehensiveness of the items (Chapter 2, Study I and Chapter 3) and acceptability and 
feasibility including an understanding of the best methods for constructing and conveying 
materials (Chapter 2, Study II and Chapter 4). The results demonstrated that superimposing 
health messaging on new target populations would not be beneficial unless 
comprehensiveness, acceptability and feasibility were considered. The processes involved 
helped demonstrate an approach that can be utilized for the cultural adaption of other health 
promotion materials. Through these processes several conceptual considerations emerged. 
For example, risk profiles of given populations should not be assumed to be universal, culture 
encompasses and influences much more than language and rituals and terminology used to 
describe fertility problems and the determinants of definitions are context specific. 
Additionally, several methodological considerations arose, namely, sampling and dearth of 
good quality primary studies. Knowledge attained from the activities was aggregated to 
produce the adapted versions of the FertiSTAT to be tested on Sudanese populations. This 
chapter presents these conceptual and methodological considerations as well as the adapted 
versions of the FertiSTAT.  
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Key Conceptual Considerations 
Culture is Bigger than its Practices 
Although, RFs could have a common underlying mechanism globally it would be 
mistaken to assume this universality necessarily implies similarity in the fertility RFs to 
which people are exposed globally or the method by which awareness of risk could be 
enhanced. There are many RFs such as age, reproductive disorders (e.g. endometriosis) and 
lifestyle (e.g. smoking) that affect women’s fertility universally (e.g. see Appendix B; 
Schmidt, 2012; Stilley, 2012; Dechanet, 2011). However, it can be inferred from the results 
of studies carried out during this project that there may also be RFs for fertility problems that 
are not universal. These non-universal RFs can be due to cultural practices and rituals such as 
CSG and FGM/C, to infections more prevalent in certain regions such as GTB or to misuse of 
clinical practices such as D&C. Therefore, the implementation of successful fertility 
awareness needs to be inclusive of such divergent risk profiles.  
The lack of universality in risk profiles can be in part due to the factors influencing 
behaviour of individual’s within different societies and one such factor that became apparent 
from the studies was the influence of culture. Results of the current studies demonstrated that 
culture is the backdrop for risk, such that risks and risk exposure is influenced by culture, 
including norms about health protection behaviours (e.g. engaging in safe sex). Culture has 
been intensely explored in health promotion because racial and ethnic differences are 
associated with numerous health issues, such as rates of mortality and morbidity of various 
diseases, prevalence of risk behaviours and the determinants of health behaviours (e.g., U.S. 
Department of Health and Human Services, National Institutes of Health, National Cancer 
Institute, 2005). Therefore, to assume that culture could only influences fertility health 
through specific rights and rituals (e.g. FGM/C), would be naïve. Culture is a broad term and 
it will have many effects on behaviour but only some will have an effect on health and it is 
important to target those and not all rituals. For example, tribal facial marking would not 
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have an impact on reproductive health while genital cutting would. It is the change to the 
anatomy or physiology that will determine the mechanism or the impact of exposure rather 
than the ritual or practice per se. Given that culture can impact on exposure to risk in many 
ways (i.e., cultural rituals such as FGM/C, norms dictating health protecting behaviours, 
nature and exposure to risk behaviours) the multifaceted influences of culture need to be 
taken in to consideration in health promotion efforts. 
Terminology and Decisions for the Selection of Risk Factors 
The work presented in this thesis raised important considerations for what a fertility 
awareness tool could and should include as risks. The FertiSTAT was conceptualised as a 
multifactorial tool that could inform on risk status for reduced fertility. By reduced fertility 
was meant reduced ability to achieve a pregnancy.  Women ticked each sign, symptom or 
preventable cause of fertility problems that applied to them and these individually and 
collectively informed on absence or presence of risk for reduced fertility for them. The tool 
minimised the number of indicators that needed to be included in the tool by only including 
indicators that did not have overlapping signs or symptoms. For example, menstrual 
irregularity puts women at risk of reduced fertility but including all causes of menstrual 
irregularity (e.g., strenuous exercise, weight loss) would reduce the predictive weight of each 
indicator, and make FertiSTAT cumbersome and unlikely to be useful in a practical context. 
Instead, the FertiSTAT included the signs of menstrual problems (short, long, irregular and 
absent periods) without naming each cause. It then provided guidance about when to seek 
medical help for these problems.  Further, only indicators that women could detect where 
included because it was a self-administered tool. The work of adapting the FertiSTAT for 
LMIC called into question some decisions taken in the original development of FertiSTAT.  
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First, was the question of which outcome (and therefore related risk) should fertility 
awareness tools target. In the current studies the decision of which of the new RFs to include 
was initially based on whether there was enough meta-analytic and aggregated evidence to 
support its inclusion as an indicator for reduced pregnancy. FGM/C, HIV, BV and GTB were 
recommended because meta-analysis showed a significant association with infertility (12 
months inability to achieve pregnancy). However in the case of CSG because results 
indicated significant association with stillbirth and neonatal death, it became apparent that the 
decision of whether CSG should or should not be included would ultimately depend on the 
perceived function of the tool. As noted, the developers of the FertiSTAT intended it to be 
used as a tool to raise awareness about fertility problems, from their perspective that included 
only problems achieving pregnancy (i.e., based on definition of infertility which only 
includes pregnancy, Bunting & Boivin, 2010). However, for LMIC the available evidence 
suggested the need for a more encompassing definition for fertility (Chapter 3, pp 50) that 
included the inability to achieve a live birth. This raises the question of how fertility problems 
in general should be defined in the context of fertility awareness. As discussed previously 
(Chapter 3, pp 50), there has been a range of definitions used for fertility problems including 
diverse outcomes (pregnancy, live birth), duration of exposure (number of months required 
before infertility is declared) and time span (that encompasses the period of infertility). This 
diversity is due to specific utility such as demographic, epidemiological or clinical purposes 
(Chapter 3, pp 50). New approaches to thinking about prevalence, for example the current 
duration, should also be evaluated (Polis, Cox, Tunçalp, McLain & Thoma, 2017; Slama et 
al., 2012). Current duration is used in cross-sectional examination of infertility prevalence 
estimates and is a way of measuring the current duration of unprotected intercourse (Polis et 
al., 2017; Slama et al., 2012).  
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In the primary studies it was noted that when the outcome was indicative of inability 
to achieve pregnancy the duration of exposure used tended to be 12 months, whereas for live 
births it was five or seven years, in line with discipline based definitions previously 
documented in the literature (Gurunath et al., 2011). In light of the diversity that already 
exists, and the plurality of purpose according to discipline, the aims of fertility awareness 
would be better served by having a broader definition of fertility problems in FertiSTAT for 
LMIC, including inability to achieve and sustain a pregnancy, or have a desired live birth. 
A second issue arising from the work of this thesis is what fertility information 
women can be reasonably expected to have at the time of completing the FertiSTAT. The 
FertiSTAT is a tool to be used to raise awareness about risks for fertility problems so that 
people can make informed decisions about their health, or know when to seek timely medical 
advice.  In the original FertiSTAT reproduction was not described and medical conditions 
impacting on fertility (e.g., cancer) were not included. It was assumed that women would 
know about such matters through their education or specialists. For example, regarding 
gestational RFs, it is safe to say that prenatal care in the UK would ensure that if a woman 
was at increased risk for a specific gestational problem she would be informed about this and 
the necessary action would be taken (e.g., screening for various conditions such as 
hypertension, see NICE Clinical guideline [CG62]). It cannot be assumed that the same 
would be true in LMIC where health care systems are overburdened, literacy rates are 
suboptimal and prenatal care may not be universal or its utility not well understood, thereby 
influencing its uptake. The same is true for medical conditions such as diabetes.  In the UK 
these need not be included because the impact of such diseases on fertility would be 
communicated by the treating physician to the patient (e.g. effects of cancer treatment, see 
Royal College of Physicians, Royal College of Radiologists, Royal College of Obstetricians 
and Gynaecologists, 2007). Again, it cannot be assumed that the same would be true in 
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LMIC. Therefore, the inclusion of such gestational RFs and medical conditions would 
enhance fertility awareness in LMIC more than it would in the UK.  
A third issue arising from this thesis is how to handle trade offs between 
comprehensiveness and implementation in designing fertility health awareness tools.  Even 
though the inclusion in the adapted FertiSTAT of each of the RFs found to be associated with 
fertility problems (Chapter 3) would be in line with the broader understanding of fertility 
problems recommended, this comprehensive inclusion may not be practical. The inclusion of 
many individual RFs could dilute the predictive ability (validity) of the tool if their 
mechanism of action is already included in the FertiSTAT (e.g., including all causes of 
‘absence of period’). Second, an exhaustive list could be time consuming and impractical to 
administer therefore reducing the likelihood of its use and increasing the cost-benefit ratio of 
the tool. An alternative approach might be to include categories of risk rather than all risks.  
For example, a question about presence or absence of medical conditions could include all 
medical conditions known to affect fertility (e.g., ‘Have you ever been diagnosed with any of 
these medical conditions: diabetes, cancer, kidney disease, sickle cell anaemia, thyroid 
disease, lupus’). This approach would be more comprehensive and culturally appropriate (i.e., 
assumption about base knowledge) than the original and yet as brief and cost effective. In 
light of all these considerations, it would be recommended that in LMIC the FertiSTAT could 
comprise the universal (original) FertiSTAT, the non-universal RFs, medical conditions and 
the RFs that have an impact on ability to achieve live births. The validity and predictive 
ability of the adapted FertiSTAT would need to be re-examined to determine if the addition 
of the new RFs diluted the predictive ability of the tool as a whole and to determine if each of 
the new RFs was an independent factor in prospective studies.  
A final issue related to the inclusion of RFs that became apparent from the results was 
the fact that results aggregated across the literature indicated that the mechanism of action of 
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several RFs involved PID (HIV, BV, D&C) and TFI (FGM/C).  These results diverged from 
the more general reproductive health literature emphasizing that in LMIC infections and PID 
are related almost exclusively to maternal infection (post-abortion and postpartum) and STIs 
(e.g. see, Ericksen & Brunette 1996; WHO, Infections, pregnancies, and infertility, 1987) 
rather than the more diverse causes shown in the reviews presented in the thesis. The findings 
suggest that perhaps the focus needs to be redirected to consider the impact of other prevalent 
diseases such BV and preventing all RFs that can lead to infection. Clinical care should also 
be directed towards treating all infections (whatever their cause) before they ascend the 
reproductive tract and lead to more severe consequences such as PID and TFI.   
Considerations about how to Address Fertility Awareness in LMIC 
An important question that emerged from the current studies was how best to increase 
priority for fertility problems in national health plans in LMIC. It is likely that many actions 
would be needed, at a minimum would seem to be first to establish the need for fertility 
health awareness and second to emphasise that preventative measures are perhaps the most 
impactful in LMICs.  
The importance of fertility health awareness comes from several arguments; the 
severe consequences, especially for women in LMIC and the ethical arguments which include 
equal rights to reproductive health and autonomy, LMIC not bearing the burden of over 
population, and prevention being the most cost effective for low resources settings were 
health care systems are overburdened (Ombelet, 2011). Globally, childlessness has severe 
negative psychosocial consequences and the burden is often borne by women in LMIC (Dyer, 
Abrahams, Mokoena, Lombard and van der Spuy, 2005; Greil, Slauson-Blevins & McQuillan, 
2009; Riessman, 2000; Rouchou, 2013; Van Balen & Bos, 2010).  
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As noted previously prevention is often key to health care initiatives that aim at 
equity. Prevention through increasing knowledge is cost effective (ESHRE Task Force on 
Ethics and Law, 2009; Macaluso et al., 2010; Ombelet, 2011) and proven to be efficacious 
(Kok et al., 1997), especially when culturally sensitive (Kreuter et al.,2002; Resnicow et al., 
1999). Moreover, it is well known that fertility knowledge is poor globally and in LMIC (Ali 
et.al., 2011; Dyer, 2008), therefore, a tool like FertiSTAT that aims to enhance fertility 
knowledge would be beneficial and cost effective. In addition to increasing knowledge the 
FertiSTAT provides personalized feedback which according to HBM the experience of 
personal risk is a motivator for acceptance of health messaging (Noar et al., 2007; Parkes et 
al., 2008; Petty & Cacioppo, 1986).  
Given the importance of fertility health awareness and the utilization of a preventative 
approach, raising awareness could be achieved by ensuring that tools developed and adapted 
are purposed for the context. LMIC contexts present unique instances of cultural diversity but 
are united by dearth of resources. Therefore, health promotion activities need to be purposed 
not only to be cost effective but to incorporate these cultural variances. 
As previously noted, culture influences risk behaviours and the exposure to risk, 
additionally the current set of studies also demonstrated that health promotion can be more 
impactful if health messaging is compatible with worldview, congruent with the literature 
(Betsch et al., 2016). Therefore, communication of health messaging needs to be done in the 
most culturally sensitive manner to achieve maximum benefit (Betsch et al., 2016; Healey et 
al., 2017). This cultural sensitivity should incorporate both cultural targeting of new 
populations and cultural tailoring to be appropriate for each user (Kreuter et al., 2002; 
Kreuter & Skinner, 2000), as noted previously. This means that self-administered versions, as 
was the original format for FertiSTAT, may not be the most suitable format for all 
populations.  
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Another issue that emerged was whether raising awareness in LMIC should also 
emphasize the importance of personalized risk, as has been demonstrated in non-LMIC 
contexts (e.g. see Noar et al., 2007; Parkes et al., 2008; Petty & Cacioppo, 1986; Sohl & 
Moyer, 2007). Alternatively, it might be more cost-effective to have generic health messages 
that can reach a wider audience. However, results from current qualitative data (Chapter 4) 
would suggest that the need for personalized information was of utmost importance and could 
possibly influence the acceptance of the information. These results were based on 
information from a small sample and would therefore need to be replicated with a larger more 
diverse sample, to allow generalizations.  
Additionally, a comprehensive fertility health awareness package would need to not 
only incorporate RFs relevant to a specific setting but should also include basic information 
about reproduction as well as de-mystifying commonly held myths. This is important 
because, not only is knowledge about fertility problems poor, knowledge about reproductive 
issues such as women’s fertile period was low in studies in both developed and developing 
nations (Sydsjo, Selling, Nyström, Oscarsson & Kjellberg 2006; Byamugisha, Mirembe, 
Faxelid & Gemzell-Danielsson 2006). Bunting and Boivin (2008) found that participants 
were significantly more able to correctly identify the impact of RFs, than myths or healthy 
habits on fertility. This was corroborated by female participants in the pilot study who were 
unaware of basic physiology of intercourse (Chapter 4, pp 305).
All previously mentioned considerations suggest that health promotion should be 
tackled from a global and multidisciplinary approach that incorporates an understanding of 
how different cultures influence exposure to risk as well as acceptance of health promotion. 
Global, multidisciplinary approach. 
Global health transcends national boundaries and aims to provide health equity among 
nations in prevention and clinical care through a highly interdisciplinary and 
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multidisciplinary approach (Koplan et al., 2009). In that sense the objectives of the current 
project were motivated by the aim of globalizing the FertiSTAT and the combination of all 
activities and the fact that the project was conducted by and advised on by researchers from 
different countries enabled us to propose that a global perspective was used in the aims, 
objectives and activities of the project. Additionally, the project took a multidisciplinary 
approach to address the multifaceted issues involved. The development of the original 
FertiSTAT was rooted in health psychology as it focused on individual processes contributing 
to that person's health, and theories like the HBM (Bunting & Boivin, 2010). Through the 
process of adapting the tool, interest shifted to include how behaviours such as FGM or CSG 
and diseases such as HIV and GTB can affect health and because these are influenced for the 
most part by cultural norms, not only on an individual level like smoking, they are considered 
public health issues as they are population based. Additionally, the intervention is 
preventative and is therefore inherently a public health issue since public health is about 
preventing people from getting sick and promoting wellness by encouraging healthy 
behaviours (Koplan et al., 2009). In general, health promotion is an intersection between 
these two disciplines because it uses health psychology models about individual behaviour 
and sets it within the backdrop of societal based issues, so that the focus of intervention 
moves beyond the individual's behaviour towards societal and environmental issues (Kok, 
2014).  This global multidisciplinary perspective entailed tackling the adaptation process 
from several dimensions to shed light on the cultural underpinnings that could influence 
content and appropriate approach of health promotion activities.  
Integrated life course approach to awareness. 
There is a growing movement towards taking a holistic life course approach to 
women’s health especially sexual, fertility and reproductive health (e.g. see Stephenson, 
2011), recently advocated in WHO training framework (WHO, Development and Research 
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Training in Human Reproduction, 2017). The framework highlights the interlinked nature of 
sexual, fertility and reproductive health, as has been demonstrated in the present study.  For 
example, STIs (sexual) have an impact on ability to become pregnant (fertility) and 
potentially ability to sustain or have a child (reproductive). It became apparent from the 
results of the studies in the thesis that this integrated holistic life course approach to sexual, 
fertility and reproductive health is the most optimal approach in Sudan and possibly other 
LMIC. Evidence from interviews (Chapter 4, pp. 305) indicated that some women felt 
comfortable discussing otherwise taboo topics such as sexuality in the context of fertility and 
reproduction and marriage. Furthermore, during the development of the flipchart (Chapter 2, 
pp. 31) it became apparent that basics of reproductive functioning such as intercourse would 
need to be explained due to lack of basic knowledge (as noted on pp. 350). An integration of 
all results in the thesis, led to the conclusion that women want an integrated sexual, fertility 
and reproductive health education. 
Future adaptations of fertility awareness tools specifically and sexual, fertility and 
reproductive health messaging generally could benefit from such an integrated approach. This 
approach could provide several advantages, such as advocacy for and acceptance of 
potentially sensitive matters (e.g. sexuality, gender-based violence), practicality, cost-
effectiveness and could benefit from researches in all relevant areas. Provision of such a 
topographic overview of the possible threats (and opportunities) in women’s health would 
help prepare women for informed decisions about their health. Therefore, information within 
health messaging should complement awareness activities and be conveyed in a manner that 
capitalizes on the holistic way women view their reproductive lives.  Carefully crafted 
educational content tailored to LMIC via effective methods (e.g., effective infographics, 
Otten, Cheng & Drewnowski, 2015) could depict the different aspects of sexual, fertility and 
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reproductive health issues faced at different times throughout the life course and how they 
interrelate with each other within and across time. 
Key methodological Issues 
The methodology used in the project was relatively strong because a mixed methods 
approach was used, such that quantitative evidence including survey and systematic reviews 
was combined with qualitative evidence from stakeholder meetings and patient interviews. A 
mixed methods approach is one that combines qualitative and quantitative methodologies to 
provide a more elaborate and deeper understanding of a phenomenon (Johnson, Onwuegbuzie 
& Turner, 2007). Therefore, the agreement or convergence of results of two methods 
validates the results as occurring due to real effects and not as a result of methodological 
characteristics (Bouchard, 1976), as was the case in the current studies. However, several 
limitations existed. 
Sampling Issues 
The main limitation of the project was recruitment in the survey of fertility doctors in 
LMIC (chapter 2). Although 150 potential participants were approached through email 
invitation, only 41 (27.3%) participated. Additionally, not all participants answered all 
questions in the survey, therefore the response rate for questions varied. The low survey 
response rate, could affect results because it is unknown whether responders were 
representative of the cohort of fertility doctors from LMIC. This is important because 
samples need to be representative of the populations to which generalizations will be made 
(Heiman, 1999).  It could be that only doctors with an interest in fertility awareness 
completed the survey or only those with enough time and they could have a different 
perspective from doctors not involved in fertility or being busier. However, the data (Chapter 
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2, pp 23-24) indicated that the doctors varied in terms of private and public sector practice 
and with regards to number of patients seen per week, indicating that while some were 
engaged in both private and public practice and saw upwards of 20 patients per day, others 
were only in private practice and saw about five patients per day. More importantly, the low 
response rate is not unique to this sample, as it is known that when surveys are received 
without prior notice, as was the case in our study, the response rate is approximately 20% 
(Kelly, Clark, Brown & Sitzia, 2003). It is important to note that information from the survey 
was not relied on solely in the identification of RFs. Rather, the survey information was used 
to confirm the selection of RFs identified through literature search and expert consultations 
using considerations cited in the literature (Ezzati et al., 2002; Chapter 2, World Health 
Report, WHO, 2002). Therefore, the limitations of the survey may have little impact on the 
results of the project as a whole.  
Sampling issues were limitations of the qualitative interviews as well (Chapter 4). 
These interviews were conducted to ascertain acceptability and feasibility of the adapted 
versions by potential users but were only conducted with Sudanese couples attending at an 
infertility clinic. This sample might not have been representative of typical potential users in 
that it was mainly urban, educated women with fertility problems that were for the most past 
due to female factor infertility. Interviews with proven fertile and untreated infertile couples 
might have led to different conclusions about the acceptability and feasibility of the adapted 
FertiSTAT. For example, couples who have children and have never faced fertility problems 
may not see the importance of raising awareness regarding fertility health and infertile 
couples who are not in treatment may be in denial about their problems and take offence.  
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Primary Studies in Systematic Review 
The main limitations of the systematic reviews related primarily to the lack of 
availability of good quality primary studies.  The lack of good quality primary studies testing 
the association of the identified RFs with fertility problems, limited the generalizability of the 
results of the systematic reviews. Available primary studies were all observational, limiting 
conclusions about causality (Mann, 2003), and for the most part had methodological 
weaknesses especially regarding operational definitions of outcomes and clinical sampling.  
Adapted versions of the FertiSTAT 
Cultural adaption of the FertiSTAT lead to the development of two tools, a flipchart 
and a provider checklist (see Appendices T and U). These tools were based on an integration 
of all materials, knowledge and experiences garnered through the activities described in the 
thesis. Both tools contained questions about age, time trying, reproductive medical history 
(e.g. endometriosis, PID and BV), lifestyle risk factors (e.g. Smoking) that would also 
include practices and rituals (e.g. FGM/C), and medical history (communicable e.g. GTB, 
HIV and non-communicable diseases e.g. diabetes). The one page checklist consisted of two 
sections (women and men) and the flipchart consisted of 34 pages each for the provider and 
the user. The provider side included instructions to assess the user’s particular level of 
education and understanding to convey information in the most appropriate manner. 
Additionally, these instructions included an assessment of religiosity and modern-traditional 
values for sensitive topics such as sex, alcohol and drug.   
The adapted tools were culturally targeted at Sudanese populations by including risk 
factors (RFs) pertinent to Sudan, namely, FGM/C, CSG, BV, GTB and HIV and by being 
linguistically and graphically culturally sensitive. Furthermore, an understanding of the deep 
structure of Sudanese culture enhanced the adaptation of these tools for use in Sudan, as 
evidenced by the need to allow for cultural tailoring of communication to suit the cultural 
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attributes of each user. In addition to the adapted tools, the specific studies within the thesis 
can be used as a protocol for adaptation of the FertiSTAT to new contexts. The original 
FertiSTAT provided women with a personalized assessment of their risk of fertility problems 
(Bunting & Boivin, 2010) and the adapted versions went further by being culturally targeted 
at a sub-population of the LMIC, Arab, African and Muslim culture (i.e. Sudanese 
population) and by affording the space necessary to provide cultural tailoring to the needs of 
each individual within that subculture.  
Future Research 
Results of the project lead to the conclusion that there is a need for more primary 
studies to be conducted to test associations of exposure to non-universal RFs and fertility 
problems. These studies should adhere to best practice in research methodology including 
using operational definitions of fertility problems such as those in the newly published 
ICMART-WHO glossary of terminology relevant to medically assisted reproduction (Zegers-
Hochschild et al., 2017). Where possible RCTs, or stratified RCTs should be carried out to 
enable assessment of cause and effect relationships between the non-universal RFs and 
fertility problems. Once more primary studies of high quality are conducted, systematic 
reviews should be updated to definitively ascertain the impact of exposure to non-universal 
RFs on fertility health.  
Future research specifically regarding fertility awareness and the adapted FertiSTAT 
tools should include several issues. First, updating the personalized guidance, to incorporate 
the new RFs, using the same methodology applied in the development, for example Delphi 
rounds with fertility health experts (Bunting & Boivin, 2010). Second, testing the adapted 
versions on more diverse populations within the Sudan (e.g. rural, fertile and/or adolescents). 
Third, testing the new FertiSTAT tools, to determine the predictive ability of the newly 
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incorporated RFs and whether they are independent and to determine if the flipchart and 
checklist modalities are the best methods to convey the information. Fourth, adapting the 
materials to other LMICs and testing new materials in those populations. Finally, further 
research on fertility awareness programmes in LMIC should not only focus on fertility 
problems, but a wider perspective more inclusive of all aspects of fertility health such as 
reproductive health, family planning, prevention of STIs and HIV, should be applied.  
Conclusion 
The principal lesson learnt through these studies was that it was possible to adapt the 
FertiSTAT but like other health education tools it required cultural adaptation because it 
could not be assumed that a global set of RFs would be able to capture all issues unique (and 
health critical) within various specific environments. Risk profiles of nations, regions and 
globally need exploration and should not be assumed to be universally analogous. Therefore, 
evaluation of the content of health messages to be culturally accurate by incorporating risk 
profiles of target populations is necessary. Furthermore, cultural adaptation needs to go 
beyond cultural targeting that includes translations and graphics to cultural tailoring of 
materials to suit individual needs. Finally, investigating the most suitable way to convey 
health messaging, including the most sensitive wording, format, setting and source need to be 
investigated within the target populations and using different methodologies (e.g. survey, 
interviews and stakeholder meetings).  
Diversity necessitates examination of the influence of global diversity on risk profiles, 
appropriate language of communication, target audiences and settings of implementation, and 
ultimately the need to engage in a process for the adaptation of fertility awareness tools.  
Lessons learnt could be applied specifically to fertility health and generally to health 
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promotion to enhance global health equity, to alleviate suffering and to help ease the burden 
of disease for individuals, communities, healthcare systems and providers globally.  
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Appendix B: Summary of Findings from Reviews on the Impact of Original FertiSTAT Risk Factors on Fertility 
Risk factor Summary findings Type of review Source 
Age, lifestyle and 
reproductive  
Age Increasing parental age is a risk factor for reduced fertility. Narrative Review Schmidt, 2012 
Age Birth rate starts to decrease when a woman reaches 35 years old. Young women 
conceive sooner than older women. Infertility increases as the age of the female 
increase. 
Narrative Review Liu, 2011 
Appendectomy No statistical association between appendectomy and infertility Systemic Review and 
meta-analysis of RCTs 
Elraiyah, 2014 
Pelvic surgery Adhesions are a common complication of gynaecological surgeries. Adhesions affect 
the interaction between the fallopian tube and ovaries consequently infertility can 
occur. 
Narrative review Hirschelmann, 2012 
Chlamydia Inflammatory tissue destruction in response to infection leads to the development of 
tubal infertility and ectopic pregnancy 
Narrative Review Carey 2010 
Endometriosis Dysfunction of pituitary-ovarian axis altering the feedback pathways, 
folliculogenesis, lower levels of estrogen and progestron, altered luteal function and 
the fact that they ovulate fewer oocytes are all accounted for infertility in women 
with endometritis 
Narrative review Stilley, 2012 
Lifestyle Fertility is decreases by being overweight and underweight. 
Folic acid and Vitamin B have been linked to infertility and spontaneous abortions. 
High alcohol consumption can affect estrogen and progestron levels leading to 
anovulation, luteal phase dysfunction and impaired implantation. 
Consumption of caffeine in moderation has no effect on fertility however some 
evidence suggest that prolongs time to conception. 
Smoking adversely effects fertility and pregnancy outcomes. 
Recreational drugs are associated with decrease fertility, some prescription 
medications such as anti-hypertensives can affect the female reproduction on 
different levels. 
Stress can supress the reproductive functions such as causing hypothalamic 
amenorrhea. 
Environmental pollutant can cause a negative effect on fertility. 
Evidence of oxidative stress has been found in women with PCOS, unexplained 
infertility and endometriosis. 
Narrative Review 
(in some cases review of 
reviews e.g. in smoking 
several systematic 
reviews and meta-
analyses are reviewed 
here) 
Anderson, 2010 
Lifestyle Increasing age of a women increases infertility and time to pregnancy. Narrative review Sharma 2013 
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Risk factor Summary findings Type of review Source 
Consuming more vitamins & proteins and less carbs & trans fats are recommended to 
preserve fertility.  
Body weight has significant effect on infertility. Obesity increases the risk of 
miscarriages however being underweight is associated with ovarian dysfunction and 
infertility. 
Vigorous exercise was found to have a negative effect on female reproduction by 
causing hypothalamic dysfunction and therefore menstrual abnormalities. 
Physical stress can prolong the time to conceive, however psychological stress is 
more prominent among women attending the infertility treatment. 
Smoking decrease the ovarian function and ovarian reserve. 
Marijuana use increases the risk of primary infertility. Prescription medications such 
as anti-psychotics, anti-hypertensives and chemotherapy. 
The amount of alcohol and caffeine consumed significantly affects the fertility of 
women.  
Exposure to heavy metals such as lead is reported to alter hypothalamic-pituitary axis 
and overall fertility. 
Obesity Obesity increases the risk of anovulatory infertility because of hyperandrogensim 
through granulosa cell apoptosis, peripheral conversion of androgens to estrogen 
leading to an increase negative feedback of gonadotropins and adverse effect on 
theca and granulosa because of increased leptin. PCOS is closely related to obesity 
but whether obesity causes PCOS is still undetermined 
Narrative review of 
retrospective studies 
Metwally, 2007 
Smoking Smoking effects fertility by impairing folliculogenesis and steroidogenesis. The 
effect of cigarette toxins depends on the amount and duration of exposure. 
Systemic review Dechanet, 2011 
Smoking There is a significant increased risk of infertility in women who smoked. Active 
cigarette smoking is associated with infertility. In some studies, smoking more than 
20 cigarettes per day seem to effect fertility. 
Systemic Review and 
metanalysis of 
observational studies 
(case-control and cohort) 
Augood, 1998 
STIs Adhesions cause by PID effects the tubes more than the uterus. Most of these 
pathogens lead to tubal infertility through an ascending infection. 
M. genitalium cause salphingitis-PID which may account for infertility. Ascending
infection from N. gonorrhoea, C. trachomatis, Gradenella vaginalis lead to tubal
factor sterility. Genital amoebiasis can cause damage to the female reproductive
system and sterility.. HIV adversely effects fertility but it is not understood whether
the impact is from the virus or concomitant genital infection or the effect of
treatment.
Narrative review Pellati, 2007 
Medical conditions 
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Risk factor Summary findings Type of review Source 
Asthma The inflammatory immune response caused by asthma was found in the uterus and 
tubes of asthmatic women. It causes chronic peripheral inflammation that alters the 
whole body’s inflammatory response. The link that metabolic response is a risk 
factor for asthma implies that PCOS is related to asthma as well. An imbalance of the 
adaptive immune system is associated with infertility. 
Narrative review Gade, 2014 
Cancer Cancer-directed therapies reduces the ovarian reserve. Many chemotherapy agents 
have been linked to ovarian failure and radiation can lead to damage to the 
reproductive organs. 
Narrative review Levine, 2015 
Chemotherapy Female infertility due to ovarian damage from chemotherapy is an inevitable 
consequence. Chemotherapy causes irreversible and progressive damage to the 
ovaries and germ cells. Radiotherapy impairs the development of the uterus in young 
women and increases the risk for ovarian failure. 
Narrative review Lmai, 2007 
Celiac Disease Celiac Disease is relevant in women with unexplained infertility. Delayed menarche 
and amenorrhoea are also symptoms of Celiac Disease. Secondary amenorrhoea and 
spontaneous abortions were common in women with Celiac Disease. This can be 
attribute to deficiency of trace elements and vitamins due to malabsorption 
associated with Celiac Disease, this are responsible for a healthy reproductive life 
such as abnormal ovarian axis, p 
Narrative review Ozgor, 2010 
Diabetes Type I diabetes impacts the reproduction in many ways. Women with Type I 
diabetes have hypogonadotropic hypogonadism which causes amenorrhoea. 
Disturbed insulin secretion whether high or low impacts ovarian development and 
function and can aid in the development of PCOS. Studies on young adult women 
show preserved ovulation however they found fewer pregnancies and live births. 
Hyperandrogenism has also been associated with diabetes,  
Systemic review Codner, 2012 
Lupus POF in lupus patients can be due to autoimmunity or drug related. Patients with SLE 
can suffer from menstrual disturbances which has been associated with anti-corpus 
luteum antibodies which suggests autoimmunity as well 
Narrative review Hickman, 2011 
Sickle cell disease Women with sickle cell disease have lower number of pregnancies and delayed 
menarche. 
Narrative review Smith-Whitley, 2014 
Thyroid diseases Both hypothyroidism and hyperthyroidism are linked to menstrual abnormalities 
ranging from amenorrhoea to menorrhagia and subsequently leading to lower 
pregnancy rate and infertility. 
Narrative review Poppe, 2007 
Note. STIs = sexually transmitted infections; PID = pelvic inflammatory disease; PCOS = polycystic ovarian syndrome 
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Appendix C: Approval for an Online International Survey of Fertility Doctors 
The School of Psychology Ethics Committee has considered your postgraduate project 
proposal: Adaptation of the FertiSTAT to low human development index countries 
(EC.15.04.14.4130G). 
The project has been approved. 
Please note that if any changes are made to the above project then you must notify the Ethics 
Committee. 
Best wishes, 
Natalie 
School of Psychology Research Ethics Committee 
Cardiff University 
Tower Building 
70 Park Place 
Cardiff 
CF10 3AT 
Approval for an amendment to administer paper copies of the survey in Sudan 
The School of Psychology Ethics Committee has considered the amendment to your 
postgraduate project: Adaptation of the FertiSTAT to low human development index 
countries (EC.15.04.14.4130GA). 
The amendment has been approved. 
Please note that if any further changes are made to the above project then you must notify the 
Ethics Committee. 
Best wishes, 
Natalie 
School of Psychology Research Ethics Committee 
Cardiff University 
Tower Building 
70 Park Place 
Cardiff 
CF10 3AT 
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Appendix D: Fertility Doctors Survey 
A. Recruitment Email:
Dear Sir or Madam, 
Your expert input is kindly requested in the Global FertiSTAT project. 
The World Health Organization and Cardiff University are jointly funding the 
project.  The primary investigator for this project is Professor Jacky Boivin 
(Boivin@cardiff.ac.uk) with the collaboration of Sheryl van der Poel (WHO, Geneva) and 
Ian Cooke (Professor Emeritus, Sheffield University) and the assistance of Ms Rasha 
Bayoumi (under the supervision of Prof Boivin). 
The Fertility Status Awareness Tool (FertiSTAT) is a self-administered, 22-item tool 
developed in the UK to raise awareness of risk factors affecting female fertility (Bunting and 
Boivin, 2010). The aim of the Global FertiSTAT project is to adapt this tool for use 
worldwide.  We hope that the Global FertiSTAT can be used by doctors and health care 
workers to help women get personalised fertility instructions, to protect their future fertility 
and to seek timely medical advice. 
Your professional opinion on the risk factors affecting female fertility is kindly requested in 
the present survey to generate risk factors that could be incorporated in the Global 
FertiSTAT. 
You will be asked to complete a short 9-item online survey that will only take about 10 
minutes, and all the information provided will be anonymous. You will not be asked to 
provide your name with the answers and only the research team will have access to 
anonymous data. If you wish to participate, please click the link below: 
https://cardiffunipsych.eu.qualtrics.com/SE/?SID=SV_5ARTZhwTlhLiYqp 
If you would like more information about the project or have any questions please do not 
hesitate to contact Professor Jacky Boivin or Rasha Bayoumi 
at cardiffertilitystudies@cardiff.ac.uk    
Thank you for your time and consideration 
Best regards 
Rasha Bayoumi 
PhD Student 
School of Psychology     
Cardiff University    
Tower Building    
Park Place   
Cardiff    
CF10 3AT     
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B. Online Survey:
Risk Factors Affecting Female Fertility 
The aim of the Global FertiSTAT project is to adapt the Fertility Status Awareness Tool 
(FertiSTAT), which was developed and tested in the UK and is designed to help women 
safeguard their fertility and increase their chances of potentially achieving a pregnancy. It is 
anticipated that the adapted FertiSTAT can be utilized as both a patient and provider 
screening tool worldwide.     
The World Health Organization and Cardiff University are jointly funding and providing 
technical support for the project. The primary investigator for this project is Professor Jacky 
Boivin (Boivin@cardiff.ac.uk) with the collaboration of Sheryl van der Poel (WHO, Geneva) 
and Ian Cooke (Professor Emeritus, Sheffield University) and the assistance of Ms Rasha 
Bayoumi (under the supervision of Prof Boivin).     
In this study you will be asked to provide your expert opinion on risk factors for infertility in 
a short online survey (10-15 minutes).  This is a voluntary study and you can stop 
participation by clicking out of the survey at any time. The information you provide is 
anonymous and there is no way of linking your name and your responses. The anonymous 
responses will be retained indefinitely for analysis.     
If you understand the statement above and freely consent to participate in this study, please 
tick YES and continue by clicking 'Next' below. If you do not want to complete 
the survey please close this window now     
 YES
This project has received ethical approval from the University of Cardiff, School of 
Psychology Research Ethics Committee.     
At the end of the survey you will be provided with additional information about the 
project.  Please feel free to discuss questions or concerns with Professor Jacky Boivin 
(Boivin@cardiff.ac.uk).     
(PAGE BREAK) 
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Section 1 
Original Risk Factors  
The list of risk factors associated with reduced fertility in the original FertiSTAT 
related to: 
 Age
 Time trying to conceive
 Sexual history
 Menstrual cycle length
 Sexually transmitted infections
 Pelvic surgery
 Pelvic inflammatory disease
 Endometriosis
 Alcohol use
 Tobacco use
 Class A drug use
 Caffeine use
 Steroid use
 Stress level
 Obesity
(PAGE BREAK) 
Section 2 
Medical Conditions    
Please indicate whether you think any of the following medical conditions or their 
treatment (e.g., medication, surgery) reduce fertility and should be included in the 
revised FertiSTAT.     
Should the condition be included in Global FertiSTAT? 
YES NO 
Diabetes   
Kidney disease   
SLE (lupus)  
Sickle cell anemia  
Cancer   
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Please list below any other medical condition(s) that you think affect fertility and should 
be considered in the Global FertiSTAT? 
(PAGE BREAK) 
Section 3 
New Risk Factors  
The following is a list of potential new risk factors that could be included in the Global 
FertiSTAT.  Please indicate if you think any of these factors should be included and 
state why in the column ‘reason/justification’. 
You can go back to see the original FertiSTAT items at any time by clicking the 
<<Back>> button. 
Please spell out any abbreviations you use  
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If you don’t 
have a reason 
please leave 
blank 
Should be included in Global 
FertiSTAT 
Reason/justification 
for inclusion 
YES   NO Answer 
Post-abortion 
Infection  
 
Postpartum 
Infection 
 
HIV  
Genital 
Tuberculosis 
 
Bacterial 
Vaginosis 
 
Repeated D&C  
Cervical 
Electrocautery 
 
Female Genital 
Circumcision  
 
Consanguinity 
(couple blood 
relatives) 
 
Waterpipe 
smoking 
 
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Other Risk Factors 
Please state other risk factors you think reduce fertility and that could be included in 
the revised FertiSTAT: 
Please include as many factors as you wish. For the present study it is sufficient to state your 
clinical or professional experience independent of actual evidence for or against these 
factors.  There are no right or wrong answers. 
New Risk Factor 
Reason/justification 
for inclusion 
Particular level 
(critical threshold) 
Other (1) 
Other (2) 
Other (3) 
Other (4) 
Other (5) 
Please provide any other comments or feedback about the Global FertiSTAT project or 
this survey?  
(PAGE BREAK) 
Medical professional background and practice 
1. In which country do you practice?
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2. What is your specialization? Please check all that apply:
 Obstetrics and Gynaecology
 Reproductive Medicine Sub-speciality
 Reproductive Endocrinology and Infertility (REI)
 Other Training in infertility, please state:  ____________________
 Other Certification in infertility, please state:  ____________________
 Other medical training, please state:  ____________________
3. How many years have you been a medical doctor?
4. How many years have you been a fertility doctor?
5. Where do your fertility consultations take place? Check all that apply
 Primary Health Care
 Public hospital
 Private hospital
 Private clinic
 Other, please state: ____________________
6. How many fertility patients do you see per week?  By fertility patients we mean patients
having trouble conceiving.
7. What percentage of your practice is spent with fertility patients?
SUBMIT 
(PAGE BREAK) 
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Further Information about the Global FertiSTAT project 
Adaptation of the FertiSTAT to Global Settings 
Thank you for your time in completing this survey 
 The Fertility Status Awareness Tool (FertiSTAT) is a self-administered, multi-factorial tool 
that can enable women to get personalized fertility guidance (Bunting and Boivin, 2010). The 
aim of the Global FertiSTAT project is to adapt this tool to raise awareness of fertility risk 
factors in settings worldwide.  The World Health Organization and Cardiff University are 
jointly funding the project. 
The purpose of the present survey was to generate new risk factors from diverse settings to 
ensure that the Global FertiSTAT is suitable for a worldwide audience. Following the 
completion of the survey, a systematic review of the newly identified risk factors will be 
conducted. Risk factors that can be empirically supported will then be included in a format of 
the FertiSTAT that can be used globally. The suitability and comprehensiveness of the new 
FertiSTAT items will be evaluated in a Sudanese population. The desired outcome of the 
project is a prototype of the Global FertiSTAT and a protocol for the adaptation process that 
could be used in other settings where there is an expressed need or desire to use this simple 
yet effective tool. 
As a patient focused tool it can help empower women because it gives them the personalized 
knowledge about how to change their lifestyle and seek medical advice to protect their 
fertility potential. As a provider focused tool it could be an initial step that bridges gaps that 
enable people to seek timely medical advice when required. The FertiSTAT can be a quick 
and cheap way of assessing risk without any medical tests or interventions which may be 
unavailable or unaffordable in settings where access to fertility assessment is limited or non-
existent. It can be administered by non-medical personnel, thus providing low resource 
clinics with a means of assessing those who may need to be referred for further investigation. 
Finally, the severe negative psychological and social consequences of childlessness (e.g., 
stigma, isolation, marital instability and divorce) are very serious and any tool that can help 
couples prevent infertility or help overcome it would be helpful to communities (Van Balen 
and Bos, 2010). 
Please note that the data provided through this survey will be held anonymously. 
If you have any further questions about this research or you would like an update of the 
activities of the Global FertiSTAT then please contact the principal investigators: 
Professor Jacky Boivin   
Supervisor  
School of Psychology   
Cardiff University   
Tower Building   
Park Place  
Cardiff   
CF10 3AT   
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Rasha Bayoumi          
PhD Student
School of Psychology   
Cardiff University   
Tower Building 
Park Place  
Cardiff 
CF10 3AT  
cardiffertilitystudies@cardiff.ac.uk   
Professor Jacky Boivin is interested in the psychosocial aspects of reproductive health. She 
has conducted many studies in this area on issues such as the link between stress and fertility, 
differences between men and women in emotional reactions to fertility problems, whether 
counselling helps people cope with fertility problems, how children conceived with fertility 
treatment develop, and much more. This research has been carried out with the help of 
women from many countries worldwide. You can see some of the published reports of this 
work on Professor Boivin's website at the School of Psychology, Cardiff University; 
http://www.cardiff.ac.uk/psvch/home/boivin/indexmain.html 
If you wish to make a complaint, please contact: 
Secretary of the Ethics Committee 
School of Psychology 
Cardiff University 
Tower Building 
Park Place 
Cardiff 
CF10 3AT 
Tel: (+44)29 2087 0360 
Email: psychethics@cardiff.ac.uk 
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Appendix E: Steps and MeSH search terms used for search 
Step 1:  
MeSH terms for fertility combined using ‘OR’: 
1. Fertility
2. Infertility
3. Female Fertility
4. Female Infertility
Step 2:  
MeSH terms for RF combined using ‘OR’ 
Step 3:  
Combine step 1 and 2 using ‘AND’ 
Step 4:  
Removed duplicates 
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Appendix F: Exclusion criteria used for all risk factors (RFs) 
Studies were excluded if: 
1. The study reported on non-human subjects only
2. The study reported on male data only
3. RF was measured but there was no fertility related outcome
4. RF and fertility related outcome measured but the fertility outcome reported was not
of interest (e.g. not specific about the duration of the infertility)
5. Both RF and fertility related outcome measured but the association between them not
tested or reported
6. RF reported not of interest (e.g. acronym stands for something else)
7. Only secondary data analysis
8. Qualitative data only (including comments or letters)
9. Related publication
10. Duplicate record
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Appendix G: MeSH terms used in the updated search 
Amenorrhea  
Time to pregnancy  
Reduced pregnancy rate 
Menstrual irregularities  
Tubal occlusion/blockage 
Reduced live birth rate  
Childlessness  
Childless 
Time to first birth  
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Appendix H: Data Extraction and Critical Appraisal Form 
Section 1. Data Extraction 
Study ref: First author/ 
year/study number 
Data extracted by: 
Date: 
Aim/hypothesis 
(explanatory or 
descriptive study) 
Study design Case-control / cohort study / RCT / Cross-sectional / 
Multi-centre / Single-centre 
Demographics Country 
Ethnicity 
Socio-economic 
Other 
Study period 
Study population 
Sample size Risk factor   (RF) No Risk factor (No-RF) Total: 
RF definition 
(exposed) 
RF: 
 POITIVE
 NEGATIVE
Self-report OR Medical 
Test (specify which test) 
Selection Convenient sample / Random sample / 
Eligible:   Invited:  
In/exclusion criteria 
Control definition 
 (non-exposed) 
Selection Self-report / other 
RF status verified 
In/exclusion criteria 
Comparability case-
control 
(exposed/non-exposed) 
Matching 
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Confounders 
Cohort specifics (if 
applicable) 
Duration of follow up 
Intervention/Comparison 
Other 
Confounding Factors Age 
Age at marriage 
Duration trying to 
conceive  
Trying to conceive Yes / no / not reported 
Use of Contraceptives 
SES 
Rural vs. Urban living 
Stage of the disease 
State of health (including 
weight) 
Education 
Marital status (never 
married, cohabiting, 
married) 
Parity 
Other (FertiSTAT 
indicators)  
Cross out all that apply 
Over 34 years, trying for more than 12 
months, severe period pain, pelvic surgery, 
irregular/short/long menstrual cycle, 
endometriosis, PID, no period, unprotected 
sex with multiple partners, smoking, can’t 
cope with stress, alcohol, caffeine, 
marijuana, STI, overweight, class A drug, 
anabolic steroids 
Other (not FertiSTAT 
indicators)  
Fertility Outcome 
measures used: 
(incl cut-off and 
Number of items) 
Risk of infertility 
Time to pregnancy 
Reduced conception rate/ Pregnancy 
rate 
Menstrual irregularities/Hormonal 
levels  
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Specific diagnosis (e.g. POI) 
Childlessness (specify time period) 
Time to first birth 
Outcome 
(infertility) 
(report test statistic, P 
value, odds ratio, 
confidence interval, CI) 
Measure 
RF No-RF Statistic 
CI or 
p-
value 
Risk of infertility 
Time to pregnancy 
Pregnancy rate 
Menstrual irregularities 
Hormonal levels 
Specific diagnosis 
Subgroup analysis 
done? (what? Sign or 
N.S.)
Results: 
Is RF related to 
infertility?  
(correlations / 
interrelationships 
between variables) 
Other significant 
differences between 
the groups? 
Context specification? 
Authors conclusions 
Data extractor 
comments (statement 
on quality which will be 
informed by data 
extraction and critical 
appraisal) 
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Section 2. Quality Assessment  
Ottawa Quality assessment scale observational studies 
Indicate two ** one * or leave blank  
SELECTION 
1. RF adequately assessed?
a. Independent validation of RF (medical testing or reference to primary
record source such as medical/hospital records) *
b. Self-report
c. No description
2. Representativeness of the RF Cohort
a. Representativeness of exposed individuals in the community *
b. Not satisfying
3. Selection of controls/non-exposed cohort
a. Adequate control selection for research question (community based /
hospital based) *
b. Same community as cases however derived from specialized
population.
c. No description
4. Definition of controls/non-exposed cohort
a. RF is excluded properly in the control population *
b. Not stated
COMPARABILITY 
5. Comparability of cases and controls (exposed/non-exposed) matching or
adjusted in analysis (max 2 stars)
a. Study controls for {most important confounder for this RF} (*)
b. Study controls for other confounds (*)
EXPOSURE/PREDICTOR/OUTCOME 
6. Were confounds (such as age) adequately assessed?
a. Obtained from medical/demographic records *
b. Obtained from interview blind to case/control *
c. Obtained from interview NOT blind to case/control
d. Self-report
e. No description
7. Was the same method used for both cases and controls?
a. Yes *
b. No
c. No description
8. Outcome (such as Risk of infertility, Time to pregnancy, Reduced
conception rate, Menstrual irregularities, Specific diagnosis) not 
present at the start of the study 
a. No *
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b. Yes
9. Were outcomes adequately assessed?
a. Independent or blind assessment stated in the paper, or confirmation of
the outcome by reference to secure records (medical records, etc.) *
b. Self-report (i.e. no reference to original medical records to confirm the
outcome)
c. No description.
10. None response rate or loss to follow-up
a. Same rate for both groups and <20% low to follow up *
b. Non respondents described and unlikely to introduce bias
c. Rate different and no designation OR not stated
d. No description
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Appendix I: Calculation of odds ratios from raw data in case-control studies for use in 
meta-analysis 
Basic premise that allows the calculation (Kirkwood & Sterne, 2003, Chapter 16, pp160): the 
odds of having the disease in the exposed compared to non-exposed groups (odds ratio of 
exposure) is equal to the odds of exposure in the disease compared to health groups (odds 
ratio of disease).  
Steps required to calculate oddrs ratios from raw data: 
1. Understanding the 4 x 4 table required to calculate the odds ratio (OR)
Exposed Non-exposed Total 
Disease a b a+b 
Healthy c d c+d 
Total a+c b+d 
2. An OR is calculated as follows:
OR  =         odds in exposed group      =     a/b   =   a x d 
odds in non-exposed group         c/d        b x c 
3. Therefore, the calcualtion is done by placing the numbers in the 4 x 4 table in step 1
and using the formula in step 2 to calculate the numbers
4. For example, if the data in a cross-sectional studie show that of 100 smokers 20 had
cancer and of 100 non-smokers 10 had cancer then the 4 x 4 would be:
Smoker Non-Smoker Total 
Cancer 20 10 30 
Healthy 80 90 170 
Total 100 100 100 
And the OR would be calculated as follows: 
OR =   a x d  = 20 x 90 =  1800   = 2.25 
 b x c   80 x 10      800 
5. Alternatively, in a case control study were the data indicate that of 30 cancer
participants, 20 were smokers and of 170 non-cancer (healthy) participants, 80 were
smokers then the 4 x 4 would be populated by entering a and c and the totals and then
then calculating b (b=30-20=10) and d (d=170-80=90), therefore the OR would be the
same.
Smoker Non-Smoker Total 
Cancer 20 b 30 
Healthy 80 d 170 
Total 100 b+d 100 
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Appendix J: MeSH terms used for consanguinity search 
Search was conducted on 21.04.2015  
Number of records retrieved for each term in parenthesis 
1     Consanguinity (10217) 
2     CSG marriage (9110) 
3     Cousin marriage (8906) 
4     Cousin adj3 marriage).mp. (114) 
5     1 or 2 or 3 or 4 (10479) 
6     Female Fertility (84496) 
7     Female Infertility (24491) 
8     Fertility (75633) 
9     Infertility (68168) 
10     6 or 7 or 8 or 9 (128384) 
11     5 AND 10 (452) 
12     Remove duplicates from 11 (439) 
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Appendix K: MeSH terms used for FGM/C search 
Search was conducted on 21.04.2015  
Number of records retrieved for each term in parenthesis 
1     Female genital mutilation (1825) 
2     FGC (600) 
4     Female circumcision or Circumcision, Female/ (2562) 
5     Female genital cutting (359) 
6     Circumcision, Female/ or FGM (2145) 
7     1 or 2 or 3 or 4 or 5 or 6 (4035) 
8     Female Fertility (10705) 
9     Female Infertility (52391) 
10     Fertility (185000) 
11     Infertility (171253) 
12     8 or 9 or 10 or 11 (317804) 
13     7 AND 12 (187) 
14     Remove duplicates from 13 (164) 
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Appendix L: MeSH terms used for HIV search 
Search was conducted on 22.11.2015 
Number of records retrieved for each term in parenthesis 
1     Infertility (200945) 
2     Female infertility (65863) 
3     Fertility (191806) 
4     Female fertility (10938) 
5     1 or 2 or 3 or 4 (348959) 
6     Human immunodeficiency virus (243280) 
7     Acquired immune deficiency syndrome [Complication, Diagnosis, Disease Management, 
Drug Resistance, Drug Therapy, Epidemiology, Etiology, Radiotherapy, 
Rehabilitation, Side Effect] (49677) 
8     6 or 7 (282734) 
9     5 AND 8 (922) 
10     NOT Neoplasm (805) 
11     NOT Practice guideline (777) 
12     NOT medical ethics or ethics (726) 
13     NOT intrauterine contraceptive device (701) 
14     NOT Tuberculosis/ or urogenital tuberculosis (685) 
15     NOT Monitoring (671) 
16     NOT Embryo transfer/ or fertilization in vitro/ or intracytoplasmic sperm injection 
(564) 
17     Remove duplicates from 16 (514) 
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Appendix M: MeSH terms used for genital tuberculosis (GTB) search 
Search was conducted from on 19.01.2016  
Number of records retrieved for each term in parenthesis 
1     Infertility (172200) 
2     Female Infertility (28296) 
3     Fertility (184811) 
4     Female Fertility (10773) 
5     1 or 2 or 3 or 4 (318509) 
6     Genital TB (490) 
7     Genital tuberculosis (2757) 
8     6 or 7 (3093) 
9     5 AND 8 (546) 
10     remove duplicates from 9 (378) 
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Appendix N: MeSH terms used for bacterial vaginosis (BV) search 
Search was conducted on 27.08.2016 
Number of records retrieved for each term in parenthesis 
1     Infertility (166798) 
2     Fertility (104796) 
3     Female infertility (66936) 
4     Female fertility (8766) 
5     1 or 2 or 3 or 4 (255953) 
6     bacterial vaginosis (7148) 
7     5 AND 6 (167) 
8     remove duplicates from 7 (129) 
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Appendix O: MeSH terms used for Dilatation and Curettage search 
Search was conducted on 05.02.2016 
Number of records retrieved for each term in parenthesis 
1     Infertility (161414) 
2     Infertility, Female (65023) 
3     Fertility (101253) 
4     Fertility/ or female fertility.mp. (102707) 
5     1 or 2 or 3 or 4 (248762) 
6     Dilatation and curettage (4904) 
7     limit 6 to humans (4420) 
8     5 AND 7 (237) 
9     remove duplicates from 8 (210) 
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Appendix P: Patient Interview Materials 
A. Procedure
Step 1: Briefing and consent form 
Step 2: Background information 
 Administer the 16-item Background Information Form
Step 3: FertiQoL (not reported in this thesis) 
Step 4: Questions regarding fertility awareness 
 Assess whether the participant knows about the following:
o Signs, symptoms of fertility problems
o Preventable causes of fertility problems
o When to seek help if they have trouble becoming pregnant
Step 5: Desire to know about fertility 
 Ask if the participant would value knowing more about these aspects of fertility?
Step 6: Administration of FertiSTAT 
 Administer the adapted FertiSTAT checklist (Arabic version)
 Step 7: Questions about FertiSTAT 
 Ask open ended questions to assess the following:
o How they talk about fertility health to others and what is their
preferred language of communication for sensitive topics
o Potential format of administration (e.g., specific format, setting, source and
time required for administration
o Would they have wanted to know this information in the past?
o How useful would it have been to have this information and when?
Step 8: Debrief 
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B. Consent Form for FertiQoL and FertiSTAT Interviews
Consent form (to be read or read out) 
I understand that my participation in this project will involve a ‘think-aloud’ task during 
which I will provide my thoughts and feelings about the FertiSTAT and FertiQoL while 
completing the tools. I will then be asked to complete a short interview and a questionnaire 
about my demographics (e.g., age, education). The whole study should take around 60 to 90 
minutes to complete. 
I understand that participation in this study is entirely voluntary and that I can withdraw from 
the study at any time without giving a reason. 
I understand that I am free to ask any questions at any time. I am free to withdraw or discuss 
my concerns with the researcher Rasha Bayoumi (bayoumir@cardiff.ac.uk). 
I understand that the think-aloud task and interview will be audio-recorded so that the topics 
raised can be transcribed and synthesised. The information provided by me will be stored on 
a password-protected computer that belongs to the researcher Rasha Bayoumi and Prof Jacky 
Boivin and will be held anonymously, so that it is impossible to trace this information back to 
me individually. Once the recording of the session has been transcribed the recording will be 
deleted and the transcribed data and questionnaire responses will be retained indefinitely.  
I also understand that at the end of the study I will be provided with additional information 
and feedback about the purpose of the study. 
I, ___________________________________(NAME) consent to participate in the study 
conducted by Rasha Bayoumi, School of Psychology, Cardiff University with the supervision 
of Professor Jacky Boivin.  
Signed: 
Date: 
 slairetaM weivretnI tneitaP   P xidneppA
 234
mrof tnesnoC cibarA
استمارة الموافقة (أن تقرأ أو تقرأ)
 TATSitreFأنا أفهم أن مشاركتي في هذا المشروع  تتضمن مهمة تقديم أفكاري ومشاعري حول 
أثناءالأداة. سيتم بعد ذلك إكمال مقابلة قصيرة واستبيان عن معلوماتي الديموغرافية (على   LoQitreFو
دقيقة للإكمال. 09إلى  06الدراسة بأكملها حوالي تأخذ  سبيل المثال، العمر، والتعليم). سوف
وأنا أفهم أن مشاركتي في هذه الدراسة طوعية تماما وأستطيع الانسحاب من الدراسة في أي وقت دون 
إبداء أسباب وأنا حر أن أسأل أي سؤال في أي وقت. أنا حر في الانسحاب أو مناقشة مخاوفي مع الباحثة 
).ku.ca.ffidrac@rimuoyabرشا بيومي (
أنا أفهم أن المقابلة ستكون مسجلة حتى يمكن نسخها وتوليفها. سيتم تخزين المعلومات التي قدمتها على 
الباحثة رشا بيومي والأستاذ جاكي بوافين وسيعقد   لدى جهاز كمبيوتر (محمي بكلمة مرور) المملوك
مجهول، بحيث أنه من المستحيل أن تتبع هذه المعلومات لي على حدة. وبمجرد أن يتم نسخ تسجيل 
سيتم حذف التسجيل وسيتم الاحتفاظ بالبيانات والردود على الاستبيان إلى أجل غير مسمى. المقابلة
ستقدم لي معلومات حول الغرض من الدراسة.أفهم أيضا أنه في نهاية الدراسة 
أنا، ___________________________________ (الاسم) موافق على المشاركة في الدراسة 
التي أجرتها رشا بيومي (كلية علم النفس، جامعة كارديف مع إشراف البروفيسور جاكي بوافين).
التوقيع:
تاريخ:ال
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C. Background Information Form for Interviews
1. Patient number ______________
2. Age  ______________ 
3. Sex  ______________ 
4. Address  ______________ 
5. Occupation      ______________ 
6. Education:
 Illiterate:
 Primary level:
 Secondary level:
 More than secondary level:
7. Duration of marriage         ______________ 
8. Duration of couple living together ______________
9. Menstruation:
 Normal
 Not normal
10. If menstruation is not normal:
 No period > 6 months
 No period < 6 months
 Increase in the amount of menstruation
 Decrease in the amount of menstruation
11. Painful intercourse
 YES
 NO
12. Medical and surgical history:
 Blood pressure (hypertension)
 Thyroid disease
13. Have you been pregnant before:
 YES
 NO
14. Number of previous pregnancies         ______________ 
 Without treatment          ______________ 
 With ovarian stimulation only ______________
 With ART          ______________ 
15. Duration of delay in pregnancy ______________ 
16. Reasons for delay in pregnancy:
 Husband
 Wife
 Both
 Unknown
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D. FertiSTAT Checklist for signs, symptoms and risk factors for fertility problems
(tentative English version)
Woman 
How old are you? ______________________ years 
How long have you been trying to become pregnant? ___________________years: months 
Please indicate if any of the following reproductive health issues relate to your situation: (tick all 
that apply) 
 Severe period pains 
 My period is unpredictable (can be more than 5 days early or late) 
 My period lasts less than 21 days (no contraception) 
 My period lasts more than 35 days (no contraception) 
 I do not have a period 
 I have had surgery in my abdominal region 
 I suffer from endometriosis 
 I have had pelvic inflammatory disease (PID) (a serious infection in my uterus that required 
more than just one prescription of antibiotics) 
Please indicate if you have been diagnosed with any of the following medical conditions, 
infections or diseases: (tick all that apply) 
 Diabetes 
 Cancer 
 Kidney disease 
 Sickle cell anaemia 
 Thyroid disease 
 Lupus 
 Tuberculosis 
 Genital tuberculosis 
 HIV or HIV/AIDS 
 Bacterial vaginosis 
Please indicate if these conditions define your situation: (tick all that apply) 
 I have been cut (Female genital cutting) 
 I am married to a blood relative  
Please indicate if your lifestyle includes any of the following situations: (tick all that apply) 
 I smoke frequently (>10 cigarettes per day) (water-pipe, chewing tobacco) 
 I can’t cope with stress I’m currently experiencing 
 I drink >14 units alcohol per week (14 glasses of wine, 28 beers (1/2 pint) or 14 shots of 
spirit) 
 I drink >7 units caffeine per day (7 cups of coffee or 14 cups of tea or 14 sodas) 
 I smoke marijuana frequently (>4 time per week) 
 I have had an STI 
 I’m more than 13kg (28 lb) overweight 
 I have unprotected sex with multiple partners 
 I have used a class A drugs in the past (heroin, cocaine, ecstasy) 
 I’m currently taking anabolic steroids (for non-medical uses) 
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Man 
How old are you? ______________________ years 
How long have you been trying with your partner to become pregnant? ___________years: months 
Please indicate if any of the following issues relate to your situation: (tick all that apply) 
 I had the “mumps” as a child (before puberty) 
 I have an undescended testicle 
 I am married to a blood relative 
 I have or had been diagnosed with tuberculosis 
 I have or had been diagnosed with genital tuberculosis 
 I have been diagnosed with HIV or HIV/AIDS 
 I have or had been diagnosed with cancer 
Please indicate if your lifestyle includes any of the following situations: (tick all that apply) 
 I smoke frequently (>10 cigarettes per day) (water-pipe, chewing tobacco) 
 I can’t cope with stress I’m currently experiencing 
 I drink >14 units alcohol per week (14 glasses of wine, 28 beers (1/2 pint) or 14 shots of 
spirit) 
 I drink >7 units caffeine per day (7 cups of coffee or 14 cups of tea or 14 sodas) 
 I smoke marijuana frequently (>4 time per week) 
 I have had an STI 
 I have unprotected sex with multiple partners 
 I have used a class A drugs in the past (heroin, cocaine, ecstasy) 
 I’m currently taking anabolic steroids (for non-medical uses) 
 slairetaM weivretnI tneitaP   P xidneppA
 634
 )noisrev hsilgnE evitatnet( TATSitreF
TATSitreF      الخصوبةلمشكلات أداة فحص للعلامات والأعراض وعوامل الخطر 
للنساء
كم عمرك؟________سنوات
 منذ متى وأنت تحاولين أن تصبح حاملا؟ _______  سنوات : أشهر
يرجى بيان ما إذا كان أي من مشكلات الصحة الإنجابية التالية تتعلق بوضعك: (ضعي علامة على كل ما ينطبق)
الدورة الشهرية الشديدة آلام 
أيام) 5بها (يمكن أن تأتي قبل موعدها أو تتأخر عن موعدها بأكثر من فترة الدورة الشهرية لا يمكن التنبؤ  
يوما (بدون وسائل منع الحمل) 12الدورة الشهرية تستمر لأقل من  
يوما (بدون وسائل منع الحمل) 53الدورة الشهرية تستمر أكثر من  
ليس لدي دورة شهرية 
أنا خضعت لعملية جراحية في منطقة البطن 
الانتباذ البطاني الرحمي (البطانة المهاجرة)أعاني من  
لقد عانيت من مرض التهاب الحوض (عدوى خطيرة في الرحم تطلبت أكثر من وصفة طبية واحدة من المضادات  
 الحيوية)
 يرجى بيان ما إذا كنت قد تم تشخيصك بأي من الحالات الطبية، والتهابات أو الأمراض التالية : (ضعي علامة على كل ما
 ينطبق)
داء السكري 
سرطان 
مرض الكلية 
فقر الدم المنجلي 
مرض الغدة الدرقية 
الذئبة 
مرض السل 
السل التناسلي 
.فيروس نقص المناعة البشرية أو الإيدز 
التهاب المهبل البكتيري 
يرجى بيان ما إذا كانت هذه الشروط تنطبق على وضعك الخاص: (ضعي علامة على كل ما ينطبق)
لقد خضعت لختان الإناث 
أنا متزوجة من أحد أقاربي 
يرجى بيان ما إذا كان نمط حياتك يشمل أيًا من الحالات التالية: (ضعي علامة على كل ما ينطبق)
سجائر يوميا) (النرجيلة، ومضغ التبغ) 01(>أدخن كثيرا  
الذي أعاني منه في الوقت الحالي نفسيلا أستطيع التعامل مع الضغط ال 
 41مللي لتر)) أو  632وحدة بيرة (نصف بينت ( 82كأًسا من النبيذ،  41(وحدة الكحول في الأسبوع  41أشرب > 
كأًسا صغيًرا من المشروبات الروحية)
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مشروبات غازية) 41أكواب من الشاي أو 41أكواب من القهوة أو  7(وحدات الكافيين يوميا  7أشرب > 
مرات في الأسبوع) 4(>أدخن الماريجوانا في كثير من الأحيان  
منقولة جنسيا.سبقت لي الإصابة بأحد الأمراض ال 
رطلا)ً 82كيلوغراما ( 31عندي زيادة في الوزن بأكثر من  
مارست الجنس دون وقاية مع عدة أشخاص 
(الهيروين والكوكايين وحبوب الهلوسة)في الماضي ) Aالعقاقير من فئة ( لقد استخدمت/تعاطيت المخدرات 
(للاستخدامات غير الطبية)أنا حاليًا أتعاطي المنشطات  
للرجال
 كم عمرك؟________سنوات
منذ متى وأنت تحاول مع شريكة حياتك لتصبح حاملا؟  _______  سنوات: أشهر
(ضع علامة على كل ما يرجى بيان ما إذا كانت أي من المشكلات التالية تنطبق على وضعك الخاص: 
 ينطبق)
(قبل البلوغ)عندما كنت طفلا (ابو عديلات) عانيت من "النكاف"  
(غير نازلة) لدي خصية معلقة 
قريباتي يمن أحد أنا متزوج 
تم تشخيصي حاليًا أو في الماضي بمرض السل 
تشخيصي حاليًا أو في الماضي بمرض السل التناسليتم  
تم تشخيصي حاليًا أو في الماضي بمرض بفيروس نقص المناعة البشرية أو الإيدز 
تم تشخيصي حاليًا أو في الماضي بمرض بالسرطان 
يرجى بيان ما إذا كان نمط حياتك يشمل أيًا من الحالات التالية: (ضع علامة على كل ما ينطبق)
سجائر يوميا) (النرجيلة، ومضغ التبغ) 01(>أدخن كثيرا  
الذي أعاني منه في الوقت الحالي النفسيلا أستطيع التعامل مع الضغط  
 632وحدة بيرة (نصف بينت ( 82كأًسا من النبيذ،  41(وحدة الكحول في الأسبوع  41أشرب > 
كأًسا صغيًرا من المشروبات الروحية) 41مللي لتر)) أو 
مشروبات  41أكواب من الشاي أو 41أكواب من القهوة أو  7(وحدات الكافيين يوميا  7أشرب>  
غازية)
مرات في الأسبوع) 4(>أدخن الماريجوانا في كثير من الأحيان  
المنقولة جنسيا سبقت لي الإصابة بأحد الأمراض 
مارست الجنس دون وقاية مع عدة أشخاص 
(الهيروين والكوكايين وحبوب في الماضي ) Aالعقاقير من فئة ( لقد استخدمت/تعاطيت المخدرات 
الهلوسة)
(للاستخدامات غير الطبية)أنا حاليًا أتعاطي المنشطات  
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E. Semi-Structured Interview Topic guide
(Only questions pertaining to FertiSTAT included)
Question Section 
Section 1: Fertility Knowledge  
(before administering the FertiSTAT) 
1 Do you know about the signs and symptoms of infertility? 
2 What are some signs and symptoms that you know? (if not understood, 
explain)  
3 Do you have info about the risk factors that people can avoid? (if not 
understood, explain)  
4 What are some risk factors that you know? 
5 Do you know when a person should consult a doctor for delayed 
pregnancy?  
6 Would you like to know more about the signs, symptoms, preventable 
risk factors and when to seek help?  
Section 2: Questions about FertiSTAT 
(after administering the FertiSTAT) 
A. Benefit of FertiSTAT
7 Where you aware of this information before? 
8 What information is new to you? 
9 Would you have wanted to know this information in the past? 
10 Do you think this information is important for people to know, here in 
Sudan, or is it unrelated to our society? 
11 How useful would it have been to have this information and when? 
12 Is this information beneficial? 
13 In what way is this information beneficial? 
B. Format, setting, source and target population
(if unable to generate spontaneously, give examples)
14 Where can people get this information from? What is the best setting? 
15 Who is the best person to convey this type of information?  
16 How can this information be conveyed? 
17 What if you find it in a magazine or a newspaper, would that be 
acceptable?  
18 When is the best timing to present this information? 
19 What age is this information most appropriate for? 
20 Should the information be given before or after marriage? 
C. Sensitive topics in FertiSTAT
21   We have been told that some of the topics in the FertiSTAT may not 
be acceptable in our society, that there are things we shouldn’t say, 
what do you think?  
22   What about information about things like drugs, alcohol and sex, how 
acceptable would it be to talk about them in our society? 
23 Is it better to talk about these sensitive topics or to avoid them? 
24 What would be the best way to talk about these topics? 
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F. Debrief for FertiQoL and FertiSTAT Interviews
One of the most important issues in determining health is how we perceive our own 
health and illness. Successful public health campaigns have used a strategy of increasing 
public awareness of certain illnesses by researching the relevant health indicators for each 
illness, ensuring most people are aware of the signs and symptoms of the diseases (e.g., 
cancer, heart disease). Such research has highlighted that this can be used to monitor 
needs for health care, and evaluate the effectiveness and impact of health care programs. 
The majority of couples will get pregnant after trying for 12 months. However, for a 
small number of couples it may take longer. There has been little research highlighting 
the main indicators for those that might take longer to get pregnant. In addition few 
people know the signs of reproductive disease or the risk factors for fertility difficulties. 
A tool was developed to raise awareness about risk factors for fertility problems and 
provide women with information on what to do when they have any risks. We also 
developed a quality of life tool called the FertiQoL. However, we do not know whether 
these tools can be used in countries other than the one where it was developed. We asked 
you to give us your thoughts and feelings about the FertiSTAT and answer questions in 
an interview and questionnaire to enable us to evaluate whether these could be used at 
this and other clinics in Sudan. 
It was important to ask a range of personal questions about your lifestyle and reproductive 
history and we would like to assure you that all the data you provided will be held 
anonymously and it will not be possible to trace the information back to you. Data will be 
stored on a computer that is password-protected and belongs to Rasha Bayoumi and Prof 
Jacky Boivin. 
If participation in the study has caused concern about your health then please contact your 
doctor in the usual way or this Facebook page – OBGYN consultations, that provides 
support to women with fertility problems. 
If you have any further questions about this research then please let Rasha Bayoumi or 
your doctor know of these concerns and they will inform Prof Jacky Boivin. 
School of Psychology 
Cardiff University 
Tower Building, Park Place 
Cardiff, Wales 
CF10 3AT 
boivin@cardiff.ac.uk 
Professor Jacky Boivin is interested in the psychosocial aspects of reproductive health. 
She has conducted many studies in this area on issues such as the link between stress and 
fertility, differences between men and women in emotional reactions to fertility issues, 
whether counselling helps people cope with fertility problems, how children conceived 
with fertility treatment develop, and much more. 
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This research has been carried out with the help of women from many countries 
worldwide. You can see some of the published reports of this work on 
www.cardifffertilitystudies.com.  
Psychology Ethics committee details: 
Email:  psychethics@cf.ac.uk 
Phone: +44 (0)29 208 74007, Fax: +44 (0)29 2087 4858. Address: Psychology Ethics 
Committee Secretary. 
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feirbeD cibarA
استجوب (شرح الغرض من المقابلة والاستبيانات)
ننظر بها لصحتنا و الأمراض. وقد استخدمت واحدة من أهم القضايا في تحديد الصحة هي الطريقة التي 
حملات الصحة العامة الناجحة استراتيجية لزيادة الوعي عن بعض الأمراض عن طريق البحث في 
المؤشرات الصحية المناسبة لكل مرض، وضمان أن معظم الناس يدركون علامات وأعراض الأمراض 
يمكن استخدامه لرصد احتياجات  هذا النهج (مثل السرطان وأمراض القلب). وقد أبرزت هذه البحوث أن
الرعاية الصحية، وتقييم مدى فعالية وتأثير برامج الرعاية الصحية.
بالنسبة لغالبية الأزواج يحدث الحمل بعد المحاولة لمدة اثني عشر شهرا. ومع ذلك، لعدد من الأزواج قد 
سية لتأخر الحمل. وبالإضافة إلى ذلك يستغرق وقتا أطول. هناك القليل من الأبحاث عن المؤشرات الرئي
قلة من الناس تعرف علامات المرض التناسلي أو عوامل صعوبات الخصوبة. وقد تم تطوير أداة لرفع 
مستوى الوعي حول عوامل الخطر لمشاكل الخصوبة وتزويد النساء بالمعلومات حول ما يجب القيام به 
. LoQitreFوير أداة/استبيان حول نوعية الحياة يسمى عندما يكون لديهم أي مخاطر. نحن أيضا قمنا بتط
ومع ذلك، فإننا لا نعرف ما إذا كانت هذه الأدوات يمكن أن تستخدم في بلدان غير حيث تم وضعها.  
والإجابة على الأسئلة في المقابلة والاستبيان  TATSitreFحول  طلبنا منك أن تعطينا أفكارك ومشاعرك
لنتمكن من تقييم ما إذا كانت هذه الاستبيانات يمكن استخدامها في هذه  العيادة وغيرها من العيادات في 
السودان.
من المهم طرح مجموعة من الأسئلة الشخصية حول نمط حياتك وتاريخ الإنجاب، ونود أن نؤكد لكم  كان
ات التي قدمتها ستعقد مجهول، وأنه لن يكون من الممكن تتبع المعلومات مرة أخرى لك. أن جميع البيان
سيتم تخزين البيانات على جهاز كمبيوتر (محمي بكلمة مرور) وينتمي إلى/المملوك لدى  رشا بيومي 
والأستاذ جاكي بوافين.
الاتصال بالطبيب بالطريقة  القلق بشأن صحتك الرجاء إذا كان الاشتراك في هذه الدراسة قد تسبب في
استشارات أمراض النساء والتوليد و الخصوبة، التي توفر  –المعتادة أو عن طريق صفحة الفيسبوك 
الدعم للنساء الذين يعانون من مشاكل الخصوبة.
عن هذه المخاوف، وأنهم سوف  إذا كان لديك أي أسئلة أخرى حول هذا البحث اسأل رشا بيومي أو طبيبك
الأستاذ جاكي بوافين.إبلاغ 
كلية علم النفس
جامعة كارديف
برج البناء، بارك بليس
كارديف، ويلز
TA3 01FC
ku.ca.ffidrac@niviob
أستاذة جاكي بوافين تهتم بالجوانب النفسية والاجتماعية للصحة الإنجابية. وقالت إنها أجرت العديد من 
بين التوتر والخصوبة، والاختلافات بين الرجال  الدراسات في هذا المجال على قضايا مثل العلاقة
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يساعد الناس على التكيف مع مشاكل  والنساء في ردود الفعل العاطفية لقضايا الخصوبة، إذا الإرشاد
الخصوبة، نمواطفال الانابيب، والكثير.
وقد تم تنفيذ هذا البحث مع مساعدة نساء من العديد من البلدان في جميع أنحاء العالم. يمكنك ان ترى 
.moc.seidutsytilitrefffidrac.wwwبعض التقارير التي نشرت على 
تفاصيل لجنة الأخلاق  بكلية علم النفس:
ku.ca.fc@scihtehcyspالبريد الإلكتروني: 
. العنوان: أمين سر لجنة 8584 7802 92) 0( 44فاكس: + 70047 802 92) 0( 44الهاتف: +
الأخلاق  بكلية علم النفس.
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Appendix Q: Ethics Approval for Patient Interviews in a Sample of Sudanese Couples 
Attending at an Infertility Clinic  
The Ethics Committee has considered the amendment to your Generic Staff project proposal: 
Fertility Health Issues (EC.07.05.01.1284GR3A7). 
The amendment has been approved. 
Please note that if any changes are made to the above project then you must notify the Ethics 
Committee. 
Best wishes, 
Mark Jones 
School of Psychology Research Ethics Committee 
Cardiff University 
Tower Building 
70 Park Place 
Cardiff 
CF10 3AT
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Appendix R: Themes, sub-themes and illustrative quotes from the interviews with fertility patients in 
Sudan 
Themes Sub-themes Illustrative quotes 
Desire for 
fertility info 
RB: OK, do you feel you want to know more info about this topic?  
13: I feel like I know about it, but when I get a desire to know more. 
RB: Ok, do you feel you want to know more about these things?  
5: yes, I’m currently searching (for info). 
State of fertility 
knowledge in 
this sample 
What is known 13: Walahi, since we have been alive we know of cutting that there is the Sunna one 
and the pharaonic one. And we are all cut Sunna, something very minimal, something 
that wouldn’t have an impact in the future. But in general I have seen people who are 
cut pharaonic that really face problems. 
14: that’s why they can have problems unrelated to age, young women can have 
problems too. 
RB: explained age and time trying 
20: yes after 35 the chance is weak, very weak (slim) 
12: there are medical conditions that prevent pregnancy. 
13: (….) Infections, for example if you get infections and you are unaware of it 
RB: were you aware of this info in the past?  
1: yes, especially drugs, coffee, fizzy drinks (caffeinated beverages), I know that, I 
have even reduced it (her consumption). 
RB: what about when to go to the doctor, when you have a fertility problem?  
1: when you are married more than 2 years, and you’re completely settled (residing 
together). When he’s in a country and you another country, when there has been a 
previous pregnancy and miscarriage. 
16: I think if residing together then after 1 year should go to the doctor, so that they 
(doctors) can give stimulants (ovulatory) or if there is infection they can get treated 
RB: what about when to go to the doctor? 
5: after one year of marriage and no pregnancy, if the age is more than 34 years 
RB: Exactly, so do you know when a girl should visit the doctor?  
13: I would say a year is good, because of life circumstances and difficulties, you find 
that your husband is settled with you (spending enough time together to allow for 
having sex regularly) during your honeymoon and then every day after that there are 
errands and stuff, you know life is really difficult. So up to a year they can be waiting 
for the natural (conception). After that they have to find out what’s the problem. 
What is not 
known 
RB: how much do you feel you know about fertility generally and your case 
(particularly)? 
1: I feel I have little info. 
RB: do you have any info about the risk factors, the things that can cause fertility 
problems? 
2: No, I don’t know. 
RB : when to seek help is related to age, so if a women is less than 34 years she should 
go after 1 yr but if she is older than 34 she should only wait 6 months, because fertility 
declines after 34, were you aware of the impact of age?  
17: no I didn’t know, especially the specific age I didn’t know that. 
Misconception
s/myths 
RB: Ok, do you know about the risk factors one can avoid so as not to get fertility 
problems?  
13: this thing, you mean before marriage? The most important thing, for example, 
taking care of the health of your reproductive system, cleanliness and things like that. 
13: or your hygiene is not good, this is something that in the end can lead to for 
example other things, like in the uterus, in the ovaries in the pelvis, and in this way, 
you will have problems. 
14: [I don’t know, I got married at 32 and I came back from my honeymoon I was 
pregnant.] 
14: And sometimes it’s the other way around, people get married much older and 
mashallah they have 2 or 3 kids. So, there is a chance. 
14: For me, I mean honestly, when I went for my laparoscopy, when I came to the 
clinic here,I know the problem they tell you about aging, getting older, delayed 
marriage, but I find girls in their 20s (in the clinic). 
16: do you mean what causes not having kids or what? For a woman?  
RB: yes. 
16: walahi cysts (ovarian) always. 
12: walahi, emotional pressure (stress) may affect a women or a man. Emotional 
pressure is one of them (risk factors). 
Benefits of 
fertility 
education 
Perceived 
personal 
4: yes, I didn’t know this information. 
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Themes  Sub-themes Illustrative quotes  
benefit (to 
self) 
  5: very much, it’s the first time I know that it (FS items) can have an impact on 
fertility. 
 Perceived 
general benefit 
(to others) 
 
11: of course, it’s important that they know. 
  13: very beneficial, they have to, they have to know it. 
  17: (….) Our society is in need of lots of raised awareness A LOT!! 
 Utility of the 
tool: addresses 
knowledge gap 
and encourage 
behaviour 
change 
RB: meaning, when would this info have been useful to you?  
16: walahi from early on is better so I can avoid things like drinking too much coffee 
and tea and things like that. 
  13: To see where there are gaps and to fill them. 
  5: yes they should know, because there are people who drink lots of coffee and such. 
  14: Or a woman at home if she feels her son wants to use chewing tobacco, she can do 
a bit of control, to show him this thing what it does later (the effect of tobacco in the 
long run). 
Specific 
suggestions for 
the tool  
 
Content: taboo 
topics 
RB: what about the sensitive topics, what’s the best way for people to talk about it?   
2: sex, drinking (alcohol)? Ask aadee (normally, casually). 
 1: depends on the people, some people consider these issues 3aib (culturally 
unacceptable), and other people see there is no gilat adab (disrespectful, rude) or that 
this person is wakiha (impolite, has no shame). 
  7: people should talk about it aadee (normally), because it’s for their benefit. 
  3: a person should explain aadee (normally) no problem. 
  17: they prefer if it’s a woman, not sure why, but when it’s a woman they feel relaxed 
and can understand. 
  4: people may not accept these subjects, and I won’t be able to face them regarding 
certain issues. 
  4: not all of them, some people don’t like to talk, to tell you their life story, not even in 
here, gesturing to indicate the clinic, about why or what’s happening to them, not all 
people. 
  19: walahi, if you introduce yourself properly in the beginning and they see you are a 
doctor, a professional, a person would have their presences (the word she used 
‘haibtoo’ suggests a dominant presence). 
  19: well with the rule of customs (the rules dictated by culture) … (looks like she is 
thinking), but I don’t think so, maybe in the olden days maybe, but now its aadee 
(normal, acceptable). 
  RB: well, we have been told that there are people in our society that will not accept 
this, that there are things we shouldn’t say because they are unacceptable in our 
society. So, is it better to say or not to say? 
14: walahi, you should say it because someone will accept it and benefit. 
 Format RB: what if you find it in a magazine or a newspaper. 
13: yes, for example, yes I can do it. No, no aadee (normal and acceptable), especially 
if it is anonymous. 
  14: walahi, this newspaper, I see, I think people here get the news from the internet, the 
newspaper, just the old people, because they are used to this ‘cross your legs and put 
on your glasses’. But in general, for people, the news info comes to them, newspapers, 
are not that much. 
  RB: but people would accept to talk about FGM and sex, this won’t be difficult?  
12: no it’s not difficult, it could be specifically for women, a seminar just for women 
so they can ask. 
  19: walahi something printed the boys will not read it, I’m talking about my brothers at 
home, from my experience, but if its lectures or seminars, or they went to the schools 
and universities, this way they will accept it, this way they will listen, because a boy by 
nature wants to hear not to read. 
  1: clear and direct questions so that the answer is clear and direct.  
  18: but there is something! This WhatsApp (a social media app that is very popular in 
Sudan and the Middle East), lately, people have really been concentrating on it, that is, 
if this info was on WhatsApp and Facebook they will read it but not a hardcopy.  
  RB: so what is the best way for us to get them to answer and give us this info in a 
suitable way, how?  
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1: via questions, from the beginning you will get a sense of whether this person is 
willing to accept things, or not accept. For example, this sex question, most people will 
say ‘enough I don’t want to (continue)’. 
12: it could be specifically for women, a seminar just for women so they can ask 
RB: so they can ask questions. 
12: yes, a specific place where they can ask, women’s questions, what’s happening to 
you. 
Setting 13: I imagine the home to be the best context, I mean the most important role, one sees 
their father and their mother and how they are, it’s better that they show them. 
12: yes, it would work in schools. 
RB: but it wouldn’t work if a doctor (feminine) came to places in the villages, one 
(feminine) comes and tells the people or something? 
12: yes, it’s possible, it’s possible yes. 
17: training course within schools and universities. 
14: walahi, I imagine raising awareness can be in schools, if they put it as 
leaflets/handouts that would be useful. 
14: It can be put out in clinics, so when you’re, when you’re done you can take it with 
you. It can be left at the mosque. 
RB: Ok so they won’t accept it, so what do you think is the best way, I mean if they are 
not going to accept this, how do we deliver this info?  
20: for girls I think they should know this info from school. 
Source 11: the best time is from the treating physician to the patient and the co-patient. When 
he is delivering (the info), they are there, he can deliver this info to them, he is the 
most trusted person. 
1: Talk in the way that makes you feel comfortable with people, the person you feel 
comfortable with and understands you, a person who understands the issue. 
19: yes it makes no difference because in the end she has the info. The real difference 
lies in whether the info is given by a specialist, not man or woman, for me personally 
makes no difference. 
13: it seems that it’s always the case that if you trust the source (person) that the info is 
coming from them, that’s better. But if it comes from someone I don’t trust, I will just 
leave him and go. 
RB: so it’s better if a woman comes and talks to the girls and she can tell them and 
show them? 
10: why not…a man, for example, I can’t ask him questions, but you are a woman like 
me so I can ask you questions.    
RB: OK, is it better for this info to come from a doctor or students like us for example, 
from a woman or a man? Who is the most suitable person to provide this info?  
10: from a doctor or a student like you, they teach it to you so you can show it to 
people. 
RB: OK, what if the father and the mother don’t have the info, where do they get this 
info?  
13: it’s better if the school, the teachers. 
12: the responsible ‘al gehat’ [entities], the mother. 
12: the educated sisters, relatives (feminine) for example, some of them are educated. 
10: your mother, older sister at home. 
10: from a doctor or a student like you, they teach it to you so you can show it to 
people. 
11: the best time is from the treating physician to the patient and the co-patient. When 
he is delivering (the info), they are there, he can deliver this info to them, he is the 
most trusted person. So when you bring this questionnaire a lot of people will give you 
false info, but they trust the doctor, they will not lie to him at all, they will understand 
what he’s saying. 
Timing RB: when should they give her info like this? 
10: leave her till she grows up. 
RB: not necessarily after marriage? 
12: no, not necessarily after marriage, she can know this from when she is a teenager. 
RB: when should they be given this info?  
17: it should be given to youngsters, before they get married. 
RB: meaning, when would this info have been useful to you?  
16: walahi from early on is better so I can avoid things like drinking too much coffee 
and tea and things like that. 
5: the first stage of high school, 17 or 20 years. 
19: when they are in the engagement period, approaching marriage, they should be 
given this info. 
18: I think at puberty they should be made aware of these things. 
Appendix R                                                                                 Additional illustrative quotes from interviews  
 
447 
 
Themes  Sub-themes Illustrative quotes  
  13: it’s better if the school, the teachers, there should be something like this, this type 
of raising awareness, infectious disuses (STIs). When one reaches this stage, there is 
no more embarrassment, he should hear this thing before he falls into it (the 
behaviour). 
  RB: ok so can you help us here, what is the best time and way?  
11: the best time is from the treating physician to the patient and the co-patient. When 
he is delivering (the info), they are there, he can deliver this info to them  
Factors 
influencing 
implementation  
 
Personal 
preferences 
(endorsed) 
 
1: depends on the people, some people consider these issues 3aib (culturally 
unacceptable), and other people see there is no gilat adab (disrespectful, rude) or that 
this person is wakiha (impolite, has no shame). 
  6: walahi, it depends, people are different, some people aadee (with ease) will accept it, 
no problem.  
 
  1: from the beginning you will get a sense of whether this person is willing to accept 
things, or not accept. For example, this sex question, most people will say ‘enough I 
don’t want to (continue)’. 
  1: yes they will benefit, it’s choices, you don’t like the page, you turn it and continue 
the rest. 
 Perceived 
benefit 
(endorsed) 
14: walahi, you should say it because someone will accept it and benefit. 
  4: no it’s not difficult, if people accept it (are willing to accept it), the topic is not that 
difficult, it’s just info that one can benefit from. 
  1: cons, there are no cons for me, the topic is normal, the pros is that it increases 
education (not scholastic in nature). 
  2: yes I would look at it, I would find it beneficial. 
  7: yes, I would complete it, because this is a useful thing for people, one would do it. 
  14: thank you so much, this has been so helpful.  
 
  13: questionnaires in general are beneficial because the person is studying this thing 
and wants to help us benefit from it. To see where there are gaps and to fill them. So no 
problem. 
 Acknowledgin
g the benefit of 
education/info 
(participant 
generated) 
 
1: clear and direct questions so that the answer is clear and direct, you benefit and I 
benefit. 
  17: yes, they can benefit, if you know you will benefit, like training course, where I 
work we do education and training course and people have learned a lot understood a 
lot. 
 The 
appropriate 
method of 
distribution 
(participant 
generated) 
 
17: lectures given by doctors, health visitors, or even lectures through ministries e.g. 
ministry of agriculture has meetings, they visit places and have workshops to raise 
awareness of citizens. 
  14: Or if everyone who comes to the clinic takes one, everyone who goes to the 
mosque takes one, the info will be delivered. 
  14: walahi if it (FertiSTAT) is distributed right. 
 
 
 
Persistence 
(participant 
generated) 
 
RB: so, you’re saying even if they say they don’t accept it we should give it anyway?  
14: I told you, he will calculate it (risk level) in his head. He might think maybe this is 
right, he will do it himself (fill out the FS). 
Challenges and 
barriers to 
implementation  
 
‘Others’ will 
not accept 
taboo topics  
 
1: cons, there are no cons for me, the topic is normal 
RB: do you think people will respond authentically?  
1: no (…) from the beginning you will get a sense of whether this person is willing to 
accept things, or not accept. For example, this sex question, most people will say 
‘enough I don’t want to (continue)’ 
  4: people may not accept these subjects, and I won’t be able to face them regarding 
certain issues. 
 
  RB: but don’t you feel that in Sudan this might be seen from a different perspective?  
5: some people will consider it and others will not 
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14: walahi, there are people, it will depend on their level of understanding, they may 
not accept it. 
11: it’s your responsibility, but you will face difficulties, you will face unacceptance of 
the idea itself I’ve done village work (working outside the capital city), acceptance of 
things like this was problematic for people. To communicate to them about family 
planning and to prevent circumcision of females (FGM) and things like that, we faced 
problems, only God knows. Our problem is our customs our society’s level of 
awareness. 
1: depends on the people, some people consider these issues 3aib (culturally 
unacceptable), and other people see there is no gilat adab (disrespectful, rude) or that 
this person is wakiha (impolite, has no shame). 
10: like if I want to explain something to people and give them info, but I wish people 
would listen and accept.  
Openness to 
health 
education in 
general and 
fertility 
specifically 
1: before marriage I didn’t have info about sexual education (sex ed) before marriage. I 
felt like I didn’t want to educate myself. But now I don’t need a lot. 
11: it’s your responsibility, but you will face difficulties, you will face unacceptance of 
the idea itself I’ve done village work (working outside the capital city), acceptance of 
things like this was problematic for people. To communicate to them about family 
planning and to prevent circumcision of females (FGM) and things like that, we faced 
problems, only God knows. Our problem is our customs. 
14: So the man can tell her ‘everyone drinks, khawagat (westerners) drink, what 
happens?’ (meaning nothing happens to them, they don’t have fertility problems). 
11: it’s your responsibility, but you will face difficulties, you will face unacceptance of 
the idea itself. 
Implementatio
n may be 
dependent on 
level of 
understanding, 
knowledge, 
education and 
religiosity 
14: walahi, there are people, it will depend on their level of understanding, they may 
not accept it…Not everyone will accept, everyone has a different level of 
understanding. 
9: some I understood and the rest I felt I needed your explanation. 
Source not 
trusted 
1: depends on the people, some people consider these issues 3aib (culturally 
unacceptable), and other people see there is no gilat adab (disrespectful, rude) or that 
this person is wakiha (impolite, has no shame). 
13: it seems that it’s always the case that if you trust the source (person) that the info is 
coming from, that’s better. But if it comes from someone I don’t trust, I will just leave 
him and go. 
Self-disclosure RB: do you think people will respond authentically (honestly)?  
1: no. 
11: they can convey the message, on one condition, the person has to understand the 
info him/herself and be convinced of it, not that he’s bemasheek (just agreeing to it to 
my face only). 
Example of inconsistent answering: 
RB: do you have info about signs, symptoms and RFs affecting fertility? 
6: I don’t have. 
RB: were you aware that these things like CSG, alcohol, smoking etc. could affect 
fertility? That if a spouse has an STI they can spread it to each other?  
6: yes I know. 
RB: was the info beneficial? And was there any info you were not aware of before?  
6: yes, useful, I’ve seen it before. 
Example of agreeing with interviewer: 
RB: so these questions didn’t bother you?  
9: no. 
RB: no problem at all?  
9: no, no. 
RB: OK, do you think there is something we can do to improve this work?  
9: no, no. 
RB: so you feel this is a good or bad thing, I mean its beneficial, or its just useless? 
What do you think?  
9: no, no its good. 
RB: do you think you know about the signs and symptoms of delayed fertility?  
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1: no, not a lot 
RB: do you have any info about the preventable risk factors for delayed fertility? 
1: very little 
Post intervention 
RB: were you aware that these things can impact on fertility?  
1: yes I’m sure (that they have an impact) 
RB: where you aware of this info in the past?  
1: yes, especially drugs, coffee, fizzy drinks (caffeinated beverages), I know that, I 
have even reduced it (her consumption).  
Participant 
generated vs 
endorsed 
Example of generated statement: 
RB: what are the pros and cons of using such a questionnaire?  
1: cons, there are no cons for me, the topic is normal, the pros is that it increases 
education (not scholastic in nature). 
Example of endorsed statement:  
RB: is it aadee (OK) to use this questionnaire about the educational material?  
1: yes. 
Influencing 
factors 
Social norms Example of social norm of agreeability: 
RB: so this is beneficial?  
4: yes, I have benefited a lot. 
RB: do you think this info is important, useful? 
10: Yes, useful 
RB: but once you were able to understand the question you had no problem answering 
us right?  
9: yes 
RB: we ask 3adee (normally) there’s nothing (meaning there’s no problem)  
2: nodding 
RB: so is it OK to talk about these things?  
6: yes, sure 
RB: in society, is society able to accept something like this?  
6: yes they will accept it 
Example of social norm of communication (I share, you share) 
RB: yes, you would read it, so do you feel you have benefited from this info? 
10: yes, I have benefited, but I didn’t get to know you? 
Social 
desirability 
Examples of wanting to appear agreeable and polite: 
RB: is there anything else you could add that you think would help us, or something to 
add about the info, or a specific way to talk about this topic?  
1: no, your way is nice/sweet. 
RB: Ok would you like to know more info?  
10: yes, if you will explain it to me. 
Gender Example of male participant disagreeing with female interviewer: 
RB: this info, did it make you think about your situation, like because of this or that, 
this happened to me? Did you think about your situation?  
2: no I didn’t think about that. 
Example of female participant (secondary school, housewife) agreeing with female 
interviewer: 
RB: do you feel like you have benefited from this?  
9: yes, I have. 
RB: do you think others would benefit too?  
9: yes, yes. 
Education Example of confident statement by educated woman: 
19: OK you really have to write this in the recommendations!! 
RB: does it make a difference if it’s a women or a man?  
19: doesn’t make that much difference  
RB: so if a man got up and gave this info to a group of girls, does that make a 
difference?  
19: no, makes no difference  
RB: and if a woman got up and gave it to a group of boys?  
19: yes it makes no difference because in the end she has the info. The real difference 
lies in whether the info is given by a specialist, not man or woman, for me personally 
makes no difference. 
19: just like right now, if you notice, you are giving info to a man and it makes no 
difference, with regards to transferring the info. 
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RB: but he is not a teenage boy, I’m talking about the acceptability of women giving 
this info to a group of teenage boys, I mean if Amel (the co-facilitator, woman about 
25 years old) or I went to a boys school, teenage boys and we started to talk about sex 
and sexual relationships and drugs, how acceptable would this be?  
19: walahi, if you introduce yourself properly in the beginning and they see you are a 
doctor, a professional, a person would have their presences (the word she used 
‘haibtoo’ suggests a dominant presence) 
  When I got to the part about how important info from patients is, the wife interrupted 
me saying:  
19: well for example, there could be info about tight clothing, sitting for too long for 
boys, violent sport, nutrition has an impact  
RB: do you mean in the lifestyle? 
19: yes, there are somethings missing in the lifestyle. 
  RB: so isn’t it our responsibility to educate? To simplify the information? 
11: it’s your responsibility, but you will face difficulties, you will face unacceptance of 
the idea itself. 
  RB: OK, what if they found out that this issue (FGM) could affect her ability to have 
children? 
11: they will tell you all their mothers had children, so why will she have a problem? 
  RB: what about approaching village leaders, whether they be men or women, and then 
they can convey the info? 
11: they can convey the message, on one condition, the person has to understand the 
info him/herself and be convinced of it, not that he’s bemasheek (just agreeing to it to 
my face only). 
  Example of uncertain response from secondary school educated housewife: 
RB: do you know about the signs, symptoms and risk factors for infertility? Do you 
have some info?  
20: no answer - looked confused. 
RB: like when to seek help? What could be a sign that there is a problem  
20: no answer - still looked confused. 
RB: would you like to know this type of info?  
20: walahi I don’t know… 
 Age 14: maybe because at that age (referring to the young women she saw), they feel 
embarrassed/shy to go to the doctor (for a vaginal infection). 
  Example of older male providing rationale for his belief:  
RB: at what time should boys know this type of info, at what age?  
8: at puberty.  
RB: do you think a teenage boy would care/think about such things ‘I will have kids in 
the future’, or he won’t be interested/care?  
8: during puberty, you are creating a human (meaning the person’s personality is being 
formed), lots of factors, and so its possible (to give the info) after puberty (meaning 
after he has reached the age or puberty) …. he may be able to comprehend it. 
  RB: so it’s not a problem, for example we say ‘this area, people should not talk about’?  
8: it’s WRONG not to talk about it!! 
RB: so we should talk about all of this?  
8: YES, YES!! 
 Presence of 
other person 
Example: (husband and wife): 
19: yes it makes no difference because in the end she has the info. The real difference 
lies in whether the info is given by a specialist, not man or woman, for me personally 
makes no difference. 
18: yes, I agree, the most important thing is that they have to be a specialist. 
Understanding 
of being at risk 
 7: Everyone knows what can harm them and can help them (meaning people can 
differentiate between what can harm and help them).  
And they are still doing the wrong, how, like, for example, sex, they know it can 
transmit diseases but they still do it. They use protection and say ‘I won’t get a 
disease’.  
They know everything but they try in different ways to do things, but this thing 
(premarital sex) is haram (forbidden by Islam) and wrong.  
They do it in ways and give it names. All these young people, they are aware and they 
know. 
 Universal RB: were you aware that the things we talked about could impact fertility negatively?  
3: no, [but she was pointing at the lifestyle items in the FS in my hand and nodding] 
RB: what about things like coffee and weight?  
3: yes 
 Age 8: yes, currently (in this day and age), nowadays people are more aware, they read, the 
media is open (meaning western media is available), aadee (it’s OK) no problem. 
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RB: OK, so when should it be ‘considered’, this info, when is the best time it can be 
presented to the community? 
13: I imagine in high school…because this is the time of being a teenager and one has 
to be aware, to know. 
1: before marriage I didn’t have info about sexual education (sex ed) before marriage. I 
felt like I didn’t want to educate myself. But now I don’t need a lot. 
11: the grandmothers tell us nehna min gumna (since they came to be or grew up or as 
far as they can remember), they have been doing this (FGM), balash kalam fareegh 
(stop saying nonsense). 
RB: for example, if you’re 15 years old, and we told you ‘if you have sex and don’t use 
protection, later in life this could affect your ability to have a child’, would you still do 
that, or would you change your mind? (meaning would you still have unprotected sex). 
2: yes this info is useful. 
7: The type of info I find that my nieces know, even I, I’m older, I don’t know it. They 
are in university.  
8: during puberty, you are creating a human (meaning the person’s personality is being 
formed), lots of factors, and so its possible (to give the info) after puberty (meaning 
after he has reached the age or puberty) …. he may be able to comprehend it. 
14: walahi, this newspaper, I see, I think people here get the news from the internet, the 
newspaper, just the old people, because they are used to this ‘cross your legs and put 
on your glasses’. But in general, for people, the news info comes to them, newspapers, 
are not that much. 
14: maybe because at that age (referring to the young women she saw), they feel 
embarrassed/shy to go to the doctor (for a vaginal infection). She may take care of it 
herself.  
Gender 14: They should show this to the men too, so they don’t say it’s just from the woman 
(the fertility problem). 
17: I’m not sure why but they don’t understand or don’t like when a man talks (is the 
provider of the message), they prefer if it’s a woman, not sure why, but when it’s a 
woman they feel relaxed and can understand.   
17: yes, my sister gets up and talks, but when her male colleagues get up to talk the 
others tell them ‘no let this girl talk, because we understand what she says better’. 
14: So the man can tell her ‘everyone drinks, khawagat (westerners) drink, what 
happens?’ (meaning nothing happens to them, they don’t have fertility problems). 
Previous 
knowledge 
13: but when I get a desire to know more I pick up a reference (book) or I go on the 
internet, certain cites, I look it up. 
1: yes, especially drugs, coffee, fizzy drinks (caffeinated beverages), I know that, I 
have even reduced it (her consumption). 
RB: was the info beneficial? And was there any info you were not aware of before? 
6: yes, useful, I’ve seen it before. 
Personal 
experience 
14: For me, I mean honestly, when I went for my laparoscopy, when I came to the 
clinic here, I know the problem they tell you about aging, getting older, delayed 
marriage. 
15: walahi, every girl MUST go and get checked out before she gets married, to get 
herself checked, I had problems with my period, and I was not bothered with it.[ I 
could have got treatment before, treatment time (duration of treatment) would not have 
been as long. 
Culture (social 
norms, 
religion) 
11: In their understanding this (FGM) is chastity, they want their daughters this way, 
it’s none of our (the provider whoever they are) business. We do this to our daughters. 
11: they will tell you all their mothers had children, so why will she have a problem? 
You brought this new thing, it wasn’t there in the past. 
RB: in society, is society able to accept something like this?  
6: yes they will accept it. 
1: depends on the people, some people consider these issues 3aib (culturally 
unacceptable), and other people see there is no gilat adab (disrespectful, rude) or that 
this person is wakiha (impolite, has no shame). 
13: So, knowing about this, awareness about such things especially here in Sudan, here 
the girl won’t go to the doctor no matter what. For example, if her period is late she 
should find out, if her period she could have a problem, go to the doctor. 
13: Sometimes there are people that God gives (a baby) them with someone else, it was 
not meant to be here (in the first marriage). 
RB: yes, exactly, this can cause STIs, which can lead to blockages internally, if 
untreated. These relationships (multiple unprotected) before or after marriage can 
cause this, these STIs can be a problem for both man and woman. 
12: anyway this is not moral. 
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1: sex outside marriage is haram (forbidden by Islam), God has forbidden certain 
things because they can harm us... 
7: this thing (premarital sex) is haram (forbidden by Islam) and wrong.  
13: knowing about this, awareness about such things especially here in Sudan, here the 
girl won’t go to the doctor no matter what. For example, if her period is late she should 
find out, if her period she could have a problem, go to the doctor. Here we don’t have 
such awareness, and for us it’s 3aeeb (culturally unacceptable) for an unmarried girl to 
go to a gynaecologist. 
13: This thing especially, boys will be boys, so you know boys can have relations (sex) 
as much as he wants before marriage and stuff, and then he comes and then, I mean 
after marriage he will have repented to God (no longer engages in sex with anyone 
other than his wife) and they have no problem (no extramarital affairs).  The family 
was not paying attention to the importance of this thing, the boy can get infected with a 
disease, he can infect his wife in the future and that will be a bigger problem. So, 
seriously this thing, it has to be considered (given importance). 
Compatibility 
with worldview 
About 
acceptability 
1: during puberty for sure, after entering university, after starting to mix (between the 
sexes), somethings should happen and somethings should not happen (behaviours).  
8: it’s wrong not to talk about it. 
RB: do you think it would be beneficial to others, men, women?  
3: yes inshallah (God willing). 
13: very beneficial, they have to, they have to know it. This thing especially, boys will 
be boys, so you know boys can have relations (sex) as much as he wants before 
marriage and stuff, and then he comes and then, I mean after marriage he will have 
repented to God (no longer engages in sex with anyone other than his wife) and they 
have no problem (no extramarital affairs). 
[RB: well, we have been told that there are people in our society that will not accept 
this, that there are things we shouldn’t say because they are unacceptable in our 
society. So, is it better to say or not to say? 
14: walahi, you should say it because someone will accept it and benefit, they will tell 
you this is right. 
RB: what is the best way to talk about this, so that it is acceptable to people? Can you 
describe it?  
5: a person just enters (meaning literally to enter but also figuratively to delve into a 
topic), this is a type of education and this is not wrong. 
About self-
disclosure 
Example of providing honest opinion which is consistent with her beliefs: 
7: And I tell you something, in this day and age, they all know, they know wrong from 
right. And they are doing the wrong (regardless).  
Everyone knows what can harm them and can help them (meaning people can 
differentiate between what can harm and help them).  
And they are still doing the wrong, how, like, for example, sex, they know it can 
transmit diseases but they still do it. They use protection and say ‘I won’t get a 
disease’.  
They know everything but they try in different ways to do things, but this thing 
(premarital sex) is haram (forbidden by Islam) and wrong.  
About 
understanding 
risk 
13: yes, early is one year, some people wait 4 or 5 years to get tested, no I mean you 
have just wasted time like this. It’s better that they find out, so that even if God did not 
will it (meaning you can’t have babies), you can separate. 
13: Sometimes there are people that God gives (a baby) them with someone else, it was 
not meant to be here (in the first marriage). 
Cultural 
tailoring 
Level of 
understanding 
or education 
RB: OK, so do you think this info should be known before or after marriage?  
11: that would depend on the educational level of the society. The problem with our 
society is that there are too few people who are educated and aware 
RB: What about the questions we asked you, were they all easy to understand or did 
you feel like you needed extra explaining?  
9: some I understood and the rest I felt I needed your explanation. 
RB: Ok so if we want to use this, to ask a lot of women, can we ask as is or do you 
think we should have the extra explanations?  
9: yes, explain 
RB: so not a lot, ok would you like to know more info?  
10: yes, if you will explain it to me 
11: By the way for older people who don’t know (fertility education/awareness), the 
simple (meaning uneducated) people, for example there are people who go to ‘khalawi’ 
(place where people are taught the Quran), or to the ‘shaikhat’ (a woman religious 
scholar) who teach Quran.] 
Gender RB: Ok, so is it better from a woman or a man? 
10: it’s better from a woman of course. 
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RB: so it’s better if a woman comes and talks to the girls and she can tell them and 
show them? 
10: why not…a man, for example, I can’t ask him questions, but you are a woman like 
me so I can ask you questions. 
RB: would printed materials be better or in the form of a lecture/seminar?  
17: They like it as a seminar, with men and women together, the girls always like to 
talk. I’m not sure why but they don’t understand or don’t like when a man talks (is the 
provider of the message), they prefer if it’s a woman, not sure why, but when it’s a 
woman they feel relaxed and can understand. 
RB: so they can ask questions  
12: yes, a specific place where they can ask, women’s questions, what’s happening to 
you. And they can give her the info she is lacking. 
RB: would printed materials be better or in the form of a lecture/seminar?  
17: They like it as a seminar, with men and women together, the girls always like to 
talk. I’m not sure why but they don’t understand or don’t like when a man talks (is the 
provider of the message), they prefer if it’s a woman, not sure why, but when it’s a 
woman they feel relaxed and can understand. 
Gender and 
age 
RB: how do you think this type of info should be given? Would it be better as printed 
materials or seminars, or?  
19: walahi something printed the boys will not read it, I’m talking about my brothers at 
home, from my experience, but if its lectures or seminars, or they went to the schools 
and universities, this way they will accept it, this way they will listen, because a boy by 
nature wants to hear not to read 
18: but there is something! This WhatsApp (a social media app that is very popular in 
Sudan and the Middle East), lately, people have really been concentrating on it, that is, 
if this info was on WhatsApp and Facebook they will read it but not a hardcopy.  
RB: so no hardcopy, but social media?  
18: yes that’s possible 
Trustworthy 
source 
RB: ok so should this info come from a doctor, a social worker, a man a woman? 
13: it seems that it’s always the case that if you trust the source (person) that the info is 
coming from them, that’s better. But if it comes from someone I don’t trust, I will just 
leave him and go. 
RB: So, it only matters if you trust them or not? 
13: yes 
Religiosity RB: so what is the best way for us to get them to answer and give us this info in a 
suitable way, how?  
1: via questions, from the beginning you will get a sense of whether this person is 
willing to accept things, or not accept. For example, this sex question, most people will 
say ‘enough I don’t want to (continue)’.  
RB: so how could we ask this question about sex?  
1: these are your questions, you will be able to decide, from the beginning of the 
interview, you will be able to decide, they will accept or they will not accept. 
RB: but if she is unwilling to accept, this info is important for them to know, they 
should know that unprotected sex with multiple partners can affect their ability to have 
kids in the future, it can lead to diseases that can infect the spouse, so how can I 
convey this info, what if I get a really shy or religious patient?  
1: the religious one, in a religious way, that sex outside marriage is haram (forbidden 
by Islam), God has forbidden certain things because they can harm us, you reach her at 
her level of understanding. Each person at their level of understanding. 
Religiosity and 
Education 
RB: OK, for this info, who is the best person to convey this, the doctor, social worker, 
for example we tell someone at a mosque and have them tell people? Who is the best 
person to deliver this info? 
14: as I told you, printed materials, posters, pamphlets that can reach the mum or the 
aunt at home, they read it. People who can’t read (illiterate) can get it at the mosque, 
you give the info to the imam (priest) and tell him to convey at least part of the 
message he will not refuse. This way the people at the mosque will know something 
and the mums will get the printed material. 
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